data_1tsk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1tsk _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.7 p . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.454 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 14.6 pt -125.59 159.66 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 122.818 1.294 . . . . 1.0 113.348 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.74 43.71 3.27 Favored Glycine 0 C--O 1.204 -1.731 0 CA-C-N 112.029 -2.35 . . . . 1.0 113.389 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -105.83 88.23 2.77 Favored 'General case' 0 C--N 1.308 -1.208 1 N-CA-C 98.638 -4.578 . . . . 1.0 98.638 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -38.94 147.19 0.06 Allowed 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 113.275 -1.784 . . . . 1.0 113.401 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 0.5 OUTLIER -112.49 160.64 17.58 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 116.919 2.192 . . . . 1.0 116.919 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.533 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.7 t80 -123.11 -58.68 1.63 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 103.301 -2.851 . . . . 1.0 103.301 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.413 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 42.6 mtt85 -116.36 165.2 13.48 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 112.689 -2.05 . . . . 1.0 110.018 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.412 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 67.3 m -34.73 -59.2 0.62 Allowed Pre-proline 0 N--CA 1.503 2.216 0 O-C-N 124.731 1.269 . . . . 1.0 113.54 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.412 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 88.2 Cg_endo -62.18 -86.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.056 0 C-N-CA 121.976 1.784 . . . . 1.0 112.253 176.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t70 34.16 36.89 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 CA-C-O 124.305 2.002 . . . . 1.0 109.129 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.402 ' N ' ' C ' ' A' ' 11' ' ' PRO . 15.9 t -170.05 -27.18 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 110.21 -3.177 . . . . 1.0 111.502 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -38.2 -55.45 1.3 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 123.712 0.632 . . . . 1.0 112.18 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 61.8 m -50.49 -51.78 44.3 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 124.386 1.054 . . . . 1.0 110.074 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.18 -47.54 83.09 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 122.825 1.297 . . . . 1.0 111.515 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 25' ' ' THR . 35.5 m -58.68 -39.55 81.02 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 113.735 -1.575 . . . . 1.0 108.688 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -64.7 -52.16 58.65 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.282 -1.377 . . . . 1.0 107.282 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -10.72 60.21 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 117.677 -1.609 . . . . 1.0 113.129 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.7 mt -92.61 -50.35 5.64 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 119.409 -0.329 . . . . 1.0 111.549 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.7 p -114.07 -32.38 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 123.481 0.488 . . . . 1.0 110.69 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.99 -19.75 3.67 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 116.031 1.172 . . . . 1.0 116.031 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -128.42 151.28 49.56 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 114.54 1.311 . . . . 1.0 114.54 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.2 70.76 0.84 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 113.784 -1.553 . . . . 1.0 110.403 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.512 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 5.1 t -122.9 176.39 6.03 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.9 0.857 . . . . 1.0 112.298 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.69 160.37 27.81 Favored Glycine 0 N--CA 1.493 2.467 0 CA-C-N 112.671 -2.058 . . . . 1.0 110.197 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.4 -178.33 4.72 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.359 1.076 . . . . 1.0 112.824 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 38.7 t -90.12 109.39 20.45 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 111.895 -2.411 . . . . 1.0 107.809 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.0 m -126.34 119.53 27.58 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 111.679 -2.509 . . . . 1.0 110.992 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 50.33 43.43 26.63 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.453 -1.703 . . . . 1.0 109.013 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.94 20.55 53.65 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-N 113.623 -1.626 . . . . 1.0 113.026 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.0 mtt85 -132.86 160.87 35.7 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.095 -1.446 . . . . 1.0 107.095 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.454 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 42.9 t -73.22 142.07 47.31 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 118.381 -1.328 . . . . 1.0 114.005 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 18.9 t70 -128.01 85.94 2.41 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 102.822 -3.029 . . . . 1.0 102.822 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.501 2.106 0 CA-C-O 116.75 -1.595 . . . . 1.0 111.47 -179.487 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 48.9 t . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 107.115 -1.439 . . . . 1.0 107.115 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.46 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 30.1 pt -129.58 163.37 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 114.301 1.223 . . . . 1.0 114.301 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.97 43.76 3.29 Favored Glycine 0 C--O 1.213 -1.196 0 CA-C-N 112.188 -2.278 . . . . 1.0 112.436 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -106.3 100.3 9.84 Favored 'General case' 0 N--CA 1.486 1.348 1 N-CA-C 99.919 -4.104 . . . . 1.0 99.919 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.486 ' HE ' HH22 ' A' ' 32' ' ' ARG . 64.6 mtt85 -38.94 144.5 0.12 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 125.253 1.596 . . . . 1.0 114.58 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.7 t -110.7 156.06 21.56 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.255 -1.793 . . . . 1.0 111.505 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -120.81 -61.9 1.51 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 103.88 -2.637 . . . . 1.0 103.88 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -118.71 167.58 11.53 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 112.861 -1.972 . . . . 1.0 107.558 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.7 m -26.57 -49.64 0.18 Allowed Pre-proline 0 N--CA 1.507 2.376 0 N-CA-C 115.015 1.487 . . . . 1.0 115.015 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.424 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . 0.9 OUTLIER -88.86 -83.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.319 -0.977 0 C-N-CA 121.864 1.709 . . . . 1.0 108.639 -176.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.9 t70 37.1 32.43 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 123.149 1.452 . . . . 1.0 110.104 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.551 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 41.8 t -164.6 -26.17 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 111.3 -2.682 . . . . 1.0 112.95 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.424 ' CD1' ' HB3' ' A' ' 11' ' ' PRO . 3.3 m-85 -38.19 -55.18 1.33 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 123.988 0.915 . . . . 1.0 113.072 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 55.5 m -47.7 -53.63 14.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 124.861 1.35 . . . . 1.0 108.648 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.09 -51.05 70.83 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.04 -0.982 . . . . 1.0 111.035 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.551 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 94.6 m -54.57 -33.48 60.33 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.247 -1.342 . . . . 1.0 109.695 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -70.67 -48.92 52.33 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.057 -1.831 . . . . 1.0 106.057 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -70.45 -14.13 62.41 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-N 114.551 -1.204 . . . . 1.0 113.538 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.7 mt -107.14 -44.08 4.46 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 113.578 0.955 . . . . 1.0 113.578 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 37.1 t -99.67 -36.56 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-N 114.647 -1.16 . . . . 1.0 109.782 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.76 -30.23 3.43 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 120.615 -0.802 . . . . 1.0 113.974 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -128.01 151.06 49.61 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 114.077 1.14 . . . . 1.0 114.077 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.39 77.06 0.76 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 114.118 -1.401 . . . . 1.0 109.327 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.1 t -128.71 -172.87 2.82 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.766 -0.652 . . . . 1.0 109.324 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.645 ' HA3' ' SG ' ' A' ' 35' ' ' CYS . . . 118.89 -179.37 16.8 Favored Glycine 0 N--CA 1.493 2.458 0 CA-C-N 113.217 -1.81 . . . . 1.0 115.902 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -142.74 168.38 19.86 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 112.296 -1.952 . . . . 1.0 107.012 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.3 t -105.63 115.03 29.55 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 105.031 -2.211 . . . . 1.0 105.031 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.419 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 92.2 m -128.23 123.76 34.99 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 112.923 -1.944 . . . . 1.0 112.48 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 45.98 42.14 8.99 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 112.92 -1.945 . . . . 1.0 110.076 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.18 27.46 67.47 Favored Glycine 0 N--CA 1.489 2.171 0 CA-C-N 113.769 -1.56 . . . . 1.0 112.752 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.486 HH22 ' HE ' ' A' ' 6' ' ' ARG . 36.0 mmt180 -135.78 161.87 34.37 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 106.308 -1.738 . . . . 1.0 106.308 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.46 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 13.8 t -73.4 142.43 46.97 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 114.807 1.41 . . . . 1.0 114.807 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 11.3 t70 -130.45 79.78 1.92 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 125.791 1.932 . . . . 1.0 108.227 178.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.645 ' SG ' ' HA3' ' A' ' 26' ' ' GLY . 1.3 m . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 118.136 -0.935 . . . . 1.0 111.067 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 52.7 t . . . . . 0 N--CA 1.496 1.86 0 N-CA-C 107.413 -1.329 . . . . 1.0 107.413 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.44 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 33.5 pt -134.03 163.63 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 115.563 1.69 . . . . 1.0 115.563 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.12 -44.63 88.55 Favored Glycine 0 N--CA 1.478 1.46 0 CA-C-N 111.499 -2.591 . . . . 1.0 110.791 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -28.37 90.5 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.455 0 O-C-N 126.096 1.704 . . . . 1.0 110.755 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -39.94 146.88 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.832 1.419 . . . . 1.0 114.832 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.8 p -125.67 159.25 32.72 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.376 -1.284 . . . . 1.0 110.057 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -119.41 -55.21 2.14 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 106.177 -1.786 . . . . 1.0 106.177 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.14 162.08 15.29 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 113.048 -1.887 . . . . 1.0 106.719 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.4 m -30.85 -55.8 0.38 Allowed Pre-proline 0 N--CA 1.503 2.199 0 O-C-N 125.091 1.494 . . . . 1.0 113.533 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.481 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 53.9 Cg_endo -70.19 -95.05 0.01 OUTLIER 'Trans proline' 0 C--O 1.205 -1.141 0 C-N-CA 121.248 1.299 . . . . 1.0 113.946 170.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 t70 39.99 32.82 0.12 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 124.862 1.351 . . . . 1.0 109.593 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.2 t -167.59 -25.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 111.809 -2.45 . . . . 1.0 112.392 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.481 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.5 m-30 -38.5 -59.15 0.94 Allowed 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 123.698 0.799 . . . . 1.0 112.173 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.9 p -45.92 -46.22 15.92 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 125.162 1.539 . . . . 1.0 111.37 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.8 -41.76 87.05 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.428 -1.26 . . . . 1.0 111.231 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.8 t -69.34 -27.46 65.38 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.267 -0.879 . . . . 1.0 109.025 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -70.17 -53.63 16.35 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.955 -1.498 . . . . 1.0 106.955 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -71.14 -21.22 62.21 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 114.161 1.171 . . . . 1.0 114.161 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.8 mp -98.26 -33.57 11.04 Favored 'General case' 0 N--CA 1.509 2.511 0 N-CA-C 112.847 0.684 . . . . 1.0 112.847 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.82 -37.78 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 123.677 0.611 . . . . 1.0 109.856 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.19 -31.75 2.65 Favored Glycine 0 N--CA 1.489 2.196 0 CA-C-O 118.785 -1.008 . . . . 1.0 114.917 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -128.13 145.67 50.94 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 115.22 1.563 . . . . 1.0 115.22 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.82 72.58 0.81 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 113.491 -1.686 . . . . 1.0 110.409 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.426 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 7.8 t -133.04 -173.43 3.19 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.278 0.561 . . . . 1.0 109.769 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.28 -170.82 13.61 Favored Glycine 0 N--CA 1.495 2.569 0 CA-C-N 113.579 -1.646 . . . . 1.0 114.219 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -147.38 167.8 23.44 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 113.683 -1.259 . . . . 1.0 108.817 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.2 t -104.82 117.59 34.43 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.322 -1.733 . . . . 1.0 106.322 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.458 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 87.7 m -125.66 122.91 37.74 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 113.319 -1.764 . . . . 1.0 111.203 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 45.74 41.54 7.57 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 112.798 -2.001 . . . . 1.0 111.279 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.67 21.95 71.36 Favored Glycine 0 N--CA 1.482 1.719 0 CA-C-N 113.385 -1.734 . . . . 1.0 113.592 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.1 mmt-85 -131.7 158.87 39.99 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.667 -1.605 . . . . 1.0 106.667 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.44 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 9.1 t -72.62 142.18 48.35 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.58 -1.248 . . . . 1.0 113.708 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.458 ' CB ' ' HG1' ' A' ' 29' ' ' THR . 10.4 t70 -135.07 78.37 1.73 Allowed 'General case' 0 C--N 1.295 -1.764 0 O-C-N 125.969 2.043 . . . . 1.0 106.862 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.426 ' SG ' ' O ' ' A' ' 25' ' ' THR . 37.1 t . . . . . 0 N--CA 1.498 1.947 0 C-N-CA 119.717 -0.793 . . . . 1.0 111.281 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.4 p . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.406 HG12 ' HB3' ' A' ' 33' ' ' CYS . 22.9 pt -135.02 169.31 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 115.1 1.518 . . . . 1.0 115.1 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.01 -47.26 81.38 Favored Glycine 0 N--CA 1.478 1.489 0 CA-C-N 111.577 -2.556 . . . . 1.0 111.869 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -20.96 90.61 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.516 0 O-C-N 125.85 1.559 . . . . 1.0 112.884 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -39.79 142.3 0.34 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 124.851 1.344 . . . . 1.0 112.361 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.1 p -124.64 162.45 24.1 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 124.58 1.175 . . . . 1.0 111.042 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -118.24 -61.87 1.62 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 102.782 -3.044 . . . . 1.0 102.782 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -117.79 168.25 10.64 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.407 -2.072 . . . . 1.0 105.407 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.7 m -29.85 -54.59 0.33 Allowed Pre-proline 0 N--CA 1.503 2.198 0 O-C-N 124.692 1.245 . . . . 1.0 113.823 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.41 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 54.3 Cg_endo -67.78 -104.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 121.568 1.512 . . . . 1.0 113.841 172.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.8 t70 39.34 30.54 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 123.2 1.476 . . . . 1.0 110.031 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.7 t -168.15 -15.29 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 111.255 -2.702 . . . . 1.0 113.598 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.41 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 6.0 m-30 -38.74 -58.8 1.02 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 113.675 0.991 . . . . 1.0 113.675 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.0 t -45.27 -48.18 12.92 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 124.849 1.343 . . . . 1.0 110.734 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.74 -53.4 54.89 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.623 -1.172 . . . . 1.0 108.734 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.2 t -49.55 -39.66 35.55 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.811 -1.086 . . . . 1.0 110.12 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -65.95 -47.79 73.5 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.503 -1.295 . . . . 1.0 107.503 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -70.09 -11.82 61.16 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 112.862 -1.972 . . . . 1.0 111.885 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.6 mt -104.47 -52.72 2.84 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.105 1.15 . . . . 1.0 114.105 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.3 m -108.61 -16.68 8.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 118.687 -0.673 . . . . 1.0 112.525 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.99 -38.23 1.97 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 118.354 2.101 . . . . 1.0 118.354 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -126.57 153.75 44.83 Favored 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 115.243 1.572 . . . . 1.0 115.243 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.54 68.88 0.59 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 113.316 -1.766 . . . . 1.0 112.204 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.8 t -130.25 -168.65 2.0 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.549 ' CA ' ' SG ' ' A' ' 35' ' ' CYS . . . 124.78 174.42 14.0 Favored Glycine 0 N--CA 1.497 2.707 0 CA-C-N 113.517 -1.674 . . . . 1.0 115.136 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -131.4 164.46 25.64 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 112.13 -2.035 . . . . 1.0 108.483 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.5 t -107.46 112.07 24.68 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 104.654 -2.35 . . . . 1.0 104.654 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.474 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 84.8 m -128.18 123.69 34.93 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 112.371 -2.195 . . . . 1.0 112.131 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 51.49 39.78 25.38 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 113.2 -1.818 . . . . 1.0 108.905 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.49 21.05 62.02 Favored Glycine 0 N--CA 1.486 2.017 0 CA-C-N 113.286 -1.779 . . . . 1.0 112.386 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.6 mtp85 -129.87 164.03 25.03 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.677 -1.231 . . . . 1.0 107.677 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.406 ' HB3' HG12 ' A' ' 3' ' ' ILE . 4.3 t -72.56 145.28 47.51 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.926 -1.109 . . . . 1.0 112.975 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.474 ' CB ' ' HG1' ' A' ' 29' ' ' THR . 10.7 t70 -133.57 83.57 2.06 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 112.693 -2.049 . . . . 1.0 107.992 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.549 ' SG ' ' CA ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.017 0 CA-C-O 118.439 -0.791 . . . . 1.0 111.106 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 55.6 t . . . . . 0 N--CA 1.497 1.879 0 N-CA-C 105.659 -1.978 . . . . 1.0 105.659 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.419 HG12 ' HB3' ' A' ' 33' ' ' CYS . 36.1 pt -135.04 168.49 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 115.875 1.806 . . . . 1.0 115.875 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.54 -45.67 83.66 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 111.814 -2.448 . . . . 1.0 111.041 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.5 tp60 -22.64 90.08 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.45 0 O-C-N 125.943 1.614 . . . . 1.0 113.112 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -39.82 143.16 0.27 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 113.916 -1.493 . . . . 1.0 113.15 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.4 p -124.36 163.93 20.7 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.916 -1.038 . . . . 1.0 109.826 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -117.15 -61.08 1.76 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 104.298 -2.482 . . . . 1.0 104.298 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -116.82 169.41 9.4 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 112.418 -2.174 . . . . 1.0 106.97 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.473 ' HG ' ' NZ ' ' A' ' 27' ' ' LYS . 73.1 m -28.55 -54.98 0.26 Allowed Pre-proline 0 N--CA 1.503 2.179 0 O-C-N 124.942 1.401 . . . . 1.0 113.944 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.518 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 28.8 Cg_endo -73.74 -100.6 0.01 OUTLIER 'Trans proline' 0 C--O 1.208 -0.984 0 C-N-CA 121.776 1.651 . . . . 1.0 114.917 170.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.5 t70 41.86 28.63 0.09 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 124.79 1.306 . . . . 1.0 110.163 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.0 t -164.58 -21.91 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 112.109 -2.314 . . . . 1.0 113.138 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.518 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 6.3 m-30 -38.78 -61.37 0.73 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 112.913 0.708 . . . . 1.0 112.913 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.3 p -43.84 -42.72 5.83 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 125.174 1.546 . . . . 1.0 112.165 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.99 -49.84 47.54 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 114.188 -1.369 . . . . 1.0 108.771 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.7 t -55.45 -34.97 64.97 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.292 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -66.49 -51.09 60.42 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 106.464 -1.68 . . . . 1.0 106.464 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -59.77 -24.74 64.33 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.039 -1.891 . . . . 1.0 112.197 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.0 mp -101.27 -33.74 9.93 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 116.101 1.889 . . . . 1.0 116.101 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.13 -37.79 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 123.453 0.471 . . . . 1.0 110.771 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.41 -30.77 2.58 Favored Glycine 0 N--CA 1.488 2.145 0 CA-C-O 118.435 -1.203 . . . . 1.0 115.041 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.48 141.46 51.98 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 115.146 1.535 . . . . 1.0 115.146 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.74 71.79 0.76 Allowed 'General case' 0 N--CA 1.503 2.209 0 CA-C-N 113.609 -1.632 . . . . 1.0 112.697 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.414 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 14.7 t -133.08 -168.16 2.04 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.431 0.634 . . . . 1.0 109.453 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.09 -174.69 16.2 Favored Glycine 0 N--CA 1.493 2.458 0 CA-C-N 113.577 -1.647 . . . . 1.0 115.359 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.473 ' NZ ' ' HG ' ' A' ' 10' ' ' SER . 0.9 OUTLIER -138.1 162.63 33.69 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 112.833 -1.683 . . . . 1.0 108.518 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.0 t -106.08 114.81 29.17 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 103.757 -2.683 . . . . 1.0 103.757 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.457 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 78.1 m -128.61 124.44 35.85 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 112.923 -1.944 . . . . 1.0 112.354 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 50.8 39.91 23.34 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 113.152 -1.84 . . . . 1.0 109.041 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.16 22.02 62.42 Favored Glycine 0 N--CA 1.484 1.854 0 CA-C-N 113.283 -1.78 . . . . 1.0 112.816 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.1 mtp-105 -130.89 163.29 27.77 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.14 -1.43 . . . . 1.0 107.14 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.419 ' HB3' HG12 ' A' ' 3' ' ' ILE . 2.5 t -72.69 142.61 48.23 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.213 1.19 . . . . 1.0 114.213 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.471 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.5 t70 -135.54 74.91 1.53 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 112.262 -2.245 . . . . 1.0 106.338 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 25' ' ' THR . 41.9 t . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 118.278 -0.868 . . . . 1.0 111.83 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.3 p . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 108.774 -0.824 . . . . 1.0 108.774 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.448 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 33.0 pt -135.37 165.42 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 115.531 1.678 . . . . 1.0 115.531 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.84 44.2 3.33 Favored Glycine 0 C--O 1.21 -1.361 0 CA-C-N 111.314 -2.675 . . . . 1.0 111.826 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -109.8 96.6 6.36 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 100.64 -3.837 . . . . 1.0 100.64 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -39.11 147.74 0.06 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 125.381 1.676 . . . . 1.0 113.732 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.1 t -116.56 154.16 30.93 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 113.523 -1.672 . . . . 1.0 111.602 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -120.23 -55.95 2.02 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 104.323 -2.473 . . . . 1.0 104.323 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.2 154.02 34.01 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 113.498 -1.683 . . . . 1.0 106.792 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.9 m -22.0 -56.01 0.09 OUTLIER Pre-proline 0 N--CA 1.506 2.364 0 N-CA-C 115.773 1.768 . . . . 1.0 115.773 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.501 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 63.6 Cg_endo -69.19 -94.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.733 1.622 . . . . 1.0 113.531 169.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.7 t70 42.52 28.19 0.11 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 124.537 1.148 . . . . 1.0 110.246 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.6 t -164.47 -26.99 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 112.49 -2.141 . . . . 1.0 112.572 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.501 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 5.9 m-30 -38.73 -61.51 0.71 Allowed 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 112.582 0.586 . . . . 1.0 112.582 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.8 m -42.04 -43.77 3.32 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 125.509 1.755 . . . . 1.0 111.062 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.51 -49.0 58.69 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 114.389 -1.278 . . . . 1.0 109.113 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.5 t -56.8 -30.04 63.3 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 124.053 0.846 . . . . 1.0 108.954 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -70.72 -51.52 26.9 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 105.912 -1.884 . . . . 1.0 105.912 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -70.65 -10.78 60.16 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 113.755 -1.566 . . . . 1.0 113.878 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.4 mt -108.69 -43.5 4.25 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 112.903 0.705 . . . . 1.0 112.903 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.4 t -105.23 -38.24 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-N 114.748 -1.114 . . . . 1.0 110.464 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.0 -30.19 2.86 Favored Glycine 0 N--CA 1.488 2.161 0 CA-C-O 118.854 -0.97 . . . . 1.0 114.378 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -122.62 139.27 54.12 Favored 'General case' 0 N--CA 1.506 2.375 0 N-CA-C 114.407 1.262 . . . . 1.0 114.407 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.16 68.93 0.74 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 125.146 1.529 . . . . 1.0 111.086 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.433 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 9.2 t -132.64 -169.14 2.18 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.303 -0.862 . . . . 1.0 109.041 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.31 -173.11 16.27 Favored Glycine 0 N--CA 1.493 2.443 0 CA-C-N 113.751 -1.568 . . . . 1.0 113.711 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -136.96 167.64 21.12 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.654 -1.273 . . . . 1.0 109.568 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.5 t -109.87 112.33 24.3 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 103.485 -2.783 . . . . 1.0 103.485 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.437 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 70.8 m -127.37 123.28 35.84 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 112.829 -1.987 . . . . 1.0 112.604 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 49.91 40.63 21.31 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 113.134 -1.848 . . . . 1.0 108.599 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.52 22.94 62.09 Favored Glycine 0 N--CA 1.484 1.85 0 CA-C-N 113.231 -1.804 . . . . 1.0 113.211 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -131.07 162.34 30.05 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 106.048 -1.834 . . . . 1.0 106.048 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.448 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 9.1 t -73.33 141.56 47.1 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.043 1.498 . . . . 1.0 115.043 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.2 t70 -136.64 77.39 1.65 Allowed 'General case' 0 C--N 1.298 -1.673 0 O-C-N 125.825 1.953 . . . . 1.0 107.699 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.433 ' SG ' ' O ' ' A' ' 25' ' ' THR . 29.9 t . . . . . 0 N--CA 1.5 2.041 0 C-N-CA 119.609 -0.836 . . . . 1.0 111.372 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.2 p . . . . . 0 N--CA 1.495 1.811 0 N-CA-C 109.009 -0.738 . . . . 1.0 109.009 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.409 HG12 ' HB3' ' A' ' 33' ' ' CYS . 1.5 pt -132.18 159.75 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 114.1 1.148 . . . . 1.0 114.1 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -40.47 -53.34 3.54 Favored Glycine 0 N--CA 1.486 1.99 0 CA-C-N 111.22 -2.718 . . . . 1.0 112.206 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -16.13 85.62 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 O-C-N 126.195 1.761 . . . . 1.0 113.217 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -51.05 144.8 8.37 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.772 -1.104 . . . . 1.0 109.607 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.0 p -123.01 164.16 19.09 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 114.249 1.203 . . . . 1.0 114.249 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -118.07 -57.77 2.06 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 104.686 -2.338 . . . . 1.0 104.686 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -114.39 168.43 9.85 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 112.949 -1.932 . . . . 1.0 107.247 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.414 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.3 m -35.29 -58.8 0.74 Allowed Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 124.961 1.413 . . . . 1.0 113.412 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.422 ' C ' ' N ' ' A' ' 13' ' ' CYS . 84.7 Cg_endo -62.15 -95.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.391 1.394 . . . . 1.0 112.423 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 t0 37.91 32.34 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 123.147 1.451 . . . . 1.0 108.809 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.422 ' N ' ' C ' ' A' ' 11' ' ' PRO . 23.9 t -165.41 -24.94 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 111.945 -2.389 . . . . 1.0 112.298 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -38.21 -55.71 1.28 Allowed 'General case' 0 N--CA 1.508 2.466 0 C-N-CA 123.1 0.56 . . . . 1.0 110.778 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.6 p -53.31 -49.18 67.57 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 124.579 1.175 . . . . 1.0 110.119 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.5 -55.62 29.67 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.681 0.753 . . . . 1.0 110.765 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 25' ' ' THR . 56.5 m -48.58 -49.33 37.1 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.165 -1.38 . . . . 1.0 108.317 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -55.61 -49.59 72.4 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.167 0.984 . . . . 1.0 108.443 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -59.8 -26.73 65.99 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-N 113.852 -1.522 . . . . 1.0 111.46 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.1 mp -85.6 -55.79 3.82 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 120.082 -0.647 . . . . 1.0 112.31 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.2 m -107.3 -46.21 7.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 C-N-CA 122.922 0.489 . . . . 1.0 112.25 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.8 28.34 1.29 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 111.215 -0.754 . . . . 1.0 111.215 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -135.41 126.84 28.58 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 124.268 0.628 . . . . 1.0 110.293 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.35 69.04 0.8 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 124.909 1.381 . . . . 1.0 108.923 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.601 ' HG1' ' H ' ' A' ' 26' ' ' GLY . 12.4 t -127.66 -173.46 2.92 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.898 0.856 . . . . 1.0 111.576 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.601 ' H ' ' HG1' ' A' ' 25' ' ' THR . . . 100.85 158.62 27.55 Favored Glycine 0 N--CA 1.495 2.572 0 CA-C-N 112.612 -2.086 . . . . 1.0 109.598 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -132.99 179.29 6.27 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.605 0.716 . . . . 1.0 110.312 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.2 t -100.04 118.07 35.64 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 113.512 -1.676 . . . . 1.0 106.704 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.48 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 58.5 m -132.24 130.39 40.88 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 112.633 -2.076 . . . . 1.0 106.552 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.6 p30 45.5 41.44 6.77 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 125.286 1.616 . . . . 1.0 112.76 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.05 12.4 49.13 Favored Glycine 0 N--CA 1.479 1.561 0 CA-C-N 113.412 -1.722 . . . . 1.0 113.435 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.8 mmt-85 -127.71 162.55 26.3 Favored 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.409 ' HB3' HG12 ' A' ' 3' ' ' ILE . 42.9 t -72.59 146.47 46.66 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 117.7 -1.6 . . . . 1.0 112.08 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.48 ' CB ' ' HG1' ' A' ' 29' ' ' THR . 34.0 t70 -129.69 85.69 2.33 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 104.878 -2.267 . . . . 1.0 104.878 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.504 2.246 0 CA-C-O 116.452 -1.737 . . . . 1.0 111.112 -179.44 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.6 p . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 107.204 -1.406 . . . . 1.0 107.204 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.424 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 35.9 pt -136.83 166.35 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 116.349 1.981 . . . . 1.0 116.349 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.03 -46.05 85.61 Favored Glycine 0 N--CA 1.478 1.448 0 CA-C-N 111.235 -2.711 . . . . 1.0 110.637 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 49.2 tp60 -22.76 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.323 0 O-C-N 125.9 1.588 . . . . 1.0 112.44 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -40.11 151.01 0.05 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 125.274 1.609 . . . . 1.0 114.041 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 t -117.21 149.6 40.14 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 113.538 -1.665 . . . . 1.0 110.318 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.413 ' HB3' ' HD3' ' A' ' 9' ' ' ARG . 3.0 t80 -122.08 -54.8 1.9 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 102.553 -3.129 . . . . 1.0 102.553 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.413 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -118.65 154.05 33.31 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 105.941 -1.874 . . . . 1.0 105.941 179.675 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.402 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 67.8 m -25.2 -55.78 0.17 Allowed Pre-proline 0 N--CA 1.505 2.324 0 N-CA-C 114.748 1.388 . . . . 1.0 114.748 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.474 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 64.4 Cg_endo -69.04 -93.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 121.149 1.233 . . . . 1.0 113.629 170.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.4 t70 42.31 30.01 0.18 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 122.616 1.198 . . . . 1.0 109.691 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.8 t -165.96 -26.22 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 112.23 -2.259 . . . . 1.0 112.658 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.474 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 3.4 m-30 -38.56 -59.03 0.96 Allowed 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 123.612 0.765 . . . . 1.0 112.244 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.6 p -45.53 -43.24 11.71 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 125.117 1.511 . . . . 1.0 111.769 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.05 -46.53 64.8 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.811 -1.086 . . . . 1.0 109.768 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.2 t -57.04 -36.14 70.13 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.103 -1.073 . . . . 1.0 108.103 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -65.69 -53.75 36.82 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 105.1 -2.185 . . . . 1.0 105.1 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.82 -31.6 7.36 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 114.236 -1.347 . . . . 1.0 109.755 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.84 -54.35 5.43 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.475 -0.784 . . . . 1.0 112.088 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 50.7 t -104.28 -54.79 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 CA-C-N 115.655 -0.702 . . . . 1.0 111.674 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.61 20.48 1.09 Allowed Glycine 0 N--CA 1.491 2.309 0 O-C-N 124.043 0.839 . . . . 1.0 112.793 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -133.16 126.26 31.27 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 124.102 0.53 . . . . 1.0 110.465 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.15 73.9 0.94 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 124.54 1.15 . . . . 1.0 108.201 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.4 t -137.38 -173.24 3.42 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.429 0.633 . . . . 1.0 110.884 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.87 -179.69 16.18 Favored Glycine 0 N--CA 1.493 2.46 0 CA-C-N 113.429 -1.714 . . . . 1.0 113.745 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -134.53 172.48 12.86 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 114.001 -1.1 . . . . 1.0 111.346 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 45.6 t -112.34 111.56 22.5 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 102.273 -3.232 . . . . 1.0 102.273 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.408 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 63.2 m -130.73 123.42 29.22 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 112.437 -2.165 . . . . 1.0 108.097 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 p30 47.8 42.0 15.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 126.679 2.487 . . . . 1.0 112.116 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.95 11.21 60.44 Favored Glycine 0 N--CA 1.476 1.309 0 CA-C-N 113.132 -1.849 . . . . 1.0 112.289 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.3 mtt85 -126.34 163.72 22.64 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.187 -1.042 . . . . 1.0 108.187 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.424 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 7.4 t -72.21 143.03 49.0 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.506 -1.278 . . . . 1.0 114.308 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 35.8 t70 -136.39 77.0 1.63 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 112.051 -2.34 . . . . 1.0 107.56 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.8 t . . . . . 0 N--CA 1.498 1.951 0 CA-C-O 118.016 -0.992 . . . . 1.0 111.27 -179.741 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.5 p . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 110.689 -0.115 . . . . 1.0 110.689 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.445 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 23.6 pt -130.23 159.29 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 CA-C-O 122.125 0.964 . . . . 1.0 112.779 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.22 -39.64 72.08 Favored Glycine 0 N--CA 1.489 2.195 0 CA-C-N 112.133 -2.303 . . . . 1.0 112.971 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -13.64 87.61 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 115.672 1.73 . . . . 1.0 115.672 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -40.7 124.31 2.04 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.693 1.246 . . . . 1.0 109.634 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 5.6 t -95.43 157.88 15.7 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 116.182 1.919 . . . . 1.0 116.182 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.515 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 14.7 t80 -121.68 -61.96 1.46 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 104.285 -2.487 . . . . 1.0 104.285 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -121.1 168.07 11.95 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 112.982 -1.917 . . . . 1.0 110.137 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.467 ' HG ' ' HZ3' ' A' ' 27' ' ' LYS . 59.9 m -32.29 -59.64 0.38 Allowed Pre-proline 0 N--CA 1.501 2.109 0 O-C-N 125.051 1.469 . . . . 1.0 114.605 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 13' ' ' CYS . 84.1 Cg_endo -61.37 -89.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.753 1.635 . . . . 1.0 112.045 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 t70 35.92 36.41 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 CA-C-O 124.113 1.911 . . . . 1.0 108.508 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.403 ' N ' ' C ' ' A' ' 11' ' ' PRO . 15.1 t -170.36 -25.33 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 111.118 -2.765 . . . . 1.0 112.382 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -38.45 -59.51 0.9 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 123.984 0.803 . . . . 1.0 111.618 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.3 t -51.83 -44.43 63.56 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 124.939 1.399 . . . . 1.0 112.657 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.43 -46.81 78.46 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 124.025 0.828 . . . . 1.0 113.055 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.1 t -68.72 -31.02 69.8 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.012 -1.477 . . . . 1.0 107.012 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -64.11 -50.29 68.87 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.24 -1.022 . . . . 1.0 108.24 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -70.15 -26.3 63.87 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.002 -1.479 . . . . 1.0 109.505 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 tt -65.15 -59.18 4.38 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.963 -0.695 . . . . 1.0 110.138 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.01 -42.73 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 114.171 1.175 . . . . 1.0 114.171 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.03 10.82 1.69 Allowed Glycine 0 N--CA 1.491 2.337 0 CA-C-O 119.569 -0.573 . . . . 1.0 112.759 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -129.68 128.9 43.49 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 123.722 0.307 . . . . 1.0 110.468 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.02 68.71 0.7 Allowed 'General case' 0 N--CA 1.503 2.202 0 O-C-N 124.87 1.356 . . . . 1.0 109.954 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.6 p -115.61 175.78 5.37 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.151 -1.386 . . . . 1.0 113.048 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.78 150.58 9.34 Favored Glycine 0 N--CA 1.49 2.263 0 CA-C-N 113.254 -1.794 . . . . 1.0 110.989 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.467 ' HZ3' ' HG ' ' A' ' 10' ' ' SER . 30.6 mmmt -122.55 -178.48 3.92 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 113.521 -1.339 . . . . 1.0 111.01 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.5 t -111.27 109.42 19.43 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 111.903 -2.408 . . . . 1.0 108.209 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.439 ' HG1' ' CG ' ' A' ' 34' ' ' ASP . 20.3 m -138.71 131.56 29.4 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 112.837 -1.983 . . . . 1.0 111.001 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 51.06 40.1 24.81 Favored 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 112.811 -1.995 . . . . 1.0 108.33 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.0 19.16 50.0 Favored Glycine 0 N--CA 1.489 2.223 0 CA-C-N 113.259 -1.791 . . . . 1.0 113.356 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.0 mtp-105 -134.26 160.11 38.88 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.445 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 43.5 t -72.53 139.17 47.41 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 114.826 1.417 . . . . 1.0 114.826 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 11.2 p-10 -134.02 94.09 3.2 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.185 -2.154 . . . . 1.0 105.185 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.504 2.227 0 CA-C-N 115.252 -0.885 . . . . 1.0 109.741 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 45.8 t . . . . . 0 N--CA 1.499 2.023 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.467 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 33.8 pt -134.93 164.04 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 N-CA-C 114.136 1.162 . . . . 1.0 114.136 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.62 -39.59 93.56 Favored Glycine 0 N--CA 1.479 1.534 0 CA-C-N 112.868 -1.969 . . . . 1.0 112.564 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -12.0 88.01 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 115.372 1.619 . . . . 1.0 115.372 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.0 mtt85 -39.8 122.91 1.49 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 124.817 1.323 . . . . 1.0 110.873 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 9.0 t -107.11 158.53 17.0 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 114.974 1.472 . . . . 1.0 114.974 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.52 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.9 t80 -123.48 -56.6 1.7 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 112.424 -2.171 . . . . 1.0 105.996 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.45 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -115.4 153.71 30.56 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 113.406 -1.724 . . . . 1.0 110.011 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.426 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.3 m -25.22 -57.94 0.16 Allowed Pre-proline 0 N--CA 1.508 2.437 0 O-C-N 125.092 1.495 . . . . 1.0 114.909 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.426 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 95.7 Cg_endo -62.82 -91.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.874 1.716 . . . . 1.0 112.058 173.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.8 t70 35.99 35.44 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 123.725 1.726 . . . . 1.0 108.889 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.4 ' N ' ' C ' ' A' ' 11' ' ' PRO . 49.3 t -170.73 -23.11 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 110.802 -2.908 . . . . 1.0 112.541 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -38.63 -59.94 0.87 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 123.415 0.447 . . . . 1.0 111.569 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.5 t -47.92 -40.4 21.86 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 124.933 1.396 . . . . 1.0 112.243 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.02 -54.48 13.0 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 123.715 0.635 . . . . 1.0 110.139 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.8 t -55.01 -32.65 61.97 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.553 -0.906 . . . . 1.0 108.553 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -67.14 -50.87 59.74 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 105.906 -1.887 . . . . 1.0 105.906 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -70.48 -9.03 55.5 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 113.756 -1.565 . . . . 1.0 111.554 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -90.68 -60.1 2.01 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.7 -0.852 . . . . 1.0 108.7 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 p -111.58 -39.24 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 124.129 0.893 . . . . 1.0 112.763 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.98 14.03 1.69 Allowed Glycine 0 N--CA 1.493 2.446 0 CA-C-O 119.635 -0.536 . . . . 1.0 113.285 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -132.23 127.45 35.8 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 123.966 0.451 . . . . 1.0 110.257 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.09 68.41 0.7 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 125.065 1.478 . . . . 1.0 109.723 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.453 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 12.2 p -119.26 -179.12 3.75 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.252 -1.34 . . . . 1.0 114.299 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.41 153.91 9.25 Favored Glycine 0 N--CA 1.494 2.542 0 CA-C-N 113.419 -1.718 . . . . 1.0 111.704 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -119.45 167.21 12.17 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.33 -0.935 . . . . 1.0 108.672 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 13.5 t -101.42 90.64 4.15 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 102.917 -2.994 . . . . 1.0 102.917 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.7 m -110.78 115.57 29.78 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 109.497 -3.501 . . . . 1.0 111.43 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 52.8 39.03 28.08 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 112.425 -2.17 . . . . 1.0 108.465 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.61 25.59 68.99 Favored Glycine 0 N--CA 1.483 1.816 0 CA-C-N 113.065 -1.88 . . . . 1.0 111.858 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.2 mtt-85 -136.42 159.25 42.36 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.004 -1.48 . . . . 1.0 107.004 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.467 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 40.1 t -72.36 140.3 48.37 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 114.293 1.22 . . . . 1.0 114.293 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 30.0 t70 -135.18 84.49 2.1 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 124.978 1.424 . . . . 1.0 107.348 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.453 ' SG ' ' C ' ' A' ' 25' ' ' THR . 6.5 t . . . . . 0 N--CA 1.501 2.104 0 CA-C-O 116.787 -1.577 . . . . 1.0 111.239 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.8 p . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.727 -0.472 . . . . 1.0 109.727 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.445 HG12 ' HB3' ' A' ' 33' ' ' CYS . 23.1 pt -128.83 160.25 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 121.916 0.865 . . . . 1.0 112.882 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.96 43.81 3.24 Favored Glycine 0 C--O 1.211 -1.338 0 CA-C-N 112.589 -2.096 . . . . 1.0 112.671 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -105.36 102.53 12.01 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 101.555 -3.498 . . . . 1.0 101.555 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -39.03 137.53 0.67 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 113.425 -1.716 . . . . 1.0 113.19 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.6 p -121.84 159.37 26.92 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.582 -1.19 . . . . 1.0 110.148 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -118.51 -59.82 1.84 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 106.175 -1.787 . . . . 1.0 106.175 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.37 163.81 12.54 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 113.188 -1.824 . . . . 1.0 106.591 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.427 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 75.5 m -35.93 -55.26 1.3 Allowed Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 125.156 1.535 . . . . 1.0 112.125 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.478 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 81.2 Cg_endo -67.07 -93.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 120.858 1.038 . . . . 1.0 113.009 171.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 t70 36.97 34.46 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 CA-C-O 123.351 1.548 . . . . 1.0 109.678 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.5 t -166.35 -27.53 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 110.766 -2.924 . . . . 1.0 111.307 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.478 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.0 m-85 -38.38 -55.34 1.38 Allowed 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 124.456 1.103 . . . . 1.0 112.45 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.539 ' HG ' ' H ' ' A' ' 16' ' ' ALA . 52.5 p -47.1 -48.72 22.79 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 124.322 1.014 . . . . 1.0 109.887 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.539 ' H ' ' HG ' ' A' ' 15' ' ' SER . . . -64.02 -45.15 90.19 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.708 -1.133 . . . . 1.0 110.379 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 25' ' ' THR . 10.5 m -57.59 -35.56 70.57 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.998 -1.001 . . . . 1.0 109.372 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.471 ' CB ' ' HZ1' ' A' ' 18' ' ' LYS . 4.4 ttpm? -70.8 -46.41 62.89 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.381 -1.711 . . . . 1.0 106.381 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.28 -15.19 62.86 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 114.157 -1.383 . . . . 1.0 113.623 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.0 mt -110.46 -43.62 3.85 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 113.86 1.059 . . . . 1.0 113.86 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.0 t -98.89 -36.22 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 114.555 -1.202 . . . . 1.0 110.033 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.57 -28.79 4.16 Favored Glycine 0 N--CA 1.489 2.207 0 O-C-N 123.866 0.729 . . . . 1.0 113.07 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -129.23 152.04 49.23 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 112.405 0.52 . . . . 1.0 112.405 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.52 78.51 0.79 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 114.274 -1.33 . . . . 1.0 109.218 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.418 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 7.6 t -128.38 -178.22 4.48 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.551 0.691 . . . . 1.0 111.627 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.53 -169.0 13.84 Favored Glycine 0 N--CA 1.495 2.6 0 CA-C-N 113.216 -1.811 . . . . 1.0 112.567 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -155.13 173.06 17.14 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.024 -1.088 . . . . 1.0 108.388 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 47.4 t -102.13 118.1 36.19 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.178 -1.786 . . . . 1.0 106.178 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.505 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 91.1 m -129.75 125.81 36.72 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 112.867 -1.97 . . . . 1.0 110.834 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 50.55 40.87 24.55 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 125.198 1.561 . . . . 1.0 109.15 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.86 18.92 55.06 Favored Glycine 0 N--CA 1.488 2.142 0 CA-C-N 113.148 -1.842 . . . . 1.0 113.51 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -128.62 163.32 25.31 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.778 -1.564 . . . . 1.0 106.778 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.445 ' HB3' HG12 ' A' ' 3' ' ' ILE . 11.2 t -73.49 143.75 46.47 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.177 -1.409 . . . . 1.0 113.263 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.505 ' CB ' ' HG1' ' A' ' 29' ' ' THR . 8.8 t70 -131.24 85.04 2.23 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 104.53 -2.396 . . . . 1.0 104.53 178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.5 2.071 0 C-N-CA 119.76 -0.776 . . . . 1.0 109.957 -179.514 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 41.1 t . . . . . 0 N--CA 1.494 1.731 0 N-CA-C 108.53 -0.915 . . . . 1.0 108.53 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.438 HG12 ' HB3' ' A' ' 33' ' ' CYS . 23.6 pt -128.96 154.64 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 114.549 1.314 . . . . 1.0 114.549 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -48.87 -43.24 30.39 Favored Glycine 0 N--CA 1.477 1.433 0 CA-C-N 110.824 -2.898 . . . . 1.0 111.758 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -26.15 91.98 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 126.106 1.709 . . . . 1.0 112.333 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -39.85 149.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.938 -1.483 . . . . 1.0 113.63 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.451 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 5.0 t -107.63 157.28 18.2 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.714 -1.13 . . . . 1.0 112.124 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.451 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 15.9 t80 -119.72 -64.88 1.22 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 103.023 -2.954 . . . . 1.0 103.023 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.45 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 9.0 mmt85 -123.85 168.83 12.23 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 112.277 -2.238 . . . . 1.0 106.533 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.41 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 67.9 m -29.02 -58.36 0.25 Allowed Pre-proline 0 N--CA 1.504 2.261 0 N-CA-C 114.677 1.362 . . . . 1.0 114.677 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.41 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 71.1 Cg_endo -66.96 -93.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.426 1.418 . . . . 1.0 113.262 175.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.6 t70 37.89 33.73 0.05 Allowed 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 123.399 1.571 . . . . 1.0 109.906 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.5 t -164.51 -26.85 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 110.851 -2.886 . . . . 1.0 111.432 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.4 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.2 m-85 -38.74 -58.27 1.09 Allowed 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 123.68 0.792 . . . . 1.0 111.777 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.0 m -48.15 -45.7 33.61 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 124.625 1.203 . . . . 1.0 110.749 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.03 -41.56 90.77 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.608 -1.178 . . . . 1.0 112.309 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 25' ' ' THR . 24.2 m -66.81 -32.02 73.03 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.907 -1.042 . . . . 1.0 109.01 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -70.77 -52.57 19.87 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.753 -1.203 . . . . 1.0 107.753 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -70.92 -17.16 62.7 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 118.903 -1.119 . . . . 1.0 113.448 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.1 mt -101.88 -41.99 6.3 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 113.25 0.833 . . . . 1.0 113.25 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.1 t -101.49 -34.7 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 124.293 0.996 . . . . 1.0 110.321 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.17 -29.64 3.85 Favored Glycine 0 N--CA 1.493 2.464 0 O-C-N 123.731 0.645 . . . . 1.0 113.065 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.47 ' H ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -128.5 156.58 43.03 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 112.97 0.73 . . . . 1.0 112.97 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.88 73.64 0.59 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 113.975 -1.466 . . . . 1.0 112.95 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.449 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 0.8 OUTLIER -114.32 -171.29 1.89 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.964 -1.016 . . . . 1.0 110.102 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.86 156.02 12.32 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.853 -0.899 . . . . 1.0 110.853 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -132.53 169.88 15.96 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.331 -0.988 . . . . 1.0 108.331 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.6 t -105.11 100.61 10.2 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 104.8 -2.296 . . . . 1.0 104.8 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.7 m -121.66 118.71 29.84 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 110.736 -2.938 . . . . 1.0 112.069 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 47.7 42.31 15.2 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 112.562 -2.108 . . . . 1.0 110.013 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.89 23.08 69.06 Favored Glycine 0 N--CA 1.482 1.763 0 CA-C-N 113.229 -1.805 . . . . 1.0 113.09 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.2 mtp85 -136.48 160.47 38.66 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.74 -1.208 . . . . 1.0 107.74 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.438 ' HB3' HG12 ' A' ' 3' ' ' ILE . 19.5 t -72.57 142.12 48.42 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.437 -1.305 . . . . 1.0 114.118 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 35.0 t0 -131.38 88.98 2.65 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 105.326 -2.102 . . . . 1.0 105.326 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.501 2.106 0 CA-C-O 118.394 -0.812 . . . . 1.0 109.372 -179.773 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 5.3 p . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.471 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 35.1 pt -133.2 152.55 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 114.603 1.335 . . . . 1.0 114.603 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.67 -38.3 63.48 Favored Glycine 0 N--CA 1.482 1.741 0 CA-C-N 111.717 -2.492 . . . . 1.0 110.747 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -32.33 103.11 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 125.918 1.599 . . . . 1.0 110.217 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -39.46 151.96 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.815 1.783 . . . . 1.0 115.815 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 1.4 t -112.87 154.62 26.04 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.222 -1.354 . . . . 1.0 111.47 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.419 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 1.2 t80 -121.31 -62.86 1.38 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 103.684 -2.71 . . . . 1.0 103.684 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -119.89 166.61 13.07 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 111.895 -2.411 . . . . 1.0 106.173 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.429 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.7 m -35.55 -55.47 1.15 Allowed Pre-proline 0 N--CA 1.506 2.364 0 N-CA-C 113.355 0.872 . . . . 1.0 113.355 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.429 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 83.6 Cg_endo -63.64 -94.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.632 1.555 . . . . 1.0 112.011 173.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.0 t70 36.09 34.76 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.373 0 CA-C-O 123.358 1.552 . . . . 1.0 109.316 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.415 ' N ' ' C ' ' A' ' 11' ' ' PRO . 42.7 t -171.14 -19.99 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 110.738 -2.937 . . . . 1.0 112.562 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -38.51 -59.2 0.94 Allowed 'General case' 0 N--CA 1.503 2.215 0 CA-C-N 118.632 0.651 . . . . 1.0 110.93 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 76.1 p -47.58 -39.95 17.98 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.99 1.431 . . . . 1.0 112.153 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.09 -49.35 51.81 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.697 -0.683 . . . . 1.0 109.573 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.6 t -55.09 -40.88 70.9 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.239 -1.393 . . . . 1.0 107.239 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -59.24 -53.53 57.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 106.566 -1.642 . . . . 1.0 106.566 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -48.43 -34.59 11.25 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 113.567 -1.651 . . . . 1.0 109.846 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.4 mt -80.97 -51.58 8.37 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.391 0.886 . . . . 1.0 113.391 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -113.49 -44.72 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-N 117.867 0.303 . . . . 1.0 111.489 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.67 12.86 2.37 Favored Glycine 0 N--CA 1.492 2.387 0 CA-C-O 119.362 -0.688 . . . . 1.0 114.056 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.79 129.99 50.55 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 123.784 0.343 . . . . 1.0 110.515 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.35 68.17 0.75 Allowed 'General case' 0 N--CA 1.506 2.358 0 O-C-N 124.624 1.203 . . . . 1.0 109.417 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.481 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 12.5 p -118.47 -179.94 3.94 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.628 -1.169 . . . . 1.0 113.418 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.8 158.95 12.24 Favored Glycine 0 N--CA 1.493 2.464 0 CA-C-N 113.852 -1.522 . . . . 1.0 113.04 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.429 ' HZ1' ' HG1' ' A' ' 29' ' ' THR . 14.6 ptmm? -127.03 177.23 6.77 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 122.076 0.941 . . . . 1.0 108.524 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.7 t -101.71 111.84 24.22 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 112.492 -2.14 . . . . 1.0 107.829 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.429 ' HG1' ' HZ1' ' A' ' 27' ' ' LYS . 49.9 m -126.23 120.69 30.66 Favored 'General case' 0 N--CA 1.503 2.175 0 CA-C-N 112.1 -2.318 . . . . 1.0 111.559 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 48.76 42.84 20.47 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 113.452 -1.704 . . . . 1.0 109.684 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.15 21.38 61.63 Favored Glycine 0 N--CA 1.486 2.005 0 CA-C-N 113.733 -1.576 . . . . 1.0 113.241 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.8 mtt-85 -133.15 161.45 34.4 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 106.916 -1.513 . . . . 1.0 106.916 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.471 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 35.0 t -72.57 141.73 48.42 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.607 1.336 . . . . 1.0 114.607 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.5 t70 -135.24 83.31 2.01 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 125.631 1.832 . . . . 1.0 109.112 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.481 ' SG ' ' C ' ' A' ' 25' ' ' THR . 9.6 t . . . . . 0 N--CA 1.502 2.13 0 C-N-CA 119.25 -0.98 . . . . 1.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 58.0 t . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 109.052 -0.721 . . . . 1.0 109.052 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.457 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 29.2 pt -133.97 163.63 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 115.273 1.583 . . . . 1.0 115.273 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.75 -43.08 96.66 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-N 111.398 -2.637 . . . . 1.0 111.572 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -15.23 88.34 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 O-C-N 126.173 1.749 . . . . 1.0 113.774 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -39.89 134.17 1.49 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 124.88 1.362 . . . . 1.0 110.75 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 9.7 t -116.69 159.19 22.61 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.663 -1.153 . . . . 1.0 113.09 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.44 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 19.1 t80 -119.46 -61.89 1.57 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 104.254 -2.499 . . . . 1.0 104.254 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.432 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -118.15 161.28 20.12 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 112.891 -1.959 . . . . 1.0 110.318 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 75.8 m -18.42 -60.09 0.05 OUTLIER Pre-proline 0 N--CA 1.506 2.338 0 N-CA-C 117.948 2.573 . . . . 1.0 117.948 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.481 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 44.7 Cg_endo -72.44 -96.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.6 1.533 . . . . 1.0 113.185 176.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 t0 44.52 28.59 0.33 Allowed 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 122.253 1.025 . . . . 1.0 109.542 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 t -167.07 -22.99 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 113.367 -1.742 . . . . 1.0 114.177 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.481 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 6.6 m-30 -39.12 -62.99 0.58 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 112.228 0.455 . . . . 1.0 112.228 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.1 t -43.36 -46.68 6.61 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 125.358 1.661 . . . . 1.0 111.13 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.61 -45.17 91.53 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 114.035 -1.439 . . . . 1.0 111.224 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.1 t -62.73 -38.97 92.6 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.935 -1.135 . . . . 1.0 107.935 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -60.95 -51.38 69.5 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.92 -18.03 62.67 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 118.091 -1.444 . . . . 1.0 112.262 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 mp -87.33 -50.14 6.78 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 112.94 0.719 . . . . 1.0 112.94 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.2 m -112.16 -30.79 2.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 118.832 -0.604 . . . . 1.0 112.172 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.89 -26.62 2.99 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 116.491 1.356 . . . . 1.0 116.491 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -122.65 135.16 54.52 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 114.542 1.312 . . . . 1.0 114.542 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.78 67.72 0.6 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 113.609 -1.632 . . . . 1.0 111.862 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.551 ' HG1' ' H ' ' A' ' 26' ' ' GLY . 14.9 t -131.79 -163.32 1.32 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.543 -0.753 . . . . 1.0 110.364 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.551 ' H ' ' HG1' ' A' ' 25' ' ' THR . . . 112.51 -176.06 17.45 Favored Glycine 0 N--CA 1.498 2.81 0 CA-C-N 113.769 -1.56 . . . . 1.0 111.222 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -136.0 171.64 14.18 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.523 0.678 . . . . 1.0 110.021 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.0 t -105.31 114.44 28.63 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 106.406 -1.702 . . . . 1.0 106.406 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.5 m -123.36 118.35 27.31 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 112.6 -2.091 . . . . 1.0 114.304 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 45.16 39.26 3.87 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 114.073 -1.421 . . . . 1.0 112.014 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.6 18.29 79.81 Favored Glycine 0 N--CA 1.476 1.335 0 CA-C-N 112.886 -1.961 . . . . 1.0 115.221 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.7 mtp-105 -135.32 156.41 49.0 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.2 -1.037 . . . . 1.0 108.2 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.457 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 20.1 t -72.9 138.49 46.25 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 116.556 2.058 . . . . 1.0 116.556 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 0.8 OUTLIER -133.36 82.34 1.98 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 125.283 1.615 . . . . 1.0 108.757 178.421 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.499 1.996 0 CA-C-O 116.52 -1.705 . . . . 1.0 110.736 -179.758 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.3 p . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 108.609 -0.885 . . . . 1.0 108.609 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.422 HG12 ' HB3' ' A' ' 33' ' ' CYS . 22.8 pt -129.21 159.72 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 114.929 1.455 . . . . 1.0 114.929 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.32 -45.16 44.87 Favored Glycine 0 N--CA 1.478 1.44 0 CA-C-N 110.755 -2.929 . . . . 1.0 111.63 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -21.26 90.73 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 O-C-N 125.794 1.526 . . . . 1.0 113.137 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.3 ptt-85 -46.2 142.51 2.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 124.63 1.206 . . . . 1.0 108.689 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 28.0 p -113.32 158.88 20.01 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 118.839 -1.144 . . . . 1.0 112.273 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -116.73 -59.79 1.92 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 105.741 -1.948 . . . . 1.0 105.741 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.3 mtt85 -114.84 169.5 9.03 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 112.058 -2.337 . . . . 1.0 106.879 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.436 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 73.5 m -37.58 -56.26 1.79 Allowed Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 124.776 1.298 . . . . 1.0 111.726 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.436 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 97.9 Cg_endo -64.97 -95.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.248 1.299 . . . . 1.0 112.945 175.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.1 t70 37.19 30.58 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 O-C-N 125.401 1.688 . . . . 1.0 109.578 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.431 ' N ' ' C ' ' A' ' 11' ' ' PRO . 42.7 t -164.81 -22.92 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 111.244 -2.707 . . . . 1.0 112.832 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.426 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.1 m-85 -38.6 -58.61 1.02 Allowed 'General case' 0 N--CA 1.503 2.206 0 CA-C-N 118.306 0.503 . . . . 1.0 110.434 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.4 p -53.54 -44.75 69.47 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 124.635 1.21 . . . . 1.0 111.086 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.23 -57.94 10.65 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 120.35 -0.54 . . . . 1.0 110.933 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.8 t -52.51 -45.24 66.15 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.412 -1.329 . . . . 1.0 107.412 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -50.98 -47.72 61.37 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -62.85 -36.31 82.84 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 114.565 -1.198 . . . . 1.0 110.126 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.46 -54.64 11.48 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 113.64 0.978 . . . . 1.0 113.64 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 m -105.42 -43.58 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 114.103 1.149 . . . . 1.0 114.103 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.28 17.23 2.01 Favored Glycine 0 N--CA 1.494 2.557 0 O-C-N 123.536 0.522 . . . . 1.0 112.199 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -134.14 130.53 37.46 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 123.877 0.398 . . . . 1.0 110.198 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.56 71.68 0.7 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 124.533 1.146 . . . . 1.0 108.555 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.3 p -119.57 177.16 5.04 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.485 -1.234 . . . . 1.0 113.281 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.93 153.35 17.56 Favored Glycine 0 N--CA 1.49 2.261 0 CA-C-N 113.64 -1.618 . . . . 1.0 111.191 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.8 -176.67 3.84 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 124.829 0.958 . . . . 1.0 108.552 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.2 t -108.42 109.34 20.61 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 112.063 -2.335 . . . . 1.0 108.661 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.466 ' HG1' ' CG ' ' A' ' 34' ' ' ASP . 19.9 m -136.26 129.34 31.37 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-N 112.683 -2.053 . . . . 1.0 110.066 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 51.15 40.73 26.55 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 112.817 -1.992 . . . . 1.0 107.729 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.35 13.56 44.21 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-N 113.358 -1.746 . . . . 1.0 114.283 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.4 mmt-85 -129.93 159.88 35.3 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.371 -0.974 . . . . 1.0 108.371 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.422 ' HB3' HG12 ' A' ' 3' ' ' ILE . 15.6 t -72.68 140.53 47.95 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.85 1.426 . . . . 1.0 114.85 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.466 ' CG ' ' HG1' ' A' ' 29' ' ' THR . 7.7 p-10 -130.7 94.98 3.74 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 105.587 -2.005 . . . . 1.0 105.587 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.502 2.161 0 CA-C-O 118.013 -0.994 . . . . 1.0 110.174 -179.887 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.5 p . . . . . 0 N--CA 1.495 1.785 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.43 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 36.6 pt -137.8 165.49 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 115.659 1.725 . . . . 1.0 115.659 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.97 -42.92 95.11 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-N 111.89 -2.414 . . . . 1.0 111.271 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -21.31 98.8 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 O-C-N 125.66 1.447 . . . . 1.0 112.929 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.1 ptt-85 -39.67 141.35 0.41 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 125.146 1.529 . . . . 1.0 112.848 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.419 ' SG ' ' O ' ' A' ' 9' ' ' ARG . 11.9 t -112.69 155.31 24.71 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.644 -1.162 . . . . 1.0 110.712 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -120.41 -61.13 1.61 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 104.986 -2.227 . . . . 1.0 104.986 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.419 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 42.6 mtt85 -117.69 165.29 13.78 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 112.69 -2.05 . . . . 1.0 108.342 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.0 m -32.02 -53.52 0.53 Allowed Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 125.189 1.556 . . . . 1.0 113.613 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.503 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 49.7 Cg_endo -70.56 -94.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.585 1.523 . . . . 1.0 114.698 169.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 t70 41.17 30.45 0.11 Allowed 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 123.156 1.455 . . . . 1.0 110.062 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.4 t -165.34 -27.91 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 112.14 -2.3 . . . . 1.0 112.524 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.503 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 5.7 m-30 -38.98 -61.48 0.74 Allowed 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 112.834 0.679 . . . . 1.0 112.834 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.9 t -42.49 -43.89 3.86 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 125.39 1.681 . . . . 1.0 110.947 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.43 -43.93 68.92 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.386 -1.279 . . . . 1.0 110.183 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.1 t -60.94 -31.34 70.89 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.117 -1.068 . . . . 1.0 108.117 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -70.48 -53.82 14.77 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.138 -1.801 . . . . 1.0 106.138 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -59.43 -19.19 45.51 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 112.397 -2.183 . . . . 1.0 112.292 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.4 tp -102.92 -54.49 2.62 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 113.357 0.873 . . . . 1.0 113.357 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.5 t -92.88 -41.31 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-N 113.121 -1.854 . . . . 1.0 112.087 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.09 -23.05 3.94 Favored Glycine 0 N--CA 1.488 2.141 0 CA-C-O 119.348 -0.695 . . . . 1.0 113.03 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -126.1 134.98 51.2 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 113.815 1.043 . . . . 1.0 113.815 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.62 70.32 0.67 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 114.331 -1.304 . . . . 1.0 112.355 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.549 ' HG1' ' H ' ' A' ' 26' ' ' GLY . 12.4 t -130.19 -166.74 1.72 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.025 -0.732 . . . . 1.0 109.025 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.549 ' H ' ' HG1' ' A' ' 25' ' ' THR . . . 122.4 -176.86 16.53 Favored Glycine 0 N--CA 1.492 2.39 0 CA-C-N 113.495 -1.684 . . . . 1.0 114.879 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -133.38 165.54 24.62 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.822 -1.689 . . . . 1.0 109.263 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.6 t -110.03 112.21 24.07 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 103.159 -2.904 . . . . 1.0 103.159 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.458 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 89.8 m -125.12 123.52 39.87 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 112.576 -2.102 . . . . 1.0 112.208 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 44.53 41.17 4.5 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 112.878 -1.965 . . . . 1.0 111.552 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.26 27.06 71.97 Favored Glycine 0 N--CA 1.484 1.861 0 CA-C-N 113.254 -1.794 . . . . 1.0 112.72 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.6 mtt-85 -136.32 159.8 40.66 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.703 -1.591 . . . . 1.0 106.703 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.43 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 13.0 t -72.87 142.3 47.94 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 113.945 1.091 . . . . 1.0 113.945 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.458 ' CB ' ' HG1' ' A' ' 29' ' ' THR . 10.6 t70 -137.59 73.79 1.46 Allowed 'General case' 0 C--N 1.298 -1.634 0 O-C-N 125.561 1.788 . . . . 1.0 108.358 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 25' ' ' THR . 13.2 t . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 116.712 -1.613 . . . . 1.0 111.194 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 50.3 t . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 109.503 -0.555 . . . . 1.0 109.503 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.485 HG12 ' HB3' ' A' ' 33' ' ' CYS . 33.1 pt -130.43 152.7 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-O 122.58 1.181 . . . . 1.0 113.585 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.73 -35.51 86.51 Favored Glycine 0 N--CA 1.483 1.783 0 CA-C-N 111.385 -2.643 . . . . 1.0 111.895 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -22.56 94.12 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 126.229 1.782 . . . . 1.0 112.318 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -39.53 131.75 1.66 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 124.549 1.156 . . . . 1.0 112.417 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.508 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 4.5 t -111.69 159.6 18.06 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 124.615 1.197 . . . . 1.0 114.001 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.508 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 0.9 OUTLIER -121.38 -57.42 1.84 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 113.365 -1.743 . . . . 1.0 107.644 179.816 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.471 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 35.5 mmt-85 -115.73 166.56 11.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.35 1.031 . . . . 1.0 110.485 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.6 m -32.85 -56.92 0.52 Allowed Pre-proline 0 N--CA 1.502 2.158 0 N-CA-C 114.84 1.422 . . . . 1.0 114.84 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.442 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 97.3 Cg_endo -65.96 -92.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.3 1.333 . . . . 1.0 112.723 176.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 t0 40.15 32.34 0.12 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 122.993 1.378 . . . . 1.0 108.774 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.3 t -166.94 -26.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 112.47 -2.15 . . . . 1.0 112.223 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.442 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.7 m-85 -38.73 -58.09 1.11 Allowed 'General case' 0 N--CA 1.505 2.32 0 C-N-CA 123.431 0.693 . . . . 1.0 111.6 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.3 t -49.14 -46.67 45.46 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 124.306 1.004 . . . . 1.0 110.641 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.35 -35.26 79.02 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.96 -1.018 . . . . 1.0 112.117 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 25' ' ' THR . 45.5 m -69.77 -35.38 74.87 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.685 -0.857 . . . . 1.0 108.685 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -70.63 -42.84 70.34 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.707 -1.22 . . . . 1.0 107.707 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -69.99 -29.07 66.07 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 112.622 -2.081 . . . . 1.0 113.648 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.63 -34.68 8.09 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.334 1.235 . . . . 1.0 114.334 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.3 t -104.42 -35.7 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 123.943 0.777 . . . . 1.0 109.953 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.23 -30.76 3.8 Favored Glycine 0 N--CA 1.489 2.177 0 C-N-CA 120.803 -0.713 . . . . 1.0 113.879 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.512 ' HZ1' ' H ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -123.84 151.19 43.69 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 120.67 -0.412 . . . . 1.0 111.189 -179.369 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.4 75.27 0.76 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 125.016 1.447 . . . . 1.0 108.643 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.534 ' HG1' ' H ' ' A' ' 26' ' ' GLY . 14.9 t -122.33 -162.8 1.03 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.046 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.534 ' H ' ' HG1' ' A' ' 25' ' ' THR . . . 82.6 167.0 39.79 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.488 -1.445 . . . . 1.0 109.488 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -139.36 -172.01 3.26 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 118.676 -1.21 . . . . 1.0 111.508 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.4 t -107.06 117.82 35.06 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 111.41 -2.632 . . . . 1.0 109.191 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.1 m -139.94 134.15 31.15 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 113.474 -1.693 . . . . 1.0 109.885 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 47.61 41.21 13.08 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 113.723 -1.58 . . . . 1.0 109.878 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.65 18.98 53.8 Favored Glycine 0 N--CA 1.491 2.362 0 CA-C-N 113.512 -1.676 . . . . 1.0 114.828 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.8 mtp85 -136.53 157.5 46.63 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.022 -1.473 . . . . 1.0 107.022 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.485 ' HB3' HG12 ' A' ' 3' ' ' ILE . 42.6 t -73.12 139.0 46.13 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.236 1.199 . . . . 1.0 114.236 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 12.5 p-10 -135.79 95.55 3.26 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 102.743 -3.058 . . . . 1.0 102.743 178.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.436 ' SG ' ' HA3' ' A' ' 26' ' ' GLY . 6.5 t . . . . . 0 N--CA 1.495 1.792 0 CA-C-N 113.546 -1.661 . . . . 1.0 110.746 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 64.8 t . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 108.446 -0.946 . . . . 1.0 108.446 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.453 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 33.5 pt -136.29 166.62 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 115.954 1.835 . . . . 1.0 115.954 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 5' ' ' GLN . . . -61.02 -43.15 99.8 Favored Glycine 0 N--CA 1.473 1.119 0 CA-C-N 111.736 -2.483 . . . . 1.0 111.469 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 4' ' ' GLY . 4.0 tp-100 -14.84 90.75 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.429 0 O-C-N 125.843 1.554 . . . . 1.0 113.135 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -39.81 133.82 1.51 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 125.224 1.578 . . . . 1.0 110.767 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.484 ' SG ' ' O ' ' A' ' 9' ' ' ARG . 35.2 t -117.6 156.61 27.84 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 124.342 1.026 . . . . 1.0 113.53 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.432 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.3 t80 -120.99 -61.07 1.59 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 105.637 -1.986 . . . . 1.0 105.637 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.484 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 20.4 mtt-85 -114.19 159.98 19.51 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 113.136 -1.847 . . . . 1.0 109.264 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.3 m -24.5 -56.14 0.15 Allowed Pre-proline 0 N--CA 1.506 2.352 0 O-C-N 125.201 1.563 . . . . 1.0 114.949 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.409 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 67.2 Cg_endo -67.1 -96.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.755 1.637 . . . . 1.0 114.07 170.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.7 t70 38.38 32.28 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 123.539 1.638 . . . . 1.0 109.819 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.6 t -171.46 -18.08 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 111.324 -2.671 . . . . 1.0 113.83 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.409 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 6.6 m-30 -38.66 -59.99 0.87 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 112.723 0.638 . . . . 1.0 112.723 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.6 p -46.48 -44.73 17.82 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 124.921 1.388 . . . . 1.0 111.86 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.78 -43.78 87.77 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 114.816 -1.084 . . . . 1.0 109.316 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.6 t -57.81 -50.56 72.86 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.739 -1.578 . . . . 1.0 106.739 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -50.67 -53.93 27.14 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.361 -0.977 . . . . 1.0 108.361 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -51.77 -32.88 32.75 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 112.724 -2.035 . . . . 1.0 110.982 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.0 mt -90.01 -57.82 2.72 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 115.771 1.767 . . . . 1.0 115.771 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 m -99.14 -35.82 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 113.155 0.798 . . . . 1.0 113.155 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.16 -22.32 3.59 Favored Glycine 0 N--CA 1.492 2.393 0 CA-C-O 118.512 -1.16 . . . . 1.0 115.915 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.486 ' H ' ' HD3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -124.56 144.68 50.01 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 118.299 1.05 . . . . 1.0 113.022 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.77 68.85 0.64 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 113.6 -1.636 . . . . 1.0 113.4 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.9 t -133.06 -163.24 1.32 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.494 ' CA ' ' SG ' ' A' ' 35' ' ' CYS . . . 122.65 174.98 14.54 Favored Glycine 0 N--CA 1.495 2.579 0 CA-C-N 114.018 -1.446 . . . . 1.0 113.534 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -121.35 161.32 22.28 Favored 'General case' 0 C--O 1.206 -1.22 0 CA-C-N 113.457 -1.372 . . . . 1.0 109.342 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.1 t -111.67 101.7 10.06 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 103.55 -2.759 . . . . 1.0 103.55 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.414 ' HG1' ' HB2' ' A' ' 34' ' ' ASP . 91.2 m -118.19 121.32 40.2 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 110.944 -2.844 . . . . 1.0 112.997 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.7 t30 45.29 39.82 4.65 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 113.204 -1.816 . . . . 1.0 111.082 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.37 29.43 75.05 Favored Glycine 0 N--CA 1.486 2.029 0 CA-C-N 112.917 -1.947 . . . . 1.0 112.792 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -139.45 153.04 47.48 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.289 -1.745 . . . . 1.0 106.289 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.453 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 6.1 t -73.8 139.01 44.87 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 117.155 2.28 . . . . 1.0 117.155 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.414 ' HB2' ' HG1' ' A' ' 29' ' ' THR . 5.0 m-20 -134.4 80.51 1.86 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 125.54 1.775 . . . . 1.0 107.167 178.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.494 ' SG ' ' CA ' ' A' ' 26' ' ' GLY . 5.8 t . . . . . 0 N--CA 1.501 2.077 0 CA-C-O 116.239 -1.839 . . . . 1.0 111.455 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 48.9 t . . . . . 0 N--CA 1.496 1.846 0 N-CA-C 106.073 -1.825 . . . . 1.0 106.073 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.47 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 37.3 pt -133.7 160.07 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 114.931 1.456 . . . . 1.0 114.931 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.95 42.76 3.18 Favored Glycine 0 C--O 1.21 -1.349 0 CA-C-N 112.153 -2.294 . . . . 1.0 111.873 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -105.15 107.31 18.22 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 101.891 -3.374 . . . . 1.0 101.891 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -39.09 138.91 0.53 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 125.425 1.703 . . . . 1.0 114.083 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.1 t -112.86 153.12 28.39 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.908 -1.496 . . . . 1.0 110.185 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -120.01 -56.87 1.99 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 104.927 -2.249 . . . . 1.0 104.927 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.89 155.08 30.79 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 113.393 -1.731 . . . . 1.0 106.57 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.413 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 71.9 m -24.01 -56.44 0.14 Allowed Pre-proline 0 N--CA 1.506 2.337 0 N-CA-C 115.137 1.532 . . . . 1.0 115.137 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.468 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 70.1 Cg_endo -67.25 -94.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.79 1.66 . . . . 1.0 113.222 170.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t70 40.93 29.53 0.08 Allowed 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.629 1.204 . . . . 1.0 109.9 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 t -166.33 -24.11 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 111.966 -2.379 . . . . 1.0 112.759 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.468 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 6.0 m-30 -38.72 -60.94 0.77 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 112.439 0.533 . . . . 1.0 112.439 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.4 t -44.74 -42.23 7.51 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 125.253 1.596 . . . . 1.0 111.375 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.28 -47.55 60.74 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 115.091 -0.958 . . . . 1.0 109.076 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.1 t -53.99 -40.72 67.17 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.324 -1.362 . . . . 1.0 107.324 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -60.84 -54.24 47.56 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 105.967 -1.864 . . . . 1.0 105.967 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -48.01 -31.71 5.7 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 113.473 -1.694 . . . . 1.0 110.03 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.7 mt -84.33 -50.84 7.46 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.569 0.952 . . . . 1.0 113.569 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 p -112.63 -45.66 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 CA-C-N 117.806 0.276 . . . . 1.0 111.159 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.18 18.8 1.46 Allowed Glycine 0 N--CA 1.491 2.324 0 CA-C-O 119.067 -0.852 . . . . 1.0 114.774 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -133.58 126.09 30.22 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 117.291 0.545 . . . . 1.0 112.207 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.43 68.78 0.8 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 124.88 1.362 . . . . 1.0 109.793 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.45 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 9.7 t -135.94 -171.53 2.89 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.679 -0.691 . . . . 1.0 110.088 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.75 -179.31 16.19 Favored Glycine 0 N--CA 1.493 2.467 0 CA-C-N 113.546 -1.661 . . . . 1.0 113.371 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -131.68 171.87 12.95 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 113.982 -1.109 . . . . 1.0 110.845 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.2 t -115.27 112.12 21.95 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 100.375 -3.935 . . . . 1.0 100.375 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.431 ' HG1' ' HB3' ' A' ' 34' ' ' ASP . 55.2 m -132.12 127.8 36.78 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 112.227 -2.261 . . . . 1.0 107.929 -179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.4 p30 46.41 43.89 12.33 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 125.929 2.018 . . . . 1.0 111.903 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.42 13.87 46.14 Favored Glycine 0 N--CA 1.479 1.547 0 CA-C-N 112.876 -1.965 . . . . 1.0 112.463 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.6 mtt-85 -128.21 163.66 24.22 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.863 -1.162 . . . . 1.0 107.863 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.47 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 9.4 t -72.93 142.17 47.84 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 114.702 1.371 . . . . 1.0 114.702 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 35.6 t70 -135.29 76.69 1.63 Allowed 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 112.454 -2.157 . . . . 1.0 107.324 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 25' ' ' THR . 23.6 t . . . . . 0 N--CA 1.502 2.125 0 CA-C-O 118.261 -0.876 . . . . 1.0 111.306 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.3 p . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 108.31 -0.996 . . . . 1.0 108.31 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.409 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 16.5 pt -133.7 163.08 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 115.214 1.561 . . . . 1.0 115.214 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.42 -46.86 36.34 Favored Glycine 0 N--CA 1.478 1.472 0 CA-C-N 111.036 -2.802 . . . . 1.0 112.528 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -19.83 92.71 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 O-C-N 125.926 1.604 . . . . 1.0 114.085 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -48.17 141.81 5.92 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 124.603 1.19 . . . . 1.0 109.662 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.7 p -123.36 160.55 26.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 124.154 0.909 . . . . 1.0 113.234 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -118.1 -58.57 1.99 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 104.454 -2.424 . . . . 1.0 104.454 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -112.73 166.45 11.35 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 126.166 2.166 . . . . 1.0 106.638 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.415 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 75.4 m -33.66 -61.24 0.4 Allowed Pre-proline 0 N--CA 1.502 2.139 0 N-CA-C 114.614 1.339 . . . . 1.0 114.614 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.417 ' C ' ' N ' ' A' ' 13' ' ' CYS . 73.2 Cg_endo -61.33 -92.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 121.255 1.304 . . . . 1.0 110.315 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t0 34.77 36.96 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 123.812 1.767 . . . . 1.0 108.765 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.417 ' N ' ' C ' ' A' ' 11' ' ' PRO . 48.5 t -168.72 -26.23 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 110.444 -3.071 . . . . 1.0 111.465 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -37.93 -56.66 1.1 Allowed 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 123.439 0.695 . . . . 1.0 111.489 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 55.0 m -54.63 -40.42 68.93 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 124.391 1.057 . . . . 1.0 111.892 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.96 -52.38 24.84 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 123.591 0.557 . . . . 1.0 110.71 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 t -60.28 -27.73 67.52 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.129 -1.063 . . . . 1.0 108.129 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.405 ' HZ2' ' N ' ' A' ' 24' ' ' ALA . 24.6 ttmm -70.38 -50.33 39.82 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.769 -1.567 . . . . 1.0 106.769 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -59.81 -29.13 68.02 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 112.77 -2.014 . . . . 1.0 113.085 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -102.02 -35.46 8.95 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.54 1.682 . . . . 1.0 115.54 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.7 t -104.97 -40.49 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 123.61 0.568 . . . . 1.0 110.049 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.12 -29.18 3.09 Favored Glycine 0 N--CA 1.486 1.986 0 CA-C-O 118.894 -0.948 . . . . 1.0 114.166 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -124.77 159.25 31.39 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.095 1.517 . . . . 1.0 115.095 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.405 ' N ' ' HZ2' ' A' ' 18' ' ' LYS . . . -71.03 71.96 0.57 Allowed 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 113.554 -1.657 . . . . 1.0 113.46 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.469 ' H ' ' HG1' ' A' ' 25' ' ' THR . 2.3 p -119.73 172.13 7.9 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.633 -1.167 . . . . 1.0 112.169 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.95 147.26 9.24 Favored Glycine 0 N--CA 1.491 2.34 0 CA-C-N 113.748 -1.569 . . . . 1.0 111.332 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -121.92 173.68 7.36 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 113.326 -1.437 . . . . 1.0 109.646 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.2 t -103.73 112.1 24.89 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 104.268 -2.493 . . . . 1.0 104.268 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.3 m -130.34 130.34 44.31 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 111.857 -2.429 . . . . 1.0 106.45 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 44.06 44.76 6.4 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 125.123 1.514 . . . . 1.0 111.825 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.46 11.76 22.83 Favored Glycine 0 N--CA 1.487 2.068 0 CA-C-N 112.982 -1.917 . . . . 1.0 114.096 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.2 mtp85 -128.06 163.95 23.48 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.409 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 49.5 t -72.41 143.69 48.44 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.212 -1.395 . . . . 1.0 113.819 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 65.2 t0 -133.17 84.08 2.11 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 126.108 2.13 . . . . 1.0 107.077 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' A' ' 25' ' ' THR . 8.8 t . . . . . 0 N--CA 1.503 2.18 0 CA-C-O 118.626 -0.702 . . . . 1.0 110.105 -179.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.8 p . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 108.129 -1.063 . . . . 1.0 108.129 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.431 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 32.7 pt -136.0 160.24 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 N-CA-C 115.794 1.775 . . . . 1.0 115.794 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.21 -44.41 57.51 Favored Glycine 0 N--CA 1.478 1.469 0 CA-C-N 111.093 -2.776 . . . . 1.0 111.183 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -24.42 91.86 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 125.873 1.572 . . . . 1.0 112.856 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -40.0 149.11 0.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 125.263 1.602 . . . . 1.0 112.966 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.412 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 2.1 t -110.1 153.48 24.61 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 124.648 1.218 . . . . 1.0 112.523 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.412 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 1.1 t80 -122.01 -62.35 1.4 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 102.801 -3.037 . . . . 1.0 102.801 179.35 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -119.62 166.11 13.59 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 112.093 -2.321 . . . . 1.0 105.838 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.432 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 75.3 m -33.37 -56.39 0.62 Allowed Pre-proline 0 N--CA 1.505 2.318 0 N-CA-C 114.229 1.196 . . . . 1.0 114.229 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.432 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 88.3 Cg_endo -64.15 -94.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 121.891 1.727 . . . . 1.0 111.826 174.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.0 t70 35.07 36.66 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 CA-C-O 123.844 1.783 . . . . 1.0 109.389 -179.282 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 50.4 t -168.61 -25.25 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 109.8 -3.364 . . . . 1.0 111.567 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -37.86 -57.21 1.04 Allowed 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 122.913 0.485 . . . . 1.0 111.587 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.8 t -49.68 -51.72 36.24 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 125.046 1.466 . . . . 1.0 109.116 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.17 -55.53 32.0 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 120.343 -0.543 . . . . 1.0 112.448 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.7 t -59.2 -27.99 66.23 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 115.397 -0.82 . . . . 1.0 109.499 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -70.12 -46.29 65.08 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 179.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -70.3 -22.6 62.82 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 114.242 -1.344 . . . . 1.0 113.034 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.2 mp -100.03 -33.48 10.47 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 113.911 1.078 . . . . 1.0 113.911 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.0 t -113.06 -43.97 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 124.05 0.844 . . . . 1.0 110.696 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.66 -25.45 3.41 Favored Glycine 0 N--CA 1.49 2.254 0 CA-C-O 119.075 -0.847 . . . . 1.0 114.429 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -120.99 155.87 33.37 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 113.476 0.917 . . . . 1.0 113.476 -179.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.86 69.88 0.71 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 125.084 1.49 . . . . 1.0 109.392 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.8 p -115.32 173.72 6.37 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.496 -1.229 . . . . 1.0 113.273 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.4 152.68 8.81 Favored Glycine 0 N--CA 1.49 2.295 0 CA-C-N 113.844 -1.525 . . . . 1.0 111.199 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -125.1 170.7 10.93 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.342 -1.355 . . . . 1.0 107.342 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.8 t -103.35 109.9 21.69 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.158 -1.793 . . . . 1.0 106.158 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.454 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 56.9 m -133.31 130.73 39.29 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 112.593 -2.094 . . . . 1.0 107.661 -179.379 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 44.64 44.17 7.17 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 125.107 1.504 . . . . 1.0 112.103 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.67 14.84 30.91 Favored Glycine 0 N--CA 1.487 2.063 0 CA-C-N 113.125 -1.852 . . . . 1.0 113.125 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.9 mtt-85 -130.65 165.52 22.66 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.552 -0.907 . . . . 1.0 108.552 179.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.431 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 13.3 t -72.45 144.91 47.93 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.517 -1.273 . . . . 1.0 114.318 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.454 ' CB ' ' HG1' ' A' ' 29' ' ' THR . 36.9 t70 -134.98 82.95 1.99 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 126.385 2.303 . . . . 1.0 107.798 179.003 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.503 2.186 0 CA-C-O 116.237 -1.839 . . . . 1.0 110.405 -179.733 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.3 p . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 108.965 -0.754 . . . . 1.0 108.965 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -131.55 159.12 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 122.278 1.037 . . . . 1.0 113.526 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -39.95 -54.07 3.07 Favored Glycine 0 N--CA 1.483 1.81 0 CA-C-N 111.471 -2.604 . . . . 1.0 112.08 179.528 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -14.0 85.42 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 O-C-N 126.619 2.011 . . . . 1.0 112.923 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -40.15 145.28 0.16 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 113.666 -1.606 . . . . 1.0 112.368 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.5 t -114.91 148.05 39.16 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 124.42 1.075 . . . . 1.0 111.987 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.424 ' HB3' ' HD3' ' A' ' 9' ' ' ARG . 3.7 t80 -123.15 -54.99 1.79 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 103.391 -2.818 . . . . 1.0 103.391 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.424 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -117.13 153.82 32.12 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 113.366 -1.743 . . . . 1.0 107.696 179.665 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.435 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.7 m -28.49 -56.23 0.25 Allowed Pre-proline 0 N--CA 1.504 2.273 0 N-CA-C 114.101 1.149 . . . . 1.0 114.101 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.435 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 86.8 Cg_endo -64.99 -90.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.931 1.754 . . . . 1.0 112.365 170.68 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 t70 36.51 34.93 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 123.572 1.653 . . . . 1.0 109.796 -179.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.7 t -168.45 -26.09 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 110.427 -3.079 . . . . 1.0 111.117 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -38.6 -58.26 1.07 Allowed 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 122.985 0.514 . . . . 1.0 111.812 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 64.8 p -45.48 -45.15 12.97 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 124.672 1.232 . . . . 1.0 110.957 179.396 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.89 -44.64 80.32 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.433 -1.258 . . . . 1.0 111.109 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 25' ' ' THR . 20.2 m -62.8 -32.38 73.54 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.444 -1.253 . . . . 1.0 108.191 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -70.18 -52.59 22.19 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.265 -1.383 . . . . 1.0 107.265 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -11.82 61.17 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 117.638 -1.625 . . . . 1.0 111.653 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 40.9 mt -93.67 -54.97 3.43 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 112.21 0.448 . . . . 1.0 112.21 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.0 m -109.36 -20.32 6.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 118.637 -0.697 . . . . 1.0 112.465 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.46 -33.89 2.59 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 117.83 1.892 . . . . 1.0 117.83 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.431 ' H ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -128.52 162.85 26.26 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 115.458 1.651 . . . . 1.0 115.458 -179.35 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.56 70.63 0.66 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 113.351 -1.749 . . . . 1.0 110.856 179.669 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.422 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 8.2 t -121.58 -177.91 3.67 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.709 0.766 . . . . 1.0 110.687 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.51 174.65 15.24 Favored Glycine 0 N--CA 1.491 2.322 0 CA-C-N 112.941 -1.936 . . . . 1.0 112.096 179.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HG2' ' N ' ' A' ' 28' ' ' CYS . 39.0 ttmt -134.19 167.46 20.64 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.78 -1.21 . . . . 1.0 108.51 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.407 ' N ' ' HG2' ' A' ' 27' ' ' LYS . 50.5 t -108.46 110.01 21.43 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 104.88 -2.267 . . . . 1.0 104.88 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.493 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 88.8 m -128.92 124.71 35.86 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 112.609 -2.087 . . . . 1.0 111.962 -179.557 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 44.32 42.16 5.03 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 112.864 -1.971 . . . . 1.0 111.424 -179.365 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.74 24.81 70.05 Favored Glycine 0 N--CA 1.484 1.854 0 CA-C-N 113.567 -1.651 . . . . 1.0 113.525 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.0 mtp85 -136.53 160.28 39.27 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 107.028 -1.471 . . . . 1.0 107.028 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 21.2 t -72.88 145.3 46.98 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.178 -1.409 . . . . 1.0 112.197 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.493 ' CB ' ' HG1' ' A' ' 29' ' ' THR . 34.3 t70 -129.75 82.58 2.08 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 103.814 -2.662 . . . . 1.0 103.814 178.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.501 2.079 0 CA-C-O 118.366 -0.826 . . . . 1.0 110.604 -179.406 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.3 p . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 109.884 -0.413 . . . . 1.0 109.884 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.467 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 28.2 pt -133.82 162.43 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 N-CA-C 114.195 1.184 . . . . 1.0 114.195 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.66 44.49 3.26 Favored Glycine 0 C--O 1.211 -1.318 0 CA-C-N 112.201 -2.272 . . . . 1.0 111.955 -179.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -103.88 92.26 4.33 Favored 'General case' 0 N--CA 1.486 1.342 1 N-CA-C 99.934 -4.099 . . . . 1.0 99.934 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -38.98 142.31 0.23 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 125.694 1.871 . . . . 1.0 112.576 -179.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 0.5 OUTLIER -112.77 160.46 17.95 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 116.093 1.886 . . . . 1.0 116.093 -179.605 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.525 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 20.3 t80 -121.24 -58.95 1.76 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 102.794 -3.039 . . . . 1.0 102.794 179.652 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.473 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 11.0 mmm180 -118.14 166.33 12.7 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 113.023 -1.898 . . . . 1.0 109.526 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.431 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.7 m -33.06 -58.7 0.46 Allowed Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 124.997 1.435 . . . . 1.0 114.305 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.431 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 91.1 Cg_endo -62.75 -92.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.951 1.767 . . . . 1.0 111.592 177.14 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 t70 38.24 31.52 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 123.368 1.556 . . . . 1.0 109.144 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.412 ' N ' ' C ' ' A' ' 11' ' ' PRO . 49.1 t -171.55 -17.1 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 111.678 -2.51 . . . . 1.0 113.687 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -38.81 -62.01 0.67 Allowed 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 118.936 0.789 . . . . 1.0 110.451 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.3 m -48.7 -47.48 41.03 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.619 1.2 . . . . 1.0 112.077 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.47 -45.07 92.69 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 114.759 -1.109 . . . . 1.0 111.567 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.1 t -62.87 -48.93 76.9 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 105.802 -1.925 . . . . 1.0 105.802 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -47.82 -50.34 26.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 123.373 0.42 . . . . 1.0 110.76 179.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -70.28 -27.63 64.56 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 117.427 -1.709 . . . . 1.0 111.207 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.0 mt -76.44 -50.97 12.75 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.027 1.121 . . . . 1.0 114.027 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 m -109.37 -36.11 2.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 123.66 0.784 . . . . 1.0 111.955 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.51 -20.41 3.92 Favored Glycine 0 N--CA 1.49 2.265 0 CA-C-O 119.083 -0.843 . . . . 1.0 114.726 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -116.98 136.82 52.65 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 112.709 0.633 . . . . 1.0 112.709 -179.467 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.12 68.37 0.71 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 125.125 1.516 . . . . 1.0 110.749 179.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.452 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 11.2 p -121.87 -175.64 3.15 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.294 -1.321 . . . . 1.0 113.032 -179.491 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.36 154.27 10.96 Favored Glycine 0 N--CA 1.492 2.383 0 CA-C-N 114.075 -1.421 . . . . 1.0 112.356 179.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.38 175.91 6.46 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.086 0.946 . . . . 1.0 109.947 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.9 t -97.37 112.03 24.03 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 112.676 -2.056 . . . . 1.0 106.488 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 37.2 m -128.18 119.64 25.67 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 111.971 -2.377 . . . . 1.0 111.933 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 50.24 43.57 26.3 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 113.519 -1.673 . . . . 1.0 108.659 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.95 16.39 57.15 Favored Glycine 0 N--CA 1.486 2.022 0 CA-C-N 113.719 -1.582 . . . . 1.0 114.131 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.8 mtp-105 -131.22 161.32 32.49 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.202 -1.036 . . . . 1.0 108.202 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.467 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 47.3 t -72.56 140.65 48.22 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.724 -1.19 . . . . 1.0 114.143 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 9.4 t70 -135.69 90.63 2.62 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 125.107 1.504 . . . . 1.0 107.13 178.526 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.452 ' SG ' ' C ' ' A' ' 25' ' ' THR . 10.8 t . . . . . 0 N--CA 1.501 2.104 0 CA-C-O 118.588 -0.72 . . . . 1.0 110.313 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 5.8 p . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 108.567 -0.901 . . . . 1.0 108.567 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.455 HG12 ' HB3' ' A' ' 33' ' ' CYS . 35.3 pt -132.02 158.0 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 N-CA-C 114.304 1.224 . . . . 1.0 114.304 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.28 -39.86 73.52 Favored Glycine 0 N--CA 1.488 2.115 0 CA-C-N 111.859 -2.428 . . . . 1.0 111.522 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -28.18 96.59 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 O-C-N 125.867 1.569 . . . . 1.0 111.309 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -39.62 144.1 0.19 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 124.934 1.396 . . . . 1.0 114.447 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.7 p -128.06 157.68 40.03 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.074 -0.966 . . . . 1.0 110.694 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -120.26 -56.69 1.98 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 105.474 -2.047 . . . . 1.0 105.474 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.48 159.9 16.32 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 125.7 1.875 . . . . 1.0 107.158 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.416 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.4 m -35.1 -57.08 0.86 Allowed Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 125.313 1.633 . . . . 1.0 112.894 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.416 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 72.5 Cg_endo -60.54 -91.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.275 1.317 . . . . 1.0 111.056 175.293 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t0 33.47 39.54 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 123.981 1.848 . . . . 1.0 108.794 -179.335 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.9 t -172.75 -26.39 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 109.972 -3.285 . . . . 1.0 110.603 -179.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -38.27 -55.41 1.33 Allowed 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 123.588 0.755 . . . . 1.0 112.084 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.7 p -49.45 -48.98 47.18 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 124.214 0.946 . . . . 1.0 110.68 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.67 -55.26 36.57 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 124.03 0.831 . . . . 1.0 109.58 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 25' ' ' THR . 98.6 m -48.86 -41.56 33.6 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.194 -1.366 . . . . 1.0 111.064 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.409 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 6.6 ttpm? -66.65 -47.01 73.87 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.559 -1.645 . . . . 1.0 106.559 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -70.27 -11.51 60.95 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 113.384 -1.735 . . . . 1.0 112.348 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.3 mt -101.52 -53.28 3.02 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 112.684 0.624 . . . . 1.0 112.684 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.7 m -109.13 -26.35 3.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 119.19 -0.433 . . . . 1.0 111.633 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 126.68 -20.17 6.12 Favored Glycine 0 N--CA 1.493 2.434 0 CA-C-O 119.026 -0.874 . . . . 1.0 114.969 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.48 ' HZ1' ' H ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -122.66 141.84 51.32 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 113.22 0.822 . . . . 1.0 113.22 -179.497 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.99 71.71 0.82 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 125.214 1.571 . . . . 1.0 110.108 179.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.515 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 6.0 t -122.64 179.1 4.73 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.748 0.785 . . . . 1.0 112.036 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.08 167.67 18.88 Favored Glycine 0 N--CA 1.498 2.774 0 CA-C-N 113.271 -1.786 . . . . 1.0 111.813 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.68 175.89 8.93 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.721 0.772 . . . . 1.0 109.955 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.4 t -103.07 116.13 31.93 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 113.31 -1.768 . . . . 1.0 106.44 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.467 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 78.4 m -127.93 127.29 43.07 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 112.525 -2.125 . . . . 1.0 109.747 -179.571 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 47.47 40.59 11.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 125.096 1.498 . . . . 1.0 111.062 -179.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.07 19.88 64.19 Favored Glycine 0 N--CA 1.483 1.832 0 CA-C-N 113.281 -1.781 . . . . 1.0 113.916 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.0 mtt-85 -132.7 162.51 31.22 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.479 -1.304 . . . . 1.0 107.479 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.455 ' HB3' HG12 ' A' ' 3' ' ' ILE . 41.8 t -72.79 143.64 47.83 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.889 -1.124 . . . . 1.0 113.243 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 36.8 t70 -134.75 78.1 1.72 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 104.128 -2.545 . . . . 1.0 104.128 178.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.1 t . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 117.863 -1.065 . . . . 1.0 111.078 -179.408 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 5.7 p . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 108.426 -0.953 . . . . 1.0 108.426 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.439 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 27.4 pt -136.7 164.23 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 N-CA-C 114.809 1.411 . . . . 1.0 114.809 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.35 -43.51 76.06 Favored Glycine 0 N--CA 1.479 1.532 0 CA-C-N 112.051 -2.34 . . . . 1.0 112.08 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -17.14 90.91 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 O-C-N 125.723 1.484 . . . . 1.0 114.12 -179.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -39.96 136.5 1.11 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 125.065 1.478 . . . . 1.0 111.338 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 10.1 t -119.52 159.33 24.53 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 114.276 1.213 . . . . 1.0 114.276 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.503 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 15.4 t80 -120.53 -62.89 1.41 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 105.519 -2.03 . . . . 1.0 105.519 179.728 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.489 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 1.6 mmp_? -113.8 161.67 17.27 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.598 -1.637 . . . . 1.0 108.753 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.1 m -23.84 -59.21 0.12 Allowed Pre-proline 0 N--CA 1.504 2.27 0 N-CA-C 115.695 1.739 . . . . 1.0 115.695 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.415 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 77.5 Cg_endo -66.92 -93.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.157 0 C-N-CA 121.265 1.31 . . . . 1.0 113.86 176.339 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t0 40.23 33.52 0.17 Allowed 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 123.253 1.501 . . . . 1.0 108.942 -179.486 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.1 t -168.74 -24.21 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 111.859 -2.428 . . . . 1.0 112.827 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.415 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.2 m-85 -38.6 -59.72 0.89 Allowed 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 123.159 0.584 . . . . 1.0 111.967 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 77.8 p -48.05 -41.91 27.15 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 124.923 1.39 . . . . 1.0 111.893 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.98 -49.06 55.39 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.637 -0.711 . . . . 1.0 110.735 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 t -60.32 -29.87 69.14 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -70.81 -50.19 38.22 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.302 -1.37 . . . . 1.0 107.302 179.287 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -70.65 -13.4 62.07 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 113.225 -1.807 . . . . 1.0 113.719 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.8 mt -109.93 -43.37 4.01 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.363 0.875 . . . . 1.0 113.363 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.4 t -102.54 -34.71 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 114.859 -1.064 . . . . 1.0 110.323 -179.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.24 -31.65 3.11 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-O 119.105 -0.83 . . . . 1.0 114.175 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -123.6 150.82 43.66 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 113.725 1.009 . . . . 1.0 113.725 -179.348 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.42 72.99 0.71 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 113.827 -1.533 . . . . 1.0 109.815 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.429 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 17.9 p -117.11 -179.0 3.57 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.705 -1.134 . . . . 1.0 112.252 -179.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.03 166.5 13.24 Favored Glycine 0 N--CA 1.494 2.504 0 CA-C-N 114.515 -1.22 . . . . 1.0 115.34 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.43 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -134.05 168.58 18.55 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 112.847 -1.677 . . . . 1.0 107.282 179.696 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.7 t -107.98 104.86 14.4 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 104.471 -2.418 . . . . 1.0 104.471 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.483 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 90.7 m -122.31 124.36 43.56 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 111.575 -2.557 . . . . 1.0 111.208 -179.371 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 46.62 39.86 7.59 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 112.89 -1.959 . . . . 1.0 110.921 -179.321 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.96 27.21 70.96 Favored Glycine 0 N--CA 1.485 1.914 0 CA-C-N 113.106 -1.861 . . . . 1.0 112.513 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.0 mtt-85 -137.36 161.27 36.74 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.334 -1.358 . . . . 1.0 107.334 179.688 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.439 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 46.8 t -72.38 143.39 48.6 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.854 1.057 . . . . 1.0 113.854 179.692 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.483 ' CB ' ' HG1' ' A' ' 29' ' ' THR . 34.2 t70 -136.39 81.99 1.91 Allowed 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.502 -1.681 . . . . 1.0 108.641 178.869 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.429 ' SG ' ' C ' ' A' ' 25' ' ' THR . 12.3 t . . . . . 0 N--CA 1.499 1.994 0 CA-C-O 116.148 -1.882 . . . . 1.0 110.828 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.1 p . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.458 HG12 ' HB3' ' A' ' 33' ' ' CYS . 19.6 pt -125.7 150.61 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-O 122.697 1.237 . . . . 1.0 113.594 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.79 -39.29 46.93 Favored Glycine 0 N--CA 1.479 1.505 0 CA-C-N 110.914 -2.857 . . . . 1.0 112.478 179.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -30.9 93.37 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 125.665 1.45 . . . . 1.0 112.89 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -40.44 144.38 0.24 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 124.879 1.362 . . . . 1.0 111.997 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.0 p -121.42 160.69 23.59 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 124.039 0.837 . . . . 1.0 110.985 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -119.96 -57.68 1.93 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.578 -1.267 . . . . 1.0 107.578 -179.953 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.18 164.87 11.92 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 113.269 -1.787 . . . . 1.0 107.152 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.449 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.1 m -39.25 -56.5 2.64 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 124.782 1.301 . . . . 1.0 112.095 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.449 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 84.0 Cg_endo -64.83 -93.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 121.252 1.301 . . . . 1.0 111.238 173.048 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.8 t70 35.51 35.12 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 125.411 1.695 . . . . 1.0 109.635 -179.614 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.404 ' N ' ' C ' ' A' ' 11' ' ' PRO . 36.7 t -167.74 -28.79 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 110.399 -3.092 . . . . 1.0 110.37 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -37.62 -52.24 1.21 Allowed 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 123.822 0.849 . . . . 1.0 112.438 179.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.8 m -56.51 -61.1 2.65 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.994 -0.743 . . . . 1.0 108.994 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.93 -54.69 5.14 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 124.314 1.008 . . . . 1.0 111.052 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 25' ' ' THR . 17.4 m -49.48 -54.42 17.88 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 113.366 -1.743 . . . . 1.0 107.601 179.473 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -50.01 -47.78 52.88 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 179.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -19.74 63.1 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 114.972 -1.013 . . . . 1.0 112.489 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.8 mt -92.41 -50.27 5.72 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 114.478 1.288 . . . . 1.0 114.478 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.5 m -105.51 -30.56 2.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 C-N-CA 123.477 0.711 . . . . 1.0 111.293 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.72 -28.12 3.43 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 116.165 1.226 . . . . 1.0 116.165 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -124.5 156.03 37.96 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 114.161 1.171 . . . . 1.0 114.161 -179.341 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.45 72.85 0.72 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 113.803 -1.544 . . . . 1.0 110.218 179.781 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.504 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 7.5 t -128.41 -176.26 3.76 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.745 0.783 . . . . 1.0 110.431 -179.839 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.5 160.33 30.04 Favored Glycine 0 N--CA 1.494 2.515 0 CA-C-N 113.411 -1.722 . . . . 1.0 109.605 179.713 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.85 -172.39 2.86 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.333 1.063 . . . . 1.0 111.127 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.1 t -110.92 114.81 28.41 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 111.482 -2.599 . . . . 1.0 107.398 179.571 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.469 ' HG1' ' CG ' ' A' ' 34' ' ' ASP . 20.2 m -139.64 133.25 30.39 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 113.161 -1.836 . . . . 1.0 109.286 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 49.22 42.19 21.21 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 113.958 -1.474 . . . . 1.0 108.208 -179.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 58.41 14.57 20.67 Favored Glycine 0 N--CA 1.49 2.287 0 CA-C-N 113.745 -1.57 . . . . 1.0 114.871 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.6 mtp-105 -130.45 160.01 35.35 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.112 -1.44 . . . . 1.0 107.112 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.458 ' HB3' HG12 ' A' ' 3' ' ' ILE . 14.6 t -73.38 143.17 46.93 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.136 -1.426 . . . . 1.0 113.381 -179.937 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.469 ' CG ' ' HG1' ' A' ' 29' ' ' THR . 5.1 p-10 -129.05 88.18 2.67 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 101.23 -3.619 . . . . 1.0 101.23 178.43 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.502 2.134 0 CA-C-O 117.001 -1.476 . . . . 1.0 111.535 -179.482 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.0 p . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 108.518 -0.919 . . . . 1.0 108.518 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.413 HG12 ' HB3' ' A' ' 33' ' ' CYS . 19.1 pt -134.39 165.26 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 N-CA-C 115.148 1.536 . . . . 1.0 115.148 -179.871 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -53.14 -48.0 59.76 Favored Glycine 0 N--CA 1.478 1.465 0 CA-C-N 111.096 -2.775 . . . . 1.0 111.575 179.847 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -20.51 86.49 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.474 0 O-C-N 125.882 1.578 . . . . 1.0 113.034 -179.917 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -40.0 146.58 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.097 -1.411 . . . . 1.0 112.37 -179.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.404 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 5.6 t -110.09 152.36 26.08 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 124.582 1.176 . . . . 1.0 113.465 -179.918 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.404 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 1.8 t80 -125.39 -58.73 1.42 Allowed 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 102.465 -3.161 . . . . 1.0 102.465 179.498 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.04 161.0 20.99 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.376 -1.712 . . . . 1.0 106.376 179.306 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.456 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 73.2 m -30.96 -57.39 0.36 Allowed Pre-proline 0 N--CA 1.506 2.369 0 N-CA-C 114.429 1.27 . . . . 1.0 114.429 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.456 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 83.9 Cg_endo -63.93 -93.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.919 1.746 . . . . 1.0 111.17 173.763 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 t70 36.55 34.12 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 CA-C-O 123.294 1.521 . . . . 1.0 109.375 -179.483 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.422 ' N ' ' C ' ' A' ' 11' ' ' PRO . 54.0 t -169.26 -21.59 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 110.579 -3.009 . . . . 1.0 112.453 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -38.65 -58.51 1.04 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 118.469 0.577 . . . . 1.0 111.64 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.2 t -50.32 -39.64 46.53 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.963 1.414 . . . . 1.0 111.828 179.574 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.16 -48.71 56.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 123.516 0.51 . . . . 1.0 111.137 179.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.0 t -61.94 -32.91 73.37 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.425 -1.324 . . . . 1.0 107.425 179.705 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.485 ' HZ2' ' N ' ' A' ' 24' ' ' ALA . 24.7 ttmm -65.04 -53.72 41.41 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 105.62 -1.992 . . . . 1.0 105.62 179.594 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -50.26 -35.56 27.54 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 114.181 -1.372 . . . . 1.0 109.189 179.692 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.0 tp -67.66 -60.06 2.84 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 114.824 -1.08 . . . . 1.0 111.669 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.09 -48.48 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 124.253 0.97 . . . . 1.0 113.046 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 133.45 23.98 0.71 Allowed Glycine 0 N--CA 1.492 2.376 0 O-C-N 123.417 0.448 . . . . 1.0 113.484 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -133.46 131.37 39.82 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.481 -0.563 . . . . 1.0 109.481 179.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.485 ' N ' ' HZ2' ' A' ' 18' ' ' LYS . . . -72.18 68.06 0.7 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 124.722 1.264 . . . . 1.0 109.63 179.364 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.6 p -115.37 174.92 5.75 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.482 -1.235 . . . . 1.0 112.895 -179.647 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.51 152.89 8.57 Favored Glycine 0 N--CA 1.489 2.213 0 CA-C-N 113.74 -1.573 . . . . 1.0 111.605 179.72 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -122.71 174.78 6.89 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 113.637 -1.282 . . . . 1.0 108.245 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.2 t -110.17 109.06 19.43 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 105.36 -2.089 . . . . 1.0 105.36 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.466 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 60.2 m -133.07 126.08 31.03 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 112.264 -2.244 . . . . 1.0 108.382 -179.61 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.3 p30 47.52 41.3 12.86 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 125.907 2.004 . . . . 1.0 112.345 -179.459 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.63 13.77 59.3 Favored Glycine 0 N--CA 1.478 1.435 0 CA-C-N 113.15 -1.841 . . . . 1.0 112.145 -179.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.7 mmt-85 -128.6 161.94 28.45 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.668 -0.864 . . . . 1.0 108.668 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.413 ' HB3' HG12 ' A' ' 3' ' ' ILE . 12.5 t -72.6 143.56 48.18 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.461 -1.296 . . . . 1.0 113.392 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.466 ' CB ' ' HG1' ' A' ' 29' ' ' THR . 9.9 t70 -134.16 84.31 2.11 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 125.971 2.045 . . . . 1.0 106.555 179.117 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.503 2.203 0 CA-C-O 118.415 -0.802 . . . . 1.0 110.472 -179.784 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.7 p . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.45 -0.574 . . . . 1.0 109.45 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.458 HG12 ' HB3' ' A' ' 33' ' ' CYS . 15.6 pt -128.19 152.89 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 122.265 1.031 . . . . 1.0 113.719 -179.883 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -46.91 -41.35 13.66 Favored Glycine 0 N--CA 1.489 2.191 0 CA-C-N 111.15 -2.75 . . . . 1.0 112.717 179.864 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.403 HE22 ' HA ' ' A' ' 13' ' ' CYS . 1.2 tm0? -28.46 99.79 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 125.501 1.353 . . . . 1.0 112.215 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -39.96 147.36 0.09 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 124.824 1.327 . . . . 1.0 113.711 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.462 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 5.2 t -113.77 157.74 21.87 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.998 -1.001 . . . . 1.0 110.985 -179.95 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.462 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.1 t80 -119.65 -62.79 1.45 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 103.189 -2.893 . . . . 1.0 103.189 179.731 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -124.97 171.45 10.2 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.141 -1.39 . . . . 1.0 107.946 179.65 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 61.1 m -31.69 -56.34 0.44 Allowed Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 125.07 1.482 . . . . 1.0 114.045 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -68.94 -94.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.674 1.583 . . . . 1.0 113.748 173.058 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.2 t70 38.17 32.54 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 CA-C-O 123.158 1.456 . . . . 1.0 109.806 -179.461 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.403 ' HA ' HE22 ' A' ' 5' ' ' GLN . 22.3 t -165.44 -25.74 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 111.341 -2.663 . . . . 1.0 111.618 -179.912 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -38.79 -59.83 0.91 Allowed 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 123.131 0.572 . . . . 1.0 112.466 179.717 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.6 m -45.13 -43.85 10.14 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 124.805 1.316 . . . . 1.0 110.987 179.609 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.02 -50.85 60.77 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.954 -1.021 . . . . 1.0 109.817 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.1 m -54.0 -34.58 60.24 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.755 -1.111 . . . . 1.0 110.276 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -70.65 -51.19 29.52 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.012 -1.848 . . . . 1.0 106.012 179.425 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -70.73 -8.95 55.98 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 113.653 -1.612 . . . . 1.0 113.049 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.72 -51.56 3.16 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 123.4 0.437 . . . . 1.0 110.096 -179.78 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.8 t -104.91 -35.73 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 114.727 -1.124 . . . . 1.0 112.437 -179.319 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 139.42 -30.56 2.41 Favored Glycine 0 N--CA 1.485 1.931 0 CA-C-O 118.676 -1.069 . . . . 1.0 114.667 179.779 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -123.01 150.65 42.75 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 114.424 1.268 . . . . 1.0 114.424 -179.529 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.5 70.49 0.64 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 113.504 -1.68 . . . . 1.0 112.022 179.76 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.9 t -124.12 -174.79 3.08 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.931 0.872 . . . . 1.0 110.791 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.38 -178.75 16.32 Favored Glycine 0 N--CA 1.492 2.425 0 CA-C-N 113.007 -1.906 . . . . 1.0 112.125 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.483 ' NZ ' ' H ' ' A' ' 28' ' ' CYS . 0.2 OUTLIER -143.46 170.65 15.4 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.78 -1.21 . . . . 1.0 108.245 179.94 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.483 ' H ' ' NZ ' ' A' ' 27' ' ' LYS . 49.4 t -108.87 115.27 29.76 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.203 -1.777 . . . . 1.0 106.203 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.463 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 95.3 m -132.33 128.48 37.78 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 113.142 -1.845 . . . . 1.0 112.28 -179.632 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 46.67 40.52 8.71 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 113.571 -1.649 . . . . 1.0 110.312 -179.707 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.55 28.22 64.78 Favored Glycine 0 N--CA 1.487 2.07 0 CA-C-N 113.544 -1.662 . . . . 1.0 112.705 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.6 mtt-85 -136.83 163.74 29.94 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.3 -1.741 . . . . 1.0 106.3 179.682 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.458 ' HB3' HG12 ' A' ' 3' ' ' ILE . 30.5 t -72.76 144.84 47.46 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 118.612 -1.235 . . . . 1.0 112.777 179.682 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.463 ' CB ' ' HG1' ' A' ' 29' ' ' THR . 11.3 t70 -129.95 81.64 2.02 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 105.595 -2.002 . . . . 1.0 105.595 178.722 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.502 2.145 0 C-N-CA 119.259 -0.976 . . . . 1.0 110.305 -179.496 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.7 p . . . . . 0 N--CA 1.497 1.913 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.438 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 24.1 pt -137.17 165.3 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 N-CA-C 116.575 2.065 . . . . 1.0 116.575 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.77 -48.41 36.87 Favored Glycine 0 N--CA 1.477 1.422 0 CA-C-N 109.94 -3.3 . . . . 1.0 111.347 179.643 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -23.44 89.77 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 O-C-N 125.787 1.522 . . . . 1.0 113.083 -179.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 -47.69 148.66 1.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.409 -1.269 . . . . 1.0 110.838 179.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 8.7 t -117.11 156.36 27.74 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.982 1.104 . . . . 1.0 113.982 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.45 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.9 t80 -123.36 -56.76 1.7 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 105.104 -2.184 . . . . 1.0 105.104 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.32 152.13 34.5 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 112.879 -1.964 . . . . 1.0 108.102 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.419 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.4 m -22.67 -59.07 0.1 OUTLIER Pre-proline 0 N--CA 1.506 2.369 0 N-CA-C 115.581 1.697 . . . . 1.0 115.581 -179.857 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.452 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 98.6 Cg_endo -65.67 -91.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.45 1.433 . . . . 1.0 113.223 174.161 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.4 t70 41.0 30.74 0.11 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 123.023 1.392 . . . . 1.0 109.166 -179.56 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.3 t -167.3 -24.88 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 112.294 -2.23 . . . . 1.0 112.737 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.452 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.2 m-85 -38.93 -59.59 0.95 Allowed 'General case' 0 N--CA 1.505 2.315 0 C-N-CA 122.947 0.499 . . . . 1.0 111.81 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 p -48.75 -39.88 26.62 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 125.01 1.444 . . . . 1.0 111.776 179.63 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.19 -50.38 40.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 123.999 0.812 . . . . 1.0 110.662 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.7 t -60.09 -30.01 68.96 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.537 -0.912 . . . . 1.0 108.537 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -70.44 -49.87 44.26 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.884 -1.154 . . . . 1.0 107.884 179.211 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -70.4 -15.11 62.8 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.102 -1.863 . . . . 1.0 113.06 -179.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.8 mt -108.41 -43.36 4.35 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 113.852 1.056 . . . . 1.0 113.852 -179.745 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.4 t -101.46 -35.29 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-N 114.802 -1.09 . . . . 1.0 110.081 -179.724 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.23 -32.14 2.9 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 120.69 -0.767 . . . . 1.0 114.106 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.415 ' HZ1' ' CG2' ' A' ' 25' ' ' THR . 12.1 ptmm? -125.72 153.41 43.97 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 113.722 1.008 . . . . 1.0 113.722 -179.465 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.79 74.59 0.6 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 113.818 -1.537 . . . . 1.0 113.556 -179.735 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.432 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 0.9 OUTLIER -120.7 -178.27 3.68 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.705 -1.134 . . . . 1.0 111.333 179.906 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.71 163.1 11.83 Favored Glycine 0 N--CA 1.492 2.432 0 CA-C-N 114.351 -1.295 . . . . 1.0 113.35 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -131.53 166.13 22.05 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 113.636 -1.282 . . . . 1.0 108.167 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.6 t -103.32 94.64 5.61 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 103.138 -2.912 . . . . 1.0 103.138 179.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 83.1 m -112.97 115.1 27.86 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 109.984 -3.28 . . . . 1.0 112.482 -179.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 48.75 41.11 17.48 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 111.453 -2.612 . . . . 1.0 108.739 -179.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.0 28.31 72.61 Favored Glycine 0 N--CA 1.482 1.74 0 CA-C-N 113.364 -1.743 . . . . 1.0 112.434 -179.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -137.6 157.25 46.91 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 106.173 -1.788 . . . . 1.0 106.173 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.438 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 34.5 t -72.78 140.74 47.92 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.451 -1.3 . . . . 1.0 113.913 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 25.6 t70 -135.55 86.56 2.25 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 125.382 1.676 . . . . 1.0 108.54 178.729 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.432 ' SG ' ' C ' ' A' ' 25' ' ' THR . 8.1 t . . . . . 0 N--CA 1.5 2.058 0 CA-C-O 116.292 -1.813 . . . . 1.0 110.58 -179.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.2 p . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 108.299 -1.0 . . . . 1.0 108.299 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.447 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 27.8 pt -131.47 164.53 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 113.7 1.0 . . . . 1.0 113.7 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.99 44.88 3.43 Favored Glycine 0 C--O 1.21 -1.393 0 CA-C-N 112.595 -2.093 . . . . 1.0 112.124 -179.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -100.27 104.94 16.45 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 102.699 -3.074 . . . . 1.0 102.699 179.59 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -39.01 129.39 1.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 113.229 -1.805 . . . . 1.0 112.7 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 24.0 t -120.93 163.09 18.77 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.481 -1.691 . . . . 1.0 112.372 179.794 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.519 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 13.2 t80 -119.8 -64.8 1.22 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 104.855 -2.276 . . . . 1.0 104.855 179.676 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.448 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -119.62 163.69 16.99 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 112.468 -2.151 . . . . 1.0 111.897 179.736 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.3 m -16.49 -62.79 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.231 0 N-CA-C 117.566 2.432 . . . . 1.0 117.566 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.421 ' HG2' ' H ' ' A' ' 12' ' ' ASP . 71.3 Cg_endo -68.48 -92.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 121.343 1.362 . . . . 1.0 112.213 178.837 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.421 ' H ' ' HG2' ' A' ' 11' ' ' PRO . 4.1 t0 36.63 35.18 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 123.502 1.62 . . . . 1.0 109.961 -179.671 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.0 t -168.3 -23.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 110.761 -2.927 . . . . 1.0 111.764 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -38.35 -56.53 1.23 Allowed 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 123.955 0.902 . . . . 1.0 113.225 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.0 t -46.08 -53.26 10.56 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 124.685 1.24 . . . . 1.0 109.326 179.496 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.07 -39.62 90.58 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 113.73 -1.577 . . . . 1.0 112.292 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 25' ' ' THR . 60.0 m -69.14 -28.68 66.66 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.842 -1.072 . . . . 1.0 108.576 179.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -71.05 -52.78 17.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.061 -1.459 . . . . 1.0 107.061 179.319 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -71.04 -19.86 62.45 Favored 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 118.091 -1.444 . . . . 1.0 114.767 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -105.92 -33.79 7.83 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 113.313 0.857 . . . . 1.0 113.313 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 t -106.89 -30.97 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 123.722 0.638 . . . . 1.0 110.07 -179.563 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.67 -34.91 2.77 Favored Glycine 0 N--CA 1.49 2.249 0 O-C-N 123.855 0.722 . . . . 1.0 114.584 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -135.81 169.29 17.8 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 113.245 0.831 . . . . 1.0 113.245 -179.363 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.86 69.33 0.69 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 113.683 -1.598 . . . . 1.0 110.797 179.521 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.5 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 4.5 t -121.67 179.01 4.61 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.61 -179.818 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.97 175.06 18.9 Favored Glycine 0 N--CA 1.493 2.459 0 CA-C-N 113.292 -1.776 . . . . 1.0 111.965 179.847 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.94 175.65 9.04 Favored 'General case' 0 C--O 1.205 -1.277 0 CA-C-O 122.074 0.94 . . . . 1.0 112.73 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.7 t -114.63 109.44 18.23 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 112.396 -2.183 . . . . 1.0 105.429 -179.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.523 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 97.9 m -126.47 126.44 43.76 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 112.103 -2.317 . . . . 1.0 110.952 -179.501 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 m120 45.18 40.86 5.3 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 113.464 -1.698 . . . . 1.0 111.52 -179.52 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.1 27.42 68.89 Favored Glycine 0 N--CA 1.485 1.942 0 CA-C-N 113.415 -1.72 . . . . 1.0 112.412 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.6 mtt-85 -136.63 160.54 38.5 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.385 -1.709 . . . . 1.0 106.385 179.796 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.447 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 38.9 t -73.06 144.52 47.04 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.609 -1.237 . . . . 1.0 113.076 179.869 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.523 ' CB ' ' HG1' ' A' ' 29' ' ' THR . 32.6 t70 -133.89 76.45 1.66 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.048 -2.204 . . . . 1.0 105.048 178.742 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.1 t . . . . . 0 N--CA 1.501 2.1 0 CA-C-O 117.761 -1.114 . . . . 1.0 111.34 -179.341 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.418 ' H1 ' ' HB3' ' A' ' 35' ' ' CYS . 14.1 t . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 108.555 -0.906 . . . . 1.0 108.555 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.7 p -71.05 123.17 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 114.477 -1.238 . . . . 1.0 109.688 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.454 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 14.6 pt -125.59 159.66 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 122.818 1.294 . . . . 1.0 113.348 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.74 43.71 3.27 Favored Glycine 0 C--O 1.204 -1.731 0 CA-C-N 112.029 -2.35 . . . . 1.0 113.389 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -105.83 88.23 2.77 Favored 'General case' 0 C--N 1.308 -1.208 1 N-CA-C 98.638 -4.578 . . . . 1.0 98.638 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -38.94 147.19 0.06 Allowed 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 113.275 -1.784 . . . . 1.0 113.401 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 0.5 OUTLIER -112.49 160.64 17.58 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 116.919 2.192 . . . . 1.0 116.919 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.533 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.7 t80 -123.11 -58.68 1.63 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 103.301 -2.851 . . . . 1.0 103.301 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.413 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 42.6 mtt85 -116.36 165.2 13.48 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 112.689 -2.05 . . . . 1.0 110.018 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.412 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 67.3 m -34.73 -59.2 0.62 Allowed Pre-proline 0 N--CA 1.503 2.216 0 O-C-N 124.731 1.269 . . . . 1.0 113.54 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.412 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 88.2 Cg_endo -62.18 -86.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.056 0 C-N-CA 121.976 1.784 . . . . 1.0 112.253 176.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t70 34.16 36.89 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 CA-C-O 124.305 2.002 . . . . 1.0 109.129 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.402 ' N ' ' C ' ' A' ' 11' ' ' PRO . 15.9 t -170.05 -27.18 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 110.21 -3.177 . . . . 1.0 111.502 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -38.2 -55.45 1.3 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 123.712 0.632 . . . . 1.0 112.18 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 61.8 m -50.49 -51.78 44.3 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 124.386 1.054 . . . . 1.0 110.074 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.18 -47.54 83.09 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 122.825 1.297 . . . . 1.0 111.515 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 25' ' ' THR . 35.5 m -58.68 -39.55 81.02 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 113.735 -1.575 . . . . 1.0 108.688 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -64.7 -52.16 58.65 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.282 -1.377 . . . . 1.0 107.282 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -10.72 60.21 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 117.677 -1.609 . . . . 1.0 113.129 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.7 mt -92.61 -50.35 5.64 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 119.409 -0.329 . . . . 1.0 111.549 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.7 p -114.07 -32.38 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 123.481 0.488 . . . . 1.0 110.69 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.99 -19.75 3.67 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 116.031 1.172 . . . . 1.0 116.031 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -128.42 151.28 49.56 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 114.54 1.311 . . . . 1.0 114.54 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.2 70.76 0.84 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 113.784 -1.553 . . . . 1.0 110.403 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.512 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 5.1 t -122.9 176.39 6.03 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.9 0.857 . . . . 1.0 112.298 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.69 160.37 27.81 Favored Glycine 0 N--CA 1.493 2.467 0 CA-C-N 112.671 -2.058 . . . . 1.0 110.197 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.4 -178.33 4.72 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.359 1.076 . . . . 1.0 112.824 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 38.7 t -90.12 109.39 20.45 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 111.895 -2.411 . . . . 1.0 107.809 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.0 m -126.34 119.53 27.58 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 111.679 -2.509 . . . . 1.0 110.992 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 50.33 43.43 26.63 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.453 -1.703 . . . . 1.0 109.013 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.94 20.55 53.65 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-N 113.623 -1.626 . . . . 1.0 113.026 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.0 mtt85 -132.86 160.87 35.7 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.095 -1.446 . . . . 1.0 107.095 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.454 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 42.9 t -73.22 142.07 47.31 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 118.381 -1.328 . . . . 1.0 114.005 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 18.9 t70 -128.01 85.94 2.41 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 102.822 -3.029 . . . . 1.0 102.822 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.418 ' HB3' ' H1 ' ' A' ' 1' ' ' VAL . 5.8 t . . . . . 0 N--CA 1.501 2.106 0 CA-C-O 116.75 -1.595 . . . . 1.0 111.47 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.478 0.656 . . . . 1.0 111.857 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 48.9 t -70.7 119.88 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 107.115 -1.439 . . . . 1.0 107.115 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.46 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 30.1 pt -129.58 163.37 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 114.301 1.223 . . . . 1.0 114.301 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.97 43.76 3.29 Favored Glycine 0 C--O 1.213 -1.196 0 CA-C-N 112.188 -2.278 . . . . 1.0 112.436 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -106.3 100.3 9.84 Favored 'General case' 0 N--CA 1.486 1.348 1 N-CA-C 99.919 -4.104 . . . . 1.0 99.919 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.486 ' HE ' HH22 ' A' ' 32' ' ' ARG . 64.6 mtt85 -38.94 144.5 0.12 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 125.253 1.596 . . . . 1.0 114.58 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.7 t -110.7 156.06 21.56 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.255 -1.793 . . . . 1.0 111.505 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -120.81 -61.9 1.51 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 103.88 -2.637 . . . . 1.0 103.88 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -118.71 167.58 11.53 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 112.861 -1.972 . . . . 1.0 107.558 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.7 m -26.57 -49.64 0.18 Allowed Pre-proline 0 N--CA 1.507 2.376 0 N-CA-C 115.015 1.487 . . . . 1.0 115.015 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.424 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . 0.9 OUTLIER -88.86 -83.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.319 -0.977 0 C-N-CA 121.864 1.709 . . . . 1.0 108.639 -176.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.9 t70 37.1 32.43 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 123.149 1.452 . . . . 1.0 110.104 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.551 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 41.8 t -164.6 -26.17 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 111.3 -2.682 . . . . 1.0 112.95 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.424 ' CD1' ' HB3' ' A' ' 11' ' ' PRO . 3.3 m-85 -38.19 -55.18 1.33 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 123.988 0.915 . . . . 1.0 113.072 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 55.5 m -47.7 -53.63 14.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 124.861 1.35 . . . . 1.0 108.648 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.09 -51.05 70.83 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.04 -0.982 . . . . 1.0 111.035 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.551 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 94.6 m -54.57 -33.48 60.33 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.247 -1.342 . . . . 1.0 109.695 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -70.67 -48.92 52.33 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.057 -1.831 . . . . 1.0 106.057 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -70.45 -14.13 62.41 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-N 114.551 -1.204 . . . . 1.0 113.538 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.7 mt -107.14 -44.08 4.46 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 113.578 0.955 . . . . 1.0 113.578 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 37.1 t -99.67 -36.56 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-N 114.647 -1.16 . . . . 1.0 109.782 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.76 -30.23 3.43 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 120.615 -0.802 . . . . 1.0 113.974 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -128.01 151.06 49.61 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 114.077 1.14 . . . . 1.0 114.077 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.39 77.06 0.76 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 114.118 -1.401 . . . . 1.0 109.327 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.1 t -128.71 -172.87 2.82 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.766 -0.652 . . . . 1.0 109.324 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.645 ' HA3' ' SG ' ' A' ' 35' ' ' CYS . . . 118.89 -179.37 16.8 Favored Glycine 0 N--CA 1.493 2.458 0 CA-C-N 113.217 -1.81 . . . . 1.0 115.902 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -142.74 168.38 19.86 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 112.296 -1.952 . . . . 1.0 107.012 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.3 t -105.63 115.03 29.55 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 105.031 -2.211 . . . . 1.0 105.031 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.419 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 92.2 m -128.23 123.76 34.99 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 112.923 -1.944 . . . . 1.0 112.48 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 45.98 42.14 8.99 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 112.92 -1.945 . . . . 1.0 110.076 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.18 27.46 67.47 Favored Glycine 0 N--CA 1.489 2.171 0 CA-C-N 113.769 -1.56 . . . . 1.0 112.752 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.486 HH22 ' HE ' ' A' ' 6' ' ' ARG . 36.0 mmt180 -135.78 161.87 34.37 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 106.308 -1.738 . . . . 1.0 106.308 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.46 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 13.8 t -73.4 142.43 46.97 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 114.807 1.41 . . . . 1.0 114.807 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 11.3 t70 -130.45 79.78 1.92 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 125.791 1.932 . . . . 1.0 108.227 178.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.645 ' SG ' ' HA3' ' A' ' 26' ' ' GLY . 1.3 m . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 118.136 -0.935 . . . . 1.0 111.067 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.582 0.706 . . . . 1.0 111.559 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 52.7 t -71.14 117.06 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 113.838 -1.528 . . . . 1.0 107.413 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.44 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 33.5 pt -134.03 163.63 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 115.563 1.69 . . . . 1.0 115.563 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.12 -44.63 88.55 Favored Glycine 0 N--CA 1.478 1.46 0 CA-C-N 111.499 -2.591 . . . . 1.0 110.791 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -28.37 90.5 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.455 0 O-C-N 126.096 1.704 . . . . 1.0 110.755 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -39.94 146.88 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.832 1.419 . . . . 1.0 114.832 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.8 p -125.67 159.25 32.72 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.376 -1.284 . . . . 1.0 110.057 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -119.41 -55.21 2.14 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 106.177 -1.786 . . . . 1.0 106.177 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.14 162.08 15.29 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 113.048 -1.887 . . . . 1.0 106.719 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.4 m -30.85 -55.8 0.38 Allowed Pre-proline 0 N--CA 1.503 2.199 0 O-C-N 125.091 1.494 . . . . 1.0 113.533 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.481 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 53.9 Cg_endo -70.19 -95.05 0.01 OUTLIER 'Trans proline' 0 C--O 1.205 -1.141 0 C-N-CA 121.248 1.299 . . . . 1.0 113.946 170.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 t70 39.99 32.82 0.12 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 124.862 1.351 . . . . 1.0 109.593 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.2 t -167.59 -25.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 111.809 -2.45 . . . . 1.0 112.392 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.481 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.5 m-30 -38.5 -59.15 0.94 Allowed 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 123.698 0.799 . . . . 1.0 112.173 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.9 p -45.92 -46.22 15.92 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 125.162 1.539 . . . . 1.0 111.37 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.8 -41.76 87.05 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.428 -1.26 . . . . 1.0 111.231 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.8 t -69.34 -27.46 65.38 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.267 -0.879 . . . . 1.0 109.025 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -70.17 -53.63 16.35 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.955 -1.498 . . . . 1.0 106.955 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -71.14 -21.22 62.21 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 114.161 1.171 . . . . 1.0 114.161 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.8 mp -98.26 -33.57 11.04 Favored 'General case' 0 N--CA 1.509 2.511 0 N-CA-C 112.847 0.684 . . . . 1.0 112.847 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.82 -37.78 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 123.677 0.611 . . . . 1.0 109.856 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.19 -31.75 2.65 Favored Glycine 0 N--CA 1.489 2.196 0 CA-C-O 118.785 -1.008 . . . . 1.0 114.917 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -128.13 145.67 50.94 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 115.22 1.563 . . . . 1.0 115.22 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.82 72.58 0.81 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 113.491 -1.686 . . . . 1.0 110.409 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.426 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 7.8 t -133.04 -173.43 3.19 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.278 0.561 . . . . 1.0 109.769 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.28 -170.82 13.61 Favored Glycine 0 N--CA 1.495 2.569 0 CA-C-N 113.579 -1.646 . . . . 1.0 114.219 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -147.38 167.8 23.44 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 113.683 -1.259 . . . . 1.0 108.817 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.2 t -104.82 117.59 34.43 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.322 -1.733 . . . . 1.0 106.322 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.458 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 87.7 m -125.66 122.91 37.74 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 113.319 -1.764 . . . . 1.0 111.203 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 45.74 41.54 7.57 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 112.798 -2.001 . . . . 1.0 111.279 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.67 21.95 71.36 Favored Glycine 0 N--CA 1.482 1.719 0 CA-C-N 113.385 -1.734 . . . . 1.0 113.592 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.1 mmt-85 -131.7 158.87 39.99 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.667 -1.605 . . . . 1.0 106.667 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.44 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 9.1 t -72.62 142.18 48.35 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.58 -1.248 . . . . 1.0 113.708 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.458 ' CB ' ' HG1' ' A' ' 29' ' ' THR . 10.4 t70 -135.07 78.37 1.73 Allowed 'General case' 0 C--N 1.295 -1.764 0 O-C-N 125.969 2.043 . . . . 1.0 106.862 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.426 ' SG ' ' O ' ' A' ' 25' ' ' THR . 37.1 t . . . . . 0 N--CA 1.498 1.947 0 C-N-CA 119.717 -0.793 . . . . 1.0 111.281 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.289 0.566 . . . . 1.0 111.071 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.4 p -70.95 120.89 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 114.426 -1.261 . . . . 1.0 108.911 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.406 HG12 ' HB3' ' A' ' 33' ' ' CYS . 22.9 pt -135.02 169.31 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 115.1 1.518 . . . . 1.0 115.1 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.01 -47.26 81.38 Favored Glycine 0 N--CA 1.478 1.489 0 CA-C-N 111.577 -2.556 . . . . 1.0 111.869 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -20.96 90.61 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.516 0 O-C-N 125.85 1.559 . . . . 1.0 112.884 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -39.79 142.3 0.34 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 124.851 1.344 . . . . 1.0 112.361 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.1 p -124.64 162.45 24.1 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 124.58 1.175 . . . . 1.0 111.042 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -118.24 -61.87 1.62 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 102.782 -3.044 . . . . 1.0 102.782 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -117.79 168.25 10.64 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.407 -2.072 . . . . 1.0 105.407 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.7 m -29.85 -54.59 0.33 Allowed Pre-proline 0 N--CA 1.503 2.198 0 O-C-N 124.692 1.245 . . . . 1.0 113.823 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.41 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 54.3 Cg_endo -67.78 -104.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 121.568 1.512 . . . . 1.0 113.841 172.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.8 t70 39.34 30.54 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 123.2 1.476 . . . . 1.0 110.031 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.7 t -168.15 -15.29 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 111.255 -2.702 . . . . 1.0 113.598 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.41 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 6.0 m-30 -38.74 -58.8 1.02 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 113.675 0.991 . . . . 1.0 113.675 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.0 t -45.27 -48.18 12.92 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 124.849 1.343 . . . . 1.0 110.734 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.74 -53.4 54.89 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.623 -1.172 . . . . 1.0 108.734 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.2 t -49.55 -39.66 35.55 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.811 -1.086 . . . . 1.0 110.12 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -65.95 -47.79 73.5 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.503 -1.295 . . . . 1.0 107.503 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -70.09 -11.82 61.16 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 112.862 -1.972 . . . . 1.0 111.885 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.6 mt -104.47 -52.72 2.84 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.105 1.15 . . . . 1.0 114.105 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.3 m -108.61 -16.68 8.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 118.687 -0.673 . . . . 1.0 112.525 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.99 -38.23 1.97 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 118.354 2.101 . . . . 1.0 118.354 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -126.57 153.75 44.83 Favored 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 115.243 1.572 . . . . 1.0 115.243 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.54 68.88 0.59 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 113.316 -1.766 . . . . 1.0 112.204 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.8 t -130.25 -168.65 2.0 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.549 ' CA ' ' SG ' ' A' ' 35' ' ' CYS . . . 124.78 174.42 14.0 Favored Glycine 0 N--CA 1.497 2.707 0 CA-C-N 113.517 -1.674 . . . . 1.0 115.136 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -131.4 164.46 25.64 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 112.13 -2.035 . . . . 1.0 108.483 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.5 t -107.46 112.07 24.68 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 104.654 -2.35 . . . . 1.0 104.654 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.474 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 84.8 m -128.18 123.69 34.93 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 112.371 -2.195 . . . . 1.0 112.131 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 51.49 39.78 25.38 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 113.2 -1.818 . . . . 1.0 108.905 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.49 21.05 62.02 Favored Glycine 0 N--CA 1.486 2.017 0 CA-C-N 113.286 -1.779 . . . . 1.0 112.386 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.6 mtp85 -129.87 164.03 25.03 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.677 -1.231 . . . . 1.0 107.677 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.406 ' HB3' HG12 ' A' ' 3' ' ' ILE . 4.3 t -72.56 145.28 47.51 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.926 -1.109 . . . . 1.0 112.975 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.474 ' CB ' ' HG1' ' A' ' 29' ' ' THR . 10.7 t70 -133.57 83.57 2.06 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 112.693 -2.049 . . . . 1.0 107.992 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.549 ' SG ' ' CA ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.017 0 CA-C-O 118.439 -0.791 . . . . 1.0 111.106 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 108.243 -1.021 . . . . 1.0 108.243 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 55.6 t -71.66 109.13 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 105.659 -1.978 . . . . 1.0 105.659 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.419 HG12 ' HB3' ' A' ' 33' ' ' CYS . 36.1 pt -135.04 168.49 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 115.875 1.806 . . . . 1.0 115.875 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.54 -45.67 83.66 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 111.814 -2.448 . . . . 1.0 111.041 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.5 tp60 -22.64 90.08 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.45 0 O-C-N 125.943 1.614 . . . . 1.0 113.112 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -39.82 143.16 0.27 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 113.916 -1.493 . . . . 1.0 113.15 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.4 p -124.36 163.93 20.7 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.916 -1.038 . . . . 1.0 109.826 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -117.15 -61.08 1.76 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 104.298 -2.482 . . . . 1.0 104.298 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -116.82 169.41 9.4 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 112.418 -2.174 . . . . 1.0 106.97 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.473 ' HG ' ' NZ ' ' A' ' 27' ' ' LYS . 73.1 m -28.55 -54.98 0.26 Allowed Pre-proline 0 N--CA 1.503 2.179 0 O-C-N 124.942 1.401 . . . . 1.0 113.944 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.518 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 28.8 Cg_endo -73.74 -100.6 0.01 OUTLIER 'Trans proline' 0 C--O 1.208 -0.984 0 C-N-CA 121.776 1.651 . . . . 1.0 114.917 170.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.5 t70 41.86 28.63 0.09 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 124.79 1.306 . . . . 1.0 110.163 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.0 t -164.58 -21.91 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 112.109 -2.314 . . . . 1.0 113.138 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.518 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 6.3 m-30 -38.78 -61.37 0.73 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 112.913 0.708 . . . . 1.0 112.913 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.3 p -43.84 -42.72 5.83 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 125.174 1.546 . . . . 1.0 112.165 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.99 -49.84 47.54 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 114.188 -1.369 . . . . 1.0 108.771 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.7 t -55.45 -34.97 64.97 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.292 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -66.49 -51.09 60.42 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 106.464 -1.68 . . . . 1.0 106.464 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -59.77 -24.74 64.33 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.039 -1.891 . . . . 1.0 112.197 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.0 mp -101.27 -33.74 9.93 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 116.101 1.889 . . . . 1.0 116.101 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.13 -37.79 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 123.453 0.471 . . . . 1.0 110.771 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.41 -30.77 2.58 Favored Glycine 0 N--CA 1.488 2.145 0 CA-C-O 118.435 -1.203 . . . . 1.0 115.041 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.48 141.46 51.98 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 115.146 1.535 . . . . 1.0 115.146 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.74 71.79 0.76 Allowed 'General case' 0 N--CA 1.503 2.209 0 CA-C-N 113.609 -1.632 . . . . 1.0 112.697 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.414 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 14.7 t -133.08 -168.16 2.04 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.431 0.634 . . . . 1.0 109.453 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.09 -174.69 16.2 Favored Glycine 0 N--CA 1.493 2.458 0 CA-C-N 113.577 -1.647 . . . . 1.0 115.359 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.473 ' NZ ' ' HG ' ' A' ' 10' ' ' SER . 0.9 OUTLIER -138.1 162.63 33.69 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 112.833 -1.683 . . . . 1.0 108.518 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.0 t -106.08 114.81 29.17 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 103.757 -2.683 . . . . 1.0 103.757 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.457 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 78.1 m -128.61 124.44 35.85 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 112.923 -1.944 . . . . 1.0 112.354 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 50.8 39.91 23.34 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 113.152 -1.84 . . . . 1.0 109.041 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.16 22.02 62.42 Favored Glycine 0 N--CA 1.484 1.854 0 CA-C-N 113.283 -1.78 . . . . 1.0 112.816 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.1 mtp-105 -130.89 163.29 27.77 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.14 -1.43 . . . . 1.0 107.14 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.419 ' HB3' HG12 ' A' ' 3' ' ' ILE . 2.5 t -72.69 142.61 48.23 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.213 1.19 . . . . 1.0 114.213 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.471 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.5 t70 -135.54 74.91 1.53 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 112.262 -2.245 . . . . 1.0 106.338 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 25' ' ' THR . 41.9 t . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 118.278 -0.868 . . . . 1.0 111.83 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.24 0.543 . . . . 1.0 111.227 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.3 p -70.82 119.78 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-N 114.371 -1.286 . . . . 1.0 108.774 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.448 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 33.0 pt -135.37 165.42 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 115.531 1.678 . . . . 1.0 115.531 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.84 44.2 3.33 Favored Glycine 0 C--O 1.21 -1.361 0 CA-C-N 111.314 -2.675 . . . . 1.0 111.826 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -109.8 96.6 6.36 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 100.64 -3.837 . . . . 1.0 100.64 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -39.11 147.74 0.06 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 125.381 1.676 . . . . 1.0 113.732 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.1 t -116.56 154.16 30.93 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 113.523 -1.672 . . . . 1.0 111.602 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -120.23 -55.95 2.02 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 104.323 -2.473 . . . . 1.0 104.323 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.2 154.02 34.01 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 113.498 -1.683 . . . . 1.0 106.792 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.9 m -22.0 -56.01 0.09 OUTLIER Pre-proline 0 N--CA 1.506 2.364 0 N-CA-C 115.773 1.768 . . . . 1.0 115.773 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.501 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 63.6 Cg_endo -69.19 -94.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.733 1.622 . . . . 1.0 113.531 169.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.7 t70 42.52 28.19 0.11 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 124.537 1.148 . . . . 1.0 110.246 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.6 t -164.47 -26.99 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 112.49 -2.141 . . . . 1.0 112.572 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.501 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 5.9 m-30 -38.73 -61.51 0.71 Allowed 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 112.582 0.586 . . . . 1.0 112.582 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.8 m -42.04 -43.77 3.32 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 125.509 1.755 . . . . 1.0 111.062 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.51 -49.0 58.69 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 114.389 -1.278 . . . . 1.0 109.113 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.5 t -56.8 -30.04 63.3 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 124.053 0.846 . . . . 1.0 108.954 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -70.72 -51.52 26.9 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 105.912 -1.884 . . . . 1.0 105.912 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -70.65 -10.78 60.16 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 113.755 -1.566 . . . . 1.0 113.878 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.4 mt -108.69 -43.5 4.25 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 112.903 0.705 . . . . 1.0 112.903 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.4 t -105.23 -38.24 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-N 114.748 -1.114 . . . . 1.0 110.464 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.0 -30.19 2.86 Favored Glycine 0 N--CA 1.488 2.161 0 CA-C-O 118.854 -0.97 . . . . 1.0 114.378 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -122.62 139.27 54.12 Favored 'General case' 0 N--CA 1.506 2.375 0 N-CA-C 114.407 1.262 . . . . 1.0 114.407 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.16 68.93 0.74 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 125.146 1.529 . . . . 1.0 111.086 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.433 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 9.2 t -132.64 -169.14 2.18 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.303 -0.862 . . . . 1.0 109.041 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.31 -173.11 16.27 Favored Glycine 0 N--CA 1.493 2.443 0 CA-C-N 113.751 -1.568 . . . . 1.0 113.711 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -136.96 167.64 21.12 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.654 -1.273 . . . . 1.0 109.568 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.5 t -109.87 112.33 24.3 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 103.485 -2.783 . . . . 1.0 103.485 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.437 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 70.8 m -127.37 123.28 35.84 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 112.829 -1.987 . . . . 1.0 112.604 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 49.91 40.63 21.31 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 113.134 -1.848 . . . . 1.0 108.599 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.52 22.94 62.09 Favored Glycine 0 N--CA 1.484 1.85 0 CA-C-N 113.231 -1.804 . . . . 1.0 113.211 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -131.07 162.34 30.05 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 106.048 -1.834 . . . . 1.0 106.048 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.448 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 9.1 t -73.33 141.56 47.1 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.043 1.498 . . . . 1.0 115.043 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.2 t70 -136.64 77.39 1.65 Allowed 'General case' 0 C--N 1.298 -1.673 0 O-C-N 125.825 1.953 . . . . 1.0 107.699 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.433 ' SG ' ' O ' ' A' ' 25' ' ' THR . 29.9 t . . . . . 0 N--CA 1.5 2.041 0 C-N-CA 119.609 -0.836 . . . . 1.0 111.372 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.0 m . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.497 0.665 . . . . 1.0 112.089 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.2 p -70.6 124.68 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-N 114.198 -1.365 . . . . 1.0 109.009 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.409 HG12 ' HB3' ' A' ' 33' ' ' CYS . 1.5 pt -132.18 159.75 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 114.1 1.148 . . . . 1.0 114.1 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -40.47 -53.34 3.54 Favored Glycine 0 N--CA 1.486 1.99 0 CA-C-N 111.22 -2.718 . . . . 1.0 112.206 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -16.13 85.62 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 O-C-N 126.195 1.761 . . . . 1.0 113.217 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -51.05 144.8 8.37 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.772 -1.104 . . . . 1.0 109.607 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.0 p -123.01 164.16 19.09 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 114.249 1.203 . . . . 1.0 114.249 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -118.07 -57.77 2.06 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 104.686 -2.338 . . . . 1.0 104.686 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -114.39 168.43 9.85 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 112.949 -1.932 . . . . 1.0 107.247 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.414 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.3 m -35.29 -58.8 0.74 Allowed Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 124.961 1.413 . . . . 1.0 113.412 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.422 ' C ' ' N ' ' A' ' 13' ' ' CYS . 84.7 Cg_endo -62.15 -95.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.391 1.394 . . . . 1.0 112.423 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 t0 37.91 32.34 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 123.147 1.451 . . . . 1.0 108.809 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.422 ' N ' ' C ' ' A' ' 11' ' ' PRO . 23.9 t -165.41 -24.94 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 111.945 -2.389 . . . . 1.0 112.298 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -38.21 -55.71 1.28 Allowed 'General case' 0 N--CA 1.508 2.466 0 C-N-CA 123.1 0.56 . . . . 1.0 110.778 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.6 p -53.31 -49.18 67.57 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 124.579 1.175 . . . . 1.0 110.119 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.5 -55.62 29.67 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.681 0.753 . . . . 1.0 110.765 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 25' ' ' THR . 56.5 m -48.58 -49.33 37.1 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.165 -1.38 . . . . 1.0 108.317 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -55.61 -49.59 72.4 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.167 0.984 . . . . 1.0 108.443 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -59.8 -26.73 65.99 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-N 113.852 -1.522 . . . . 1.0 111.46 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.1 mp -85.6 -55.79 3.82 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 120.082 -0.647 . . . . 1.0 112.31 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.2 m -107.3 -46.21 7.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 C-N-CA 122.922 0.489 . . . . 1.0 112.25 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.8 28.34 1.29 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 111.215 -0.754 . . . . 1.0 111.215 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -135.41 126.84 28.58 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 124.268 0.628 . . . . 1.0 110.293 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.35 69.04 0.8 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 124.909 1.381 . . . . 1.0 108.923 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.601 ' HG1' ' H ' ' A' ' 26' ' ' GLY . 12.4 t -127.66 -173.46 2.92 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.898 0.856 . . . . 1.0 111.576 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.601 ' H ' ' HG1' ' A' ' 25' ' ' THR . . . 100.85 158.62 27.55 Favored Glycine 0 N--CA 1.495 2.572 0 CA-C-N 112.612 -2.086 . . . . 1.0 109.598 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -132.99 179.29 6.27 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.605 0.716 . . . . 1.0 110.312 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.2 t -100.04 118.07 35.64 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 113.512 -1.676 . . . . 1.0 106.704 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.48 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 58.5 m -132.24 130.39 40.88 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 112.633 -2.076 . . . . 1.0 106.552 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.6 p30 45.5 41.44 6.77 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 125.286 1.616 . . . . 1.0 112.76 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.05 12.4 49.13 Favored Glycine 0 N--CA 1.479 1.561 0 CA-C-N 113.412 -1.722 . . . . 1.0 113.435 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.8 mmt-85 -127.71 162.55 26.3 Favored 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.409 ' HB3' HG12 ' A' ' 3' ' ' ILE . 42.9 t -72.59 146.47 46.66 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 117.7 -1.6 . . . . 1.0 112.08 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.48 ' CB ' ' HG1' ' A' ' 29' ' ' THR . 34.0 t70 -129.69 85.69 2.33 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 104.878 -2.267 . . . . 1.0 104.878 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.504 2.246 0 CA-C-O 116.452 -1.737 . . . . 1.0 111.112 -179.44 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 108.245 -1.02 . . . . 1.0 108.245 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.6 p -71.39 115.41 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.204 -1.406 . . . . 1.0 107.204 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.424 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 35.9 pt -136.83 166.35 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 116.349 1.981 . . . . 1.0 116.349 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.03 -46.05 85.61 Favored Glycine 0 N--CA 1.478 1.448 0 CA-C-N 111.235 -2.711 . . . . 1.0 110.637 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 49.2 tp60 -22.76 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.323 0 O-C-N 125.9 1.588 . . . . 1.0 112.44 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -40.11 151.01 0.05 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 125.274 1.609 . . . . 1.0 114.041 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 t -117.21 149.6 40.14 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 113.538 -1.665 . . . . 1.0 110.318 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.413 ' HB3' ' HD3' ' A' ' 9' ' ' ARG . 3.0 t80 -122.08 -54.8 1.9 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 102.553 -3.129 . . . . 1.0 102.553 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.413 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -118.65 154.05 33.31 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 105.941 -1.874 . . . . 1.0 105.941 179.675 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.402 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 67.8 m -25.2 -55.78 0.17 Allowed Pre-proline 0 N--CA 1.505 2.324 0 N-CA-C 114.748 1.388 . . . . 1.0 114.748 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.474 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 64.4 Cg_endo -69.04 -93.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 121.149 1.233 . . . . 1.0 113.629 170.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.4 t70 42.31 30.01 0.18 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 122.616 1.198 . . . . 1.0 109.691 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.8 t -165.96 -26.22 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 112.23 -2.259 . . . . 1.0 112.658 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.474 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 3.4 m-30 -38.56 -59.03 0.96 Allowed 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 123.612 0.765 . . . . 1.0 112.244 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.6 p -45.53 -43.24 11.71 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 125.117 1.511 . . . . 1.0 111.769 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.05 -46.53 64.8 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.811 -1.086 . . . . 1.0 109.768 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.2 t -57.04 -36.14 70.13 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.103 -1.073 . . . . 1.0 108.103 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -65.69 -53.75 36.82 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 105.1 -2.185 . . . . 1.0 105.1 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.82 -31.6 7.36 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 114.236 -1.347 . . . . 1.0 109.755 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.84 -54.35 5.43 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.475 -0.784 . . . . 1.0 112.088 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 50.7 t -104.28 -54.79 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 CA-C-N 115.655 -0.702 . . . . 1.0 111.674 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.61 20.48 1.09 Allowed Glycine 0 N--CA 1.491 2.309 0 O-C-N 124.043 0.839 . . . . 1.0 112.793 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -133.16 126.26 31.27 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 124.102 0.53 . . . . 1.0 110.465 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.15 73.9 0.94 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 124.54 1.15 . . . . 1.0 108.201 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.4 t -137.38 -173.24 3.42 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.429 0.633 . . . . 1.0 110.884 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.87 -179.69 16.18 Favored Glycine 0 N--CA 1.493 2.46 0 CA-C-N 113.429 -1.714 . . . . 1.0 113.745 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -134.53 172.48 12.86 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 114.001 -1.1 . . . . 1.0 111.346 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 45.6 t -112.34 111.56 22.5 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 102.273 -3.232 . . . . 1.0 102.273 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.408 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 63.2 m -130.73 123.42 29.22 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 112.437 -2.165 . . . . 1.0 108.097 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 p30 47.8 42.0 15.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 126.679 2.487 . . . . 1.0 112.116 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.95 11.21 60.44 Favored Glycine 0 N--CA 1.476 1.309 0 CA-C-N 113.132 -1.849 . . . . 1.0 112.289 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.3 mtt85 -126.34 163.72 22.64 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.187 -1.042 . . . . 1.0 108.187 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.424 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 7.4 t -72.21 143.03 49.0 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.506 -1.278 . . . . 1.0 114.308 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 35.8 t70 -136.39 77.0 1.63 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 112.051 -2.34 . . . . 1.0 107.56 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.8 t . . . . . 0 N--CA 1.498 1.951 0 CA-C-O 118.016 -0.992 . . . . 1.0 111.27 -179.741 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.57 0.7 . . . . 1.0 110.672 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.5 p -71.03 119.19 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 113.966 -1.47 . . . . 1.0 110.689 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.445 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 23.6 pt -130.23 159.29 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 CA-C-O 122.125 0.964 . . . . 1.0 112.779 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.22 -39.64 72.08 Favored Glycine 0 N--CA 1.489 2.195 0 CA-C-N 112.133 -2.303 . . . . 1.0 112.971 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -13.64 87.61 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 115.672 1.73 . . . . 1.0 115.672 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -40.7 124.31 2.04 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.693 1.246 . . . . 1.0 109.634 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 5.6 t -95.43 157.88 15.7 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 116.182 1.919 . . . . 1.0 116.182 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.515 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 14.7 t80 -121.68 -61.96 1.46 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 104.285 -2.487 . . . . 1.0 104.285 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -121.1 168.07 11.95 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 112.982 -1.917 . . . . 1.0 110.137 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.467 ' HG ' ' HZ3' ' A' ' 27' ' ' LYS . 59.9 m -32.29 -59.64 0.38 Allowed Pre-proline 0 N--CA 1.501 2.109 0 O-C-N 125.051 1.469 . . . . 1.0 114.605 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 13' ' ' CYS . 84.1 Cg_endo -61.37 -89.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.753 1.635 . . . . 1.0 112.045 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 t70 35.92 36.41 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 CA-C-O 124.113 1.911 . . . . 1.0 108.508 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.403 ' N ' ' C ' ' A' ' 11' ' ' PRO . 15.1 t -170.36 -25.33 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 111.118 -2.765 . . . . 1.0 112.382 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -38.45 -59.51 0.9 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 123.984 0.803 . . . . 1.0 111.618 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.3 t -51.83 -44.43 63.56 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 124.939 1.399 . . . . 1.0 112.657 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.43 -46.81 78.46 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 124.025 0.828 . . . . 1.0 113.055 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.1 t -68.72 -31.02 69.8 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.012 -1.477 . . . . 1.0 107.012 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -64.11 -50.29 68.87 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.24 -1.022 . . . . 1.0 108.24 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -70.15 -26.3 63.87 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.002 -1.479 . . . . 1.0 109.505 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 tt -65.15 -59.18 4.38 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.963 -0.695 . . . . 1.0 110.138 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.01 -42.73 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 114.171 1.175 . . . . 1.0 114.171 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.03 10.82 1.69 Allowed Glycine 0 N--CA 1.491 2.337 0 CA-C-O 119.569 -0.573 . . . . 1.0 112.759 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -129.68 128.9 43.49 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 123.722 0.307 . . . . 1.0 110.468 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.02 68.71 0.7 Allowed 'General case' 0 N--CA 1.503 2.202 0 O-C-N 124.87 1.356 . . . . 1.0 109.954 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.6 p -115.61 175.78 5.37 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.151 -1.386 . . . . 1.0 113.048 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.78 150.58 9.34 Favored Glycine 0 N--CA 1.49 2.263 0 CA-C-N 113.254 -1.794 . . . . 1.0 110.989 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.467 ' HZ3' ' HG ' ' A' ' 10' ' ' SER . 30.6 mmmt -122.55 -178.48 3.92 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 113.521 -1.339 . . . . 1.0 111.01 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.5 t -111.27 109.42 19.43 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 111.903 -2.408 . . . . 1.0 108.209 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.439 ' HG1' ' CG ' ' A' ' 34' ' ' ASP . 20.3 m -138.71 131.56 29.4 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 112.837 -1.983 . . . . 1.0 111.001 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 51.06 40.1 24.81 Favored 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 112.811 -1.995 . . . . 1.0 108.33 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.0 19.16 50.0 Favored Glycine 0 N--CA 1.489 2.223 0 CA-C-N 113.259 -1.791 . . . . 1.0 113.356 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.0 mtp-105 -134.26 160.11 38.88 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.445 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 43.5 t -72.53 139.17 47.41 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 114.826 1.417 . . . . 1.0 114.826 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 11.2 p-10 -134.02 94.09 3.2 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.185 -2.154 . . . . 1.0 105.185 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.504 2.227 0 CA-C-N 115.252 -0.885 . . . . 1.0 109.741 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 121.602 0.715 . . . . 1.0 111.355 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 45.8 t -71.01 114.24 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-N 114.163 -1.38 . . . . 1.0 109.094 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.467 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 33.8 pt -134.93 164.04 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 N-CA-C 114.136 1.162 . . . . 1.0 114.136 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.62 -39.59 93.56 Favored Glycine 0 N--CA 1.479 1.534 0 CA-C-N 112.868 -1.969 . . . . 1.0 112.564 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -12.0 88.01 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 115.372 1.619 . . . . 1.0 115.372 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.0 mtt85 -39.8 122.91 1.49 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 124.817 1.323 . . . . 1.0 110.873 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 9.0 t -107.11 158.53 17.0 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 114.974 1.472 . . . . 1.0 114.974 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.52 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.9 t80 -123.48 -56.6 1.7 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 112.424 -2.171 . . . . 1.0 105.996 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.45 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -115.4 153.71 30.56 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 113.406 -1.724 . . . . 1.0 110.011 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.426 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.3 m -25.22 -57.94 0.16 Allowed Pre-proline 0 N--CA 1.508 2.437 0 O-C-N 125.092 1.495 . . . . 1.0 114.909 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.426 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 95.7 Cg_endo -62.82 -91.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.874 1.716 . . . . 1.0 112.058 173.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.8 t70 35.99 35.44 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 123.725 1.726 . . . . 1.0 108.889 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.4 ' N ' ' C ' ' A' ' 11' ' ' PRO . 49.3 t -170.73 -23.11 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 110.802 -2.908 . . . . 1.0 112.541 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -38.63 -59.94 0.87 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 123.415 0.447 . . . . 1.0 111.569 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.5 t -47.92 -40.4 21.86 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 124.933 1.396 . . . . 1.0 112.243 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.02 -54.48 13.0 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 123.715 0.635 . . . . 1.0 110.139 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.8 t -55.01 -32.65 61.97 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.553 -0.906 . . . . 1.0 108.553 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -67.14 -50.87 59.74 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 105.906 -1.887 . . . . 1.0 105.906 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -70.48 -9.03 55.5 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 113.756 -1.565 . . . . 1.0 111.554 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -90.68 -60.1 2.01 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.7 -0.852 . . . . 1.0 108.7 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 p -111.58 -39.24 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 124.129 0.893 . . . . 1.0 112.763 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.98 14.03 1.69 Allowed Glycine 0 N--CA 1.493 2.446 0 CA-C-O 119.635 -0.536 . . . . 1.0 113.285 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -132.23 127.45 35.8 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 123.966 0.451 . . . . 1.0 110.257 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.09 68.41 0.7 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 125.065 1.478 . . . . 1.0 109.723 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.453 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 12.2 p -119.26 -179.12 3.75 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.252 -1.34 . . . . 1.0 114.299 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.41 153.91 9.25 Favored Glycine 0 N--CA 1.494 2.542 0 CA-C-N 113.419 -1.718 . . . . 1.0 111.704 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -119.45 167.21 12.17 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.33 -0.935 . . . . 1.0 108.672 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 13.5 t -101.42 90.64 4.15 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 102.917 -2.994 . . . . 1.0 102.917 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.7 m -110.78 115.57 29.78 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 109.497 -3.501 . . . . 1.0 111.43 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 52.8 39.03 28.08 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 112.425 -2.17 . . . . 1.0 108.465 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.61 25.59 68.99 Favored Glycine 0 N--CA 1.483 1.816 0 CA-C-N 113.065 -1.88 . . . . 1.0 111.858 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.2 mtt-85 -136.42 159.25 42.36 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.004 -1.48 . . . . 1.0 107.004 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.467 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 40.1 t -72.36 140.3 48.37 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 114.293 1.22 . . . . 1.0 114.293 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 30.0 t70 -135.18 84.49 2.1 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 124.978 1.424 . . . . 1.0 107.348 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.453 ' SG ' ' C ' ' A' ' 25' ' ' THR . 6.5 t . . . . . 0 N--CA 1.501 2.104 0 CA-C-O 116.787 -1.577 . . . . 1.0 111.239 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 122.023 0.916 . . . . 1.0 111.508 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.8 p -70.55 121.44 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-N 113.493 -1.685 . . . . 1.0 109.727 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.445 HG12 ' HB3' ' A' ' 33' ' ' CYS . 23.1 pt -128.83 160.25 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 121.916 0.865 . . . . 1.0 112.882 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.96 43.81 3.24 Favored Glycine 0 C--O 1.211 -1.338 0 CA-C-N 112.589 -2.096 . . . . 1.0 112.671 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -105.36 102.53 12.01 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 101.555 -3.498 . . . . 1.0 101.555 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -39.03 137.53 0.67 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 113.425 -1.716 . . . . 1.0 113.19 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.6 p -121.84 159.37 26.92 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.582 -1.19 . . . . 1.0 110.148 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -118.51 -59.82 1.84 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 106.175 -1.787 . . . . 1.0 106.175 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.37 163.81 12.54 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 113.188 -1.824 . . . . 1.0 106.591 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.427 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 75.5 m -35.93 -55.26 1.3 Allowed Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 125.156 1.535 . . . . 1.0 112.125 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.478 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 81.2 Cg_endo -67.07 -93.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 120.858 1.038 . . . . 1.0 113.009 171.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 t70 36.97 34.46 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 CA-C-O 123.351 1.548 . . . . 1.0 109.678 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.5 t -166.35 -27.53 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 110.766 -2.924 . . . . 1.0 111.307 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.478 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.0 m-85 -38.38 -55.34 1.38 Allowed 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 124.456 1.103 . . . . 1.0 112.45 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.539 ' HG ' ' H ' ' A' ' 16' ' ' ALA . 52.5 p -47.1 -48.72 22.79 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 124.322 1.014 . . . . 1.0 109.887 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.539 ' H ' ' HG ' ' A' ' 15' ' ' SER . . . -64.02 -45.15 90.19 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.708 -1.133 . . . . 1.0 110.379 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 25' ' ' THR . 10.5 m -57.59 -35.56 70.57 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.998 -1.001 . . . . 1.0 109.372 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.471 ' CB ' ' HZ1' ' A' ' 18' ' ' LYS . 4.4 ttpm? -70.8 -46.41 62.89 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.381 -1.711 . . . . 1.0 106.381 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.28 -15.19 62.86 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 114.157 -1.383 . . . . 1.0 113.623 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.0 mt -110.46 -43.62 3.85 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 113.86 1.059 . . . . 1.0 113.86 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.0 t -98.89 -36.22 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 114.555 -1.202 . . . . 1.0 110.033 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.57 -28.79 4.16 Favored Glycine 0 N--CA 1.489 2.207 0 O-C-N 123.866 0.729 . . . . 1.0 113.07 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -129.23 152.04 49.23 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 112.405 0.52 . . . . 1.0 112.405 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.52 78.51 0.79 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 114.274 -1.33 . . . . 1.0 109.218 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.418 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 7.6 t -128.38 -178.22 4.48 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.551 0.691 . . . . 1.0 111.627 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.53 -169.0 13.84 Favored Glycine 0 N--CA 1.495 2.6 0 CA-C-N 113.216 -1.811 . . . . 1.0 112.567 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -155.13 173.06 17.14 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.024 -1.088 . . . . 1.0 108.388 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 47.4 t -102.13 118.1 36.19 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.178 -1.786 . . . . 1.0 106.178 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.505 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 91.1 m -129.75 125.81 36.72 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 112.867 -1.97 . . . . 1.0 110.834 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 50.55 40.87 24.55 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 125.198 1.561 . . . . 1.0 109.15 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.86 18.92 55.06 Favored Glycine 0 N--CA 1.488 2.142 0 CA-C-N 113.148 -1.842 . . . . 1.0 113.51 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -128.62 163.32 25.31 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.778 -1.564 . . . . 1.0 106.778 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.445 ' HB3' HG12 ' A' ' 3' ' ' ILE . 11.2 t -73.49 143.75 46.47 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.177 -1.409 . . . . 1.0 113.263 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.505 ' CB ' ' HG1' ' A' ' 29' ' ' THR . 8.8 t70 -131.24 85.04 2.23 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 104.53 -2.396 . . . . 1.0 104.53 178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.5 2.071 0 C-N-CA 119.76 -0.776 . . . . 1.0 109.957 -179.514 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.887 0.851 . . . . 1.0 111.617 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 41.1 t -70.78 117.84 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-N 113.61 -1.632 . . . . 1.0 108.53 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.438 HG12 ' HB3' ' A' ' 33' ' ' CYS . 23.6 pt -128.96 154.64 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 114.549 1.314 . . . . 1.0 114.549 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -48.87 -43.24 30.39 Favored Glycine 0 N--CA 1.477 1.433 0 CA-C-N 110.824 -2.898 . . . . 1.0 111.758 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -26.15 91.98 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 126.106 1.709 . . . . 1.0 112.333 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -39.85 149.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.938 -1.483 . . . . 1.0 113.63 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.451 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 5.0 t -107.63 157.28 18.2 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.714 -1.13 . . . . 1.0 112.124 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.451 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 15.9 t80 -119.72 -64.88 1.22 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 103.023 -2.954 . . . . 1.0 103.023 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.45 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 9.0 mmt85 -123.85 168.83 12.23 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 112.277 -2.238 . . . . 1.0 106.533 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.41 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 67.9 m -29.02 -58.36 0.25 Allowed Pre-proline 0 N--CA 1.504 2.261 0 N-CA-C 114.677 1.362 . . . . 1.0 114.677 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.41 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 71.1 Cg_endo -66.96 -93.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.426 1.418 . . . . 1.0 113.262 175.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.6 t70 37.89 33.73 0.05 Allowed 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 123.399 1.571 . . . . 1.0 109.906 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.5 t -164.51 -26.85 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 110.851 -2.886 . . . . 1.0 111.432 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.4 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.2 m-85 -38.74 -58.27 1.09 Allowed 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 123.68 0.792 . . . . 1.0 111.777 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.0 m -48.15 -45.7 33.61 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 124.625 1.203 . . . . 1.0 110.749 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.03 -41.56 90.77 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.608 -1.178 . . . . 1.0 112.309 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 25' ' ' THR . 24.2 m -66.81 -32.02 73.03 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.907 -1.042 . . . . 1.0 109.01 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -70.77 -52.57 19.87 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.753 -1.203 . . . . 1.0 107.753 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -70.92 -17.16 62.7 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 118.903 -1.119 . . . . 1.0 113.448 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.1 mt -101.88 -41.99 6.3 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 113.25 0.833 . . . . 1.0 113.25 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.1 t -101.49 -34.7 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 124.293 0.996 . . . . 1.0 110.321 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.17 -29.64 3.85 Favored Glycine 0 N--CA 1.493 2.464 0 O-C-N 123.731 0.645 . . . . 1.0 113.065 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.47 ' H ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -128.5 156.58 43.03 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 112.97 0.73 . . . . 1.0 112.97 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.88 73.64 0.59 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 113.975 -1.466 . . . . 1.0 112.95 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.449 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 0.8 OUTLIER -114.32 -171.29 1.89 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.964 -1.016 . . . . 1.0 110.102 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.86 156.02 12.32 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.853 -0.899 . . . . 1.0 110.853 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -132.53 169.88 15.96 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.331 -0.988 . . . . 1.0 108.331 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.6 t -105.11 100.61 10.2 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 104.8 -2.296 . . . . 1.0 104.8 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.7 m -121.66 118.71 29.84 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 110.736 -2.938 . . . . 1.0 112.069 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 47.7 42.31 15.2 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 112.562 -2.108 . . . . 1.0 110.013 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.89 23.08 69.06 Favored Glycine 0 N--CA 1.482 1.763 0 CA-C-N 113.229 -1.805 . . . . 1.0 113.09 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.2 mtp85 -136.48 160.47 38.66 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.74 -1.208 . . . . 1.0 107.74 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.438 ' HB3' HG12 ' A' ' 3' ' ' ILE . 19.5 t -72.57 142.12 48.42 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.437 -1.305 . . . . 1.0 114.118 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 35.0 t0 -131.38 88.98 2.65 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 105.326 -2.102 . . . . 1.0 105.326 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.501 2.106 0 CA-C-O 118.394 -0.812 . . . . 1.0 109.372 -179.773 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.6 t . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 108.438 -0.949 . . . . 1.0 108.438 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 5.3 p -71.39 118.61 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-N 114.901 -1.045 . . . . 1.0 109.272 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.471 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 35.1 pt -133.2 152.55 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 114.603 1.335 . . . . 1.0 114.603 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.67 -38.3 63.48 Favored Glycine 0 N--CA 1.482 1.741 0 CA-C-N 111.717 -2.492 . . . . 1.0 110.747 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -32.33 103.11 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 125.918 1.599 . . . . 1.0 110.217 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -39.46 151.96 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.815 1.783 . . . . 1.0 115.815 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 1.4 t -112.87 154.62 26.04 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.222 -1.354 . . . . 1.0 111.47 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.419 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 1.2 t80 -121.31 -62.86 1.38 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 103.684 -2.71 . . . . 1.0 103.684 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -119.89 166.61 13.07 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 111.895 -2.411 . . . . 1.0 106.173 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.429 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.7 m -35.55 -55.47 1.15 Allowed Pre-proline 0 N--CA 1.506 2.364 0 N-CA-C 113.355 0.872 . . . . 1.0 113.355 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.429 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 83.6 Cg_endo -63.64 -94.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.632 1.555 . . . . 1.0 112.011 173.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.0 t70 36.09 34.76 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.373 0 CA-C-O 123.358 1.552 . . . . 1.0 109.316 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.415 ' N ' ' C ' ' A' ' 11' ' ' PRO . 42.7 t -171.14 -19.99 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 110.738 -2.937 . . . . 1.0 112.562 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -38.51 -59.2 0.94 Allowed 'General case' 0 N--CA 1.503 2.215 0 CA-C-N 118.632 0.651 . . . . 1.0 110.93 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 76.1 p -47.58 -39.95 17.98 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.99 1.431 . . . . 1.0 112.153 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.09 -49.35 51.81 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.697 -0.683 . . . . 1.0 109.573 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.6 t -55.09 -40.88 70.9 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.239 -1.393 . . . . 1.0 107.239 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -59.24 -53.53 57.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 106.566 -1.642 . . . . 1.0 106.566 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -48.43 -34.59 11.25 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 113.567 -1.651 . . . . 1.0 109.846 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.4 mt -80.97 -51.58 8.37 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.391 0.886 . . . . 1.0 113.391 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -113.49 -44.72 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-N 117.867 0.303 . . . . 1.0 111.489 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.67 12.86 2.37 Favored Glycine 0 N--CA 1.492 2.387 0 CA-C-O 119.362 -0.688 . . . . 1.0 114.056 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.79 129.99 50.55 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 123.784 0.343 . . . . 1.0 110.515 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.35 68.17 0.75 Allowed 'General case' 0 N--CA 1.506 2.358 0 O-C-N 124.624 1.203 . . . . 1.0 109.417 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.481 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 12.5 p -118.47 -179.94 3.94 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.628 -1.169 . . . . 1.0 113.418 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.8 158.95 12.24 Favored Glycine 0 N--CA 1.493 2.464 0 CA-C-N 113.852 -1.522 . . . . 1.0 113.04 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.429 ' HZ1' ' HG1' ' A' ' 29' ' ' THR . 14.6 ptmm? -127.03 177.23 6.77 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 122.076 0.941 . . . . 1.0 108.524 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.7 t -101.71 111.84 24.22 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 112.492 -2.14 . . . . 1.0 107.829 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.429 ' HG1' ' HZ1' ' A' ' 27' ' ' LYS . 49.9 m -126.23 120.69 30.66 Favored 'General case' 0 N--CA 1.503 2.175 0 CA-C-N 112.1 -2.318 . . . . 1.0 111.559 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 48.76 42.84 20.47 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 113.452 -1.704 . . . . 1.0 109.684 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.15 21.38 61.63 Favored Glycine 0 N--CA 1.486 2.005 0 CA-C-N 113.733 -1.576 . . . . 1.0 113.241 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.8 mtt-85 -133.15 161.45 34.4 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 106.916 -1.513 . . . . 1.0 106.916 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.471 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 35.0 t -72.57 141.73 48.42 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.607 1.336 . . . . 1.0 114.607 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.5 t70 -135.24 83.31 2.01 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 125.631 1.832 . . . . 1.0 109.112 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.481 ' SG ' ' C ' ' A' ' 25' ' ' THR . 9.6 t . . . . . 0 N--CA 1.502 2.13 0 C-N-CA 119.25 -0.98 . . . . 1.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.711 0.767 . . . . 1.0 112.407 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 58.0 t -71.04 115.28 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 113.839 -1.528 . . . . 1.0 109.052 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.457 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 29.2 pt -133.97 163.63 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 115.273 1.583 . . . . 1.0 115.273 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.75 -43.08 96.66 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-N 111.398 -2.637 . . . . 1.0 111.572 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -15.23 88.34 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 O-C-N 126.173 1.749 . . . . 1.0 113.774 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -39.89 134.17 1.49 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 124.88 1.362 . . . . 1.0 110.75 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 9.7 t -116.69 159.19 22.61 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.663 -1.153 . . . . 1.0 113.09 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.44 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 19.1 t80 -119.46 -61.89 1.57 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 104.254 -2.499 . . . . 1.0 104.254 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.432 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -118.15 161.28 20.12 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 112.891 -1.959 . . . . 1.0 110.318 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 75.8 m -18.42 -60.09 0.05 OUTLIER Pre-proline 0 N--CA 1.506 2.338 0 N-CA-C 117.948 2.573 . . . . 1.0 117.948 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.481 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 44.7 Cg_endo -72.44 -96.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.6 1.533 . . . . 1.0 113.185 176.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 t0 44.52 28.59 0.33 Allowed 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 122.253 1.025 . . . . 1.0 109.542 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 t -167.07 -22.99 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 113.367 -1.742 . . . . 1.0 114.177 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.481 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 6.6 m-30 -39.12 -62.99 0.58 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 112.228 0.455 . . . . 1.0 112.228 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.1 t -43.36 -46.68 6.61 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 125.358 1.661 . . . . 1.0 111.13 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.61 -45.17 91.53 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 114.035 -1.439 . . . . 1.0 111.224 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.1 t -62.73 -38.97 92.6 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.935 -1.135 . . . . 1.0 107.935 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -60.95 -51.38 69.5 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.92 -18.03 62.67 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 118.091 -1.444 . . . . 1.0 112.262 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 mp -87.33 -50.14 6.78 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 112.94 0.719 . . . . 1.0 112.94 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.2 m -112.16 -30.79 2.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 118.832 -0.604 . . . . 1.0 112.172 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.89 -26.62 2.99 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 116.491 1.356 . . . . 1.0 116.491 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -122.65 135.16 54.52 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 114.542 1.312 . . . . 1.0 114.542 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.78 67.72 0.6 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 113.609 -1.632 . . . . 1.0 111.862 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.551 ' HG1' ' H ' ' A' ' 26' ' ' GLY . 14.9 t -131.79 -163.32 1.32 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.543 -0.753 . . . . 1.0 110.364 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.551 ' H ' ' HG1' ' A' ' 25' ' ' THR . . . 112.51 -176.06 17.45 Favored Glycine 0 N--CA 1.498 2.81 0 CA-C-N 113.769 -1.56 . . . . 1.0 111.222 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -136.0 171.64 14.18 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.523 0.678 . . . . 1.0 110.021 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.0 t -105.31 114.44 28.63 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 106.406 -1.702 . . . . 1.0 106.406 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.5 m -123.36 118.35 27.31 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 112.6 -2.091 . . . . 1.0 114.304 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 45.16 39.26 3.87 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 114.073 -1.421 . . . . 1.0 112.014 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.6 18.29 79.81 Favored Glycine 0 N--CA 1.476 1.335 0 CA-C-N 112.886 -1.961 . . . . 1.0 115.221 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.7 mtp-105 -135.32 156.41 49.0 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.2 -1.037 . . . . 1.0 108.2 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.457 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 20.1 t -72.9 138.49 46.25 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 116.556 2.058 . . . . 1.0 116.556 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 0.8 OUTLIER -133.36 82.34 1.98 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 125.283 1.615 . . . . 1.0 108.757 178.421 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.499 1.996 0 CA-C-O 116.52 -1.705 . . . . 1.0 110.736 -179.758 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.425 ' H1 ' ' HB3' ' A' ' 35' ' ' CYS . 22.6 t . . . . . 0 N--CA 1.497 1.924 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.3 p -70.89 119.98 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 114.998 -1.001 . . . . 1.0 108.609 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.422 HG12 ' HB3' ' A' ' 33' ' ' CYS . 22.8 pt -129.21 159.72 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 114.929 1.455 . . . . 1.0 114.929 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.32 -45.16 44.87 Favored Glycine 0 N--CA 1.478 1.44 0 CA-C-N 110.755 -2.929 . . . . 1.0 111.63 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -21.26 90.73 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 O-C-N 125.794 1.526 . . . . 1.0 113.137 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.3 ptt-85 -46.2 142.51 2.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 124.63 1.206 . . . . 1.0 108.689 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 28.0 p -113.32 158.88 20.01 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 118.839 -1.144 . . . . 1.0 112.273 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -116.73 -59.79 1.92 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 105.741 -1.948 . . . . 1.0 105.741 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.3 mtt85 -114.84 169.5 9.03 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 112.058 -2.337 . . . . 1.0 106.879 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.436 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 73.5 m -37.58 -56.26 1.79 Allowed Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 124.776 1.298 . . . . 1.0 111.726 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.436 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 97.9 Cg_endo -64.97 -95.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.248 1.299 . . . . 1.0 112.945 175.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.1 t70 37.19 30.58 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 O-C-N 125.401 1.688 . . . . 1.0 109.578 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.431 ' N ' ' C ' ' A' ' 11' ' ' PRO . 42.7 t -164.81 -22.92 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 111.244 -2.707 . . . . 1.0 112.832 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.426 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.1 m-85 -38.6 -58.61 1.02 Allowed 'General case' 0 N--CA 1.503 2.206 0 CA-C-N 118.306 0.503 . . . . 1.0 110.434 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.4 p -53.54 -44.75 69.47 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 124.635 1.21 . . . . 1.0 111.086 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.23 -57.94 10.65 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 120.35 -0.54 . . . . 1.0 110.933 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.8 t -52.51 -45.24 66.15 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.412 -1.329 . . . . 1.0 107.412 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -50.98 -47.72 61.37 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -62.85 -36.31 82.84 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 114.565 -1.198 . . . . 1.0 110.126 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.46 -54.64 11.48 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 113.64 0.978 . . . . 1.0 113.64 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 m -105.42 -43.58 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 114.103 1.149 . . . . 1.0 114.103 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.28 17.23 2.01 Favored Glycine 0 N--CA 1.494 2.557 0 O-C-N 123.536 0.522 . . . . 1.0 112.199 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -134.14 130.53 37.46 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 123.877 0.398 . . . . 1.0 110.198 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.56 71.68 0.7 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 124.533 1.146 . . . . 1.0 108.555 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.3 p -119.57 177.16 5.04 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.485 -1.234 . . . . 1.0 113.281 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.93 153.35 17.56 Favored Glycine 0 N--CA 1.49 2.261 0 CA-C-N 113.64 -1.618 . . . . 1.0 111.191 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.8 -176.67 3.84 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 124.829 0.958 . . . . 1.0 108.552 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.2 t -108.42 109.34 20.61 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 112.063 -2.335 . . . . 1.0 108.661 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.466 ' HG1' ' CG ' ' A' ' 34' ' ' ASP . 19.9 m -136.26 129.34 31.37 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-N 112.683 -2.053 . . . . 1.0 110.066 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 51.15 40.73 26.55 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 112.817 -1.992 . . . . 1.0 107.729 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.35 13.56 44.21 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-N 113.358 -1.746 . . . . 1.0 114.283 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.4 mmt-85 -129.93 159.88 35.3 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.371 -0.974 . . . . 1.0 108.371 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.422 ' HB3' HG12 ' A' ' 3' ' ' ILE . 15.6 t -72.68 140.53 47.95 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.85 1.426 . . . . 1.0 114.85 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.466 ' CG ' ' HG1' ' A' ' 29' ' ' THR . 7.7 p-10 -130.7 94.98 3.74 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 105.587 -2.005 . . . . 1.0 105.587 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.425 ' HB3' ' H1 ' ' A' ' 1' ' ' VAL . 14.1 t . . . . . 0 N--CA 1.502 2.161 0 CA-C-O 118.013 -0.994 . . . . 1.0 110.174 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.635 0.731 . . . . 1.0 111.098 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.5 p -70.49 115.03 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-N 113.949 -1.478 . . . . 1.0 109.243 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.43 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 36.6 pt -137.8 165.49 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 115.659 1.725 . . . . 1.0 115.659 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.97 -42.92 95.11 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-N 111.89 -2.414 . . . . 1.0 111.271 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -21.31 98.8 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 O-C-N 125.66 1.447 . . . . 1.0 112.929 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.1 ptt-85 -39.67 141.35 0.41 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 125.146 1.529 . . . . 1.0 112.848 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.419 ' SG ' ' O ' ' A' ' 9' ' ' ARG . 11.9 t -112.69 155.31 24.71 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.644 -1.162 . . . . 1.0 110.712 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -120.41 -61.13 1.61 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 104.986 -2.227 . . . . 1.0 104.986 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.419 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 42.6 mtt85 -117.69 165.29 13.78 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 112.69 -2.05 . . . . 1.0 108.342 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.0 m -32.02 -53.52 0.53 Allowed Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 125.189 1.556 . . . . 1.0 113.613 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.503 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 49.7 Cg_endo -70.56 -94.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.585 1.523 . . . . 1.0 114.698 169.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 t70 41.17 30.45 0.11 Allowed 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 123.156 1.455 . . . . 1.0 110.062 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.4 t -165.34 -27.91 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 112.14 -2.3 . . . . 1.0 112.524 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.503 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 5.7 m-30 -38.98 -61.48 0.74 Allowed 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 112.834 0.679 . . . . 1.0 112.834 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.9 t -42.49 -43.89 3.86 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 125.39 1.681 . . . . 1.0 110.947 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.43 -43.93 68.92 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.386 -1.279 . . . . 1.0 110.183 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.1 t -60.94 -31.34 70.89 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.117 -1.068 . . . . 1.0 108.117 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -70.48 -53.82 14.77 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.138 -1.801 . . . . 1.0 106.138 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -59.43 -19.19 45.51 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 112.397 -2.183 . . . . 1.0 112.292 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.4 tp -102.92 -54.49 2.62 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 113.357 0.873 . . . . 1.0 113.357 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.5 t -92.88 -41.31 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-N 113.121 -1.854 . . . . 1.0 112.087 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.09 -23.05 3.94 Favored Glycine 0 N--CA 1.488 2.141 0 CA-C-O 119.348 -0.695 . . . . 1.0 113.03 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -126.1 134.98 51.2 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 113.815 1.043 . . . . 1.0 113.815 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.62 70.32 0.67 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 114.331 -1.304 . . . . 1.0 112.355 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.549 ' HG1' ' H ' ' A' ' 26' ' ' GLY . 12.4 t -130.19 -166.74 1.72 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.025 -0.732 . . . . 1.0 109.025 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.549 ' H ' ' HG1' ' A' ' 25' ' ' THR . . . 122.4 -176.86 16.53 Favored Glycine 0 N--CA 1.492 2.39 0 CA-C-N 113.495 -1.684 . . . . 1.0 114.879 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -133.38 165.54 24.62 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.822 -1.689 . . . . 1.0 109.263 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.6 t -110.03 112.21 24.07 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 103.159 -2.904 . . . . 1.0 103.159 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.458 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 89.8 m -125.12 123.52 39.87 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 112.576 -2.102 . . . . 1.0 112.208 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 44.53 41.17 4.5 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 112.878 -1.965 . . . . 1.0 111.552 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.26 27.06 71.97 Favored Glycine 0 N--CA 1.484 1.861 0 CA-C-N 113.254 -1.794 . . . . 1.0 112.72 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.6 mtt-85 -136.32 159.8 40.66 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.703 -1.591 . . . . 1.0 106.703 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.43 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 13.0 t -72.87 142.3 47.94 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 113.945 1.091 . . . . 1.0 113.945 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.458 ' CB ' ' HG1' ' A' ' 29' ' ' THR . 10.6 t70 -137.59 73.79 1.46 Allowed 'General case' 0 C--N 1.298 -1.634 0 O-C-N 125.561 1.788 . . . . 1.0 108.358 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 25' ' ' THR . 13.2 t . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 116.712 -1.613 . . . . 1.0 111.194 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.704 0.764 . . . . 1.0 111.693 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 50.3 t -70.59 116.07 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-N 113.949 -1.478 . . . . 1.0 109.503 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.485 HG12 ' HB3' ' A' ' 33' ' ' CYS . 33.1 pt -130.43 152.7 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-O 122.58 1.181 . . . . 1.0 113.585 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.73 -35.51 86.51 Favored Glycine 0 N--CA 1.483 1.783 0 CA-C-N 111.385 -2.643 . . . . 1.0 111.895 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -22.56 94.12 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 126.229 1.782 . . . . 1.0 112.318 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -39.53 131.75 1.66 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 124.549 1.156 . . . . 1.0 112.417 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.508 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 4.5 t -111.69 159.6 18.06 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 124.615 1.197 . . . . 1.0 114.001 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.508 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 0.9 OUTLIER -121.38 -57.42 1.84 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 113.365 -1.743 . . . . 1.0 107.644 179.816 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.471 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 35.5 mmt-85 -115.73 166.56 11.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.35 1.031 . . . . 1.0 110.485 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.6 m -32.85 -56.92 0.52 Allowed Pre-proline 0 N--CA 1.502 2.158 0 N-CA-C 114.84 1.422 . . . . 1.0 114.84 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.442 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 97.3 Cg_endo -65.96 -92.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.3 1.333 . . . . 1.0 112.723 176.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 t0 40.15 32.34 0.12 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 122.993 1.378 . . . . 1.0 108.774 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.3 t -166.94 -26.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 112.47 -2.15 . . . . 1.0 112.223 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.442 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.7 m-85 -38.73 -58.09 1.11 Allowed 'General case' 0 N--CA 1.505 2.32 0 C-N-CA 123.431 0.693 . . . . 1.0 111.6 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.3 t -49.14 -46.67 45.46 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 124.306 1.004 . . . . 1.0 110.641 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.35 -35.26 79.02 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.96 -1.018 . . . . 1.0 112.117 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 25' ' ' THR . 45.5 m -69.77 -35.38 74.87 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.685 -0.857 . . . . 1.0 108.685 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -70.63 -42.84 70.34 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.707 -1.22 . . . . 1.0 107.707 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -69.99 -29.07 66.07 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 112.622 -2.081 . . . . 1.0 113.648 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.63 -34.68 8.09 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.334 1.235 . . . . 1.0 114.334 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.3 t -104.42 -35.7 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 123.943 0.777 . . . . 1.0 109.953 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.23 -30.76 3.8 Favored Glycine 0 N--CA 1.489 2.177 0 C-N-CA 120.803 -0.713 . . . . 1.0 113.879 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.512 ' HZ1' ' H ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -123.84 151.19 43.69 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 120.67 -0.412 . . . . 1.0 111.189 -179.369 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.4 75.27 0.76 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 125.016 1.447 . . . . 1.0 108.643 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.534 ' HG1' ' H ' ' A' ' 26' ' ' GLY . 14.9 t -122.33 -162.8 1.03 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.046 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.534 ' H ' ' HG1' ' A' ' 25' ' ' THR . . . 82.6 167.0 39.79 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.488 -1.445 . . . . 1.0 109.488 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -139.36 -172.01 3.26 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 118.676 -1.21 . . . . 1.0 111.508 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.4 t -107.06 117.82 35.06 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 111.41 -2.632 . . . . 1.0 109.191 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.1 m -139.94 134.15 31.15 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 113.474 -1.693 . . . . 1.0 109.885 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 47.61 41.21 13.08 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 113.723 -1.58 . . . . 1.0 109.878 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.65 18.98 53.8 Favored Glycine 0 N--CA 1.491 2.362 0 CA-C-N 113.512 -1.676 . . . . 1.0 114.828 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.8 mtp85 -136.53 157.5 46.63 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.022 -1.473 . . . . 1.0 107.022 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.485 ' HB3' HG12 ' A' ' 3' ' ' ILE . 42.6 t -73.12 139.0 46.13 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.236 1.199 . . . . 1.0 114.236 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 12.5 p-10 -135.79 95.55 3.26 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 102.743 -3.058 . . . . 1.0 102.743 178.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.436 ' SG ' ' HA3' ' A' ' 26' ' ' GLY . 6.5 t . . . . . 0 N--CA 1.495 1.792 0 CA-C-N 113.546 -1.661 . . . . 1.0 110.746 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 122.105 0.955 . . . . 1.0 112.408 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 64.8 t -70.71 114.75 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-N 113.232 -1.803 . . . . 1.0 108.446 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.453 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 33.5 pt -136.29 166.62 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 115.954 1.835 . . . . 1.0 115.954 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 5' ' ' GLN . . . -61.02 -43.15 99.8 Favored Glycine 0 N--CA 1.473 1.119 0 CA-C-N 111.736 -2.483 . . . . 1.0 111.469 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 4' ' ' GLY . 4.0 tp-100 -14.84 90.75 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.429 0 O-C-N 125.843 1.554 . . . . 1.0 113.135 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -39.81 133.82 1.51 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 125.224 1.578 . . . . 1.0 110.767 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.484 ' SG ' ' O ' ' A' ' 9' ' ' ARG . 35.2 t -117.6 156.61 27.84 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 124.342 1.026 . . . . 1.0 113.53 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.432 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.3 t80 -120.99 -61.07 1.59 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 105.637 -1.986 . . . . 1.0 105.637 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.484 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 20.4 mtt-85 -114.19 159.98 19.51 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 113.136 -1.847 . . . . 1.0 109.264 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.3 m -24.5 -56.14 0.15 Allowed Pre-proline 0 N--CA 1.506 2.352 0 O-C-N 125.201 1.563 . . . . 1.0 114.949 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.409 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 67.2 Cg_endo -67.1 -96.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.755 1.637 . . . . 1.0 114.07 170.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.7 t70 38.38 32.28 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 123.539 1.638 . . . . 1.0 109.819 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.6 t -171.46 -18.08 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 111.324 -2.671 . . . . 1.0 113.83 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.409 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 6.6 m-30 -38.66 -59.99 0.87 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 112.723 0.638 . . . . 1.0 112.723 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.6 p -46.48 -44.73 17.82 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 124.921 1.388 . . . . 1.0 111.86 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.78 -43.78 87.77 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 114.816 -1.084 . . . . 1.0 109.316 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.6 t -57.81 -50.56 72.86 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.739 -1.578 . . . . 1.0 106.739 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -50.67 -53.93 27.14 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.361 -0.977 . . . . 1.0 108.361 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -51.77 -32.88 32.75 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 112.724 -2.035 . . . . 1.0 110.982 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.0 mt -90.01 -57.82 2.72 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 115.771 1.767 . . . . 1.0 115.771 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 m -99.14 -35.82 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 113.155 0.798 . . . . 1.0 113.155 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.16 -22.32 3.59 Favored Glycine 0 N--CA 1.492 2.393 0 CA-C-O 118.512 -1.16 . . . . 1.0 115.915 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.486 ' H ' ' HD3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -124.56 144.68 50.01 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 118.299 1.05 . . . . 1.0 113.022 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.77 68.85 0.64 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 113.6 -1.636 . . . . 1.0 113.4 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.9 t -133.06 -163.24 1.32 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.494 ' CA ' ' SG ' ' A' ' 35' ' ' CYS . . . 122.65 174.98 14.54 Favored Glycine 0 N--CA 1.495 2.579 0 CA-C-N 114.018 -1.446 . . . . 1.0 113.534 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -121.35 161.32 22.28 Favored 'General case' 0 C--O 1.206 -1.22 0 CA-C-N 113.457 -1.372 . . . . 1.0 109.342 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.1 t -111.67 101.7 10.06 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 103.55 -2.759 . . . . 1.0 103.55 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.414 ' HG1' ' HB2' ' A' ' 34' ' ' ASP . 91.2 m -118.19 121.32 40.2 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 110.944 -2.844 . . . . 1.0 112.997 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.7 t30 45.29 39.82 4.65 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 113.204 -1.816 . . . . 1.0 111.082 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.37 29.43 75.05 Favored Glycine 0 N--CA 1.486 2.029 0 CA-C-N 112.917 -1.947 . . . . 1.0 112.792 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -139.45 153.04 47.48 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.289 -1.745 . . . . 1.0 106.289 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.453 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 6.1 t -73.8 139.01 44.87 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 117.155 2.28 . . . . 1.0 117.155 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.414 ' HB2' ' HG1' ' A' ' 29' ' ' THR . 5.0 m-20 -134.4 80.51 1.86 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 125.54 1.775 . . . . 1.0 107.167 178.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.494 ' SG ' ' CA ' ' A' ' 26' ' ' GLY . 5.8 t . . . . . 0 N--CA 1.501 2.077 0 CA-C-O 116.239 -1.839 . . . . 1.0 111.455 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.6 t . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 108.373 -0.973 . . . . 1.0 108.373 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 48.9 t -71.68 111.65 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 106.073 -1.825 . . . . 1.0 106.073 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.47 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 37.3 pt -133.7 160.07 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 114.931 1.456 . . . . 1.0 114.931 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.95 42.76 3.18 Favored Glycine 0 C--O 1.21 -1.349 0 CA-C-N 112.153 -2.294 . . . . 1.0 111.873 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -105.15 107.31 18.22 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 101.891 -3.374 . . . . 1.0 101.891 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -39.09 138.91 0.53 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 125.425 1.703 . . . . 1.0 114.083 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.1 t -112.86 153.12 28.39 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.908 -1.496 . . . . 1.0 110.185 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -120.01 -56.87 1.99 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 104.927 -2.249 . . . . 1.0 104.927 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.89 155.08 30.79 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 113.393 -1.731 . . . . 1.0 106.57 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.413 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 71.9 m -24.01 -56.44 0.14 Allowed Pre-proline 0 N--CA 1.506 2.337 0 N-CA-C 115.137 1.532 . . . . 1.0 115.137 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.468 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 70.1 Cg_endo -67.25 -94.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.79 1.66 . . . . 1.0 113.222 170.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t70 40.93 29.53 0.08 Allowed 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.629 1.204 . . . . 1.0 109.9 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 t -166.33 -24.11 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 111.966 -2.379 . . . . 1.0 112.759 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.468 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 6.0 m-30 -38.72 -60.94 0.77 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 112.439 0.533 . . . . 1.0 112.439 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.4 t -44.74 -42.23 7.51 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 125.253 1.596 . . . . 1.0 111.375 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.28 -47.55 60.74 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 115.091 -0.958 . . . . 1.0 109.076 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.1 t -53.99 -40.72 67.17 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.324 -1.362 . . . . 1.0 107.324 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -60.84 -54.24 47.56 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 105.967 -1.864 . . . . 1.0 105.967 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -48.01 -31.71 5.7 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 113.473 -1.694 . . . . 1.0 110.03 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.7 mt -84.33 -50.84 7.46 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.569 0.952 . . . . 1.0 113.569 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 p -112.63 -45.66 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 CA-C-N 117.806 0.276 . . . . 1.0 111.159 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.18 18.8 1.46 Allowed Glycine 0 N--CA 1.491 2.324 0 CA-C-O 119.067 -0.852 . . . . 1.0 114.774 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -133.58 126.09 30.22 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 117.291 0.545 . . . . 1.0 112.207 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.43 68.78 0.8 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 124.88 1.362 . . . . 1.0 109.793 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.45 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 9.7 t -135.94 -171.53 2.89 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.679 -0.691 . . . . 1.0 110.088 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.75 -179.31 16.19 Favored Glycine 0 N--CA 1.493 2.467 0 CA-C-N 113.546 -1.661 . . . . 1.0 113.371 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -131.68 171.87 12.95 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 113.982 -1.109 . . . . 1.0 110.845 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.2 t -115.27 112.12 21.95 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 100.375 -3.935 . . . . 1.0 100.375 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.431 ' HG1' ' HB3' ' A' ' 34' ' ' ASP . 55.2 m -132.12 127.8 36.78 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 112.227 -2.261 . . . . 1.0 107.929 -179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.4 p30 46.41 43.89 12.33 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 125.929 2.018 . . . . 1.0 111.903 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.42 13.87 46.14 Favored Glycine 0 N--CA 1.479 1.547 0 CA-C-N 112.876 -1.965 . . . . 1.0 112.463 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.6 mtt-85 -128.21 163.66 24.22 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.863 -1.162 . . . . 1.0 107.863 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.47 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 9.4 t -72.93 142.17 47.84 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 114.702 1.371 . . . . 1.0 114.702 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 35.6 t70 -135.29 76.69 1.63 Allowed 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 112.454 -2.157 . . . . 1.0 107.324 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 25' ' ' THR . 23.6 t . . . . . 0 N--CA 1.502 2.125 0 CA-C-O 118.261 -0.876 . . . . 1.0 111.306 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.74 0.781 . . . . 1.0 111.575 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.3 p -70.85 123.61 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-N 113.473 -1.694 . . . . 1.0 108.31 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.409 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 16.5 pt -133.7 163.08 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 115.214 1.561 . . . . 1.0 115.214 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.42 -46.86 36.34 Favored Glycine 0 N--CA 1.478 1.472 0 CA-C-N 111.036 -2.802 . . . . 1.0 112.528 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -19.83 92.71 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 O-C-N 125.926 1.604 . . . . 1.0 114.085 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -48.17 141.81 5.92 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 124.603 1.19 . . . . 1.0 109.662 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.7 p -123.36 160.55 26.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 124.154 0.909 . . . . 1.0 113.234 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -118.1 -58.57 1.99 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 104.454 -2.424 . . . . 1.0 104.454 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -112.73 166.45 11.35 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 126.166 2.166 . . . . 1.0 106.638 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.415 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 75.4 m -33.66 -61.24 0.4 Allowed Pre-proline 0 N--CA 1.502 2.139 0 N-CA-C 114.614 1.339 . . . . 1.0 114.614 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.417 ' C ' ' N ' ' A' ' 13' ' ' CYS . 73.2 Cg_endo -61.33 -92.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 121.255 1.304 . . . . 1.0 110.315 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t0 34.77 36.96 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 123.812 1.767 . . . . 1.0 108.765 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.417 ' N ' ' C ' ' A' ' 11' ' ' PRO . 48.5 t -168.72 -26.23 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 110.444 -3.071 . . . . 1.0 111.465 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -37.93 -56.66 1.1 Allowed 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 123.439 0.695 . . . . 1.0 111.489 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 55.0 m -54.63 -40.42 68.93 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 124.391 1.057 . . . . 1.0 111.892 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.96 -52.38 24.84 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 123.591 0.557 . . . . 1.0 110.71 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 t -60.28 -27.73 67.52 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.129 -1.063 . . . . 1.0 108.129 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.405 ' HZ2' ' N ' ' A' ' 24' ' ' ALA . 24.6 ttmm -70.38 -50.33 39.82 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.769 -1.567 . . . . 1.0 106.769 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -59.81 -29.13 68.02 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 112.77 -2.014 . . . . 1.0 113.085 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -102.02 -35.46 8.95 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.54 1.682 . . . . 1.0 115.54 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.7 t -104.97 -40.49 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 123.61 0.568 . . . . 1.0 110.049 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.12 -29.18 3.09 Favored Glycine 0 N--CA 1.486 1.986 0 CA-C-O 118.894 -0.948 . . . . 1.0 114.166 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -124.77 159.25 31.39 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.095 1.517 . . . . 1.0 115.095 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.405 ' N ' ' HZ2' ' A' ' 18' ' ' LYS . . . -71.03 71.96 0.57 Allowed 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 113.554 -1.657 . . . . 1.0 113.46 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.469 ' H ' ' HG1' ' A' ' 25' ' ' THR . 2.3 p -119.73 172.13 7.9 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.633 -1.167 . . . . 1.0 112.169 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.95 147.26 9.24 Favored Glycine 0 N--CA 1.491 2.34 0 CA-C-N 113.748 -1.569 . . . . 1.0 111.332 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -121.92 173.68 7.36 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 113.326 -1.437 . . . . 1.0 109.646 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.2 t -103.73 112.1 24.89 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 104.268 -2.493 . . . . 1.0 104.268 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.3 m -130.34 130.34 44.31 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 111.857 -2.429 . . . . 1.0 106.45 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 44.06 44.76 6.4 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 125.123 1.514 . . . . 1.0 111.825 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.46 11.76 22.83 Favored Glycine 0 N--CA 1.487 2.068 0 CA-C-N 112.982 -1.917 . . . . 1.0 114.096 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.2 mtp85 -128.06 163.95 23.48 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.409 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 49.5 t -72.41 143.69 48.44 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.212 -1.395 . . . . 1.0 113.819 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 65.2 t0 -133.17 84.08 2.11 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 126.108 2.13 . . . . 1.0 107.077 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' A' ' 25' ' ' THR . 8.8 t . . . . . 0 N--CA 1.503 2.18 0 CA-C-O 118.626 -0.702 . . . . 1.0 110.105 -179.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.498 0.666 . . . . 1.0 111.634 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.8 p -70.71 122.78 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 114.447 -1.251 . . . . 1.0 108.129 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.431 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 32.7 pt -136.0 160.24 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 N-CA-C 115.794 1.775 . . . . 1.0 115.794 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.21 -44.41 57.51 Favored Glycine 0 N--CA 1.478 1.469 0 CA-C-N 111.093 -2.776 . . . . 1.0 111.183 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -24.42 91.86 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 125.873 1.572 . . . . 1.0 112.856 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -40.0 149.11 0.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 125.263 1.602 . . . . 1.0 112.966 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.412 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 2.1 t -110.1 153.48 24.61 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 124.648 1.218 . . . . 1.0 112.523 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.412 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 1.1 t80 -122.01 -62.35 1.4 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 102.801 -3.037 . . . . 1.0 102.801 179.35 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -119.62 166.11 13.59 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 112.093 -2.321 . . . . 1.0 105.838 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.432 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 75.3 m -33.37 -56.39 0.62 Allowed Pre-proline 0 N--CA 1.505 2.318 0 N-CA-C 114.229 1.196 . . . . 1.0 114.229 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.432 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 88.3 Cg_endo -64.15 -94.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 121.891 1.727 . . . . 1.0 111.826 174.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.0 t70 35.07 36.66 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 CA-C-O 123.844 1.783 . . . . 1.0 109.389 -179.282 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 50.4 t -168.61 -25.25 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 109.8 -3.364 . . . . 1.0 111.567 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -37.86 -57.21 1.04 Allowed 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 122.913 0.485 . . . . 1.0 111.587 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.8 t -49.68 -51.72 36.24 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 125.046 1.466 . . . . 1.0 109.116 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.17 -55.53 32.0 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 120.343 -0.543 . . . . 1.0 112.448 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.7 t -59.2 -27.99 66.23 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 115.397 -0.82 . . . . 1.0 109.499 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -70.12 -46.29 65.08 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 179.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -70.3 -22.6 62.82 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 114.242 -1.344 . . . . 1.0 113.034 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.2 mp -100.03 -33.48 10.47 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 113.911 1.078 . . . . 1.0 113.911 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.0 t -113.06 -43.97 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 124.05 0.844 . . . . 1.0 110.696 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.66 -25.45 3.41 Favored Glycine 0 N--CA 1.49 2.254 0 CA-C-O 119.075 -0.847 . . . . 1.0 114.429 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -120.99 155.87 33.37 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 113.476 0.917 . . . . 1.0 113.476 -179.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.86 69.88 0.71 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 125.084 1.49 . . . . 1.0 109.392 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.8 p -115.32 173.72 6.37 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.496 -1.229 . . . . 1.0 113.273 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.4 152.68 8.81 Favored Glycine 0 N--CA 1.49 2.295 0 CA-C-N 113.844 -1.525 . . . . 1.0 111.199 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -125.1 170.7 10.93 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.342 -1.355 . . . . 1.0 107.342 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.8 t -103.35 109.9 21.69 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.158 -1.793 . . . . 1.0 106.158 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.454 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 56.9 m -133.31 130.73 39.29 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 112.593 -2.094 . . . . 1.0 107.661 -179.379 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 44.64 44.17 7.17 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 125.107 1.504 . . . . 1.0 112.103 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.67 14.84 30.91 Favored Glycine 0 N--CA 1.487 2.063 0 CA-C-N 113.125 -1.852 . . . . 1.0 113.125 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.9 mtt-85 -130.65 165.52 22.66 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.552 -0.907 . . . . 1.0 108.552 179.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.431 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 13.3 t -72.45 144.91 47.93 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.517 -1.273 . . . . 1.0 114.318 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.454 ' CB ' ' HG1' ' A' ' 29' ' ' THR . 36.9 t70 -134.98 82.95 1.99 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 126.385 2.303 . . . . 1.0 107.798 179.003 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.503 2.186 0 CA-C-O 116.237 -1.839 . . . . 1.0 110.405 -179.733 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 122.113 0.959 . . . . 1.0 111.995 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.3 p -70.22 122.4 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-N 112.998 -1.91 . . . . 1.0 108.965 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -131.55 159.12 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 122.278 1.037 . . . . 1.0 113.526 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -39.95 -54.07 3.07 Favored Glycine 0 N--CA 1.483 1.81 0 CA-C-N 111.471 -2.604 . . . . 1.0 112.08 179.528 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -14.0 85.42 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 O-C-N 126.619 2.011 . . . . 1.0 112.923 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -40.15 145.28 0.16 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 113.666 -1.606 . . . . 1.0 112.368 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.5 t -114.91 148.05 39.16 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 124.42 1.075 . . . . 1.0 111.987 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.424 ' HB3' ' HD3' ' A' ' 9' ' ' ARG . 3.7 t80 -123.15 -54.99 1.79 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 103.391 -2.818 . . . . 1.0 103.391 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.424 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -117.13 153.82 32.12 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 113.366 -1.743 . . . . 1.0 107.696 179.665 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.435 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.7 m -28.49 -56.23 0.25 Allowed Pre-proline 0 N--CA 1.504 2.273 0 N-CA-C 114.101 1.149 . . . . 1.0 114.101 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.435 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 86.8 Cg_endo -64.99 -90.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.931 1.754 . . . . 1.0 112.365 170.68 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 t70 36.51 34.93 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 123.572 1.653 . . . . 1.0 109.796 -179.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.7 t -168.45 -26.09 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 110.427 -3.079 . . . . 1.0 111.117 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -38.6 -58.26 1.07 Allowed 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 122.985 0.514 . . . . 1.0 111.812 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 64.8 p -45.48 -45.15 12.97 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 124.672 1.232 . . . . 1.0 110.957 179.396 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.89 -44.64 80.32 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.433 -1.258 . . . . 1.0 111.109 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 25' ' ' THR . 20.2 m -62.8 -32.38 73.54 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.444 -1.253 . . . . 1.0 108.191 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -70.18 -52.59 22.19 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.265 -1.383 . . . . 1.0 107.265 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -11.82 61.17 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 117.638 -1.625 . . . . 1.0 111.653 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 40.9 mt -93.67 -54.97 3.43 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 112.21 0.448 . . . . 1.0 112.21 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.0 m -109.36 -20.32 6.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 118.637 -0.697 . . . . 1.0 112.465 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.46 -33.89 2.59 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 117.83 1.892 . . . . 1.0 117.83 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.431 ' H ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -128.52 162.85 26.26 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 115.458 1.651 . . . . 1.0 115.458 -179.35 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.56 70.63 0.66 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 113.351 -1.749 . . . . 1.0 110.856 179.669 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.422 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 8.2 t -121.58 -177.91 3.67 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.709 0.766 . . . . 1.0 110.687 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.51 174.65 15.24 Favored Glycine 0 N--CA 1.491 2.322 0 CA-C-N 112.941 -1.936 . . . . 1.0 112.096 179.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HG2' ' N ' ' A' ' 28' ' ' CYS . 39.0 ttmt -134.19 167.46 20.64 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.78 -1.21 . . . . 1.0 108.51 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.407 ' N ' ' HG2' ' A' ' 27' ' ' LYS . 50.5 t -108.46 110.01 21.43 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 104.88 -2.267 . . . . 1.0 104.88 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.493 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 88.8 m -128.92 124.71 35.86 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 112.609 -2.087 . . . . 1.0 111.962 -179.557 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 44.32 42.16 5.03 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 112.864 -1.971 . . . . 1.0 111.424 -179.365 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.74 24.81 70.05 Favored Glycine 0 N--CA 1.484 1.854 0 CA-C-N 113.567 -1.651 . . . . 1.0 113.525 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.0 mtp85 -136.53 160.28 39.27 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 107.028 -1.471 . . . . 1.0 107.028 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 21.2 t -72.88 145.3 46.98 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.178 -1.409 . . . . 1.0 112.197 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.493 ' CB ' ' HG1' ' A' ' 29' ' ' THR . 34.3 t70 -129.75 82.58 2.08 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 103.814 -2.662 . . . . 1.0 103.814 178.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.501 2.079 0 CA-C-O 118.366 -0.826 . . . . 1.0 110.604 -179.406 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.174 0.512 . . . . 1.0 111.141 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.3 p -70.88 122.38 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-N 114.654 -1.157 . . . . 1.0 109.884 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.467 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 28.2 pt -133.82 162.43 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 N-CA-C 114.195 1.184 . . . . 1.0 114.195 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.66 44.49 3.26 Favored Glycine 0 C--O 1.211 -1.318 0 CA-C-N 112.201 -2.272 . . . . 1.0 111.955 -179.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -103.88 92.26 4.33 Favored 'General case' 0 N--CA 1.486 1.342 1 N-CA-C 99.934 -4.099 . . . . 1.0 99.934 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -38.98 142.31 0.23 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 125.694 1.871 . . . . 1.0 112.576 -179.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 0.5 OUTLIER -112.77 160.46 17.95 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 116.093 1.886 . . . . 1.0 116.093 -179.605 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.525 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 20.3 t80 -121.24 -58.95 1.76 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 102.794 -3.039 . . . . 1.0 102.794 179.652 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.473 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 11.0 mmm180 -118.14 166.33 12.7 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 113.023 -1.898 . . . . 1.0 109.526 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.431 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.7 m -33.06 -58.7 0.46 Allowed Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 124.997 1.435 . . . . 1.0 114.305 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.431 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 91.1 Cg_endo -62.75 -92.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.951 1.767 . . . . 1.0 111.592 177.14 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 t70 38.24 31.52 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 123.368 1.556 . . . . 1.0 109.144 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.412 ' N ' ' C ' ' A' ' 11' ' ' PRO . 49.1 t -171.55 -17.1 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 111.678 -2.51 . . . . 1.0 113.687 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -38.81 -62.01 0.67 Allowed 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 118.936 0.789 . . . . 1.0 110.451 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.3 m -48.7 -47.48 41.03 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.619 1.2 . . . . 1.0 112.077 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.47 -45.07 92.69 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 114.759 -1.109 . . . . 1.0 111.567 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.1 t -62.87 -48.93 76.9 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 105.802 -1.925 . . . . 1.0 105.802 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -47.82 -50.34 26.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 123.373 0.42 . . . . 1.0 110.76 179.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -70.28 -27.63 64.56 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 117.427 -1.709 . . . . 1.0 111.207 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.0 mt -76.44 -50.97 12.75 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.027 1.121 . . . . 1.0 114.027 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 m -109.37 -36.11 2.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 123.66 0.784 . . . . 1.0 111.955 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.51 -20.41 3.92 Favored Glycine 0 N--CA 1.49 2.265 0 CA-C-O 119.083 -0.843 . . . . 1.0 114.726 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -116.98 136.82 52.65 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 112.709 0.633 . . . . 1.0 112.709 -179.467 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.12 68.37 0.71 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 125.125 1.516 . . . . 1.0 110.749 179.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.452 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 11.2 p -121.87 -175.64 3.15 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.294 -1.321 . . . . 1.0 113.032 -179.491 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.36 154.27 10.96 Favored Glycine 0 N--CA 1.492 2.383 0 CA-C-N 114.075 -1.421 . . . . 1.0 112.356 179.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.38 175.91 6.46 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.086 0.946 . . . . 1.0 109.947 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.9 t -97.37 112.03 24.03 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 112.676 -2.056 . . . . 1.0 106.488 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 37.2 m -128.18 119.64 25.67 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 111.971 -2.377 . . . . 1.0 111.933 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 50.24 43.57 26.3 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 113.519 -1.673 . . . . 1.0 108.659 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.95 16.39 57.15 Favored Glycine 0 N--CA 1.486 2.022 0 CA-C-N 113.719 -1.582 . . . . 1.0 114.131 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.8 mtp-105 -131.22 161.32 32.49 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.202 -1.036 . . . . 1.0 108.202 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.467 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 47.3 t -72.56 140.65 48.22 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.724 -1.19 . . . . 1.0 114.143 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 9.4 t70 -135.69 90.63 2.62 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 125.107 1.504 . . . . 1.0 107.13 178.526 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.452 ' SG ' ' C ' ' A' ' 25' ' ' THR . 10.8 t . . . . . 0 N--CA 1.501 2.104 0 CA-C-O 118.588 -0.72 . . . . 1.0 110.313 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.2 t . . . . . 0 N--CA 1.499 2.005 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 5.8 p -71.03 116.87 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.567 -0.901 . . . . 1.0 108.567 179.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.455 HG12 ' HB3' ' A' ' 33' ' ' CYS . 35.3 pt -132.02 158.0 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 N-CA-C 114.304 1.224 . . . . 1.0 114.304 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.28 -39.86 73.52 Favored Glycine 0 N--CA 1.488 2.115 0 CA-C-N 111.859 -2.428 . . . . 1.0 111.522 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -28.18 96.59 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 O-C-N 125.867 1.569 . . . . 1.0 111.309 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -39.62 144.1 0.19 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 124.934 1.396 . . . . 1.0 114.447 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.7 p -128.06 157.68 40.03 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.074 -0.966 . . . . 1.0 110.694 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -120.26 -56.69 1.98 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 105.474 -2.047 . . . . 1.0 105.474 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.48 159.9 16.32 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 125.7 1.875 . . . . 1.0 107.158 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.416 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.4 m -35.1 -57.08 0.86 Allowed Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 125.313 1.633 . . . . 1.0 112.894 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.416 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 72.5 Cg_endo -60.54 -91.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.275 1.317 . . . . 1.0 111.056 175.293 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t0 33.47 39.54 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 123.981 1.848 . . . . 1.0 108.794 -179.335 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.9 t -172.75 -26.39 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 109.972 -3.285 . . . . 1.0 110.603 -179.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -38.27 -55.41 1.33 Allowed 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 123.588 0.755 . . . . 1.0 112.084 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.7 p -49.45 -48.98 47.18 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 124.214 0.946 . . . . 1.0 110.68 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.67 -55.26 36.57 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 124.03 0.831 . . . . 1.0 109.58 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 25' ' ' THR . 98.6 m -48.86 -41.56 33.6 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.194 -1.366 . . . . 1.0 111.064 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.409 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 6.6 ttpm? -66.65 -47.01 73.87 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.559 -1.645 . . . . 1.0 106.559 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -70.27 -11.51 60.95 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 113.384 -1.735 . . . . 1.0 112.348 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.3 mt -101.52 -53.28 3.02 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 112.684 0.624 . . . . 1.0 112.684 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.7 m -109.13 -26.35 3.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 119.19 -0.433 . . . . 1.0 111.633 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 126.68 -20.17 6.12 Favored Glycine 0 N--CA 1.493 2.434 0 CA-C-O 119.026 -0.874 . . . . 1.0 114.969 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.48 ' HZ1' ' H ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -122.66 141.84 51.32 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 113.22 0.822 . . . . 1.0 113.22 -179.497 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.99 71.71 0.82 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 125.214 1.571 . . . . 1.0 110.108 179.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.515 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 6.0 t -122.64 179.1 4.73 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.748 0.785 . . . . 1.0 112.036 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.08 167.67 18.88 Favored Glycine 0 N--CA 1.498 2.774 0 CA-C-N 113.271 -1.786 . . . . 1.0 111.813 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.68 175.89 8.93 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.721 0.772 . . . . 1.0 109.955 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.4 t -103.07 116.13 31.93 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 113.31 -1.768 . . . . 1.0 106.44 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.467 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 78.4 m -127.93 127.29 43.07 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 112.525 -2.125 . . . . 1.0 109.747 -179.571 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 47.47 40.59 11.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 125.096 1.498 . . . . 1.0 111.062 -179.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.07 19.88 64.19 Favored Glycine 0 N--CA 1.483 1.832 0 CA-C-N 113.281 -1.781 . . . . 1.0 113.916 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.0 mtt-85 -132.7 162.51 31.22 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.479 -1.304 . . . . 1.0 107.479 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.455 ' HB3' HG12 ' A' ' 3' ' ' ILE . 41.8 t -72.79 143.64 47.83 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.889 -1.124 . . . . 1.0 113.243 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 36.8 t70 -134.75 78.1 1.72 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 104.128 -2.545 . . . . 1.0 104.128 178.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.1 t . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 117.863 -1.065 . . . . 1.0 111.078 -179.408 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.402 ' H1 ' ' HB3' ' A' ' 35' ' ' CYS . 10.6 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 108.381 -0.97 . . . . 1.0 108.381 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 5.7 p -71.51 119.02 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.426 -0.953 . . . . 1.0 108.426 179.384 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.439 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 27.4 pt -136.7 164.23 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 N-CA-C 114.809 1.411 . . . . 1.0 114.809 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.35 -43.51 76.06 Favored Glycine 0 N--CA 1.479 1.532 0 CA-C-N 112.051 -2.34 . . . . 1.0 112.08 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -17.14 90.91 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 O-C-N 125.723 1.484 . . . . 1.0 114.12 -179.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -39.96 136.5 1.11 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 125.065 1.478 . . . . 1.0 111.338 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 10.1 t -119.52 159.33 24.53 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 114.276 1.213 . . . . 1.0 114.276 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.503 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 15.4 t80 -120.53 -62.89 1.41 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 105.519 -2.03 . . . . 1.0 105.519 179.728 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.489 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 1.6 mmp_? -113.8 161.67 17.27 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.598 -1.637 . . . . 1.0 108.753 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.1 m -23.84 -59.21 0.12 Allowed Pre-proline 0 N--CA 1.504 2.27 0 N-CA-C 115.695 1.739 . . . . 1.0 115.695 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.415 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 77.5 Cg_endo -66.92 -93.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.157 0 C-N-CA 121.265 1.31 . . . . 1.0 113.86 176.339 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t0 40.23 33.52 0.17 Allowed 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 123.253 1.501 . . . . 1.0 108.942 -179.486 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.1 t -168.74 -24.21 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 111.859 -2.428 . . . . 1.0 112.827 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.415 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.2 m-85 -38.6 -59.72 0.89 Allowed 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 123.159 0.584 . . . . 1.0 111.967 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 77.8 p -48.05 -41.91 27.15 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 124.923 1.39 . . . . 1.0 111.893 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.98 -49.06 55.39 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.637 -0.711 . . . . 1.0 110.735 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 t -60.32 -29.87 69.14 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -70.81 -50.19 38.22 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.302 -1.37 . . . . 1.0 107.302 179.287 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -70.65 -13.4 62.07 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 113.225 -1.807 . . . . 1.0 113.719 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.8 mt -109.93 -43.37 4.01 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.363 0.875 . . . . 1.0 113.363 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.4 t -102.54 -34.71 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 114.859 -1.064 . . . . 1.0 110.323 -179.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.24 -31.65 3.11 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-O 119.105 -0.83 . . . . 1.0 114.175 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -123.6 150.82 43.66 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 113.725 1.009 . . . . 1.0 113.725 -179.348 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.42 72.99 0.71 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 113.827 -1.533 . . . . 1.0 109.815 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.429 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 17.9 p -117.11 -179.0 3.57 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.705 -1.134 . . . . 1.0 112.252 -179.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.03 166.5 13.24 Favored Glycine 0 N--CA 1.494 2.504 0 CA-C-N 114.515 -1.22 . . . . 1.0 115.34 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.43 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -134.05 168.58 18.55 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 112.847 -1.677 . . . . 1.0 107.282 179.696 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 30.7 t -107.98 104.86 14.4 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 104.471 -2.418 . . . . 1.0 104.471 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.483 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 90.7 m -122.31 124.36 43.56 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 111.575 -2.557 . . . . 1.0 111.208 -179.371 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 46.62 39.86 7.59 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 112.89 -1.959 . . . . 1.0 110.921 -179.321 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.96 27.21 70.96 Favored Glycine 0 N--CA 1.485 1.914 0 CA-C-N 113.106 -1.861 . . . . 1.0 112.513 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.0 mtt-85 -137.36 161.27 36.74 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.334 -1.358 . . . . 1.0 107.334 179.688 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.439 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 46.8 t -72.38 143.39 48.6 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.854 1.057 . . . . 1.0 113.854 179.692 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.483 ' CB ' ' HG1' ' A' ' 29' ' ' THR . 34.2 t70 -136.39 81.99 1.91 Allowed 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.502 -1.681 . . . . 1.0 108.641 178.869 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.429 ' SG ' ' C ' ' A' ' 25' ' ' THR . 12.3 t . . . . . 0 N--CA 1.499 1.994 0 CA-C-O 116.148 -1.882 . . . . 1.0 110.828 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.448 ' H1 ' ' HB3' ' A' ' 35' ' ' CYS . 11.5 t . . . . . 0 N--CA 1.495 1.825 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.1 p -71.23 121.66 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-N 114.683 -1.144 . . . . 1.0 109.682 179.763 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.458 HG12 ' HB3' ' A' ' 33' ' ' CYS . 19.6 pt -125.7 150.61 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-O 122.697 1.237 . . . . 1.0 113.594 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.79 -39.29 46.93 Favored Glycine 0 N--CA 1.479 1.505 0 CA-C-N 110.914 -2.857 . . . . 1.0 112.478 179.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -30.9 93.37 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 125.665 1.45 . . . . 1.0 112.89 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -40.44 144.38 0.24 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 124.879 1.362 . . . . 1.0 111.997 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.0 p -121.42 160.69 23.59 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 124.039 0.837 . . . . 1.0 110.985 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -119.96 -57.68 1.93 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.578 -1.267 . . . . 1.0 107.578 -179.953 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.18 164.87 11.92 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 113.269 -1.787 . . . . 1.0 107.152 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.449 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.1 m -39.25 -56.5 2.64 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 124.782 1.301 . . . . 1.0 112.095 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.449 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 84.0 Cg_endo -64.83 -93.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 121.252 1.301 . . . . 1.0 111.238 173.048 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.8 t70 35.51 35.12 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 125.411 1.695 . . . . 1.0 109.635 -179.614 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.404 ' N ' ' C ' ' A' ' 11' ' ' PRO . 36.7 t -167.74 -28.79 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 110.399 -3.092 . . . . 1.0 110.37 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -37.62 -52.24 1.21 Allowed 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 123.822 0.849 . . . . 1.0 112.438 179.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.8 m -56.51 -61.1 2.65 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.994 -0.743 . . . . 1.0 108.994 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.93 -54.69 5.14 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 124.314 1.008 . . . . 1.0 111.052 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 25' ' ' THR . 17.4 m -49.48 -54.42 17.88 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 113.366 -1.743 . . . . 1.0 107.601 179.473 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -50.01 -47.78 52.88 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 179.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -19.74 63.1 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 114.972 -1.013 . . . . 1.0 112.489 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.8 mt -92.41 -50.27 5.72 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 114.478 1.288 . . . . 1.0 114.478 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.5 m -105.51 -30.56 2.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 C-N-CA 123.477 0.711 . . . . 1.0 111.293 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.72 -28.12 3.43 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 116.165 1.226 . . . . 1.0 116.165 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -124.5 156.03 37.96 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 114.161 1.171 . . . . 1.0 114.161 -179.341 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.45 72.85 0.72 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 113.803 -1.544 . . . . 1.0 110.218 179.781 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.504 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 7.5 t -128.41 -176.26 3.76 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.745 0.783 . . . . 1.0 110.431 -179.839 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.5 160.33 30.04 Favored Glycine 0 N--CA 1.494 2.515 0 CA-C-N 113.411 -1.722 . . . . 1.0 109.605 179.713 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.85 -172.39 2.86 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.333 1.063 . . . . 1.0 111.127 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.1 t -110.92 114.81 28.41 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 111.482 -2.599 . . . . 1.0 107.398 179.571 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.469 ' HG1' ' CG ' ' A' ' 34' ' ' ASP . 20.2 m -139.64 133.25 30.39 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 113.161 -1.836 . . . . 1.0 109.286 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 49.22 42.19 21.21 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 113.958 -1.474 . . . . 1.0 108.208 -179.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 58.41 14.57 20.67 Favored Glycine 0 N--CA 1.49 2.287 0 CA-C-N 113.745 -1.57 . . . . 1.0 114.871 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.6 mtp-105 -130.45 160.01 35.35 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.112 -1.44 . . . . 1.0 107.112 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.458 ' HB3' HG12 ' A' ' 3' ' ' ILE . 14.6 t -73.38 143.17 46.93 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.136 -1.426 . . . . 1.0 113.381 -179.937 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.469 ' CG ' ' HG1' ' A' ' 29' ' ' THR . 5.1 p-10 -129.05 88.18 2.67 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 101.23 -3.619 . . . . 1.0 101.23 178.43 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.448 ' HB3' ' H1 ' ' A' ' 1' ' ' VAL . 4.5 t . . . . . 0 N--CA 1.502 2.134 0 CA-C-O 117.001 -1.476 . . . . 1.0 111.535 -179.482 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 121.757 0.789 . . . . 1.0 111.608 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.0 p -70.66 123.63 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-N 113.721 -1.581 . . . . 1.0 108.518 179.664 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.413 HG12 ' HB3' ' A' ' 33' ' ' CYS . 19.1 pt -134.39 165.26 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 N-CA-C 115.148 1.536 . . . . 1.0 115.148 -179.871 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -53.14 -48.0 59.76 Favored Glycine 0 N--CA 1.478 1.465 0 CA-C-N 111.096 -2.775 . . . . 1.0 111.575 179.847 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -20.51 86.49 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.474 0 O-C-N 125.882 1.578 . . . . 1.0 113.034 -179.917 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -40.0 146.58 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.097 -1.411 . . . . 1.0 112.37 -179.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.404 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 5.6 t -110.09 152.36 26.08 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 124.582 1.176 . . . . 1.0 113.465 -179.918 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.404 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 1.8 t80 -125.39 -58.73 1.42 Allowed 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 102.465 -3.161 . . . . 1.0 102.465 179.498 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.04 161.0 20.99 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.376 -1.712 . . . . 1.0 106.376 179.306 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.456 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 73.2 m -30.96 -57.39 0.36 Allowed Pre-proline 0 N--CA 1.506 2.369 0 N-CA-C 114.429 1.27 . . . . 1.0 114.429 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.456 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 83.9 Cg_endo -63.93 -93.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.919 1.746 . . . . 1.0 111.17 173.763 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 t70 36.55 34.12 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 CA-C-O 123.294 1.521 . . . . 1.0 109.375 -179.483 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.422 ' N ' ' C ' ' A' ' 11' ' ' PRO . 54.0 t -169.26 -21.59 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 110.579 -3.009 . . . . 1.0 112.453 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -38.65 -58.51 1.04 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 118.469 0.577 . . . . 1.0 111.64 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.2 t -50.32 -39.64 46.53 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.963 1.414 . . . . 1.0 111.828 179.574 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.16 -48.71 56.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 123.516 0.51 . . . . 1.0 111.137 179.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.0 t -61.94 -32.91 73.37 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.425 -1.324 . . . . 1.0 107.425 179.705 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.485 ' HZ2' ' N ' ' A' ' 24' ' ' ALA . 24.7 ttmm -65.04 -53.72 41.41 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 105.62 -1.992 . . . . 1.0 105.62 179.594 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -50.26 -35.56 27.54 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 114.181 -1.372 . . . . 1.0 109.189 179.692 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.0 tp -67.66 -60.06 2.84 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 114.824 -1.08 . . . . 1.0 111.669 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.09 -48.48 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 124.253 0.97 . . . . 1.0 113.046 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 133.45 23.98 0.71 Allowed Glycine 0 N--CA 1.492 2.376 0 O-C-N 123.417 0.448 . . . . 1.0 113.484 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -133.46 131.37 39.82 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.481 -0.563 . . . . 1.0 109.481 179.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.485 ' N ' ' HZ2' ' A' ' 18' ' ' LYS . . . -72.18 68.06 0.7 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 124.722 1.264 . . . . 1.0 109.63 179.364 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.6 p -115.37 174.92 5.75 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.482 -1.235 . . . . 1.0 112.895 -179.647 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.51 152.89 8.57 Favored Glycine 0 N--CA 1.489 2.213 0 CA-C-N 113.74 -1.573 . . . . 1.0 111.605 179.72 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -122.71 174.78 6.89 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 113.637 -1.282 . . . . 1.0 108.245 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.2 t -110.17 109.06 19.43 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 105.36 -2.089 . . . . 1.0 105.36 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.466 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 60.2 m -133.07 126.08 31.03 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 112.264 -2.244 . . . . 1.0 108.382 -179.61 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.3 p30 47.52 41.3 12.86 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 125.907 2.004 . . . . 1.0 112.345 -179.459 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.63 13.77 59.3 Favored Glycine 0 N--CA 1.478 1.435 0 CA-C-N 113.15 -1.841 . . . . 1.0 112.145 -179.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.7 mmt-85 -128.6 161.94 28.45 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.668 -0.864 . . . . 1.0 108.668 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.413 ' HB3' HG12 ' A' ' 3' ' ' ILE . 12.5 t -72.6 143.56 48.18 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.461 -1.296 . . . . 1.0 113.392 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.466 ' CB ' ' HG1' ' A' ' 29' ' ' THR . 9.9 t70 -134.16 84.31 2.11 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 125.971 2.045 . . . . 1.0 106.555 179.117 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.503 2.203 0 CA-C-O 118.415 -0.802 . . . . 1.0 110.472 -179.784 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.6 m . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 122.028 0.918 . . . . 1.0 111.644 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.7 p -70.39 121.44 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-N 113.502 -1.681 . . . . 1.0 109.45 179.653 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.458 HG12 ' HB3' ' A' ' 33' ' ' CYS . 15.6 pt -128.19 152.89 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 122.265 1.031 . . . . 1.0 113.719 -179.883 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -46.91 -41.35 13.66 Favored Glycine 0 N--CA 1.489 2.191 0 CA-C-N 111.15 -2.75 . . . . 1.0 112.717 179.864 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.403 HE22 ' HA ' ' A' ' 13' ' ' CYS . 1.2 tm0? -28.46 99.79 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 125.501 1.353 . . . . 1.0 112.215 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -39.96 147.36 0.09 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 124.824 1.327 . . . . 1.0 113.711 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.462 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 5.2 t -113.77 157.74 21.87 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.998 -1.001 . . . . 1.0 110.985 -179.95 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.462 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.1 t80 -119.65 -62.79 1.45 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 103.189 -2.893 . . . . 1.0 103.189 179.731 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -124.97 171.45 10.2 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.141 -1.39 . . . . 1.0 107.946 179.65 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 61.1 m -31.69 -56.34 0.44 Allowed Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 125.07 1.482 . . . . 1.0 114.045 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -68.94 -94.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.674 1.583 . . . . 1.0 113.748 173.058 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.2 t70 38.17 32.54 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 CA-C-O 123.158 1.456 . . . . 1.0 109.806 -179.461 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.403 ' HA ' HE22 ' A' ' 5' ' ' GLN . 22.3 t -165.44 -25.74 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 111.341 -2.663 . . . . 1.0 111.618 -179.912 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -38.79 -59.83 0.91 Allowed 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 123.131 0.572 . . . . 1.0 112.466 179.717 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.6 m -45.13 -43.85 10.14 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 124.805 1.316 . . . . 1.0 110.987 179.609 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.02 -50.85 60.77 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.954 -1.021 . . . . 1.0 109.817 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.1 m -54.0 -34.58 60.24 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.755 -1.111 . . . . 1.0 110.276 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -70.65 -51.19 29.52 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.012 -1.848 . . . . 1.0 106.012 179.425 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -70.73 -8.95 55.98 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 113.653 -1.612 . . . . 1.0 113.049 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.72 -51.56 3.16 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 123.4 0.437 . . . . 1.0 110.096 -179.78 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.8 t -104.91 -35.73 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 114.727 -1.124 . . . . 1.0 112.437 -179.319 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 139.42 -30.56 2.41 Favored Glycine 0 N--CA 1.485 1.931 0 CA-C-O 118.676 -1.069 . . . . 1.0 114.667 179.779 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -123.01 150.65 42.75 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 114.424 1.268 . . . . 1.0 114.424 -179.529 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.5 70.49 0.64 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 113.504 -1.68 . . . . 1.0 112.022 179.76 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.9 t -124.12 -174.79 3.08 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.931 0.872 . . . . 1.0 110.791 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.38 -178.75 16.32 Favored Glycine 0 N--CA 1.492 2.425 0 CA-C-N 113.007 -1.906 . . . . 1.0 112.125 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.483 ' NZ ' ' H ' ' A' ' 28' ' ' CYS . 0.2 OUTLIER -143.46 170.65 15.4 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.78 -1.21 . . . . 1.0 108.245 179.94 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.483 ' H ' ' NZ ' ' A' ' 27' ' ' LYS . 49.4 t -108.87 115.27 29.76 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.203 -1.777 . . . . 1.0 106.203 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.463 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 95.3 m -132.33 128.48 37.78 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 113.142 -1.845 . . . . 1.0 112.28 -179.632 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 46.67 40.52 8.71 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 113.571 -1.649 . . . . 1.0 110.312 -179.707 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.55 28.22 64.78 Favored Glycine 0 N--CA 1.487 2.07 0 CA-C-N 113.544 -1.662 . . . . 1.0 112.705 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.6 mtt-85 -136.83 163.74 29.94 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.3 -1.741 . . . . 1.0 106.3 179.682 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.458 ' HB3' HG12 ' A' ' 3' ' ' ILE . 30.5 t -72.76 144.84 47.46 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 118.612 -1.235 . . . . 1.0 112.777 179.682 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.463 ' CB ' ' HG1' ' A' ' 29' ' ' THR . 11.3 t70 -129.95 81.64 2.02 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 105.595 -2.002 . . . . 1.0 105.595 178.722 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.502 2.145 0 C-N-CA 119.259 -0.976 . . . . 1.0 110.305 -179.496 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 121.214 0.531 . . . . 1.0 111.728 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.7 p -70.79 123.48 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-N 114.777 -1.101 . . . . 1.0 108.651 179.603 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.438 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 24.1 pt -137.17 165.3 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 N-CA-C 116.575 2.065 . . . . 1.0 116.575 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.77 -48.41 36.87 Favored Glycine 0 N--CA 1.477 1.422 0 CA-C-N 109.94 -3.3 . . . . 1.0 111.347 179.643 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -23.44 89.77 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 O-C-N 125.787 1.522 . . . . 1.0 113.083 -179.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 -47.69 148.66 1.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.409 -1.269 . . . . 1.0 110.838 179.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 8.7 t -117.11 156.36 27.74 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.982 1.104 . . . . 1.0 113.982 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.45 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.9 t80 -123.36 -56.76 1.7 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 105.104 -2.184 . . . . 1.0 105.104 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.32 152.13 34.5 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 112.879 -1.964 . . . . 1.0 108.102 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.419 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.4 m -22.67 -59.07 0.1 OUTLIER Pre-proline 0 N--CA 1.506 2.369 0 N-CA-C 115.581 1.697 . . . . 1.0 115.581 -179.857 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.452 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 98.6 Cg_endo -65.67 -91.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.45 1.433 . . . . 1.0 113.223 174.161 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.4 t70 41.0 30.74 0.11 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 123.023 1.392 . . . . 1.0 109.166 -179.56 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.3 t -167.3 -24.88 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 112.294 -2.23 . . . . 1.0 112.737 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.452 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.2 m-85 -38.93 -59.59 0.95 Allowed 'General case' 0 N--CA 1.505 2.315 0 C-N-CA 122.947 0.499 . . . . 1.0 111.81 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 p -48.75 -39.88 26.62 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 125.01 1.444 . . . . 1.0 111.776 179.63 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.19 -50.38 40.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 123.999 0.812 . . . . 1.0 110.662 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.7 t -60.09 -30.01 68.96 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.537 -0.912 . . . . 1.0 108.537 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -70.44 -49.87 44.26 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.884 -1.154 . . . . 1.0 107.884 179.211 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -70.4 -15.11 62.8 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.102 -1.863 . . . . 1.0 113.06 -179.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.8 mt -108.41 -43.36 4.35 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 113.852 1.056 . . . . 1.0 113.852 -179.745 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.4 t -101.46 -35.29 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-N 114.802 -1.09 . . . . 1.0 110.081 -179.724 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.23 -32.14 2.9 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 120.69 -0.767 . . . . 1.0 114.106 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.415 ' HZ1' ' CG2' ' A' ' 25' ' ' THR . 12.1 ptmm? -125.72 153.41 43.97 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 113.722 1.008 . . . . 1.0 113.722 -179.465 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.79 74.59 0.6 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 113.818 -1.537 . . . . 1.0 113.556 -179.735 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.432 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 0.9 OUTLIER -120.7 -178.27 3.68 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.705 -1.134 . . . . 1.0 111.333 179.906 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.71 163.1 11.83 Favored Glycine 0 N--CA 1.492 2.432 0 CA-C-N 114.351 -1.295 . . . . 1.0 113.35 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -131.53 166.13 22.05 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 113.636 -1.282 . . . . 1.0 108.167 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.6 t -103.32 94.64 5.61 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 103.138 -2.912 . . . . 1.0 103.138 179.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 83.1 m -112.97 115.1 27.86 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 109.984 -3.28 . . . . 1.0 112.482 -179.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 48.75 41.11 17.48 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 111.453 -2.612 . . . . 1.0 108.739 -179.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.0 28.31 72.61 Favored Glycine 0 N--CA 1.482 1.74 0 CA-C-N 113.364 -1.743 . . . . 1.0 112.434 -179.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -137.6 157.25 46.91 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 106.173 -1.788 . . . . 1.0 106.173 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.438 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 34.5 t -72.78 140.74 47.92 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.451 -1.3 . . . . 1.0 113.913 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 25.6 t70 -135.55 86.56 2.25 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 125.382 1.676 . . . . 1.0 108.54 178.729 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.432 ' SG ' ' C ' ' A' ' 25' ' ' THR . 8.1 t . . . . . 0 N--CA 1.5 2.058 0 CA-C-O 116.292 -1.813 . . . . 1.0 110.58 -179.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.413 ' H1 ' ' HB3' ' A' ' 35' ' ' CYS . 19.5 t . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 108.497 -0.927 . . . . 1.0 108.497 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.2 p -71.26 117.57 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.299 -1.0 . . . . 1.0 108.299 179.377 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.447 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 27.8 pt -131.47 164.53 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 113.7 1.0 . . . . 1.0 113.7 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.99 44.88 3.43 Favored Glycine 0 C--O 1.21 -1.393 0 CA-C-N 112.595 -2.093 . . . . 1.0 112.124 -179.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -100.27 104.94 16.45 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 102.699 -3.074 . . . . 1.0 102.699 179.59 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -39.01 129.39 1.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 113.229 -1.805 . . . . 1.0 112.7 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 24.0 t -120.93 163.09 18.77 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.481 -1.691 . . . . 1.0 112.372 179.794 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.519 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 13.2 t80 -119.8 -64.8 1.22 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 104.855 -2.276 . . . . 1.0 104.855 179.676 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.448 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -119.62 163.69 16.99 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 112.468 -2.151 . . . . 1.0 111.897 179.736 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.3 m -16.49 -62.79 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.231 0 N-CA-C 117.566 2.432 . . . . 1.0 117.566 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.421 ' HG2' ' H ' ' A' ' 12' ' ' ASP . 71.3 Cg_endo -68.48 -92.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 121.343 1.362 . . . . 1.0 112.213 178.837 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.421 ' H ' ' HG2' ' A' ' 11' ' ' PRO . 4.1 t0 36.63 35.18 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 123.502 1.62 . . . . 1.0 109.961 -179.671 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.0 t -168.3 -23.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 110.761 -2.927 . . . . 1.0 111.764 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -38.35 -56.53 1.23 Allowed 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 123.955 0.902 . . . . 1.0 113.225 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.0 t -46.08 -53.26 10.56 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 124.685 1.24 . . . . 1.0 109.326 179.496 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.07 -39.62 90.58 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 113.73 -1.577 . . . . 1.0 112.292 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 25' ' ' THR . 60.0 m -69.14 -28.68 66.66 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.842 -1.072 . . . . 1.0 108.576 179.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -71.05 -52.78 17.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.061 -1.459 . . . . 1.0 107.061 179.319 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -71.04 -19.86 62.45 Favored 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 118.091 -1.444 . . . . 1.0 114.767 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -105.92 -33.79 7.83 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 113.313 0.857 . . . . 1.0 113.313 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 t -106.89 -30.97 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 123.722 0.638 . . . . 1.0 110.07 -179.563 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.67 -34.91 2.77 Favored Glycine 0 N--CA 1.49 2.249 0 O-C-N 123.855 0.722 . . . . 1.0 114.584 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -135.81 169.29 17.8 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 113.245 0.831 . . . . 1.0 113.245 -179.363 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.86 69.33 0.69 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 113.683 -1.598 . . . . 1.0 110.797 179.521 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.5 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 4.5 t -121.67 179.01 4.61 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.61 -179.818 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.97 175.06 18.9 Favored Glycine 0 N--CA 1.493 2.459 0 CA-C-N 113.292 -1.776 . . . . 1.0 111.965 179.847 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.94 175.65 9.04 Favored 'General case' 0 C--O 1.205 -1.277 0 CA-C-O 122.074 0.94 . . . . 1.0 112.73 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.7 t -114.63 109.44 18.23 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 112.396 -2.183 . . . . 1.0 105.429 -179.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.523 ' HG1' ' CB ' ' A' ' 34' ' ' ASP . 97.9 m -126.47 126.44 43.76 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 112.103 -2.317 . . . . 1.0 110.952 -179.501 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 m120 45.18 40.86 5.3 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 113.464 -1.698 . . . . 1.0 111.52 -179.52 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.1 27.42 68.89 Favored Glycine 0 N--CA 1.485 1.942 0 CA-C-N 113.415 -1.72 . . . . 1.0 112.412 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.6 mtt-85 -136.63 160.54 38.5 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.385 -1.709 . . . . 1.0 106.385 179.796 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.447 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 38.9 t -73.06 144.52 47.04 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.609 -1.237 . . . . 1.0 113.076 179.869 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.523 ' CB ' ' HG1' ' A' ' 29' ' ' THR . 32.6 t70 -133.89 76.45 1.66 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.048 -2.204 . . . . 1.0 105.048 178.742 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.413 ' HB3' ' H1 ' ' A' ' 1' ' ' VAL . 17.1 t . . . . . 0 N--CA 1.501 2.1 0 CA-C-O 117.761 -1.114 . . . . 1.0 111.34 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.569 HG12 ' HB3' ' A' ' 33' ' ' CYS . 14.6 pt -125.59 159.66 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 122.818 1.294 . . . . 1.0 113.348 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.74 43.71 3.27 Favored Glycine 0 C--O 1.204 -1.731 0 CA-C-N 112.029 -2.35 . . . . 1.0 113.389 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -105.83 88.23 2.77 Favored 'General case' 0 C--N 1.308 -1.208 1 N-CA-C 98.638 -4.578 . . . . 1.0 98.638 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -38.94 147.19 0.06 Allowed 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 113.275 -1.784 . . . . 1.0 113.401 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 0.5 OUTLIER -112.49 160.64 17.58 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 116.919 2.192 . . . . 1.0 116.919 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.533 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.7 t80 -123.11 -58.68 1.63 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 103.301 -2.851 . . . . 1.0 103.301 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.413 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 42.6 mtt85 -116.36 165.2 13.48 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 112.689 -2.05 . . . . 1.0 110.018 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.458 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 67.3 m -34.73 -59.2 0.62 Allowed Pre-proline 0 N--CA 1.503 2.216 0 O-C-N 124.731 1.269 . . . . 1.0 113.54 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.458 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 88.2 Cg_endo -62.18 -86.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.056 0 C-N-CA 121.976 1.784 . . . . 1.0 112.253 176.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.41 ' H ' ' HG2' ' A' ' 11' ' ' PRO . 6.1 t70 34.16 36.89 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 CA-C-O 124.305 2.002 . . . . 1.0 109.129 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.402 ' N ' ' C ' ' A' ' 11' ' ' PRO . 15.9 t -170.05 -27.18 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 110.21 -3.177 . . . . 1.0 111.502 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -38.2 -55.45 1.3 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 123.712 0.632 . . . . 1.0 112.18 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 61.8 m -50.49 -51.78 44.3 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 124.386 1.054 . . . . 1.0 110.074 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.438 ' HA ' ' HG3' ' A' ' 19' ' ' LYS . . . -58.18 -47.54 83.09 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 122.825 1.297 . . . . 1.0 111.515 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 25' ' ' THR . 35.5 m -58.68 -39.55 81.02 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 113.735 -1.575 . . . . 1.0 108.688 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -64.7 -52.16 58.65 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.282 -1.377 . . . . 1.0 107.282 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HG3' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -71.58 -10.72 60.21 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 117.677 -1.609 . . . . 1.0 113.129 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.7 mt -92.61 -50.35 5.64 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 119.409 -0.329 . . . . 1.0 111.549 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.7 p -114.07 -32.38 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 123.481 0.488 . . . . 1.0 110.69 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.99 -19.75 3.67 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 116.031 1.172 . . . . 1.0 116.031 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -128.42 151.28 49.56 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 114.54 1.311 . . . . 1.0 114.54 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.2 70.76 0.84 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 113.784 -1.553 . . . . 1.0 110.403 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.512 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 5.1 t -122.9 176.39 6.03 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.9 0.857 . . . . 1.0 112.298 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.69 160.37 27.81 Favored Glycine 0 N--CA 1.493 2.467 0 CA-C-N 112.671 -2.058 . . . . 1.0 110.197 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.415 ' HD3' ' H ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -130.4 -178.33 4.72 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.359 1.076 . . . . 1.0 112.824 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 38.7 t -90.12 109.39 20.45 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 111.895 -2.411 . . . . 1.0 107.809 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.434 ' CB ' ' HB2' ' A' ' 34' ' ' ASP . 44.0 m -126.34 119.53 27.58 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 111.679 -2.509 . . . . 1.0 110.992 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 50.33 43.43 26.63 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.453 -1.703 . . . . 1.0 109.013 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.94 20.55 53.65 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-N 113.623 -1.626 . . . . 1.0 113.026 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.0 mtt85 -132.86 160.87 35.7 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.095 -1.446 . . . . 1.0 107.095 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.569 ' HB3' HG12 ' A' ' 3' ' ' ILE . 42.9 t -73.22 142.07 47.31 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 118.381 -1.328 . . . . 1.0 114.005 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.434 ' HB2' ' CB ' ' A' ' 29' ' ' THR . 18.9 t70 -128.01 85.94 2.41 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 102.822 -3.029 . . . . 1.0 102.822 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.501 2.106 0 CA-C-O 116.75 -1.595 . . . . 1.0 111.47 -179.487 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 48.9 t . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 107.115 -1.439 . . . . 1.0 107.115 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.548 HG12 ' HB3' ' A' ' 33' ' ' CYS . 30.1 pt -129.58 163.37 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 114.301 1.223 . . . . 1.0 114.301 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.97 43.76 3.29 Favored Glycine 0 C--O 1.213 -1.196 0 CA-C-N 112.188 -2.278 . . . . 1.0 112.436 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -106.3 100.3 9.84 Favored 'General case' 0 N--CA 1.486 1.348 1 N-CA-C 99.919 -4.104 . . . . 1.0 99.919 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.525 ' HE ' HH22 ' A' ' 32' ' ' ARG . 64.6 mtt85 -38.94 144.5 0.12 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 125.253 1.596 . . . . 1.0 114.58 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.7 t -110.7 156.06 21.56 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.255 -1.793 . . . . 1.0 111.505 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -120.81 -61.9 1.51 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 103.88 -2.637 . . . . 1.0 103.88 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -118.71 167.58 11.53 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 112.861 -1.972 . . . . 1.0 107.558 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.409 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 50.7 m -26.57 -49.64 0.18 Allowed Pre-proline 0 N--CA 1.507 2.376 0 N-CA-C 115.015 1.487 . . . . 1.0 115.015 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.464 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . 0.9 OUTLIER -88.86 -83.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.319 -0.977 0 C-N-CA 121.864 1.709 . . . . 1.0 108.639 -176.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.9 t70 37.1 32.43 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 123.149 1.452 . . . . 1.0 110.104 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.551 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 41.8 t -164.6 -26.17 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 111.3 -2.682 . . . . 1.0 112.95 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.464 ' CD1' ' HB3' ' A' ' 11' ' ' PRO . 3.3 m-85 -38.19 -55.18 1.33 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 123.988 0.915 . . . . 1.0 113.072 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 55.5 m -47.7 -53.63 14.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 124.861 1.35 . . . . 1.0 108.648 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.09 -51.05 70.83 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.04 -0.982 . . . . 1.0 111.035 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.551 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 94.6 m -54.57 -33.48 60.33 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.247 -1.342 . . . . 1.0 109.695 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -70.67 -48.92 52.33 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.057 -1.831 . . . . 1.0 106.057 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -70.45 -14.13 62.41 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-N 114.551 -1.204 . . . . 1.0 113.538 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.7 mt -107.14 -44.08 4.46 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 113.578 0.955 . . . . 1.0 113.578 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 37.1 t -99.67 -36.56 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-N 114.647 -1.16 . . . . 1.0 109.782 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.76 -30.23 3.43 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 120.615 -0.802 . . . . 1.0 113.974 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -128.01 151.06 49.61 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 114.077 1.14 . . . . 1.0 114.077 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.39 77.06 0.76 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 114.118 -1.401 . . . . 1.0 109.327 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.1 t -128.71 -172.87 2.82 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.766 -0.652 . . . . 1.0 109.324 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.677 ' HA3' ' SG ' ' A' ' 35' ' ' CYS . . . 118.89 -179.37 16.8 Favored Glycine 0 N--CA 1.493 2.458 0 CA-C-N 113.217 -1.81 . . . . 1.0 115.902 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -142.74 168.38 19.86 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 112.296 -1.952 . . . . 1.0 107.012 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.3 t -105.63 115.03 29.55 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 105.031 -2.211 . . . . 1.0 105.031 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.2 m -128.23 123.76 34.99 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 112.923 -1.944 . . . . 1.0 112.48 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 45.98 42.14 8.99 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 112.92 -1.945 . . . . 1.0 110.076 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.18 27.46 67.47 Favored Glycine 0 N--CA 1.489 2.171 0 CA-C-N 113.769 -1.56 . . . . 1.0 112.752 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.525 HH22 ' HE ' ' A' ' 6' ' ' ARG . 36.0 mmt180 -135.78 161.87 34.37 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 106.308 -1.738 . . . . 1.0 106.308 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.548 ' HB3' HG12 ' A' ' 3' ' ' ILE . 13.8 t -73.4 142.43 46.97 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 114.807 1.41 . . . . 1.0 114.807 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 11.3 t70 -130.45 79.78 1.92 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 125.791 1.932 . . . . 1.0 108.227 178.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.677 ' SG ' ' HA3' ' A' ' 26' ' ' GLY . 1.3 m . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 118.136 -0.935 . . . . 1.0 111.067 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 52.7 t . . . . . 0 N--CA 1.496 1.86 0 N-CA-C 107.413 -1.329 . . . . 1.0 107.413 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.557 HG12 ' HB3' ' A' ' 33' ' ' CYS . 33.5 pt -134.03 163.63 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 115.563 1.69 . . . . 1.0 115.563 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.12 -44.63 88.55 Favored Glycine 0 N--CA 1.478 1.46 0 CA-C-N 111.499 -2.591 . . . . 1.0 110.791 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -28.37 90.5 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.455 0 O-C-N 126.096 1.704 . . . . 1.0 110.755 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -39.94 146.88 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.832 1.419 . . . . 1.0 114.832 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.8 p -125.67 159.25 32.72 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.376 -1.284 . . . . 1.0 110.057 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.401 ' H ' ' CB ' ' A' ' 12' ' ' ASP . 12.8 t80 -119.41 -55.21 2.14 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 106.177 -1.786 . . . . 1.0 106.177 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.464 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -111.14 162.08 15.29 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 113.048 -1.887 . . . . 1.0 106.719 179.785 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.447 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 58.4 m -30.85 -55.8 0.38 Allowed Pre-proline 0 N--CA 1.503 2.199 0 O-C-N 125.091 1.494 . . . . 1.0 113.533 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.495 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 53.9 Cg_endo -70.19 -95.05 0.01 OUTLIER 'Trans proline' 0 C--O 1.205 -1.141 0 C-N-CA 121.248 1.299 . . . . 1.0 113.946 170.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.401 ' CB ' ' H ' ' A' ' 8' ' ' TYR . 4.9 t70 39.99 32.82 0.12 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 124.862 1.351 . . . . 1.0 109.593 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.2 t -167.59 -25.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 111.809 -2.45 . . . . 1.0 112.392 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.495 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.5 m-30 -38.5 -59.15 0.94 Allowed 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 123.698 0.799 . . . . 1.0 112.173 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.9 p -45.92 -46.22 15.92 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 125.162 1.539 . . . . 1.0 111.37 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.8 -41.76 87.05 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.428 -1.26 . . . . 1.0 111.231 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.8 t -69.34 -27.46 65.38 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.267 -0.879 . . . . 1.0 109.025 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -70.17 -53.63 16.35 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.955 -1.498 . . . . 1.0 106.955 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -71.14 -21.22 62.21 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 114.161 1.171 . . . . 1.0 114.161 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.8 mp -98.26 -33.57 11.04 Favored 'General case' 0 N--CA 1.509 2.511 0 N-CA-C 112.847 0.684 . . . . 1.0 112.847 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.82 -37.78 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 123.677 0.611 . . . . 1.0 109.856 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.19 -31.75 2.65 Favored Glycine 0 N--CA 1.489 2.196 0 CA-C-O 118.785 -1.008 . . . . 1.0 114.917 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -128.13 145.67 50.94 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 115.22 1.563 . . . . 1.0 115.22 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.82 72.58 0.81 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 113.491 -1.686 . . . . 1.0 110.409 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.426 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 7.8 t -133.04 -173.43 3.19 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.278 0.561 . . . . 1.0 109.769 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.28 -170.82 13.61 Favored Glycine 0 N--CA 1.495 2.569 0 CA-C-N 113.579 -1.646 . . . . 1.0 114.219 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -147.38 167.8 23.44 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 113.683 -1.259 . . . . 1.0 108.817 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.2 t -104.82 117.59 34.43 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.322 -1.733 . . . . 1.0 106.322 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.7 m -125.66 122.91 37.74 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 113.319 -1.764 . . . . 1.0 111.203 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.4 m120 45.74 41.54 7.57 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 112.798 -2.001 . . . . 1.0 111.279 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.67 21.95 71.36 Favored Glycine 0 N--CA 1.482 1.719 0 CA-C-N 113.385 -1.734 . . . . 1.0 113.592 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.1 mmt-85 -131.7 158.87 39.99 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.667 -1.605 . . . . 1.0 106.667 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.557 ' HB3' HG12 ' A' ' 3' ' ' ILE . 9.1 t -72.62 142.18 48.35 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.58 -1.248 . . . . 1.0 113.708 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.4 t70 -135.07 78.37 1.73 Allowed 'General case' 0 C--N 1.295 -1.764 0 O-C-N 125.969 2.043 . . . . 1.0 106.862 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.426 ' SG ' ' O ' ' A' ' 25' ' ' THR . 37.1 t . . . . . 0 N--CA 1.498 1.947 0 C-N-CA 119.717 -0.793 . . . . 1.0 111.281 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.4 p . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.481 HG12 ' HB3' ' A' ' 33' ' ' CYS . 22.9 pt -135.02 169.31 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 115.1 1.518 . . . . 1.0 115.1 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.01 -47.26 81.38 Favored Glycine 0 N--CA 1.478 1.489 0 CA-C-N 111.577 -2.556 . . . . 1.0 111.869 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -20.96 90.61 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.516 0 O-C-N 125.85 1.559 . . . . 1.0 112.884 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -39.79 142.3 0.34 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 124.851 1.344 . . . . 1.0 112.361 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.1 p -124.64 162.45 24.1 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 124.58 1.175 . . . . 1.0 111.042 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -118.24 -61.87 1.62 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 102.782 -3.044 . . . . 1.0 102.782 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -117.79 168.25 10.64 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.407 -2.072 . . . . 1.0 105.407 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.426 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.7 m -29.85 -54.59 0.33 Allowed Pre-proline 0 N--CA 1.503 2.198 0 O-C-N 124.692 1.245 . . . . 1.0 113.823 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.426 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 54.3 Cg_endo -67.78 -104.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 121.568 1.512 . . . . 1.0 113.841 172.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.8 t70 39.34 30.54 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 123.2 1.476 . . . . 1.0 110.031 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.7 t -168.15 -15.29 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 111.255 -2.702 . . . . 1.0 113.598 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.4 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 6.0 m-30 -38.74 -58.8 1.02 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 113.675 0.991 . . . . 1.0 113.675 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.0 t -45.27 -48.18 12.92 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 124.849 1.343 . . . . 1.0 110.734 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.74 -53.4 54.89 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.623 -1.172 . . . . 1.0 108.734 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.2 t -49.55 -39.66 35.55 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.811 -1.086 . . . . 1.0 110.12 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -65.95 -47.79 73.5 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.503 -1.295 . . . . 1.0 107.503 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -70.09 -11.82 61.16 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 112.862 -1.972 . . . . 1.0 111.885 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.6 mt -104.47 -52.72 2.84 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.105 1.15 . . . . 1.0 114.105 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.3 m -108.61 -16.68 8.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 118.687 -0.673 . . . . 1.0 112.525 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.99 -38.23 1.97 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 118.354 2.101 . . . . 1.0 118.354 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -126.57 153.75 44.83 Favored 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 115.243 1.572 . . . . 1.0 115.243 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.54 68.88 0.59 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 113.316 -1.766 . . . . 1.0 112.204 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.8 t -130.25 -168.65 2.0 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.549 ' CA ' ' SG ' ' A' ' 35' ' ' CYS . . . 124.78 174.42 14.0 Favored Glycine 0 N--CA 1.497 2.707 0 CA-C-N 113.517 -1.674 . . . . 1.0 115.136 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -131.4 164.46 25.64 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 112.13 -2.035 . . . . 1.0 108.483 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.5 t -107.46 112.07 24.68 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 104.654 -2.35 . . . . 1.0 104.654 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 84.8 m -128.18 123.69 34.93 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 112.371 -2.195 . . . . 1.0 112.131 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 51.49 39.78 25.38 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 113.2 -1.818 . . . . 1.0 108.905 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.49 21.05 62.02 Favored Glycine 0 N--CA 1.486 2.017 0 CA-C-N 113.286 -1.779 . . . . 1.0 112.386 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.6 mtp85 -129.87 164.03 25.03 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.677 -1.231 . . . . 1.0 107.677 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.481 ' HB3' HG12 ' A' ' 3' ' ' ILE . 4.3 t -72.56 145.28 47.51 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.926 -1.109 . . . . 1.0 112.975 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.7 t70 -133.57 83.57 2.06 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 112.693 -2.049 . . . . 1.0 107.992 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.549 ' SG ' ' CA ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.017 0 CA-C-O 118.439 -0.791 . . . . 1.0 111.106 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 55.6 t . . . . . 0 N--CA 1.497 1.879 0 N-CA-C 105.659 -1.978 . . . . 1.0 105.659 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.498 HG12 ' HB3' ' A' ' 33' ' ' CYS . 36.1 pt -135.04 168.49 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 115.875 1.806 . . . . 1.0 115.875 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.54 -45.67 83.66 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 111.814 -2.448 . . . . 1.0 111.041 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.5 tp60 -22.64 90.08 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.45 0 O-C-N 125.943 1.614 . . . . 1.0 113.112 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -39.82 143.16 0.27 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 113.916 -1.493 . . . . 1.0 113.15 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.4 p -124.36 163.93 20.7 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.916 -1.038 . . . . 1.0 109.826 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.439 ' H ' ' HB3' ' A' ' 12' ' ' ASP . 17.0 t80 -117.15 -61.08 1.76 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 104.298 -2.482 . . . . 1.0 104.298 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -116.82 169.41 9.4 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 112.418 -2.174 . . . . 1.0 106.97 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.462 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 73.1 m -28.55 -54.98 0.26 Allowed Pre-proline 0 N--CA 1.503 2.179 0 O-C-N 124.942 1.401 . . . . 1.0 113.944 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.462 ' HD3' ' HB2' ' A' ' 10' ' ' SER . 28.8 Cg_endo -73.74 -100.6 0.01 OUTLIER 'Trans proline' 0 C--O 1.208 -0.984 0 C-N-CA 121.776 1.651 . . . . 1.0 114.917 170.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.439 ' HB3' ' H ' ' A' ' 8' ' ' TYR . 12.5 t70 41.86 28.63 0.09 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 124.79 1.306 . . . . 1.0 110.163 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.0 t -164.58 -21.91 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 112.109 -2.314 . . . . 1.0 113.138 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.459 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 6.3 m-30 -38.78 -61.37 0.73 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 112.913 0.708 . . . . 1.0 112.913 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.3 p -43.84 -42.72 5.83 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 125.174 1.546 . . . . 1.0 112.165 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.99 -49.84 47.54 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 114.188 -1.369 . . . . 1.0 108.771 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.7 t -55.45 -34.97 64.97 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.292 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -66.49 -51.09 60.42 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 106.464 -1.68 . . . . 1.0 106.464 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.41 ' NZ ' ' HB2' ' A' ' 19' ' ' LYS . 4.4 ttmp? -59.77 -24.74 64.33 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.039 -1.891 . . . . 1.0 112.197 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.0 mp -101.27 -33.74 9.93 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 116.101 1.889 . . . . 1.0 116.101 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.13 -37.79 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 123.453 0.471 . . . . 1.0 110.771 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.41 -30.77 2.58 Favored Glycine 0 N--CA 1.488 2.145 0 CA-C-O 118.435 -1.203 . . . . 1.0 115.041 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.48 141.46 51.98 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 115.146 1.535 . . . . 1.0 115.146 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.74 71.79 0.76 Allowed 'General case' 0 N--CA 1.503 2.209 0 CA-C-N 113.609 -1.632 . . . . 1.0 112.697 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.414 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 14.7 t -133.08 -168.16 2.04 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.431 0.634 . . . . 1.0 109.453 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.09 -174.69 16.2 Favored Glycine 0 N--CA 1.493 2.458 0 CA-C-N 113.577 -1.647 . . . . 1.0 115.359 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.48 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -138.1 162.63 33.69 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 112.833 -1.683 . . . . 1.0 108.518 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.417 ' H ' ' HE2' ' A' ' 27' ' ' LYS . 42.0 t -106.08 114.81 29.17 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 103.757 -2.683 . . . . 1.0 103.757 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 78.1 m -128.61 124.44 35.85 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 112.923 -1.944 . . . . 1.0 112.354 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 50.8 39.91 23.34 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 113.152 -1.84 . . . . 1.0 109.041 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.16 22.02 62.42 Favored Glycine 0 N--CA 1.484 1.854 0 CA-C-N 113.283 -1.78 . . . . 1.0 112.816 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.1 mtp-105 -130.89 163.29 27.77 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.14 -1.43 . . . . 1.0 107.14 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.498 ' HB3' HG12 ' A' ' 3' ' ' ILE . 2.5 t -72.69 142.61 48.23 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.213 1.19 . . . . 1.0 114.213 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.515 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.5 t70 -135.54 74.91 1.53 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 112.262 -2.245 . . . . 1.0 106.338 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 25' ' ' THR . 41.9 t . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 118.278 -0.868 . . . . 1.0 111.83 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.3 p . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 108.774 -0.824 . . . . 1.0 108.774 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.507 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 33.0 pt -135.37 165.42 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 115.531 1.678 . . . . 1.0 115.531 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.84 44.2 3.33 Favored Glycine 0 C--O 1.21 -1.361 0 CA-C-N 111.314 -2.675 . . . . 1.0 111.826 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -109.8 96.6 6.36 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 100.64 -3.837 . . . . 1.0 100.64 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -39.11 147.74 0.06 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 125.381 1.676 . . . . 1.0 113.732 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.1 t -116.56 154.16 30.93 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 113.523 -1.672 . . . . 1.0 111.602 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -120.23 -55.95 2.02 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 104.323 -2.473 . . . . 1.0 104.323 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.434 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -119.2 154.02 34.01 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 113.498 -1.683 . . . . 1.0 106.792 179.72 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.438 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.9 m -22.0 -56.01 0.09 OUTLIER Pre-proline 0 N--CA 1.506 2.364 0 N-CA-C 115.773 1.768 . . . . 1.0 115.773 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.473 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 63.6 Cg_endo -69.19 -94.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.733 1.622 . . . . 1.0 113.531 169.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.7 t70 42.52 28.19 0.11 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 124.537 1.148 . . . . 1.0 110.246 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.6 t -164.47 -26.99 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 112.49 -2.141 . . . . 1.0 112.572 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.473 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 5.9 m-30 -38.73 -61.51 0.71 Allowed 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 112.582 0.586 . . . . 1.0 112.582 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.8 m -42.04 -43.77 3.32 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 125.509 1.755 . . . . 1.0 111.062 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.51 -49.0 58.69 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 114.389 -1.278 . . . . 1.0 109.113 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.5 t -56.8 -30.04 63.3 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 124.053 0.846 . . . . 1.0 108.954 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -70.72 -51.52 26.9 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 105.912 -1.884 . . . . 1.0 105.912 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -70.65 -10.78 60.16 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 113.755 -1.566 . . . . 1.0 113.878 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.4 mt -108.69 -43.5 4.25 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 112.903 0.705 . . . . 1.0 112.903 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.4 t -105.23 -38.24 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-N 114.748 -1.114 . . . . 1.0 110.464 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.0 -30.19 2.86 Favored Glycine 0 N--CA 1.488 2.161 0 CA-C-O 118.854 -0.97 . . . . 1.0 114.378 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -122.62 139.27 54.12 Favored 'General case' 0 N--CA 1.506 2.375 0 N-CA-C 114.407 1.262 . . . . 1.0 114.407 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.16 68.93 0.74 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 125.146 1.529 . . . . 1.0 111.086 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.433 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 9.2 t -132.64 -169.14 2.18 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.303 -0.862 . . . . 1.0 109.041 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.31 -173.11 16.27 Favored Glycine 0 N--CA 1.493 2.443 0 CA-C-N 113.751 -1.568 . . . . 1.0 113.711 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -136.96 167.64 21.12 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.654 -1.273 . . . . 1.0 109.568 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.5 t -109.87 112.33 24.3 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 103.485 -2.783 . . . . 1.0 103.485 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.8 m -127.37 123.28 35.84 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 112.829 -1.987 . . . . 1.0 112.604 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 49.91 40.63 21.31 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 113.134 -1.848 . . . . 1.0 108.599 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.52 22.94 62.09 Favored Glycine 0 N--CA 1.484 1.85 0 CA-C-N 113.231 -1.804 . . . . 1.0 113.211 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -131.07 162.34 30.05 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 106.048 -1.834 . . . . 1.0 106.048 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.507 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 9.1 t -73.33 141.56 47.1 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.043 1.498 . . . . 1.0 115.043 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.2 t70 -136.64 77.39 1.65 Allowed 'General case' 0 C--N 1.298 -1.673 0 O-C-N 125.825 1.953 . . . . 1.0 107.699 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.433 ' SG ' ' O ' ' A' ' 25' ' ' THR . 29.9 t . . . . . 0 N--CA 1.5 2.041 0 C-N-CA 119.609 -0.836 . . . . 1.0 111.372 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.2 p . . . . . 0 N--CA 1.495 1.811 0 N-CA-C 109.009 -0.738 . . . . 1.0 109.009 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.495 HG12 ' HB3' ' A' ' 33' ' ' CYS . 1.5 pt -132.18 159.75 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 114.1 1.148 . . . . 1.0 114.1 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -40.47 -53.34 3.54 Favored Glycine 0 N--CA 1.486 1.99 0 CA-C-N 111.22 -2.718 . . . . 1.0 112.206 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -16.13 85.62 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 O-C-N 126.195 1.761 . . . . 1.0 113.217 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -51.05 144.8 8.37 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.772 -1.104 . . . . 1.0 109.607 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.0 p -123.01 164.16 19.09 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 114.249 1.203 . . . . 1.0 114.249 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -118.07 -57.77 2.06 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 104.686 -2.338 . . . . 1.0 104.686 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -114.39 168.43 9.85 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 112.949 -1.932 . . . . 1.0 107.247 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.452 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.3 m -35.29 -58.8 0.74 Allowed Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 124.961 1.413 . . . . 1.0 113.412 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.452 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 84.7 Cg_endo -62.15 -95.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.391 1.394 . . . . 1.0 112.423 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 t0 37.91 32.34 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 123.147 1.451 . . . . 1.0 108.809 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.422 ' N ' ' C ' ' A' ' 11' ' ' PRO . 23.9 t -165.41 -24.94 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 111.945 -2.389 . . . . 1.0 112.298 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -38.21 -55.71 1.28 Allowed 'General case' 0 N--CA 1.508 2.466 0 C-N-CA 123.1 0.56 . . . . 1.0 110.778 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.6 p -53.31 -49.18 67.57 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 124.579 1.175 . . . . 1.0 110.119 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.5 -55.62 29.67 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.681 0.753 . . . . 1.0 110.765 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 25' ' ' THR . 56.5 m -48.58 -49.33 37.1 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.165 -1.38 . . . . 1.0 108.317 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -55.61 -49.59 72.4 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.167 0.984 . . . . 1.0 108.443 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -59.8 -26.73 65.99 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-N 113.852 -1.522 . . . . 1.0 111.46 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.1 mp -85.6 -55.79 3.82 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 120.082 -0.647 . . . . 1.0 112.31 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.2 m -107.3 -46.21 7.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 C-N-CA 122.922 0.489 . . . . 1.0 112.25 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.8 28.34 1.29 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 111.215 -0.754 . . . . 1.0 111.215 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -135.41 126.84 28.58 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 124.268 0.628 . . . . 1.0 110.293 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.35 69.04 0.8 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 124.909 1.381 . . . . 1.0 108.923 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.463 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 12.4 t -127.66 -173.46 2.92 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.898 0.856 . . . . 1.0 111.576 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.85 158.62 27.55 Favored Glycine 0 N--CA 1.495 2.572 0 CA-C-N 112.612 -2.086 . . . . 1.0 109.598 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -132.99 179.29 6.27 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.605 0.716 . . . . 1.0 110.312 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.2 t -100.04 118.07 35.64 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 113.512 -1.676 . . . . 1.0 106.704 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.5 m -132.24 130.39 40.88 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 112.633 -2.076 . . . . 1.0 106.552 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.6 p30 45.5 41.44 6.77 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 125.286 1.616 . . . . 1.0 112.76 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.05 12.4 49.13 Favored Glycine 0 N--CA 1.479 1.561 0 CA-C-N 113.412 -1.722 . . . . 1.0 113.435 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.8 mmt-85 -127.71 162.55 26.3 Favored 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.495 ' HB3' HG12 ' A' ' 3' ' ' ILE . 42.9 t -72.59 146.47 46.66 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 117.7 -1.6 . . . . 1.0 112.08 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 34.0 t70 -129.69 85.69 2.33 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 104.878 -2.267 . . . . 1.0 104.878 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.504 2.246 0 CA-C-O 116.452 -1.737 . . . . 1.0 111.112 -179.44 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.6 p . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 107.204 -1.406 . . . . 1.0 107.204 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.496 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 35.9 pt -136.83 166.35 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 116.349 1.981 . . . . 1.0 116.349 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.03 -46.05 85.61 Favored Glycine 0 N--CA 1.478 1.448 0 CA-C-N 111.235 -2.711 . . . . 1.0 110.637 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.419 ' HB3' HG13 ' A' ' 3' ' ' ILE . 49.2 tp60 -22.76 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.323 0 O-C-N 125.9 1.588 . . . . 1.0 112.44 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -40.11 151.01 0.05 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 125.274 1.609 . . . . 1.0 114.041 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 t -117.21 149.6 40.14 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 113.538 -1.665 . . . . 1.0 110.318 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.484 ' HB3' ' HD3' ' A' ' 9' ' ' ARG . 3.0 t80 -122.08 -54.8 1.9 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 102.553 -3.129 . . . . 1.0 102.553 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.484 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -118.65 154.05 33.31 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 105.941 -1.874 . . . . 1.0 105.941 179.675 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.45 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 67.8 m -25.2 -55.78 0.17 Allowed Pre-proline 0 N--CA 1.505 2.324 0 N-CA-C 114.748 1.388 . . . . 1.0 114.748 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.488 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 64.4 Cg_endo -69.04 -93.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 121.149 1.233 . . . . 1.0 113.629 170.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.4 t70 42.31 30.01 0.18 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 122.616 1.198 . . . . 1.0 109.691 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.8 t -165.96 -26.22 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 112.23 -2.259 . . . . 1.0 112.658 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.488 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.4 m-30 -38.56 -59.03 0.96 Allowed 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 123.612 0.765 . . . . 1.0 112.244 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.6 p -45.53 -43.24 11.71 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 125.117 1.511 . . . . 1.0 111.769 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.05 -46.53 64.8 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.811 -1.086 . . . . 1.0 109.768 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.2 t -57.04 -36.14 70.13 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.103 -1.073 . . . . 1.0 108.103 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -65.69 -53.75 36.82 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 105.1 -2.185 . . . . 1.0 105.1 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.82 -31.6 7.36 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 114.236 -1.347 . . . . 1.0 109.755 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.84 -54.35 5.43 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.475 -0.784 . . . . 1.0 112.088 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 50.7 t -104.28 -54.79 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 CA-C-N 115.655 -0.702 . . . . 1.0 111.674 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.61 20.48 1.09 Allowed Glycine 0 N--CA 1.491 2.309 0 O-C-N 124.043 0.839 . . . . 1.0 112.793 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -133.16 126.26 31.27 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 124.102 0.53 . . . . 1.0 110.465 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.15 73.9 0.94 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 124.54 1.15 . . . . 1.0 108.201 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.411 HG23 ' SG ' ' A' ' 35' ' ' CYS . 9.4 t -137.38 -173.24 3.42 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.429 0.633 . . . . 1.0 110.884 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.87 -179.69 16.18 Favored Glycine 0 N--CA 1.493 2.46 0 CA-C-N 113.429 -1.714 . . . . 1.0 113.745 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -134.53 172.48 12.86 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 114.001 -1.1 . . . . 1.0 111.346 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 45.6 t -112.34 111.56 22.5 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 102.273 -3.232 . . . . 1.0 102.273 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.2 m -130.73 123.42 29.22 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 112.437 -2.165 . . . . 1.0 108.097 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 p30 47.8 42.0 15.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 126.679 2.487 . . . . 1.0 112.116 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.95 11.21 60.44 Favored Glycine 0 N--CA 1.476 1.309 0 CA-C-N 113.132 -1.849 . . . . 1.0 112.289 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.3 mtt85 -126.34 163.72 22.64 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.187 -1.042 . . . . 1.0 108.187 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.496 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 7.4 t -72.21 143.03 49.0 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.506 -1.278 . . . . 1.0 114.308 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 35.8 t70 -136.39 77.0 1.63 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 112.051 -2.34 . . . . 1.0 107.56 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.411 ' SG ' HG23 ' A' ' 25' ' ' THR . 21.8 t . . . . . 0 N--CA 1.498 1.951 0 CA-C-O 118.016 -0.992 . . . . 1.0 111.27 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.5 p . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 110.689 -0.115 . . . . 1.0 110.689 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.559 HG12 ' HB3' ' A' ' 33' ' ' CYS . 23.6 pt -130.23 159.29 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 CA-C-O 122.125 0.964 . . . . 1.0 112.779 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.22 -39.64 72.08 Favored Glycine 0 N--CA 1.489 2.195 0 CA-C-N 112.133 -2.303 . . . . 1.0 112.971 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -13.64 87.61 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 115.672 1.73 . . . . 1.0 115.672 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -40.7 124.31 2.04 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.693 1.246 . . . . 1.0 109.634 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 5.6 t -95.43 157.88 15.7 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 116.182 1.919 . . . . 1.0 116.182 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.515 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 14.7 t80 -121.68 -61.96 1.46 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 104.285 -2.487 . . . . 1.0 104.285 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -121.1 168.07 11.95 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 112.982 -1.917 . . . . 1.0 110.137 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.435 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 59.9 m -32.29 -59.64 0.38 Allowed Pre-proline 0 N--CA 1.501 2.109 0 O-C-N 125.051 1.469 . . . . 1.0 114.605 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.435 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 84.1 Cg_endo -61.37 -89.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.753 1.635 . . . . 1.0 112.045 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 t70 35.92 36.41 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 CA-C-O 124.113 1.911 . . . . 1.0 108.508 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.403 ' N ' ' C ' ' A' ' 11' ' ' PRO . 15.1 t -170.36 -25.33 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 111.118 -2.765 . . . . 1.0 112.382 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -38.45 -59.51 0.9 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 123.984 0.803 . . . . 1.0 111.618 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.3 t -51.83 -44.43 63.56 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 124.939 1.399 . . . . 1.0 112.657 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.43 -46.81 78.46 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 124.025 0.828 . . . . 1.0 113.055 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.1 t -68.72 -31.02 69.8 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.012 -1.477 . . . . 1.0 107.012 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.419 ' HZ3' ' HB3' ' A' ' 18' ' ' LYS . 6.0 ttpm? -64.11 -50.29 68.87 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.24 -1.022 . . . . 1.0 108.24 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -70.15 -26.3 63.87 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.002 -1.479 . . . . 1.0 109.505 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 tt -65.15 -59.18 4.38 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.963 -0.695 . . . . 1.0 110.138 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.01 -42.73 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 114.171 1.175 . . . . 1.0 114.171 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.03 10.82 1.69 Allowed Glycine 0 N--CA 1.491 2.337 0 CA-C-O 119.569 -0.573 . . . . 1.0 112.759 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -129.68 128.9 43.49 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 123.722 0.307 . . . . 1.0 110.468 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.02 68.71 0.7 Allowed 'General case' 0 N--CA 1.503 2.202 0 O-C-N 124.87 1.356 . . . . 1.0 109.954 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.6 p -115.61 175.78 5.37 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.151 -1.386 . . . . 1.0 113.048 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.78 150.58 9.34 Favored Glycine 0 N--CA 1.49 2.263 0 CA-C-N 113.254 -1.794 . . . . 1.0 110.989 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -122.55 -178.48 3.92 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 113.521 -1.339 . . . . 1.0 111.01 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.5 t -111.27 109.42 19.43 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 111.903 -2.408 . . . . 1.0 108.209 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.3 m -138.71 131.56 29.4 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 112.837 -1.983 . . . . 1.0 111.001 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 51.06 40.1 24.81 Favored 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 112.811 -1.995 . . . . 1.0 108.33 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.0 19.16 50.0 Favored Glycine 0 N--CA 1.489 2.223 0 CA-C-N 113.259 -1.791 . . . . 1.0 113.356 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.0 mtp-105 -134.26 160.11 38.88 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.559 ' HB3' HG12 ' A' ' 3' ' ' ILE . 43.5 t -72.53 139.17 47.41 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 114.826 1.417 . . . . 1.0 114.826 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 11.2 p-10 -134.02 94.09 3.2 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.185 -2.154 . . . . 1.0 105.185 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.504 2.227 0 CA-C-N 115.252 -0.885 . . . . 1.0 109.741 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.8 t . . . . . 0 N--CA 1.499 2.023 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.54 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 33.8 pt -134.93 164.04 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 N-CA-C 114.136 1.162 . . . . 1.0 114.136 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.62 -39.59 93.56 Favored Glycine 0 N--CA 1.479 1.534 0 CA-C-N 112.868 -1.969 . . . . 1.0 112.564 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -12.0 88.01 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 115.372 1.619 . . . . 1.0 115.372 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.0 mtt85 -39.8 122.91 1.49 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 124.817 1.323 . . . . 1.0 110.873 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 9.0 t -107.11 158.53 17.0 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 114.974 1.472 . . . . 1.0 114.974 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.52 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.9 t80 -123.48 -56.6 1.7 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 112.424 -2.171 . . . . 1.0 105.996 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.458 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -115.4 153.71 30.56 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 113.406 -1.724 . . . . 1.0 110.011 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.473 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.3 m -25.22 -57.94 0.16 Allowed Pre-proline 0 N--CA 1.508 2.437 0 O-C-N 125.092 1.495 . . . . 1.0 114.909 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.473 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 95.7 Cg_endo -62.82 -91.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.874 1.716 . . . . 1.0 112.058 173.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.8 t70 35.99 35.44 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 123.725 1.726 . . . . 1.0 108.889 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.4 ' N ' ' C ' ' A' ' 11' ' ' PRO . 49.3 t -170.73 -23.11 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 110.802 -2.908 . . . . 1.0 112.541 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -38.63 -59.94 0.87 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 123.415 0.447 . . . . 1.0 111.569 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.5 t -47.92 -40.4 21.86 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 124.933 1.396 . . . . 1.0 112.243 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.02 -54.48 13.0 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 123.715 0.635 . . . . 1.0 110.139 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.8 t -55.01 -32.65 61.97 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.553 -0.906 . . . . 1.0 108.553 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -67.14 -50.87 59.74 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 105.906 -1.887 . . . . 1.0 105.906 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -70.48 -9.03 55.5 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 113.756 -1.565 . . . . 1.0 111.554 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -90.68 -60.1 2.01 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.7 -0.852 . . . . 1.0 108.7 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 p -111.58 -39.24 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 124.129 0.893 . . . . 1.0 112.763 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.98 14.03 1.69 Allowed Glycine 0 N--CA 1.493 2.446 0 CA-C-O 119.635 -0.536 . . . . 1.0 113.285 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.426 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 3.2 mptp? -132.23 127.45 35.8 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 123.966 0.451 . . . . 1.0 110.257 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.09 68.41 0.7 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 125.065 1.478 . . . . 1.0 109.723 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.453 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 12.2 p -119.26 -179.12 3.75 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.252 -1.34 . . . . 1.0 114.299 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.41 153.91 9.25 Favored Glycine 0 N--CA 1.494 2.542 0 CA-C-N 113.419 -1.718 . . . . 1.0 111.704 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -119.45 167.21 12.17 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.33 -0.935 . . . . 1.0 108.672 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 13.5 t -101.42 90.64 4.15 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 102.917 -2.994 . . . . 1.0 102.917 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.7 m -110.78 115.57 29.78 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 109.497 -3.501 . . . . 1.0 111.43 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 52.8 39.03 28.08 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 112.425 -2.17 . . . . 1.0 108.465 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.61 25.59 68.99 Favored Glycine 0 N--CA 1.483 1.816 0 CA-C-N 113.065 -1.88 . . . . 1.0 111.858 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.2 mtt-85 -136.42 159.25 42.36 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.004 -1.48 . . . . 1.0 107.004 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.54 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 40.1 t -72.36 140.3 48.37 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 114.293 1.22 . . . . 1.0 114.293 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -135.18 84.49 2.1 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 124.978 1.424 . . . . 1.0 107.348 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.453 ' SG ' ' C ' ' A' ' 25' ' ' THR . 6.5 t . . . . . 0 N--CA 1.501 2.104 0 CA-C-O 116.787 -1.577 . . . . 1.0 111.239 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.727 -0.472 . . . . 1.0 109.727 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.58 HG12 ' HB3' ' A' ' 33' ' ' CYS . 23.1 pt -128.83 160.25 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 121.916 0.865 . . . . 1.0 112.882 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.96 43.81 3.24 Favored Glycine 0 C--O 1.211 -1.338 0 CA-C-N 112.589 -2.096 . . . . 1.0 112.671 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -105.36 102.53 12.01 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 101.555 -3.498 . . . . 1.0 101.555 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -39.03 137.53 0.67 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 113.425 -1.716 . . . . 1.0 113.19 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.6 p -121.84 159.37 26.92 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.582 -1.19 . . . . 1.0 110.148 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -118.51 -59.82 1.84 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 106.175 -1.787 . . . . 1.0 106.175 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.37 163.81 12.54 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 113.188 -1.824 . . . . 1.0 106.591 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.472 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 75.5 m -35.93 -55.26 1.3 Allowed Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 125.156 1.535 . . . . 1.0 112.125 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.5 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 81.2 Cg_endo -67.07 -93.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 120.858 1.038 . . . . 1.0 113.009 171.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 t70 36.97 34.46 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 CA-C-O 123.351 1.548 . . . . 1.0 109.678 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.5 t -166.35 -27.53 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 110.766 -2.924 . . . . 1.0 111.307 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.5 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.0 m-85 -38.38 -55.34 1.38 Allowed 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 124.456 1.103 . . . . 1.0 112.45 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.5 p -47.1 -48.72 22.79 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 124.322 1.014 . . . . 1.0 109.887 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.02 -45.15 90.19 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.708 -1.133 . . . . 1.0 110.379 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 25' ' ' THR . 10.5 m -57.59 -35.56 70.57 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.998 -1.001 . . . . 1.0 109.372 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -70.8 -46.41 62.89 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.381 -1.711 . . . . 1.0 106.381 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.28 -15.19 62.86 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 114.157 -1.383 . . . . 1.0 113.623 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.0 mt -110.46 -43.62 3.85 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 113.86 1.059 . . . . 1.0 113.86 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.0 t -98.89 -36.22 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 114.555 -1.202 . . . . 1.0 110.033 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.57 -28.79 4.16 Favored Glycine 0 N--CA 1.489 2.207 0 O-C-N 123.866 0.729 . . . . 1.0 113.07 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.428 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 8.6 mptt -129.23 152.04 49.23 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 112.405 0.52 . . . . 1.0 112.405 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.52 78.51 0.79 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 114.274 -1.33 . . . . 1.0 109.218 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.418 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 7.6 t -128.38 -178.22 4.48 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.551 0.691 . . . . 1.0 111.627 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.53 -169.0 13.84 Favored Glycine 0 N--CA 1.495 2.6 0 CA-C-N 113.216 -1.811 . . . . 1.0 112.567 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -155.13 173.06 17.14 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.024 -1.088 . . . . 1.0 108.388 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 47.4 t -102.13 118.1 36.19 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.178 -1.786 . . . . 1.0 106.178 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.1 m -129.75 125.81 36.72 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 112.867 -1.97 . . . . 1.0 110.834 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 50.55 40.87 24.55 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 125.198 1.561 . . . . 1.0 109.15 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.86 18.92 55.06 Favored Glycine 0 N--CA 1.488 2.142 0 CA-C-N 113.148 -1.842 . . . . 1.0 113.51 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -128.62 163.32 25.31 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.778 -1.564 . . . . 1.0 106.778 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.58 ' HB3' HG12 ' A' ' 3' ' ' ILE . 11.2 t -73.49 143.75 46.47 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.177 -1.409 . . . . 1.0 113.263 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -131.24 85.04 2.23 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 104.53 -2.396 . . . . 1.0 104.53 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.5 2.071 0 C-N-CA 119.76 -0.776 . . . . 1.0 109.957 -179.514 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 41.1 t . . . . . 0 N--CA 1.494 1.731 0 N-CA-C 108.53 -0.915 . . . . 1.0 108.53 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.566 HG12 ' HB3' ' A' ' 33' ' ' CYS . 23.6 pt -128.96 154.64 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 114.549 1.314 . . . . 1.0 114.549 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -48.87 -43.24 30.39 Favored Glycine 0 N--CA 1.477 1.433 0 CA-C-N 110.824 -2.898 . . . . 1.0 111.758 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -26.15 91.98 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 126.106 1.709 . . . . 1.0 112.333 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -39.85 149.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.938 -1.483 . . . . 1.0 113.63 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.451 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 5.0 t -107.63 157.28 18.2 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.714 -1.13 . . . . 1.0 112.124 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.467 ' CD2' ' HG2' ' A' ' 9' ' ' ARG . 15.9 t80 -119.72 -64.88 1.22 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 103.023 -2.954 . . . . 1.0 103.023 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.467 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 9.0 mmt85 -123.85 168.83 12.23 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 112.277 -2.238 . . . . 1.0 106.533 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.457 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 67.9 m -29.02 -58.36 0.25 Allowed Pre-proline 0 N--CA 1.504 2.261 0 N-CA-C 114.677 1.362 . . . . 1.0 114.677 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.457 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 71.1 Cg_endo -66.96 -93.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.426 1.418 . . . . 1.0 113.262 175.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.401 ' H ' ' HG2' ' A' ' 11' ' ' PRO . 15.6 t70 37.89 33.73 0.05 Allowed 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 123.399 1.571 . . . . 1.0 109.906 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.5 t -164.51 -26.85 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 110.851 -2.886 . . . . 1.0 111.432 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.407 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.2 m-85 -38.74 -58.27 1.09 Allowed 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 123.68 0.792 . . . . 1.0 111.777 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.0 m -48.15 -45.7 33.61 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 124.625 1.203 . . . . 1.0 110.749 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.444 ' HA ' ' HG2' ' A' ' 19' ' ' LYS . . . -66.03 -41.56 90.77 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.608 -1.178 . . . . 1.0 112.309 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 25' ' ' THR . 24.2 m -66.81 -32.02 73.03 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.907 -1.042 . . . . 1.0 109.01 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.405 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 6.6 ttpm? -70.77 -52.57 19.87 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.753 -1.203 . . . . 1.0 107.753 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HG2' ' HA ' ' A' ' 16' ' ' ALA . 58.6 pttt -70.92 -17.16 62.7 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 118.903 -1.119 . . . . 1.0 113.448 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.1 mt -101.88 -41.99 6.3 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 113.25 0.833 . . . . 1.0 113.25 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.1 t -101.49 -34.7 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 124.293 0.996 . . . . 1.0 110.321 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.17 -29.64 3.85 Favored Glycine 0 N--CA 1.493 2.464 0 O-C-N 123.731 0.645 . . . . 1.0 113.065 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.612 ' H ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -128.5 156.58 43.03 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 112.97 0.73 . . . . 1.0 112.97 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.88 73.64 0.59 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 113.975 -1.466 . . . . 1.0 112.95 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.449 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 0.8 OUTLIER -114.32 -171.29 1.89 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.964 -1.016 . . . . 1.0 110.102 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.86 156.02 12.32 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.853 -0.899 . . . . 1.0 110.853 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 54.5 mtmt -132.53 169.88 15.96 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.331 -0.988 . . . . 1.0 108.331 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.6 t -105.11 100.61 10.2 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 104.8 -2.296 . . . . 1.0 104.8 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.7 m -121.66 118.71 29.84 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 110.736 -2.938 . . . . 1.0 112.069 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.7 m120 47.7 42.31 15.2 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 112.562 -2.108 . . . . 1.0 110.013 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.89 23.08 69.06 Favored Glycine 0 N--CA 1.482 1.763 0 CA-C-N 113.229 -1.805 . . . . 1.0 113.09 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.2 mtp85 -136.48 160.47 38.66 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.74 -1.208 . . . . 1.0 107.74 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.566 ' HB3' HG12 ' A' ' 3' ' ' ILE . 19.5 t -72.57 142.12 48.42 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.437 -1.305 . . . . 1.0 114.118 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 35.0 t0 -131.38 88.98 2.65 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 105.326 -2.102 . . . . 1.0 105.326 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.501 2.106 0 CA-C-O 118.394 -0.812 . . . . 1.0 109.372 -179.773 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 5.3 p . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.571 HG12 ' HB3' ' A' ' 33' ' ' CYS . 35.1 pt -133.2 152.55 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 114.603 1.335 . . . . 1.0 114.603 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.67 -38.3 63.48 Favored Glycine 0 N--CA 1.482 1.741 0 CA-C-N 111.717 -2.492 . . . . 1.0 110.747 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -32.33 103.11 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 125.918 1.599 . . . . 1.0 110.217 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -39.46 151.96 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.815 1.783 . . . . 1.0 115.815 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 1.4 t -112.87 154.62 26.04 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.222 -1.354 . . . . 1.0 111.47 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.419 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 1.2 t80 -121.31 -62.86 1.38 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 103.684 -2.71 . . . . 1.0 103.684 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -119.89 166.61 13.07 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 111.895 -2.411 . . . . 1.0 106.173 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.467 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.7 m -35.55 -55.47 1.15 Allowed Pre-proline 0 N--CA 1.506 2.364 0 N-CA-C 113.355 0.872 . . . . 1.0 113.355 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.467 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 83.6 Cg_endo -63.64 -94.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.632 1.555 . . . . 1.0 112.011 173.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.0 t70 36.09 34.76 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.373 0 CA-C-O 123.358 1.552 . . . . 1.0 109.316 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.415 ' N ' ' C ' ' A' ' 11' ' ' PRO . 42.7 t -171.14 -19.99 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 110.738 -2.937 . . . . 1.0 112.562 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -38.51 -59.2 0.94 Allowed 'General case' 0 N--CA 1.503 2.215 0 CA-C-N 118.632 0.651 . . . . 1.0 110.93 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 76.1 p -47.58 -39.95 17.98 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.99 1.431 . . . . 1.0 112.153 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.09 -49.35 51.81 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.697 -0.683 . . . . 1.0 109.573 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.6 t -55.09 -40.88 70.9 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.239 -1.393 . . . . 1.0 107.239 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -59.24 -53.53 57.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 106.566 -1.642 . . . . 1.0 106.566 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -48.43 -34.59 11.25 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 113.567 -1.651 . . . . 1.0 109.846 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.4 mt -80.97 -51.58 8.37 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.391 0.886 . . . . 1.0 113.391 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -113.49 -44.72 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-N 117.867 0.303 . . . . 1.0 111.489 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.67 12.86 2.37 Favored Glycine 0 N--CA 1.492 2.387 0 CA-C-O 119.362 -0.688 . . . . 1.0 114.056 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.79 129.99 50.55 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 123.784 0.343 . . . . 1.0 110.515 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.35 68.17 0.75 Allowed 'General case' 0 N--CA 1.506 2.358 0 O-C-N 124.624 1.203 . . . . 1.0 109.417 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.481 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 12.5 p -118.47 -179.94 3.94 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.628 -1.169 . . . . 1.0 113.418 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.8 158.95 12.24 Favored Glycine 0 N--CA 1.493 2.464 0 CA-C-N 113.852 -1.522 . . . . 1.0 113.04 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -127.03 177.23 6.77 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 122.076 0.941 . . . . 1.0 108.524 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.7 t -101.71 111.84 24.22 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 112.492 -2.14 . . . . 1.0 107.829 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 49.9 m -126.23 120.69 30.66 Favored 'General case' 0 N--CA 1.503 2.175 0 CA-C-N 112.1 -2.318 . . . . 1.0 111.559 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 48.76 42.84 20.47 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 113.452 -1.704 . . . . 1.0 109.684 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.15 21.38 61.63 Favored Glycine 0 N--CA 1.486 2.005 0 CA-C-N 113.733 -1.576 . . . . 1.0 113.241 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.8 mtt-85 -133.15 161.45 34.4 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 106.916 -1.513 . . . . 1.0 106.916 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.571 ' HB3' HG12 ' A' ' 3' ' ' ILE . 35.0 t -72.57 141.73 48.42 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.607 1.336 . . . . 1.0 114.607 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.5 t70 -135.24 83.31 2.01 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 125.631 1.832 . . . . 1.0 109.112 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.481 ' SG ' ' C ' ' A' ' 25' ' ' THR . 9.6 t . . . . . 0 N--CA 1.502 2.13 0 C-N-CA 119.25 -0.98 . . . . 1.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 58.0 t . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 109.052 -0.721 . . . . 1.0 109.052 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.521 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 29.2 pt -133.97 163.63 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 115.273 1.583 . . . . 1.0 115.273 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.75 -43.08 96.66 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-N 111.398 -2.637 . . . . 1.0 111.572 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.42 ' HB3' HG13 ' A' ' 3' ' ' ILE . 53.1 tp60 -15.23 88.34 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 O-C-N 126.173 1.749 . . . . 1.0 113.774 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -39.89 134.17 1.49 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 124.88 1.362 . . . . 1.0 110.75 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 9.7 t -116.69 159.19 22.61 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.663 -1.153 . . . . 1.0 113.09 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.44 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 19.1 t80 -119.46 -61.89 1.57 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 104.254 -2.499 . . . . 1.0 104.254 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.432 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -118.15 161.28 20.12 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 112.891 -1.959 . . . . 1.0 110.318 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.425 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 75.8 m -18.42 -60.09 0.05 OUTLIER Pre-proline 0 N--CA 1.506 2.338 0 N-CA-C 117.948 2.573 . . . . 1.0 117.948 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 44.7 Cg_endo -72.44 -96.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.6 1.533 . . . . 1.0 113.185 176.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.404 ' H ' ' HG2' ' A' ' 11' ' ' PRO . 5.5 t0 44.52 28.59 0.33 Allowed 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 122.253 1.025 . . . . 1.0 109.542 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 t -167.07 -22.99 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 113.367 -1.742 . . . . 1.0 114.177 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.453 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 6.6 m-30 -39.12 -62.99 0.58 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 112.228 0.455 . . . . 1.0 112.228 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.1 t -43.36 -46.68 6.61 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 125.358 1.661 . . . . 1.0 111.13 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.434 ' HA ' ' HG2' ' A' ' 19' ' ' LYS . . . -63.61 -45.17 91.53 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 114.035 -1.439 . . . . 1.0 111.224 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.1 t -62.73 -38.97 92.6 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.935 -1.135 . . . . 1.0 107.935 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -60.95 -51.38 69.5 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.434 ' HG2' ' HA ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -70.92 -18.03 62.67 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 118.091 -1.444 . . . . 1.0 112.262 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 mp -87.33 -50.14 6.78 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 112.94 0.719 . . . . 1.0 112.94 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.2 m -112.16 -30.79 2.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 118.832 -0.604 . . . . 1.0 112.172 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.89 -26.62 2.99 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 116.491 1.356 . . . . 1.0 116.491 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -122.65 135.16 54.52 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 114.542 1.312 . . . . 1.0 114.542 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.78 67.72 0.6 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 113.609 -1.632 . . . . 1.0 111.862 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.9 t -131.79 -163.32 1.32 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.543 -0.753 . . . . 1.0 110.364 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.51 -176.06 17.45 Favored Glycine 0 N--CA 1.498 2.81 0 CA-C-N 113.769 -1.56 . . . . 1.0 111.222 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -136.0 171.64 14.18 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.523 0.678 . . . . 1.0 110.021 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.0 t -105.31 114.44 28.63 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 106.406 -1.702 . . . . 1.0 106.406 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.5 m -123.36 118.35 27.31 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 112.6 -2.091 . . . . 1.0 114.304 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 45.16 39.26 3.87 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 114.073 -1.421 . . . . 1.0 112.014 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.6 18.29 79.81 Favored Glycine 0 N--CA 1.476 1.335 0 CA-C-N 112.886 -1.961 . . . . 1.0 115.221 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.7 mtp-105 -135.32 156.41 49.0 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.2 -1.037 . . . . 1.0 108.2 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.521 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 20.1 t -72.9 138.49 46.25 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 116.556 2.058 . . . . 1.0 116.556 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 0.8 OUTLIER -133.36 82.34 1.98 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 125.283 1.615 . . . . 1.0 108.757 178.421 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.499 1.996 0 CA-C-O 116.52 -1.705 . . . . 1.0 110.736 -179.758 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.3 p . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 108.609 -0.885 . . . . 1.0 108.609 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.519 HG12 ' HB3' ' A' ' 33' ' ' CYS . 22.8 pt -129.21 159.72 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 114.929 1.455 . . . . 1.0 114.929 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.32 -45.16 44.87 Favored Glycine 0 N--CA 1.478 1.44 0 CA-C-N 110.755 -2.929 . . . . 1.0 111.63 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.452 ' HB3' HG13 ' A' ' 3' ' ' ILE . 3.7 tp-100 -21.26 90.73 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 O-C-N 125.794 1.526 . . . . 1.0 113.137 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.3 ptt-85 -46.2 142.51 2.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 124.63 1.206 . . . . 1.0 108.689 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 28.0 p -113.32 158.88 20.01 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 118.839 -1.144 . . . . 1.0 112.273 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -116.73 -59.79 1.92 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 105.741 -1.948 . . . . 1.0 105.741 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.3 mtt85 -114.84 169.5 9.03 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 112.058 -2.337 . . . . 1.0 106.879 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.475 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 73.5 m -37.58 -56.26 1.79 Allowed Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 124.776 1.298 . . . . 1.0 111.726 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.475 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 97.9 Cg_endo -64.97 -95.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.248 1.299 . . . . 1.0 112.945 175.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.1 t70 37.19 30.58 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 O-C-N 125.401 1.688 . . . . 1.0 109.578 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.431 ' N ' ' C ' ' A' ' 11' ' ' PRO . 42.7 t -164.81 -22.92 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 111.244 -2.707 . . . . 1.0 112.832 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.426 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.1 m-85 -38.6 -58.61 1.02 Allowed 'General case' 0 N--CA 1.503 2.206 0 CA-C-N 118.306 0.503 . . . . 1.0 110.434 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.4 p -53.54 -44.75 69.47 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 124.635 1.21 . . . . 1.0 111.086 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.23 -57.94 10.65 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 120.35 -0.54 . . . . 1.0 110.933 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.8 t -52.51 -45.24 66.15 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.412 -1.329 . . . . 1.0 107.412 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -50.98 -47.72 61.37 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -62.85 -36.31 82.84 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 114.565 -1.198 . . . . 1.0 110.126 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.46 -54.64 11.48 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 113.64 0.978 . . . . 1.0 113.64 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 m -105.42 -43.58 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 114.103 1.149 . . . . 1.0 114.103 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.28 17.23 2.01 Favored Glycine 0 N--CA 1.494 2.557 0 O-C-N 123.536 0.522 . . . . 1.0 112.199 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -134.14 130.53 37.46 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 123.877 0.398 . . . . 1.0 110.198 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.56 71.68 0.7 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 124.533 1.146 . . . . 1.0 108.555 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.3 p -119.57 177.16 5.04 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.485 -1.234 . . . . 1.0 113.281 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.93 153.35 17.56 Favored Glycine 0 N--CA 1.49 2.261 0 CA-C-N 113.64 -1.618 . . . . 1.0 111.191 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.8 -176.67 3.84 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 124.829 0.958 . . . . 1.0 108.552 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.2 t -108.42 109.34 20.61 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 112.063 -2.335 . . . . 1.0 108.661 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.9 m -136.26 129.34 31.37 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-N 112.683 -2.053 . . . . 1.0 110.066 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 51.15 40.73 26.55 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 112.817 -1.992 . . . . 1.0 107.729 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.35 13.56 44.21 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-N 113.358 -1.746 . . . . 1.0 114.283 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.4 mmt-85 -129.93 159.88 35.3 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.371 -0.974 . . . . 1.0 108.371 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.519 ' HB3' HG12 ' A' ' 3' ' ' ILE . 15.6 t -72.68 140.53 47.95 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.85 1.426 . . . . 1.0 114.85 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 7.7 p-10 -130.7 94.98 3.74 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 105.587 -2.005 . . . . 1.0 105.587 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.502 2.161 0 CA-C-O 118.013 -0.994 . . . . 1.0 110.174 -179.887 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.5 p . . . . . 0 N--CA 1.495 1.785 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.514 HG12 ' HB3' ' A' ' 33' ' ' CYS . 36.6 pt -137.8 165.49 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 115.659 1.725 . . . . 1.0 115.659 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.97 -42.92 95.11 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-N 111.89 -2.414 . . . . 1.0 111.271 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -21.31 98.8 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 O-C-N 125.66 1.447 . . . . 1.0 112.929 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.1 ptt-85 -39.67 141.35 0.41 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 125.146 1.529 . . . . 1.0 112.848 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.419 ' SG ' ' O ' ' A' ' 9' ' ' ARG . 11.9 t -112.69 155.31 24.71 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.644 -1.162 . . . . 1.0 110.712 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -120.41 -61.13 1.61 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 104.986 -2.227 . . . . 1.0 104.986 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.419 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 42.6 mtt85 -117.69 165.29 13.78 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 112.69 -2.05 . . . . 1.0 108.342 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.419 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.0 m -32.02 -53.52 0.53 Allowed Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 125.189 1.556 . . . . 1.0 113.613 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.462 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 49.7 Cg_endo -70.56 -94.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.585 1.523 . . . . 1.0 114.698 169.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 t70 41.17 30.45 0.11 Allowed 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 123.156 1.455 . . . . 1.0 110.062 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.4 t -165.34 -27.91 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 112.14 -2.3 . . . . 1.0 112.524 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.462 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 5.7 m-30 -38.98 -61.48 0.74 Allowed 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 112.834 0.679 . . . . 1.0 112.834 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.9 t -42.49 -43.89 3.86 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 125.39 1.681 . . . . 1.0 110.947 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.43 -43.93 68.92 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.386 -1.279 . . . . 1.0 110.183 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.1 t -60.94 -31.34 70.89 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.117 -1.068 . . . . 1.0 108.117 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -70.48 -53.82 14.77 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.138 -1.801 . . . . 1.0 106.138 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -59.43 -19.19 45.51 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 112.397 -2.183 . . . . 1.0 112.292 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.4 tp -102.92 -54.49 2.62 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 113.357 0.873 . . . . 1.0 113.357 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.5 t -92.88 -41.31 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-N 113.121 -1.854 . . . . 1.0 112.087 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.09 -23.05 3.94 Favored Glycine 0 N--CA 1.488 2.141 0 CA-C-O 119.348 -0.695 . . . . 1.0 113.03 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -126.1 134.98 51.2 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 113.815 1.043 . . . . 1.0 113.815 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.62 70.32 0.67 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 114.331 -1.304 . . . . 1.0 112.355 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.405 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 12.4 t -130.19 -166.74 1.72 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.025 -0.732 . . . . 1.0 109.025 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.4 -176.86 16.53 Favored Glycine 0 N--CA 1.492 2.39 0 CA-C-N 113.495 -1.684 . . . . 1.0 114.879 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HG2' ' N ' ' A' ' 28' ' ' CYS . 24.5 ttmm -133.38 165.54 24.62 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.822 -1.689 . . . . 1.0 109.263 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.409 ' N ' ' HG2' ' A' ' 27' ' ' LYS . 49.6 t -110.03 112.21 24.07 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 103.159 -2.904 . . . . 1.0 103.159 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 89.8 m -125.12 123.52 39.87 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 112.576 -2.102 . . . . 1.0 112.208 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.5 m120 44.53 41.17 4.5 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 112.878 -1.965 . . . . 1.0 111.552 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.26 27.06 71.97 Favored Glycine 0 N--CA 1.484 1.861 0 CA-C-N 113.254 -1.794 . . . . 1.0 112.72 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.6 mtt-85 -136.32 159.8 40.66 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.703 -1.591 . . . . 1.0 106.703 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.514 ' HB3' HG12 ' A' ' 3' ' ' ILE . 13.0 t -72.87 142.3 47.94 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 113.945 1.091 . . . . 1.0 113.945 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.6 t70 -137.59 73.79 1.46 Allowed 'General case' 0 C--N 1.298 -1.634 0 O-C-N 125.561 1.788 . . . . 1.0 108.358 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 25' ' ' THR . 13.2 t . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 116.712 -1.613 . . . . 1.0 111.194 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 50.3 t . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 109.503 -0.555 . . . . 1.0 109.503 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.658 HG12 ' HB3' ' A' ' 33' ' ' CYS . 33.1 pt -130.43 152.7 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-O 122.58 1.181 . . . . 1.0 113.585 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.73 -35.51 86.51 Favored Glycine 0 N--CA 1.483 1.783 0 CA-C-N 111.385 -2.643 . . . . 1.0 111.895 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.426 ' HB2' HD12 ' A' ' 3' ' ' ILE . 3.4 tm0? -22.56 94.12 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 126.229 1.782 . . . . 1.0 112.318 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -39.53 131.75 1.66 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 124.549 1.156 . . . . 1.0 112.417 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.508 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 4.5 t -111.69 159.6 18.06 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 124.615 1.197 . . . . 1.0 114.001 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.508 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 0.9 OUTLIER -121.38 -57.42 1.84 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 113.365 -1.743 . . . . 1.0 107.644 179.816 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.471 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 35.5 mmt-85 -115.73 166.56 11.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.35 1.031 . . . . 1.0 110.485 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.431 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.6 m -32.85 -56.92 0.52 Allowed Pre-proline 0 N--CA 1.502 2.158 0 N-CA-C 114.84 1.422 . . . . 1.0 114.84 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.465 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 97.3 Cg_endo -65.96 -92.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.3 1.333 . . . . 1.0 112.723 176.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.405 ' H ' ' HG2' ' A' ' 11' ' ' PRO . 6.0 t0 40.15 32.34 0.12 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 122.993 1.378 . . . . 1.0 108.774 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.3 t -166.94 -26.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 112.47 -2.15 . . . . 1.0 112.223 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.465 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.7 m-85 -38.73 -58.09 1.11 Allowed 'General case' 0 N--CA 1.505 2.32 0 C-N-CA 123.431 0.693 . . . . 1.0 111.6 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.3 t -49.14 -46.67 45.46 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 124.306 1.004 . . . . 1.0 110.641 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.35 -35.26 79.02 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.96 -1.018 . . . . 1.0 112.117 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 25' ' ' THR . 45.5 m -69.77 -35.38 74.87 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.685 -0.857 . . . . 1.0 108.685 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -70.63 -42.84 70.34 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.707 -1.22 . . . . 1.0 107.707 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -69.99 -29.07 66.07 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 112.622 -2.081 . . . . 1.0 113.648 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.63 -34.68 8.09 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.334 1.235 . . . . 1.0 114.334 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.3 t -104.42 -35.7 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 123.943 0.777 . . . . 1.0 109.953 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.23 -30.76 3.8 Favored Glycine 0 N--CA 1.489 2.177 0 C-N-CA 120.803 -0.713 . . . . 1.0 113.879 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.644 ' H ' ' HZ2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -123.84 151.19 43.69 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 120.67 -0.412 . . . . 1.0 111.189 -179.369 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.4 75.27 0.76 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 125.016 1.447 . . . . 1.0 108.643 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.473 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 14.9 t -122.33 -162.8 1.03 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.046 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.459 ' HA3' ' SG ' ' A' ' 35' ' ' CYS . . . 82.6 167.0 39.79 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.488 -1.445 . . . . 1.0 109.488 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -139.36 -172.01 3.26 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 118.676 -1.21 . . . . 1.0 111.508 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.4 t -107.06 117.82 35.06 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 111.41 -2.632 . . . . 1.0 109.191 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.1 m -139.94 134.15 31.15 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 113.474 -1.693 . . . . 1.0 109.885 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 47.61 41.21 13.08 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 113.723 -1.58 . . . . 1.0 109.878 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.65 18.98 53.8 Favored Glycine 0 N--CA 1.491 2.362 0 CA-C-N 113.512 -1.676 . . . . 1.0 114.828 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.8 mtp85 -136.53 157.5 46.63 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.022 -1.473 . . . . 1.0 107.022 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.658 ' HB3' HG12 ' A' ' 3' ' ' ILE . 42.6 t -73.12 139.0 46.13 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.236 1.199 . . . . 1.0 114.236 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -135.79 95.55 3.26 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 102.743 -3.058 . . . . 1.0 102.743 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.459 ' SG ' ' HA3' ' A' ' 26' ' ' GLY . 6.5 t . . . . . 0 N--CA 1.495 1.792 0 CA-C-N 113.546 -1.661 . . . . 1.0 110.746 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 64.8 t . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 108.446 -0.946 . . . . 1.0 108.446 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.502 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 33.5 pt -136.29 166.62 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 115.954 1.835 . . . . 1.0 115.954 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 5' ' ' GLN . . . -61.02 -43.15 99.8 Favored Glycine 0 N--CA 1.473 1.119 0 CA-C-N 111.736 -2.483 . . . . 1.0 111.469 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.408 ' HB3' HG13 ' A' ' 3' ' ' ILE . 4.0 tp-100 -14.84 90.75 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.429 0 O-C-N 125.843 1.554 . . . . 1.0 113.135 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -39.81 133.82 1.51 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 125.224 1.578 . . . . 1.0 110.767 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.484 ' SG ' ' O ' ' A' ' 9' ' ' ARG . 35.2 t -117.6 156.61 27.84 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 124.342 1.026 . . . . 1.0 113.53 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.432 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.3 t80 -120.99 -61.07 1.59 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 105.637 -1.986 . . . . 1.0 105.637 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.484 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 20.4 mtt-85 -114.19 159.98 19.51 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 113.136 -1.847 . . . . 1.0 109.264 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.449 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.3 m -24.5 -56.14 0.15 Allowed Pre-proline 0 N--CA 1.506 2.352 0 O-C-N 125.201 1.563 . . . . 1.0 114.949 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.449 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 67.2 Cg_endo -67.1 -96.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.755 1.637 . . . . 1.0 114.07 170.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.7 t70 38.38 32.28 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 123.539 1.638 . . . . 1.0 109.819 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.6 t -171.46 -18.08 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 111.324 -2.671 . . . . 1.0 113.83 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -38.66 -59.99 0.87 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 112.723 0.638 . . . . 1.0 112.723 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.6 p -46.48 -44.73 17.82 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 124.921 1.388 . . . . 1.0 111.86 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.78 -43.78 87.77 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 114.816 -1.084 . . . . 1.0 109.316 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.6 t -57.81 -50.56 72.86 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.739 -1.578 . . . . 1.0 106.739 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -50.67 -53.93 27.14 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.361 -0.977 . . . . 1.0 108.361 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -51.77 -32.88 32.75 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 112.724 -2.035 . . . . 1.0 110.982 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.0 mt -90.01 -57.82 2.72 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 115.771 1.767 . . . . 1.0 115.771 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 m -99.14 -35.82 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 113.155 0.798 . . . . 1.0 113.155 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.16 -22.32 3.59 Favored Glycine 0 N--CA 1.492 2.393 0 CA-C-O 118.512 -1.16 . . . . 1.0 115.915 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.574 ' H ' ' HD3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -124.56 144.68 50.01 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 118.299 1.05 . . . . 1.0 113.022 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.77 68.85 0.64 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 113.6 -1.636 . . . . 1.0 113.4 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.432 HG23 ' SG ' ' A' ' 35' ' ' CYS . 8.9 t -133.06 -163.24 1.32 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.494 ' CA ' ' SG ' ' A' ' 35' ' ' CYS . . . 122.65 174.98 14.54 Favored Glycine 0 N--CA 1.495 2.579 0 CA-C-N 114.018 -1.446 . . . . 1.0 113.534 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -121.35 161.32 22.28 Favored 'General case' 0 C--O 1.206 -1.22 0 CA-C-N 113.457 -1.372 . . . . 1.0 109.342 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.1 t -111.67 101.7 10.06 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 103.55 -2.759 . . . . 1.0 103.55 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.2 m -118.19 121.32 40.2 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 110.944 -2.844 . . . . 1.0 112.997 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 45.29 39.82 4.65 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 113.204 -1.816 . . . . 1.0 111.082 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.37 29.43 75.05 Favored Glycine 0 N--CA 1.486 2.029 0 CA-C-N 112.917 -1.947 . . . . 1.0 112.792 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -139.45 153.04 47.48 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.289 -1.745 . . . . 1.0 106.289 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.502 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 6.1 t -73.8 139.01 44.87 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 117.155 2.28 . . . . 1.0 117.155 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -134.4 80.51 1.86 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 125.54 1.775 . . . . 1.0 107.167 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.494 ' SG ' ' CA ' ' A' ' 26' ' ' GLY . 5.8 t . . . . . 0 N--CA 1.501 2.077 0 CA-C-O 116.239 -1.839 . . . . 1.0 111.455 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 48.9 t . . . . . 0 N--CA 1.496 1.846 0 N-CA-C 106.073 -1.825 . . . . 1.0 106.073 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.55 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 37.3 pt -133.7 160.07 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 114.931 1.456 . . . . 1.0 114.931 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.95 42.76 3.18 Favored Glycine 0 C--O 1.21 -1.349 0 CA-C-N 112.153 -2.294 . . . . 1.0 111.873 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -105.15 107.31 18.22 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 101.891 -3.374 . . . . 1.0 101.891 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -39.09 138.91 0.53 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 125.425 1.703 . . . . 1.0 114.083 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.1 t -112.86 153.12 28.39 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.908 -1.496 . . . . 1.0 110.185 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -120.01 -56.87 1.99 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 104.927 -2.249 . . . . 1.0 104.927 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.439 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -117.89 155.08 30.79 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 113.393 -1.731 . . . . 1.0 106.57 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.46 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 71.9 m -24.01 -56.44 0.14 Allowed Pre-proline 0 N--CA 1.506 2.337 0 N-CA-C 115.137 1.532 . . . . 1.0 115.137 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.46 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 70.1 Cg_endo -67.25 -94.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.79 1.66 . . . . 1.0 113.222 170.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t70 40.93 29.53 0.08 Allowed 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.629 1.204 . . . . 1.0 109.9 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 t -166.33 -24.11 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 111.966 -2.379 . . . . 1.0 112.759 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 6.0 m-30 -38.72 -60.94 0.77 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 112.439 0.533 . . . . 1.0 112.439 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.4 t -44.74 -42.23 7.51 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 125.253 1.596 . . . . 1.0 111.375 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.28 -47.55 60.74 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 115.091 -0.958 . . . . 1.0 109.076 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.1 t -53.99 -40.72 67.17 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.324 -1.362 . . . . 1.0 107.324 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.4 ' HA ' ' N ' ' A' ' 23' ' ' LYS . 32.4 ttmt -60.84 -54.24 47.56 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 105.967 -1.864 . . . . 1.0 105.967 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -48.01 -31.71 5.7 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 113.473 -1.694 . . . . 1.0 110.03 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.7 mt -84.33 -50.84 7.46 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.569 0.952 . . . . 1.0 113.569 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 p -112.63 -45.66 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 CA-C-N 117.806 0.276 . . . . 1.0 111.159 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.18 18.8 1.46 Allowed Glycine 0 N--CA 1.491 2.324 0 CA-C-O 119.067 -0.852 . . . . 1.0 114.774 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.4 ' N ' ' HA ' ' A' ' 18' ' ' LYS . 14.2 mmmm -133.58 126.09 30.22 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 117.291 0.545 . . . . 1.0 112.207 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.43 68.78 0.8 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 124.88 1.362 . . . . 1.0 109.793 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.45 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 9.7 t -135.94 -171.53 2.89 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.679 -0.691 . . . . 1.0 110.088 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.75 -179.31 16.19 Favored Glycine 0 N--CA 1.493 2.467 0 CA-C-N 113.546 -1.661 . . . . 1.0 113.371 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -131.68 171.87 12.95 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 113.982 -1.109 . . . . 1.0 110.845 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.2 t -115.27 112.12 21.95 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 100.375 -3.935 . . . . 1.0 100.375 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.2 m -132.12 127.8 36.78 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 112.227 -2.261 . . . . 1.0 107.929 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.4 p30 46.41 43.89 12.33 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 125.929 2.018 . . . . 1.0 111.903 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.42 13.87 46.14 Favored Glycine 0 N--CA 1.479 1.547 0 CA-C-N 112.876 -1.965 . . . . 1.0 112.463 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.6 mtt-85 -128.21 163.66 24.22 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.863 -1.162 . . . . 1.0 107.863 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.55 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 9.4 t -72.93 142.17 47.84 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 114.702 1.371 . . . . 1.0 114.702 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.487 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 35.6 t70 -135.29 76.69 1.63 Allowed 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 112.454 -2.157 . . . . 1.0 107.324 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 25' ' ' THR . 23.6 t . . . . . 0 N--CA 1.502 2.125 0 CA-C-O 118.261 -0.876 . . . . 1.0 111.306 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.3 p . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 108.31 -0.996 . . . . 1.0 108.31 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.505 HG12 ' HB3' ' A' ' 33' ' ' CYS . 16.5 pt -133.7 163.08 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 115.214 1.561 . . . . 1.0 115.214 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.42 -46.86 36.34 Favored Glycine 0 N--CA 1.478 1.472 0 CA-C-N 111.036 -2.802 . . . . 1.0 112.528 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.402 ' HB3' HG13 ' A' ' 3' ' ' ILE . 3.8 tp-100 -19.83 92.71 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 O-C-N 125.926 1.604 . . . . 1.0 114.085 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -48.17 141.81 5.92 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 124.603 1.19 . . . . 1.0 109.662 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.7 p -123.36 160.55 26.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 124.154 0.909 . . . . 1.0 113.234 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -118.1 -58.57 1.99 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 104.454 -2.424 . . . . 1.0 104.454 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -112.73 166.45 11.35 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 126.166 2.166 . . . . 1.0 106.638 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.456 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 75.4 m -33.66 -61.24 0.4 Allowed Pre-proline 0 N--CA 1.502 2.139 0 N-CA-C 114.614 1.339 . . . . 1.0 114.614 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.456 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 73.2 Cg_endo -61.33 -92.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 121.255 1.304 . . . . 1.0 110.315 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t0 34.77 36.96 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 123.812 1.767 . . . . 1.0 108.765 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.417 ' N ' ' C ' ' A' ' 11' ' ' PRO . 48.5 t -168.72 -26.23 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 110.444 -3.071 . . . . 1.0 111.465 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -37.93 -56.66 1.1 Allowed 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 123.439 0.695 . . . . 1.0 111.489 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 55.0 m -54.63 -40.42 68.93 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 124.391 1.057 . . . . 1.0 111.892 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.96 -52.38 24.84 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 123.591 0.557 . . . . 1.0 110.71 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 t -60.28 -27.73 67.52 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.129 -1.063 . . . . 1.0 108.129 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -70.38 -50.33 39.82 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.769 -1.567 . . . . 1.0 106.769 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -59.81 -29.13 68.02 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 112.77 -2.014 . . . . 1.0 113.085 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -102.02 -35.46 8.95 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.54 1.682 . . . . 1.0 115.54 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.7 t -104.97 -40.49 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 123.61 0.568 . . . . 1.0 110.049 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.12 -29.18 3.09 Favored Glycine 0 N--CA 1.486 1.986 0 CA-C-O 118.894 -0.948 . . . . 1.0 114.166 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -124.77 159.25 31.39 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.095 1.517 . . . . 1.0 115.095 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.03 71.96 0.57 Allowed 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 113.554 -1.657 . . . . 1.0 113.46 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.427 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 2.3 p -119.73 172.13 7.9 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.633 -1.167 . . . . 1.0 112.169 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.95 147.26 9.24 Favored Glycine 0 N--CA 1.491 2.34 0 CA-C-N 113.748 -1.569 . . . . 1.0 111.332 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -121.92 173.68 7.36 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 113.326 -1.437 . . . . 1.0 109.646 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.2 t -103.73 112.1 24.89 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 104.268 -2.493 . . . . 1.0 104.268 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.3 m -130.34 130.34 44.31 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 111.857 -2.429 . . . . 1.0 106.45 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 44.06 44.76 6.4 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 125.123 1.514 . . . . 1.0 111.825 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.46 11.76 22.83 Favored Glycine 0 N--CA 1.487 2.068 0 CA-C-N 112.982 -1.917 . . . . 1.0 114.096 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.2 mtp85 -128.06 163.95 23.48 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.505 ' HB3' HG12 ' A' ' 3' ' ' ILE . 49.5 t -72.41 143.69 48.44 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.212 -1.395 . . . . 1.0 113.819 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 65.2 t0 -133.17 84.08 2.11 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 126.108 2.13 . . . . 1.0 107.077 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' A' ' 25' ' ' THR . 8.8 t . . . . . 0 N--CA 1.503 2.18 0 CA-C-O 118.626 -0.702 . . . . 1.0 110.105 -179.793 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.8 p . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 108.129 -1.063 . . . . 1.0 108.129 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.529 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 32.7 pt -136.0 160.24 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 N-CA-C 115.794 1.775 . . . . 1.0 115.794 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.21 -44.41 57.51 Favored Glycine 0 N--CA 1.478 1.469 0 CA-C-N 111.093 -2.776 . . . . 1.0 111.183 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.427 ' HB3' HG13 ' A' ' 3' ' ' ILE . 46.5 tp60 -24.42 91.86 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 125.873 1.572 . . . . 1.0 112.856 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -40.0 149.11 0.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 125.263 1.602 . . . . 1.0 112.966 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.412 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 2.1 t -110.1 153.48 24.61 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 124.648 1.218 . . . . 1.0 112.523 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.412 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 1.1 t80 -122.01 -62.35 1.4 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 102.801 -3.037 . . . . 1.0 102.801 179.35 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -119.62 166.11 13.59 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 112.093 -2.321 . . . . 1.0 105.838 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.471 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 75.3 m -33.37 -56.39 0.62 Allowed Pre-proline 0 N--CA 1.505 2.318 0 N-CA-C 114.229 1.196 . . . . 1.0 114.229 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.471 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 88.3 Cg_endo -64.15 -94.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 121.891 1.727 . . . . 1.0 111.826 174.542 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.0 t70 35.07 36.66 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 CA-C-O 123.844 1.783 . . . . 1.0 109.389 -179.282 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 50.4 t -168.61 -25.25 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 109.8 -3.364 . . . . 1.0 111.567 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -37.86 -57.21 1.04 Allowed 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 122.913 0.485 . . . . 1.0 111.587 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.8 t -49.68 -51.72 36.24 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 125.046 1.466 . . . . 1.0 109.116 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.17 -55.53 32.0 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 120.343 -0.543 . . . . 1.0 112.448 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.7 t -59.2 -27.99 66.23 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 115.397 -0.82 . . . . 1.0 109.499 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -70.12 -46.29 65.08 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 179.268 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -70.3 -22.6 62.82 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 114.242 -1.344 . . . . 1.0 113.034 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.2 mp -100.03 -33.48 10.47 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 113.911 1.078 . . . . 1.0 113.911 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.0 t -113.06 -43.97 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 124.05 0.844 . . . . 1.0 110.696 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.66 -25.45 3.41 Favored Glycine 0 N--CA 1.49 2.254 0 CA-C-O 119.075 -0.847 . . . . 1.0 114.429 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -120.99 155.87 33.37 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 113.476 0.917 . . . . 1.0 113.476 -179.426 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.86 69.88 0.71 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 125.084 1.49 . . . . 1.0 109.392 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.8 p -115.32 173.72 6.37 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.496 -1.229 . . . . 1.0 113.273 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.4 152.68 8.81 Favored Glycine 0 N--CA 1.49 2.295 0 CA-C-N 113.844 -1.525 . . . . 1.0 111.199 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -125.1 170.7 10.93 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.342 -1.355 . . . . 1.0 107.342 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.8 t -103.35 109.9 21.69 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.158 -1.793 . . . . 1.0 106.158 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.9 m -133.31 130.73 39.29 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 112.593 -2.094 . . . . 1.0 107.661 -179.379 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.417 ' ND2' ' HD2' ' A' ' 32' ' ' ARG . 6.1 p-10 44.64 44.17 7.17 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 125.107 1.504 . . . . 1.0 112.103 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.67 14.84 30.91 Favored Glycine 0 N--CA 1.487 2.063 0 CA-C-N 113.125 -1.852 . . . . 1.0 113.125 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.417 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 44.9 mtt-85 -130.65 165.52 22.66 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.552 -0.907 . . . . 1.0 108.552 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.529 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 13.3 t -72.45 144.91 47.93 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.517 -1.273 . . . . 1.0 114.318 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 36.9 t70 -134.98 82.95 1.99 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 126.385 2.303 . . . . 1.0 107.798 179.003 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.503 2.186 0 CA-C-O 116.237 -1.839 . . . . 1.0 110.405 -179.733 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.3 p . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 108.965 -0.754 . . . . 1.0 108.965 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.472 HG12 ' HB3' ' A' ' 33' ' ' CYS . 1.2 pt -131.55 159.12 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 122.278 1.037 . . . . 1.0 113.526 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -39.95 -54.07 3.07 Favored Glycine 0 N--CA 1.483 1.81 0 CA-C-N 111.471 -2.604 . . . . 1.0 112.08 179.528 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -14.0 85.42 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 O-C-N 126.619 2.011 . . . . 1.0 112.923 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -40.15 145.28 0.16 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 113.666 -1.606 . . . . 1.0 112.368 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.5 t -114.91 148.05 39.16 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 124.42 1.075 . . . . 1.0 111.987 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.492 ' HB3' ' HD3' ' A' ' 9' ' ' ARG . 3.7 t80 -123.15 -54.99 1.79 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 103.391 -2.818 . . . . 1.0 103.391 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.492 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -117.13 153.82 32.12 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 113.366 -1.743 . . . . 1.0 107.696 179.665 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.482 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.7 m -28.49 -56.23 0.25 Allowed Pre-proline 0 N--CA 1.504 2.273 0 N-CA-C 114.101 1.149 . . . . 1.0 114.101 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.482 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 86.8 Cg_endo -64.99 -90.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.931 1.754 . . . . 1.0 112.365 170.68 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.408 ' H ' ' HG2' ' A' ' 11' ' ' PRO . 8.4 t70 36.51 34.93 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 123.572 1.653 . . . . 1.0 109.796 -179.448 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.7 t -168.45 -26.09 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 110.427 -3.079 . . . . 1.0 111.117 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -38.6 -58.26 1.07 Allowed 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 122.985 0.514 . . . . 1.0 111.812 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 64.8 p -45.48 -45.15 12.97 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 124.672 1.232 . . . . 1.0 110.957 179.396 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.462 ' HA ' ' HG3' ' A' ' 19' ' ' LYS . . . -66.89 -44.64 80.32 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.433 -1.258 . . . . 1.0 111.109 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 25' ' ' THR . 20.2 m -62.8 -32.38 73.54 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.444 -1.253 . . . . 1.0 108.191 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -70.18 -52.59 22.19 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.265 -1.383 . . . . 1.0 107.265 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HG3' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -71.08 -11.82 61.17 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 117.638 -1.625 . . . . 1.0 111.653 179.986 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 40.9 mt -93.67 -54.97 3.43 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 112.21 0.448 . . . . 1.0 112.21 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.0 m -109.36 -20.32 6.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 118.637 -0.697 . . . . 1.0 112.465 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.46 -33.89 2.59 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 117.83 1.892 . . . . 1.0 117.83 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.571 ' H ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -128.52 162.85 26.26 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 115.458 1.651 . . . . 1.0 115.458 -179.35 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.56 70.63 0.66 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 113.351 -1.749 . . . . 1.0 110.856 179.669 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.422 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 8.2 t -121.58 -177.91 3.67 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.709 0.766 . . . . 1.0 110.687 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.51 174.65 15.24 Favored Glycine 0 N--CA 1.491 2.322 0 CA-C-N 112.941 -1.936 . . . . 1.0 112.096 179.845 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.459 ' HG2' ' N ' ' A' ' 28' ' ' CYS . 39.0 ttmt -134.19 167.46 20.64 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.78 -1.21 . . . . 1.0 108.51 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.459 ' N ' ' HG2' ' A' ' 27' ' ' LYS . 50.5 t -108.46 110.01 21.43 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 104.88 -2.267 . . . . 1.0 104.88 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.8 m -128.92 124.71 35.86 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 112.609 -2.087 . . . . 1.0 111.962 -179.557 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.4 m120 44.32 42.16 5.03 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 112.864 -1.971 . . . . 1.0 111.424 -179.365 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.74 24.81 70.05 Favored Glycine 0 N--CA 1.484 1.854 0 CA-C-N 113.567 -1.651 . . . . 1.0 113.525 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.0 mtp85 -136.53 160.28 39.27 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 107.028 -1.471 . . . . 1.0 107.028 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.472 ' HB3' HG12 ' A' ' 3' ' ' ILE . 21.2 t -72.88 145.3 46.98 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.178 -1.409 . . . . 1.0 112.197 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 34.3 t70 -129.75 82.58 2.08 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 103.814 -2.662 . . . . 1.0 103.814 178.886 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.501 2.079 0 CA-C-O 118.366 -0.826 . . . . 1.0 110.604 -179.406 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.3 p . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 109.884 -0.413 . . . . 1.0 109.884 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.538 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 28.2 pt -133.82 162.43 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 N-CA-C 114.195 1.184 . . . . 1.0 114.195 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.66 44.49 3.26 Favored Glycine 0 C--O 1.211 -1.318 0 CA-C-N 112.201 -2.272 . . . . 1.0 111.955 -179.877 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -103.88 92.26 4.33 Favored 'General case' 0 N--CA 1.486 1.342 1 N-CA-C 99.934 -4.099 . . . . 1.0 99.934 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -38.98 142.31 0.23 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 125.694 1.871 . . . . 1.0 112.576 -179.584 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 0.5 OUTLIER -112.77 160.46 17.95 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 116.093 1.886 . . . . 1.0 116.093 -179.605 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.525 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 20.3 t80 -121.24 -58.95 1.76 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 102.794 -3.039 . . . . 1.0 102.794 179.652 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.473 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 11.0 mmm180 -118.14 166.33 12.7 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 113.023 -1.898 . . . . 1.0 109.526 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.473 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.7 m -33.06 -58.7 0.46 Allowed Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 124.997 1.435 . . . . 1.0 114.305 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.473 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 91.1 Cg_endo -62.75 -92.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.951 1.767 . . . . 1.0 111.592 177.14 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 t70 38.24 31.52 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 123.368 1.556 . . . . 1.0 109.144 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.412 ' N ' ' C ' ' A' ' 11' ' ' PRO . 49.1 t -171.55 -17.1 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 111.678 -2.51 . . . . 1.0 113.687 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -38.81 -62.01 0.67 Allowed 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 118.936 0.789 . . . . 1.0 110.451 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.3 m -48.7 -47.48 41.03 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.619 1.2 . . . . 1.0 112.077 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.47 -45.07 92.69 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 114.759 -1.109 . . . . 1.0 111.567 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.1 t -62.87 -48.93 76.9 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 105.802 -1.925 . . . . 1.0 105.802 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.43 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 5.3 ttpm? -47.82 -50.34 26.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 123.373 0.42 . . . . 1.0 110.76 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -70.28 -27.63 64.56 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 117.427 -1.709 . . . . 1.0 111.207 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.0 mt -76.44 -50.97 12.75 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.027 1.121 . . . . 1.0 114.027 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 m -109.37 -36.11 2.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 123.66 0.784 . . . . 1.0 111.955 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.421 ' C ' ' HD3' ' A' ' 23' ' ' LYS . . . 134.51 -20.41 3.92 Favored Glycine 0 N--CA 1.49 2.265 0 CA-C-O 119.083 -0.843 . . . . 1.0 114.726 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.421 ' HD3' ' C ' ' A' ' 22' ' ' GLY . 1.7 mppt? -116.98 136.82 52.65 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 112.709 0.633 . . . . 1.0 112.709 -179.467 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.12 68.37 0.71 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 125.125 1.516 . . . . 1.0 110.749 179.591 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.452 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 11.2 p -121.87 -175.64 3.15 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.294 -1.321 . . . . 1.0 113.032 -179.491 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.36 154.27 10.96 Favored Glycine 0 N--CA 1.492 2.383 0 CA-C-N 114.075 -1.421 . . . . 1.0 112.356 179.625 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.38 175.91 6.46 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.086 0.946 . . . . 1.0 109.947 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.9 t -97.37 112.03 24.03 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 112.676 -2.056 . . . . 1.0 106.488 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.417 ' HB ' ' HB2' ' A' ' 34' ' ' ASP . 37.2 m -128.18 119.64 25.67 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 111.971 -2.377 . . . . 1.0 111.933 -179.572 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 50.24 43.57 26.3 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 113.519 -1.673 . . . . 1.0 108.659 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.95 16.39 57.15 Favored Glycine 0 N--CA 1.486 2.022 0 CA-C-N 113.719 -1.582 . . . . 1.0 114.131 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.8 mtp-105 -131.22 161.32 32.49 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.202 -1.036 . . . . 1.0 108.202 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.538 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 47.3 t -72.56 140.65 48.22 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.724 -1.19 . . . . 1.0 114.143 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.417 ' HB2' ' HB ' ' A' ' 29' ' ' THR . 9.4 t70 -135.69 90.63 2.62 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 125.107 1.504 . . . . 1.0 107.13 178.526 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.452 ' SG ' ' C ' ' A' ' 25' ' ' THR . 10.8 t . . . . . 0 N--CA 1.501 2.104 0 CA-C-O 118.588 -0.72 . . . . 1.0 110.313 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 5.8 p . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 108.567 -0.901 . . . . 1.0 108.567 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.61 HG12 ' HB3' ' A' ' 33' ' ' CYS . 35.3 pt -132.02 158.0 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 N-CA-C 114.304 1.224 . . . . 1.0 114.304 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.28 -39.86 73.52 Favored Glycine 0 N--CA 1.488 2.115 0 CA-C-N 111.859 -2.428 . . . . 1.0 111.522 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -28.18 96.59 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 O-C-N 125.867 1.569 . . . . 1.0 111.309 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -39.62 144.1 0.19 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 124.934 1.396 . . . . 1.0 114.447 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.7 p -128.06 157.68 40.03 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.074 -0.966 . . . . 1.0 110.694 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -120.26 -56.69 1.98 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 105.474 -2.047 . . . . 1.0 105.474 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.48 159.9 16.32 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 125.7 1.875 . . . . 1.0 107.158 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.455 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.4 m -35.1 -57.08 0.86 Allowed Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 125.313 1.633 . . . . 1.0 112.894 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.455 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 72.5 Cg_endo -60.54 -91.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.275 1.317 . . . . 1.0 111.056 175.293 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t0 33.47 39.54 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 123.981 1.848 . . . . 1.0 108.794 -179.335 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.9 t -172.75 -26.39 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 109.972 -3.285 . . . . 1.0 110.603 -179.628 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -38.27 -55.41 1.33 Allowed 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 123.588 0.755 . . . . 1.0 112.084 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.7 p -49.45 -48.98 47.18 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 124.214 0.946 . . . . 1.0 110.68 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.67 -55.26 36.57 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 124.03 0.831 . . . . 1.0 109.58 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 25' ' ' THR . 98.6 m -48.86 -41.56 33.6 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.194 -1.366 . . . . 1.0 111.064 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.451 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 6.6 ttpm? -66.65 -47.01 73.87 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.559 -1.645 . . . . 1.0 106.559 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -70.27 -11.51 60.95 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 113.384 -1.735 . . . . 1.0 112.348 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.3 mt -101.52 -53.28 3.02 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 112.684 0.624 . . . . 1.0 112.684 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.7 m -109.13 -26.35 3.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 119.19 -0.433 . . . . 1.0 111.633 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 126.68 -20.17 6.12 Favored Glycine 0 N--CA 1.493 2.434 0 CA-C-O 119.026 -0.874 . . . . 1.0 114.969 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.509 ' HB2' ' HZ3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -122.66 141.84 51.32 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 113.22 0.822 . . . . 1.0 113.22 -179.497 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.99 71.71 0.82 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 125.214 1.571 . . . . 1.0 110.108 179.365 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.515 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 6.0 t -122.64 179.1 4.73 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.748 0.785 . . . . 1.0 112.036 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.08 167.67 18.88 Favored Glycine 0 N--CA 1.498 2.774 0 CA-C-N 113.271 -1.786 . . . . 1.0 111.813 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.402 ' HB3' ' NZ ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -132.68 175.89 8.93 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.721 0.772 . . . . 1.0 109.955 179.95 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.4 t -103.07 116.13 31.93 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 113.31 -1.768 . . . . 1.0 106.44 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 78.4 m -127.93 127.29 43.07 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 112.525 -2.125 . . . . 1.0 109.747 -179.571 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.3 m120 47.47 40.59 11.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 125.096 1.498 . . . . 1.0 111.062 -179.488 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.07 19.88 64.19 Favored Glycine 0 N--CA 1.483 1.832 0 CA-C-N 113.281 -1.781 . . . . 1.0 113.916 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.0 mtt-85 -132.7 162.51 31.22 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.479 -1.304 . . . . 1.0 107.479 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.61 ' HB3' HG12 ' A' ' 3' ' ' ILE . 41.8 t -72.79 143.64 47.83 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.889 -1.124 . . . . 1.0 113.243 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 36.8 t70 -134.75 78.1 1.72 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 104.128 -2.545 . . . . 1.0 104.128 178.745 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.1 t . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 117.863 -1.065 . . . . 1.0 111.078 -179.408 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 5.7 p . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 108.426 -0.953 . . . . 1.0 108.426 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.53 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 27.4 pt -136.7 164.23 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 N-CA-C 114.809 1.411 . . . . 1.0 114.809 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.35 -43.51 76.06 Favored Glycine 0 N--CA 1.479 1.532 0 CA-C-N 112.051 -2.34 . . . . 1.0 112.08 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.401 ' HB3' HG13 ' A' ' 3' ' ' ILE . 52.4 tp60 -17.14 90.91 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 O-C-N 125.723 1.484 . . . . 1.0 114.12 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -39.96 136.5 1.11 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 125.065 1.478 . . . . 1.0 111.338 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 10.1 t -119.52 159.33 24.53 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 114.276 1.213 . . . . 1.0 114.276 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.503 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 15.4 t80 -120.53 -62.89 1.41 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 105.519 -2.03 . . . . 1.0 105.519 179.728 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.489 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 1.6 mmp_? -113.8 161.67 17.27 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.598 -1.637 . . . . 1.0 108.753 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.43 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 62.1 m -23.84 -59.21 0.12 Allowed Pre-proline 0 N--CA 1.504 2.27 0 N-CA-C 115.695 1.739 . . . . 1.0 115.695 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.43 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 77.5 Cg_endo -66.92 -93.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.157 0 C-N-CA 121.265 1.31 . . . . 1.0 113.86 176.339 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t0 40.23 33.52 0.17 Allowed 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 123.253 1.501 . . . . 1.0 108.942 -179.486 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.1 t -168.74 -24.21 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 111.859 -2.428 . . . . 1.0 112.827 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.414 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.2 m-85 -38.6 -59.72 0.89 Allowed 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 123.159 0.584 . . . . 1.0 111.967 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 77.8 p -48.05 -41.91 27.15 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 124.923 1.39 . . . . 1.0 111.893 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.98 -49.06 55.39 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.637 -0.711 . . . . 1.0 110.735 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 t -60.32 -29.87 69.14 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -70.81 -50.19 38.22 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.302 -1.37 . . . . 1.0 107.302 179.287 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -70.65 -13.4 62.07 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 113.225 -1.807 . . . . 1.0 113.719 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.8 mt -109.93 -43.37 4.01 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.363 0.875 . . . . 1.0 113.363 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.4 t -102.54 -34.71 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 114.859 -1.064 . . . . 1.0 110.323 -179.638 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.24 -31.65 3.11 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-O 119.105 -0.83 . . . . 1.0 114.175 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -123.6 150.82 43.66 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 113.725 1.009 . . . . 1.0 113.725 -179.348 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.42 72.99 0.71 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 113.827 -1.533 . . . . 1.0 109.815 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.429 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 17.9 p -117.11 -179.0 3.57 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.705 -1.134 . . . . 1.0 112.252 -179.786 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.03 166.5 13.24 Favored Glycine 0 N--CA 1.494 2.504 0 CA-C-N 114.515 -1.22 . . . . 1.0 115.34 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.561 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -134.05 168.58 18.55 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 112.847 -1.677 . . . . 1.0 107.282 179.696 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.439 ' N ' ' HG3' ' A' ' 27' ' ' LYS . 30.7 t -107.98 104.86 14.4 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 104.471 -2.418 . . . . 1.0 104.471 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.7 m -122.31 124.36 43.56 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 111.575 -2.557 . . . . 1.0 111.208 -179.371 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.2 m120 46.62 39.86 7.59 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 112.89 -1.959 . . . . 1.0 110.921 -179.321 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.96 27.21 70.96 Favored Glycine 0 N--CA 1.485 1.914 0 CA-C-N 113.106 -1.861 . . . . 1.0 112.513 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.0 mtt-85 -137.36 161.27 36.74 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.334 -1.358 . . . . 1.0 107.334 179.688 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.53 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 46.8 t -72.38 143.39 48.6 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.854 1.057 . . . . 1.0 113.854 179.692 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 34.2 t70 -136.39 81.99 1.91 Allowed 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.502 -1.681 . . . . 1.0 108.641 178.869 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.429 ' SG ' ' C ' ' A' ' 25' ' ' THR . 12.3 t . . . . . 0 N--CA 1.499 1.994 0 CA-C-O 116.148 -1.882 . . . . 1.0 110.828 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.588 HG12 ' HB3' ' A' ' 33' ' ' CYS . 19.6 pt -125.7 150.61 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-O 122.697 1.237 . . . . 1.0 113.594 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.79 -39.29 46.93 Favored Glycine 0 N--CA 1.479 1.505 0 CA-C-N 110.914 -2.857 . . . . 1.0 112.478 179.826 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -30.9 93.37 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 125.665 1.45 . . . . 1.0 112.89 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -40.44 144.38 0.24 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 124.879 1.362 . . . . 1.0 111.997 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.0 p -121.42 160.69 23.59 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 124.039 0.837 . . . . 1.0 110.985 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.475 ' HB3' ' HD3' ' A' ' 9' ' ' ARG . 3.4 t80 -119.96 -57.68 1.93 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.578 -1.267 . . . . 1.0 107.578 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.475 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -108.18 164.87 11.92 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 113.269 -1.787 . . . . 1.0 107.152 -179.975 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.485 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.1 m -39.25 -56.5 2.64 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 124.782 1.301 . . . . 1.0 112.095 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.485 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 84.0 Cg_endo -64.83 -93.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 121.252 1.301 . . . . 1.0 111.238 173.048 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.8 t70 35.51 35.12 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 125.411 1.695 . . . . 1.0 109.635 -179.614 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.404 ' N ' ' C ' ' A' ' 11' ' ' PRO . 36.7 t -167.74 -28.79 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 110.399 -3.092 . . . . 1.0 110.37 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -37.62 -52.24 1.21 Allowed 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 123.822 0.849 . . . . 1.0 112.438 179.697 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.8 m -56.51 -61.1 2.65 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.994 -0.743 . . . . 1.0 108.994 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.93 -54.69 5.14 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 124.314 1.008 . . . . 1.0 111.052 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 25' ' ' THR . 17.4 m -49.48 -54.42 17.88 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 113.366 -1.743 . . . . 1.0 107.601 179.473 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.428 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 5.7 ttpm? -50.01 -47.78 52.88 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 179.576 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -19.74 63.1 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 114.972 -1.013 . . . . 1.0 112.489 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.8 mt -92.41 -50.27 5.72 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 114.478 1.288 . . . . 1.0 114.478 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.5 m -105.51 -30.56 2.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 C-N-CA 123.477 0.711 . . . . 1.0 111.293 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.72 -28.12 3.43 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 116.165 1.226 . . . . 1.0 116.165 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -124.5 156.03 37.96 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 114.161 1.171 . . . . 1.0 114.161 -179.341 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.45 72.85 0.72 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 113.803 -1.544 . . . . 1.0 110.218 179.781 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.504 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 7.5 t -128.41 -176.26 3.76 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.745 0.783 . . . . 1.0 110.431 -179.839 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.5 160.33 30.04 Favored Glycine 0 N--CA 1.494 2.515 0 CA-C-N 113.411 -1.722 . . . . 1.0 109.605 179.713 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.85 -172.39 2.86 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.333 1.063 . . . . 1.0 111.127 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.1 t -110.92 114.81 28.41 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 111.482 -2.599 . . . . 1.0 107.398 179.571 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.2 m -139.64 133.25 30.39 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 113.161 -1.836 . . . . 1.0 109.286 -179.781 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 49.22 42.19 21.21 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 113.958 -1.474 . . . . 1.0 108.208 -179.545 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 58.41 14.57 20.67 Favored Glycine 0 N--CA 1.49 2.287 0 CA-C-N 113.745 -1.57 . . . . 1.0 114.871 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.6 mtp-105 -130.45 160.01 35.35 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.112 -1.44 . . . . 1.0 107.112 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.588 ' HB3' HG12 ' A' ' 3' ' ' ILE . 14.6 t -73.38 143.17 46.93 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.136 -1.426 . . . . 1.0 113.381 -179.937 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -129.05 88.18 2.67 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 101.23 -3.619 . . . . 1.0 101.23 178.43 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.502 2.134 0 CA-C-O 117.001 -1.476 . . . . 1.0 111.535 -179.482 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.0 p . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 108.518 -0.919 . . . . 1.0 108.518 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.509 HG12 ' HB3' ' A' ' 33' ' ' CYS . 19.1 pt -134.39 165.26 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 N-CA-C 115.148 1.536 . . . . 1.0 115.148 -179.871 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -53.14 -48.0 59.76 Favored Glycine 0 N--CA 1.478 1.465 0 CA-C-N 111.096 -2.775 . . . . 1.0 111.575 179.847 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -20.51 86.49 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.474 0 O-C-N 125.882 1.578 . . . . 1.0 113.034 -179.917 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -40.0 146.58 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.097 -1.411 . . . . 1.0 112.37 -179.961 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.404 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 5.6 t -110.09 152.36 26.08 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 124.582 1.176 . . . . 1.0 113.465 -179.918 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.404 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 1.8 t80 -125.39 -58.73 1.42 Allowed 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 102.465 -3.161 . . . . 1.0 102.465 179.498 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.04 161.0 20.99 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.376 -1.712 . . . . 1.0 106.376 179.306 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.496 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 73.2 m -30.96 -57.39 0.36 Allowed Pre-proline 0 N--CA 1.506 2.369 0 N-CA-C 114.429 1.27 . . . . 1.0 114.429 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.496 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 83.9 Cg_endo -63.93 -93.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.919 1.746 . . . . 1.0 111.17 173.763 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 t70 36.55 34.12 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 CA-C-O 123.294 1.521 . . . . 1.0 109.375 -179.483 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.422 ' N ' ' C ' ' A' ' 11' ' ' PRO . 54.0 t -169.26 -21.59 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 110.579 -3.009 . . . . 1.0 112.453 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -38.65 -58.51 1.04 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 118.469 0.577 . . . . 1.0 111.64 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.2 t -50.32 -39.64 46.53 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.963 1.414 . . . . 1.0 111.828 179.574 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.16 -48.71 56.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 123.516 0.51 . . . . 1.0 111.137 179.878 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.0 t -61.94 -32.91 73.37 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.425 -1.324 . . . . 1.0 107.425 179.705 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.416 ' O ' ' N ' ' A' ' 22' ' ' GLY . 24.7 ttmm -65.04 -53.72 41.41 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 105.62 -1.992 . . . . 1.0 105.62 179.594 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -50.26 -35.56 27.54 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 114.181 -1.372 . . . . 1.0 109.189 179.692 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.0 tp -67.66 -60.06 2.84 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 114.824 -1.08 . . . . 1.0 111.669 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.09 -48.48 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 124.253 0.97 . . . . 1.0 113.046 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 133.45 23.98 0.71 Allowed Glycine 0 N--CA 1.492 2.376 0 O-C-N 123.417 0.448 . . . . 1.0 113.484 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -133.46 131.37 39.82 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.481 -0.563 . . . . 1.0 109.481 179.881 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.18 68.06 0.7 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 124.722 1.264 . . . . 1.0 109.63 179.364 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.6 p -115.37 174.92 5.75 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.482 -1.235 . . . . 1.0 112.895 -179.647 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.51 152.89 8.57 Favored Glycine 0 N--CA 1.489 2.213 0 CA-C-N 113.74 -1.573 . . . . 1.0 111.605 179.72 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 36.8 mtmm -122.71 174.78 6.89 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 113.637 -1.282 . . . . 1.0 108.245 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.2 t -110.17 109.06 19.43 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 105.36 -2.089 . . . . 1.0 105.36 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.2 m -133.07 126.08 31.03 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 112.264 -2.244 . . . . 1.0 108.382 -179.61 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.3 p30 47.52 41.3 12.86 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 125.907 2.004 . . . . 1.0 112.345 -179.459 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.63 13.77 59.3 Favored Glycine 0 N--CA 1.478 1.435 0 CA-C-N 113.15 -1.841 . . . . 1.0 112.145 -179.83 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.7 mmt-85 -128.6 161.94 28.45 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.668 -0.864 . . . . 1.0 108.668 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.509 ' HB3' HG12 ' A' ' 3' ' ' ILE . 12.5 t -72.6 143.56 48.18 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.461 -1.296 . . . . 1.0 113.392 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 9.9 t70 -134.16 84.31 2.11 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 125.971 2.045 . . . . 1.0 106.555 179.117 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.503 2.203 0 CA-C-O 118.415 -0.802 . . . . 1.0 110.472 -179.784 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.7 p . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.45 -0.574 . . . . 1.0 109.45 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.592 HG12 ' HB3' ' A' ' 33' ' ' CYS . 15.6 pt -128.19 152.89 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 122.265 1.031 . . . . 1.0 113.719 -179.883 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -46.91 -41.35 13.66 Favored Glycine 0 N--CA 1.489 2.191 0 CA-C-N 111.15 -2.75 . . . . 1.0 112.717 179.864 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -28.46 99.79 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 125.501 1.353 . . . . 1.0 112.215 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -39.96 147.36 0.09 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 124.824 1.327 . . . . 1.0 113.711 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.462 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 5.2 t -113.77 157.74 21.87 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.998 -1.001 . . . . 1.0 110.985 -179.95 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.462 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.1 t80 -119.65 -62.79 1.45 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 103.189 -2.893 . . . . 1.0 103.189 179.731 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -124.97 171.45 10.2 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.141 -1.39 . . . . 1.0 107.946 179.65 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.443 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 61.1 m -31.69 -56.34 0.44 Allowed Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 125.07 1.482 . . . . 1.0 114.045 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.443 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 63.1 Cg_endo -68.94 -94.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.674 1.583 . . . . 1.0 113.748 173.058 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.2 t70 38.17 32.54 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 CA-C-O 123.158 1.456 . . . . 1.0 109.806 -179.461 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.3 t -165.44 -25.74 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 111.341 -2.663 . . . . 1.0 111.618 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -38.79 -59.83 0.91 Allowed 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 123.131 0.572 . . . . 1.0 112.466 179.717 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.6 m -45.13 -43.85 10.14 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 124.805 1.316 . . . . 1.0 110.987 179.609 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.02 -50.85 60.77 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.954 -1.021 . . . . 1.0 109.817 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.1 m -54.0 -34.58 60.24 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.755 -1.111 . . . . 1.0 110.276 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -70.65 -51.19 29.52 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.012 -1.848 . . . . 1.0 106.012 179.425 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -70.73 -8.95 55.98 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 113.653 -1.612 . . . . 1.0 113.049 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.72 -51.56 3.16 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 123.4 0.437 . . . . 1.0 110.096 -179.78 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.8 t -104.91 -35.73 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 114.727 -1.124 . . . . 1.0 112.437 -179.319 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 139.42 -30.56 2.41 Favored Glycine 0 N--CA 1.485 1.931 0 CA-C-O 118.676 -1.069 . . . . 1.0 114.667 179.779 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.51 ' HD3' ' N ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -123.01 150.65 42.75 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 114.424 1.268 . . . . 1.0 114.424 -179.529 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.5 70.49 0.64 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 113.504 -1.68 . . . . 1.0 112.022 179.76 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.9 t -124.12 -174.79 3.08 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.931 0.872 . . . . 1.0 110.791 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.38 -178.75 16.32 Favored Glycine 0 N--CA 1.492 2.425 0 CA-C-N 113.007 -1.906 . . . . 1.0 112.125 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.497 ' NZ ' ' H ' ' A' ' 28' ' ' CYS . 0.2 OUTLIER -143.46 170.65 15.4 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.78 -1.21 . . . . 1.0 108.245 179.94 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.497 ' H ' ' NZ ' ' A' ' 27' ' ' LYS . 49.4 t -108.87 115.27 29.76 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.203 -1.777 . . . . 1.0 106.203 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.415 ' CB ' ' HB2' ' A' ' 34' ' ' ASP . 95.3 m -132.33 128.48 37.78 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 113.142 -1.845 . . . . 1.0 112.28 -179.632 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 46.67 40.52 8.71 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 113.571 -1.649 . . . . 1.0 110.312 -179.707 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.55 28.22 64.78 Favored Glycine 0 N--CA 1.487 2.07 0 CA-C-N 113.544 -1.662 . . . . 1.0 112.705 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.6 mtt-85 -136.83 163.74 29.94 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.3 -1.741 . . . . 1.0 106.3 179.682 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.592 ' HB3' HG12 ' A' ' 3' ' ' ILE . 30.5 t -72.76 144.84 47.46 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 118.612 -1.235 . . . . 1.0 112.777 179.682 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 11.3 t70 -129.95 81.64 2.02 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 105.595 -2.002 . . . . 1.0 105.595 178.722 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.502 2.145 0 C-N-CA 119.259 -0.976 . . . . 1.0 110.305 -179.496 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.7 p . . . . . 0 N--CA 1.497 1.913 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.497 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 24.1 pt -137.17 165.3 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 N-CA-C 116.575 2.065 . . . . 1.0 116.575 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.77 -48.41 36.87 Favored Glycine 0 N--CA 1.477 1.422 0 CA-C-N 109.94 -3.3 . . . . 1.0 111.347 179.643 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.424 ' HB3' HG13 ' A' ' 3' ' ' ILE . 3.6 tp-100 -23.44 89.77 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 O-C-N 125.787 1.522 . . . . 1.0 113.083 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 -47.69 148.66 1.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.409 -1.269 . . . . 1.0 110.838 179.85 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 8.7 t -117.11 156.36 27.74 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.982 1.104 . . . . 1.0 113.982 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.45 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.9 t80 -123.36 -56.76 1.7 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 105.104 -2.184 . . . . 1.0 105.104 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.468 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -116.32 152.13 34.5 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 112.879 -1.964 . . . . 1.0 108.102 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.463 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.4 m -22.67 -59.07 0.1 OUTLIER Pre-proline 0 N--CA 1.506 2.369 0 N-CA-C 115.581 1.697 . . . . 1.0 115.581 -179.857 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.47 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 98.6 Cg_endo -65.67 -91.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.45 1.433 . . . . 1.0 113.223 174.161 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.407 ' H ' ' HG2' ' A' ' 11' ' ' PRO . 6.4 t70 41.0 30.74 0.11 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 123.023 1.392 . . . . 1.0 109.166 -179.56 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.3 t -167.3 -24.88 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 112.294 -2.23 . . . . 1.0 112.737 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.47 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.2 m-85 -38.93 -59.59 0.95 Allowed 'General case' 0 N--CA 1.505 2.315 0 C-N-CA 122.947 0.499 . . . . 1.0 111.81 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 p -48.75 -39.88 26.62 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 125.01 1.444 . . . . 1.0 111.776 179.63 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.404 ' HA ' ' HZ3' ' A' ' 19' ' ' LYS . . . -70.19 -50.38 40.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 123.999 0.812 . . . . 1.0 110.662 179.855 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.7 t -60.09 -30.01 68.96 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.537 -0.912 . . . . 1.0 108.537 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -70.44 -49.87 44.26 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.884 -1.154 . . . . 1.0 107.884 179.211 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HZ3' ' HA ' ' A' ' 16' ' ' ALA . 7.1 ttpm? -70.4 -15.11 62.8 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.102 -1.863 . . . . 1.0 113.06 -179.918 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.8 mt -108.41 -43.36 4.35 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 113.852 1.056 . . . . 1.0 113.852 -179.745 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.4 t -101.46 -35.29 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-N 114.802 -1.09 . . . . 1.0 110.081 -179.724 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.23 -32.14 2.9 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 120.69 -0.767 . . . . 1.0 114.106 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -125.72 153.41 43.97 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 113.722 1.008 . . . . 1.0 113.722 -179.465 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.79 74.59 0.6 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 113.818 -1.537 . . . . 1.0 113.556 -179.735 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.432 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 0.9 OUTLIER -120.7 -178.27 3.68 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.705 -1.134 . . . . 1.0 111.333 179.906 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.71 163.1 11.83 Favored Glycine 0 N--CA 1.492 2.432 0 CA-C-N 114.351 -1.295 . . . . 1.0 113.35 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -131.53 166.13 22.05 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 113.636 -1.282 . . . . 1.0 108.167 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.6 t -103.32 94.64 5.61 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 103.138 -2.912 . . . . 1.0 103.138 179.992 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 83.1 m -112.97 115.1 27.86 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 109.984 -3.28 . . . . 1.0 112.482 -179.328 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 48.75 41.11 17.48 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 111.453 -2.612 . . . . 1.0 108.739 -179.78 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.0 28.31 72.61 Favored Glycine 0 N--CA 1.482 1.74 0 CA-C-N 113.364 -1.743 . . . . 1.0 112.434 -179.767 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -137.6 157.25 46.91 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 106.173 -1.788 . . . . 1.0 106.173 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.497 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 34.5 t -72.78 140.74 47.92 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.451 -1.3 . . . . 1.0 113.913 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 25.6 t70 -135.55 86.56 2.25 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 125.382 1.676 . . . . 1.0 108.54 178.729 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.432 ' SG ' ' C ' ' A' ' 25' ' ' THR . 8.1 t . . . . . 0 N--CA 1.5 2.058 0 CA-C-O 116.292 -1.813 . . . . 1.0 110.58 -179.861 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.2 p . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 108.299 -1.0 . . . . 1.0 108.299 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.573 HG12 ' HB3' ' A' ' 33' ' ' CYS . 27.8 pt -131.47 164.53 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 113.7 1.0 . . . . 1.0 113.7 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.99 44.88 3.43 Favored Glycine 0 C--O 1.21 -1.393 0 CA-C-N 112.595 -2.093 . . . . 1.0 112.124 -179.861 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -100.27 104.94 16.45 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 102.699 -3.074 . . . . 1.0 102.699 179.59 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -39.01 129.39 1.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 113.229 -1.805 . . . . 1.0 112.7 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 24.0 t -120.93 163.09 18.77 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.481 -1.691 . . . . 1.0 112.372 179.794 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.519 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 13.2 t80 -119.8 -64.8 1.22 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 104.855 -2.276 . . . . 1.0 104.855 179.676 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.448 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -119.62 163.69 16.99 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 112.468 -2.151 . . . . 1.0 111.897 179.736 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.3 m -16.49 -62.79 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.231 0 N-CA-C 117.566 2.432 . . . . 1.0 117.566 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.426 ' HG2' ' H ' ' A' ' 12' ' ' ASP . 71.3 Cg_endo -68.48 -92.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 121.343 1.362 . . . . 1.0 112.213 178.837 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.441 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 4.1 t0 36.63 35.18 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 123.502 1.62 . . . . 1.0 109.961 -179.671 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.0 t -168.3 -23.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 110.761 -2.927 . . . . 1.0 111.764 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -38.35 -56.53 1.23 Allowed 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 123.955 0.902 . . . . 1.0 113.225 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.0 t -46.08 -53.26 10.56 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 124.685 1.24 . . . . 1.0 109.326 179.496 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.07 -39.62 90.58 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 113.73 -1.577 . . . . 1.0 112.292 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 25' ' ' THR . 60.0 m -69.14 -28.68 66.66 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.842 -1.072 . . . . 1.0 108.576 179.936 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -71.05 -52.78 17.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.061 -1.459 . . . . 1.0 107.061 179.319 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -71.04 -19.86 62.45 Favored 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 118.091 -1.444 . . . . 1.0 114.767 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -105.92 -33.79 7.83 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 113.313 0.857 . . . . 1.0 113.313 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 t -106.89 -30.97 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 123.722 0.638 . . . . 1.0 110.07 -179.563 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.67 -34.91 2.77 Favored Glycine 0 N--CA 1.49 2.249 0 O-C-N 123.855 0.722 . . . . 1.0 114.584 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -135.81 169.29 17.8 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 113.245 0.831 . . . . 1.0 113.245 -179.363 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.86 69.33 0.69 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 113.683 -1.598 . . . . 1.0 110.797 179.521 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.5 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 4.5 t -121.67 179.01 4.61 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.61 -179.818 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.97 175.06 18.9 Favored Glycine 0 N--CA 1.493 2.459 0 CA-C-N 113.292 -1.776 . . . . 1.0 111.965 179.847 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.94 175.65 9.04 Favored 'General case' 0 C--O 1.205 -1.277 0 CA-C-O 122.074 0.94 . . . . 1.0 112.73 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.7 t -114.63 109.44 18.23 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 112.396 -2.183 . . . . 1.0 105.429 -179.926 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.9 m -126.47 126.44 43.76 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 112.103 -2.317 . . . . 1.0 110.952 -179.501 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 m120 45.18 40.86 5.3 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 113.464 -1.698 . . . . 1.0 111.52 -179.52 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.1 27.42 68.89 Favored Glycine 0 N--CA 1.485 1.942 0 CA-C-N 113.415 -1.72 . . . . 1.0 112.412 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.6 mtt-85 -136.63 160.54 38.5 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.385 -1.709 . . . . 1.0 106.385 179.796 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.573 ' HB3' HG12 ' A' ' 3' ' ' ILE . 38.9 t -73.06 144.52 47.04 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.609 -1.237 . . . . 1.0 113.076 179.869 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 32.6 t70 -133.89 76.45 1.66 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.048 -2.204 . . . . 1.0 105.048 178.742 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.1 t . . . . . 0 N--CA 1.501 2.1 0 CA-C-O 117.761 -1.114 . . . . 1.0 111.34 -179.341 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.444 ' H2 ' ' HB3' ' A' ' 35' ' ' CYS . 14.1 t . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 108.555 -0.906 . . . . 1.0 108.555 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.431 ' N ' HG12 ' A' ' 1' ' ' VAL . 7.7 p -71.05 123.17 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 114.477 -1.238 . . . . 1.0 109.688 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.569 HG12 ' HB3' ' A' ' 33' ' ' CYS . 14.6 pt -125.59 159.66 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 122.818 1.294 . . . . 1.0 113.348 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.74 43.71 3.27 Favored Glycine 0 C--O 1.204 -1.731 0 CA-C-N 112.029 -2.35 . . . . 1.0 113.389 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -105.83 88.23 2.77 Favored 'General case' 0 C--N 1.308 -1.208 1 N-CA-C 98.638 -4.578 . . . . 1.0 98.638 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -38.94 147.19 0.06 Allowed 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 113.275 -1.784 . . . . 1.0 113.401 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 0.5 OUTLIER -112.49 160.64 17.58 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 116.919 2.192 . . . . 1.0 116.919 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.533 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.7 t80 -123.11 -58.68 1.63 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 103.301 -2.851 . . . . 1.0 103.301 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.413 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 42.6 mtt85 -116.36 165.2 13.48 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 112.689 -2.05 . . . . 1.0 110.018 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.458 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 67.3 m -34.73 -59.2 0.62 Allowed Pre-proline 0 N--CA 1.503 2.216 0 O-C-N 124.731 1.269 . . . . 1.0 113.54 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.458 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 88.2 Cg_endo -62.18 -86.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.056 0 C-N-CA 121.976 1.784 . . . . 1.0 112.253 176.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.41 ' H ' ' HG2' ' A' ' 11' ' ' PRO . 6.1 t70 34.16 36.89 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 CA-C-O 124.305 2.002 . . . . 1.0 109.129 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.402 ' N ' ' C ' ' A' ' 11' ' ' PRO . 15.9 t -170.05 -27.18 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 110.21 -3.177 . . . . 1.0 111.502 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -38.2 -55.45 1.3 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 123.712 0.632 . . . . 1.0 112.18 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 61.8 m -50.49 -51.78 44.3 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 124.386 1.054 . . . . 1.0 110.074 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.438 ' HA ' ' HG3' ' A' ' 19' ' ' LYS . . . -58.18 -47.54 83.09 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 122.825 1.297 . . . . 1.0 111.515 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 25' ' ' THR . 35.5 m -58.68 -39.55 81.02 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 113.735 -1.575 . . . . 1.0 108.688 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -64.7 -52.16 58.65 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.282 -1.377 . . . . 1.0 107.282 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HG3' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -71.58 -10.72 60.21 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 117.677 -1.609 . . . . 1.0 113.129 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.7 mt -92.61 -50.35 5.64 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 119.409 -0.329 . . . . 1.0 111.549 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.7 p -114.07 -32.38 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 123.481 0.488 . . . . 1.0 110.69 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.99 -19.75 3.67 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 116.031 1.172 . . . . 1.0 116.031 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -128.42 151.28 49.56 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 114.54 1.311 . . . . 1.0 114.54 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.2 70.76 0.84 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 113.784 -1.553 . . . . 1.0 110.403 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.512 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 5.1 t -122.9 176.39 6.03 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.9 0.857 . . . . 1.0 112.298 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.69 160.37 27.81 Favored Glycine 0 N--CA 1.493 2.467 0 CA-C-N 112.671 -2.058 . . . . 1.0 110.197 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.415 ' HD3' ' H ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -130.4 -178.33 4.72 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.359 1.076 . . . . 1.0 112.824 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 38.7 t -90.12 109.39 20.45 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 111.895 -2.411 . . . . 1.0 107.809 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.434 ' CB ' ' HB2' ' A' ' 34' ' ' ASP . 44.0 m -126.34 119.53 27.58 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 111.679 -2.509 . . . . 1.0 110.992 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 50.33 43.43 26.63 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.453 -1.703 . . . . 1.0 109.013 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.94 20.55 53.65 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-N 113.623 -1.626 . . . . 1.0 113.026 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.0 mtt85 -132.86 160.87 35.7 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.095 -1.446 . . . . 1.0 107.095 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.569 ' HB3' HG12 ' A' ' 3' ' ' ILE . 42.9 t -73.22 142.07 47.31 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 118.381 -1.328 . . . . 1.0 114.005 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.434 ' HB2' ' CB ' ' A' ' 29' ' ' THR . 18.9 t70 -128.01 85.94 2.41 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 102.822 -3.029 . . . . 1.0 102.822 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.444 ' HB3' ' H2 ' ' A' ' 1' ' ' VAL . 5.8 t . . . . . 0 N--CA 1.501 2.106 0 CA-C-O 116.75 -1.595 . . . . 1.0 111.47 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.478 0.656 . . . . 1.0 111.857 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 48.9 t -70.7 119.88 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 107.115 -1.439 . . . . 1.0 107.115 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.548 HG12 ' HB3' ' A' ' 33' ' ' CYS . 30.1 pt -129.58 163.37 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 114.301 1.223 . . . . 1.0 114.301 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.97 43.76 3.29 Favored Glycine 0 C--O 1.213 -1.196 0 CA-C-N 112.188 -2.278 . . . . 1.0 112.436 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -106.3 100.3 9.84 Favored 'General case' 0 N--CA 1.486 1.348 1 N-CA-C 99.919 -4.104 . . . . 1.0 99.919 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.525 ' HE ' HH22 ' A' ' 32' ' ' ARG . 64.6 mtt85 -38.94 144.5 0.12 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 125.253 1.596 . . . . 1.0 114.58 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.7 t -110.7 156.06 21.56 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.255 -1.793 . . . . 1.0 111.505 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -120.81 -61.9 1.51 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 103.88 -2.637 . . . . 1.0 103.88 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -118.71 167.58 11.53 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 112.861 -1.972 . . . . 1.0 107.558 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.409 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 50.7 m -26.57 -49.64 0.18 Allowed Pre-proline 0 N--CA 1.507 2.376 0 N-CA-C 115.015 1.487 . . . . 1.0 115.015 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.464 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . 0.9 OUTLIER -88.86 -83.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.319 -0.977 0 C-N-CA 121.864 1.709 . . . . 1.0 108.639 -176.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.9 t70 37.1 32.43 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 123.149 1.452 . . . . 1.0 110.104 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.551 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 41.8 t -164.6 -26.17 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 111.3 -2.682 . . . . 1.0 112.95 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.464 ' CD1' ' HB3' ' A' ' 11' ' ' PRO . 3.3 m-85 -38.19 -55.18 1.33 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 123.988 0.915 . . . . 1.0 113.072 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 55.5 m -47.7 -53.63 14.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 124.861 1.35 . . . . 1.0 108.648 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.09 -51.05 70.83 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.04 -0.982 . . . . 1.0 111.035 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.551 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 94.6 m -54.57 -33.48 60.33 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.247 -1.342 . . . . 1.0 109.695 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -70.67 -48.92 52.33 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.057 -1.831 . . . . 1.0 106.057 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -70.45 -14.13 62.41 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-N 114.551 -1.204 . . . . 1.0 113.538 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.7 mt -107.14 -44.08 4.46 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 113.578 0.955 . . . . 1.0 113.578 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 37.1 t -99.67 -36.56 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-N 114.647 -1.16 . . . . 1.0 109.782 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.76 -30.23 3.43 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 120.615 -0.802 . . . . 1.0 113.974 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -128.01 151.06 49.61 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 114.077 1.14 . . . . 1.0 114.077 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.39 77.06 0.76 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 114.118 -1.401 . . . . 1.0 109.327 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.1 t -128.71 -172.87 2.82 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.766 -0.652 . . . . 1.0 109.324 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.677 ' HA3' ' SG ' ' A' ' 35' ' ' CYS . . . 118.89 -179.37 16.8 Favored Glycine 0 N--CA 1.493 2.458 0 CA-C-N 113.217 -1.81 . . . . 1.0 115.902 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -142.74 168.38 19.86 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 112.296 -1.952 . . . . 1.0 107.012 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.3 t -105.63 115.03 29.55 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 105.031 -2.211 . . . . 1.0 105.031 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.2 m -128.23 123.76 34.99 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 112.923 -1.944 . . . . 1.0 112.48 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 45.98 42.14 8.99 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 112.92 -1.945 . . . . 1.0 110.076 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.18 27.46 67.47 Favored Glycine 0 N--CA 1.489 2.171 0 CA-C-N 113.769 -1.56 . . . . 1.0 112.752 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.525 HH22 ' HE ' ' A' ' 6' ' ' ARG . 36.0 mmt180 -135.78 161.87 34.37 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 106.308 -1.738 . . . . 1.0 106.308 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.548 ' HB3' HG12 ' A' ' 3' ' ' ILE . 13.8 t -73.4 142.43 46.97 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 114.807 1.41 . . . . 1.0 114.807 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 11.3 t70 -130.45 79.78 1.92 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 125.791 1.932 . . . . 1.0 108.227 178.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.677 ' SG ' ' HA3' ' A' ' 26' ' ' GLY . 1.3 m . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 118.136 -0.935 . . . . 1.0 111.067 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.582 0.706 . . . . 1.0 111.559 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 52.7 t -71.14 117.06 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 113.838 -1.528 . . . . 1.0 107.413 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.557 HG12 ' HB3' ' A' ' 33' ' ' CYS . 33.5 pt -134.03 163.63 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 115.563 1.69 . . . . 1.0 115.563 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.12 -44.63 88.55 Favored Glycine 0 N--CA 1.478 1.46 0 CA-C-N 111.499 -2.591 . . . . 1.0 110.791 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -28.37 90.5 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.455 0 O-C-N 126.096 1.704 . . . . 1.0 110.755 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -39.94 146.88 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.832 1.419 . . . . 1.0 114.832 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.8 p -125.67 159.25 32.72 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.376 -1.284 . . . . 1.0 110.057 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.401 ' H ' ' CB ' ' A' ' 12' ' ' ASP . 12.8 t80 -119.41 -55.21 2.14 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 106.177 -1.786 . . . . 1.0 106.177 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.464 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -111.14 162.08 15.29 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 113.048 -1.887 . . . . 1.0 106.719 179.785 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.447 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 58.4 m -30.85 -55.8 0.38 Allowed Pre-proline 0 N--CA 1.503 2.199 0 O-C-N 125.091 1.494 . . . . 1.0 113.533 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.495 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 53.9 Cg_endo -70.19 -95.05 0.01 OUTLIER 'Trans proline' 0 C--O 1.205 -1.141 0 C-N-CA 121.248 1.299 . . . . 1.0 113.946 170.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.401 ' CB ' ' H ' ' A' ' 8' ' ' TYR . 4.9 t70 39.99 32.82 0.12 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 124.862 1.351 . . . . 1.0 109.593 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.2 t -167.59 -25.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 111.809 -2.45 . . . . 1.0 112.392 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.495 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.5 m-30 -38.5 -59.15 0.94 Allowed 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 123.698 0.799 . . . . 1.0 112.173 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.9 p -45.92 -46.22 15.92 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 125.162 1.539 . . . . 1.0 111.37 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.8 -41.76 87.05 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.428 -1.26 . . . . 1.0 111.231 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.8 t -69.34 -27.46 65.38 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.267 -0.879 . . . . 1.0 109.025 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -70.17 -53.63 16.35 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.955 -1.498 . . . . 1.0 106.955 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -71.14 -21.22 62.21 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 114.161 1.171 . . . . 1.0 114.161 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.8 mp -98.26 -33.57 11.04 Favored 'General case' 0 N--CA 1.509 2.511 0 N-CA-C 112.847 0.684 . . . . 1.0 112.847 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.82 -37.78 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 123.677 0.611 . . . . 1.0 109.856 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.19 -31.75 2.65 Favored Glycine 0 N--CA 1.489 2.196 0 CA-C-O 118.785 -1.008 . . . . 1.0 114.917 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -128.13 145.67 50.94 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 115.22 1.563 . . . . 1.0 115.22 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.82 72.58 0.81 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 113.491 -1.686 . . . . 1.0 110.409 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.426 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 7.8 t -133.04 -173.43 3.19 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.278 0.561 . . . . 1.0 109.769 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.28 -170.82 13.61 Favored Glycine 0 N--CA 1.495 2.569 0 CA-C-N 113.579 -1.646 . . . . 1.0 114.219 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -147.38 167.8 23.44 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 113.683 -1.259 . . . . 1.0 108.817 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.2 t -104.82 117.59 34.43 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.322 -1.733 . . . . 1.0 106.322 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.7 m -125.66 122.91 37.74 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 113.319 -1.764 . . . . 1.0 111.203 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.4 m120 45.74 41.54 7.57 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 112.798 -2.001 . . . . 1.0 111.279 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.67 21.95 71.36 Favored Glycine 0 N--CA 1.482 1.719 0 CA-C-N 113.385 -1.734 . . . . 1.0 113.592 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.1 mmt-85 -131.7 158.87 39.99 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.667 -1.605 . . . . 1.0 106.667 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.557 ' HB3' HG12 ' A' ' 3' ' ' ILE . 9.1 t -72.62 142.18 48.35 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.58 -1.248 . . . . 1.0 113.708 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.4 t70 -135.07 78.37 1.73 Allowed 'General case' 0 C--N 1.295 -1.764 0 O-C-N 125.969 2.043 . . . . 1.0 106.862 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.426 ' SG ' ' O ' ' A' ' 25' ' ' THR . 37.1 t . . . . . 0 N--CA 1.498 1.947 0 C-N-CA 119.717 -0.793 . . . . 1.0 111.281 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.289 0.566 . . . . 1.0 111.071 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.4 p -70.95 120.89 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 114.426 -1.261 . . . . 1.0 108.911 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.481 HG12 ' HB3' ' A' ' 33' ' ' CYS . 22.9 pt -135.02 169.31 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 115.1 1.518 . . . . 1.0 115.1 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.01 -47.26 81.38 Favored Glycine 0 N--CA 1.478 1.489 0 CA-C-N 111.577 -2.556 . . . . 1.0 111.869 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -20.96 90.61 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.516 0 O-C-N 125.85 1.559 . . . . 1.0 112.884 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -39.79 142.3 0.34 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 124.851 1.344 . . . . 1.0 112.361 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.1 p -124.64 162.45 24.1 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 124.58 1.175 . . . . 1.0 111.042 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -118.24 -61.87 1.62 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 102.782 -3.044 . . . . 1.0 102.782 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -117.79 168.25 10.64 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.407 -2.072 . . . . 1.0 105.407 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.426 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.7 m -29.85 -54.59 0.33 Allowed Pre-proline 0 N--CA 1.503 2.198 0 O-C-N 124.692 1.245 . . . . 1.0 113.823 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.426 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 54.3 Cg_endo -67.78 -104.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 121.568 1.512 . . . . 1.0 113.841 172.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.8 t70 39.34 30.54 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 123.2 1.476 . . . . 1.0 110.031 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.7 t -168.15 -15.29 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 111.255 -2.702 . . . . 1.0 113.598 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.4 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 6.0 m-30 -38.74 -58.8 1.02 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 113.675 0.991 . . . . 1.0 113.675 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.0 t -45.27 -48.18 12.92 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 124.849 1.343 . . . . 1.0 110.734 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.74 -53.4 54.89 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.623 -1.172 . . . . 1.0 108.734 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.2 t -49.55 -39.66 35.55 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.811 -1.086 . . . . 1.0 110.12 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -65.95 -47.79 73.5 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.503 -1.295 . . . . 1.0 107.503 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -70.09 -11.82 61.16 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 112.862 -1.972 . . . . 1.0 111.885 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.6 mt -104.47 -52.72 2.84 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.105 1.15 . . . . 1.0 114.105 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.3 m -108.61 -16.68 8.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 118.687 -0.673 . . . . 1.0 112.525 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.99 -38.23 1.97 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 118.354 2.101 . . . . 1.0 118.354 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -126.57 153.75 44.83 Favored 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 115.243 1.572 . . . . 1.0 115.243 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.54 68.88 0.59 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 113.316 -1.766 . . . . 1.0 112.204 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.8 t -130.25 -168.65 2.0 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.549 ' CA ' ' SG ' ' A' ' 35' ' ' CYS . . . 124.78 174.42 14.0 Favored Glycine 0 N--CA 1.497 2.707 0 CA-C-N 113.517 -1.674 . . . . 1.0 115.136 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -131.4 164.46 25.64 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 112.13 -2.035 . . . . 1.0 108.483 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.5 t -107.46 112.07 24.68 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 104.654 -2.35 . . . . 1.0 104.654 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 84.8 m -128.18 123.69 34.93 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 112.371 -2.195 . . . . 1.0 112.131 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 51.49 39.78 25.38 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 113.2 -1.818 . . . . 1.0 108.905 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.49 21.05 62.02 Favored Glycine 0 N--CA 1.486 2.017 0 CA-C-N 113.286 -1.779 . . . . 1.0 112.386 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.6 mtp85 -129.87 164.03 25.03 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.677 -1.231 . . . . 1.0 107.677 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.481 ' HB3' HG12 ' A' ' 3' ' ' ILE . 4.3 t -72.56 145.28 47.51 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.926 -1.109 . . . . 1.0 112.975 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.7 t70 -133.57 83.57 2.06 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 112.693 -2.049 . . . . 1.0 107.992 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.549 ' SG ' ' CA ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.017 0 CA-C-O 118.439 -0.791 . . . . 1.0 111.106 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 2' ' ' VAL . 17.2 t . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 108.243 -1.021 . . . . 1.0 108.243 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 55.6 t -71.66 109.13 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 105.659 -1.978 . . . . 1.0 105.659 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.498 HG12 ' HB3' ' A' ' 33' ' ' CYS . 36.1 pt -135.04 168.49 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 115.875 1.806 . . . . 1.0 115.875 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.54 -45.67 83.66 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 111.814 -2.448 . . . . 1.0 111.041 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.5 tp60 -22.64 90.08 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.45 0 O-C-N 125.943 1.614 . . . . 1.0 113.112 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -39.82 143.16 0.27 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 113.916 -1.493 . . . . 1.0 113.15 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.4 p -124.36 163.93 20.7 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.916 -1.038 . . . . 1.0 109.826 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.439 ' H ' ' HB3' ' A' ' 12' ' ' ASP . 17.0 t80 -117.15 -61.08 1.76 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 104.298 -2.482 . . . . 1.0 104.298 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -116.82 169.41 9.4 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 112.418 -2.174 . . . . 1.0 106.97 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.462 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 73.1 m -28.55 -54.98 0.26 Allowed Pre-proline 0 N--CA 1.503 2.179 0 O-C-N 124.942 1.401 . . . . 1.0 113.944 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.462 ' HD3' ' HB2' ' A' ' 10' ' ' SER . 28.8 Cg_endo -73.74 -100.6 0.01 OUTLIER 'Trans proline' 0 C--O 1.208 -0.984 0 C-N-CA 121.776 1.651 . . . . 1.0 114.917 170.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.439 ' HB3' ' H ' ' A' ' 8' ' ' TYR . 12.5 t70 41.86 28.63 0.09 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 124.79 1.306 . . . . 1.0 110.163 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.0 t -164.58 -21.91 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 112.109 -2.314 . . . . 1.0 113.138 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.459 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 6.3 m-30 -38.78 -61.37 0.73 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 112.913 0.708 . . . . 1.0 112.913 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.3 p -43.84 -42.72 5.83 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 125.174 1.546 . . . . 1.0 112.165 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.99 -49.84 47.54 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 114.188 -1.369 . . . . 1.0 108.771 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.7 t -55.45 -34.97 64.97 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.292 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -66.49 -51.09 60.42 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 106.464 -1.68 . . . . 1.0 106.464 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.41 ' NZ ' ' HB2' ' A' ' 19' ' ' LYS . 4.4 ttmp? -59.77 -24.74 64.33 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.039 -1.891 . . . . 1.0 112.197 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.0 mp -101.27 -33.74 9.93 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 116.101 1.889 . . . . 1.0 116.101 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.13 -37.79 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 123.453 0.471 . . . . 1.0 110.771 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.41 -30.77 2.58 Favored Glycine 0 N--CA 1.488 2.145 0 CA-C-O 118.435 -1.203 . . . . 1.0 115.041 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.48 141.46 51.98 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 115.146 1.535 . . . . 1.0 115.146 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.74 71.79 0.76 Allowed 'General case' 0 N--CA 1.503 2.209 0 CA-C-N 113.609 -1.632 . . . . 1.0 112.697 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.414 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 14.7 t -133.08 -168.16 2.04 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.431 0.634 . . . . 1.0 109.453 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.09 -174.69 16.2 Favored Glycine 0 N--CA 1.493 2.458 0 CA-C-N 113.577 -1.647 . . . . 1.0 115.359 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.48 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -138.1 162.63 33.69 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 112.833 -1.683 . . . . 1.0 108.518 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.417 ' H ' ' HE2' ' A' ' 27' ' ' LYS . 42.0 t -106.08 114.81 29.17 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 103.757 -2.683 . . . . 1.0 103.757 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 78.1 m -128.61 124.44 35.85 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 112.923 -1.944 . . . . 1.0 112.354 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 50.8 39.91 23.34 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 113.152 -1.84 . . . . 1.0 109.041 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.16 22.02 62.42 Favored Glycine 0 N--CA 1.484 1.854 0 CA-C-N 113.283 -1.78 . . . . 1.0 112.816 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.1 mtp-105 -130.89 163.29 27.77 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.14 -1.43 . . . . 1.0 107.14 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.498 ' HB3' HG12 ' A' ' 3' ' ' ILE . 2.5 t -72.69 142.61 48.23 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.213 1.19 . . . . 1.0 114.213 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.515 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.5 t70 -135.54 74.91 1.53 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 112.262 -2.245 . . . . 1.0 106.338 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 25' ' ' THR . 41.9 t . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 118.278 -0.868 . . . . 1.0 111.83 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.24 0.543 . . . . 1.0 111.227 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.3 p -70.82 119.78 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-N 114.371 -1.286 . . . . 1.0 108.774 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.507 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 33.0 pt -135.37 165.42 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 115.531 1.678 . . . . 1.0 115.531 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.84 44.2 3.33 Favored Glycine 0 C--O 1.21 -1.361 0 CA-C-N 111.314 -2.675 . . . . 1.0 111.826 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -109.8 96.6 6.36 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 100.64 -3.837 . . . . 1.0 100.64 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -39.11 147.74 0.06 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 125.381 1.676 . . . . 1.0 113.732 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.1 t -116.56 154.16 30.93 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 113.523 -1.672 . . . . 1.0 111.602 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -120.23 -55.95 2.02 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 104.323 -2.473 . . . . 1.0 104.323 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.434 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -119.2 154.02 34.01 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 113.498 -1.683 . . . . 1.0 106.792 179.72 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.438 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.9 m -22.0 -56.01 0.09 OUTLIER Pre-proline 0 N--CA 1.506 2.364 0 N-CA-C 115.773 1.768 . . . . 1.0 115.773 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.473 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 63.6 Cg_endo -69.19 -94.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.733 1.622 . . . . 1.0 113.531 169.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.7 t70 42.52 28.19 0.11 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 124.537 1.148 . . . . 1.0 110.246 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.6 t -164.47 -26.99 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 112.49 -2.141 . . . . 1.0 112.572 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.473 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 5.9 m-30 -38.73 -61.51 0.71 Allowed 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 112.582 0.586 . . . . 1.0 112.582 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.8 m -42.04 -43.77 3.32 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 125.509 1.755 . . . . 1.0 111.062 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.51 -49.0 58.69 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 114.389 -1.278 . . . . 1.0 109.113 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.5 t -56.8 -30.04 63.3 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 124.053 0.846 . . . . 1.0 108.954 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -70.72 -51.52 26.9 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 105.912 -1.884 . . . . 1.0 105.912 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -70.65 -10.78 60.16 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 113.755 -1.566 . . . . 1.0 113.878 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.4 mt -108.69 -43.5 4.25 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 112.903 0.705 . . . . 1.0 112.903 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.4 t -105.23 -38.24 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-N 114.748 -1.114 . . . . 1.0 110.464 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.0 -30.19 2.86 Favored Glycine 0 N--CA 1.488 2.161 0 CA-C-O 118.854 -0.97 . . . . 1.0 114.378 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -122.62 139.27 54.12 Favored 'General case' 0 N--CA 1.506 2.375 0 N-CA-C 114.407 1.262 . . . . 1.0 114.407 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.16 68.93 0.74 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 125.146 1.529 . . . . 1.0 111.086 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.433 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 9.2 t -132.64 -169.14 2.18 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.303 -0.862 . . . . 1.0 109.041 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.31 -173.11 16.27 Favored Glycine 0 N--CA 1.493 2.443 0 CA-C-N 113.751 -1.568 . . . . 1.0 113.711 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -136.96 167.64 21.12 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.654 -1.273 . . . . 1.0 109.568 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.5 t -109.87 112.33 24.3 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 103.485 -2.783 . . . . 1.0 103.485 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.8 m -127.37 123.28 35.84 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 112.829 -1.987 . . . . 1.0 112.604 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 49.91 40.63 21.31 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 113.134 -1.848 . . . . 1.0 108.599 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.52 22.94 62.09 Favored Glycine 0 N--CA 1.484 1.85 0 CA-C-N 113.231 -1.804 . . . . 1.0 113.211 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -131.07 162.34 30.05 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 106.048 -1.834 . . . . 1.0 106.048 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.507 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 9.1 t -73.33 141.56 47.1 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.043 1.498 . . . . 1.0 115.043 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.2 t70 -136.64 77.39 1.65 Allowed 'General case' 0 C--N 1.298 -1.673 0 O-C-N 125.825 1.953 . . . . 1.0 107.699 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.433 ' SG ' ' O ' ' A' ' 25' ' ' THR . 29.9 t . . . . . 0 N--CA 1.5 2.041 0 C-N-CA 119.609 -0.836 . . . . 1.0 111.372 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.0 m . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.497 0.665 . . . . 1.0 112.089 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.2 p -70.6 124.68 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-N 114.198 -1.365 . . . . 1.0 109.009 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.495 HG12 ' HB3' ' A' ' 33' ' ' CYS . 1.5 pt -132.18 159.75 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 114.1 1.148 . . . . 1.0 114.1 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -40.47 -53.34 3.54 Favored Glycine 0 N--CA 1.486 1.99 0 CA-C-N 111.22 -2.718 . . . . 1.0 112.206 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -16.13 85.62 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 O-C-N 126.195 1.761 . . . . 1.0 113.217 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -51.05 144.8 8.37 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.772 -1.104 . . . . 1.0 109.607 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.0 p -123.01 164.16 19.09 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 114.249 1.203 . . . . 1.0 114.249 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -118.07 -57.77 2.06 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 104.686 -2.338 . . . . 1.0 104.686 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -114.39 168.43 9.85 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 112.949 -1.932 . . . . 1.0 107.247 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.452 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.3 m -35.29 -58.8 0.74 Allowed Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 124.961 1.413 . . . . 1.0 113.412 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.452 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 84.7 Cg_endo -62.15 -95.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.391 1.394 . . . . 1.0 112.423 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 t0 37.91 32.34 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 123.147 1.451 . . . . 1.0 108.809 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.422 ' N ' ' C ' ' A' ' 11' ' ' PRO . 23.9 t -165.41 -24.94 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 111.945 -2.389 . . . . 1.0 112.298 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -38.21 -55.71 1.28 Allowed 'General case' 0 N--CA 1.508 2.466 0 C-N-CA 123.1 0.56 . . . . 1.0 110.778 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.6 p -53.31 -49.18 67.57 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 124.579 1.175 . . . . 1.0 110.119 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.5 -55.62 29.67 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.681 0.753 . . . . 1.0 110.765 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 25' ' ' THR . 56.5 m -48.58 -49.33 37.1 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.165 -1.38 . . . . 1.0 108.317 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -55.61 -49.59 72.4 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.167 0.984 . . . . 1.0 108.443 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -59.8 -26.73 65.99 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-N 113.852 -1.522 . . . . 1.0 111.46 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.1 mp -85.6 -55.79 3.82 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 120.082 -0.647 . . . . 1.0 112.31 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.2 m -107.3 -46.21 7.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 C-N-CA 122.922 0.489 . . . . 1.0 112.25 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.8 28.34 1.29 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 111.215 -0.754 . . . . 1.0 111.215 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -135.41 126.84 28.58 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 124.268 0.628 . . . . 1.0 110.293 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.35 69.04 0.8 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 124.909 1.381 . . . . 1.0 108.923 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.463 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 12.4 t -127.66 -173.46 2.92 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.898 0.856 . . . . 1.0 111.576 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.85 158.62 27.55 Favored Glycine 0 N--CA 1.495 2.572 0 CA-C-N 112.612 -2.086 . . . . 1.0 109.598 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -132.99 179.29 6.27 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.605 0.716 . . . . 1.0 110.312 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.2 t -100.04 118.07 35.64 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 113.512 -1.676 . . . . 1.0 106.704 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.5 m -132.24 130.39 40.88 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 112.633 -2.076 . . . . 1.0 106.552 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.6 p30 45.5 41.44 6.77 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 125.286 1.616 . . . . 1.0 112.76 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.05 12.4 49.13 Favored Glycine 0 N--CA 1.479 1.561 0 CA-C-N 113.412 -1.722 . . . . 1.0 113.435 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.8 mmt-85 -127.71 162.55 26.3 Favored 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.495 ' HB3' HG12 ' A' ' 3' ' ' ILE . 42.9 t -72.59 146.47 46.66 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 117.7 -1.6 . . . . 1.0 112.08 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 34.0 t70 -129.69 85.69 2.33 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 104.878 -2.267 . . . . 1.0 104.878 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.504 2.246 0 CA-C-O 116.452 -1.737 . . . . 1.0 111.112 -179.44 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 2' ' ' VAL . 14.4 t . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 108.245 -1.02 . . . . 1.0 108.245 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.6 p -71.39 115.41 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.204 -1.406 . . . . 1.0 107.204 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.496 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 35.9 pt -136.83 166.35 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 116.349 1.981 . . . . 1.0 116.349 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.03 -46.05 85.61 Favored Glycine 0 N--CA 1.478 1.448 0 CA-C-N 111.235 -2.711 . . . . 1.0 110.637 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.419 ' HB3' HG13 ' A' ' 3' ' ' ILE . 49.2 tp60 -22.76 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.323 0 O-C-N 125.9 1.588 . . . . 1.0 112.44 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -40.11 151.01 0.05 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 125.274 1.609 . . . . 1.0 114.041 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 t -117.21 149.6 40.14 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 113.538 -1.665 . . . . 1.0 110.318 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.484 ' HB3' ' HD3' ' A' ' 9' ' ' ARG . 3.0 t80 -122.08 -54.8 1.9 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 102.553 -3.129 . . . . 1.0 102.553 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.484 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -118.65 154.05 33.31 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 105.941 -1.874 . . . . 1.0 105.941 179.675 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.45 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 67.8 m -25.2 -55.78 0.17 Allowed Pre-proline 0 N--CA 1.505 2.324 0 N-CA-C 114.748 1.388 . . . . 1.0 114.748 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.488 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 64.4 Cg_endo -69.04 -93.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 121.149 1.233 . . . . 1.0 113.629 170.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.4 t70 42.31 30.01 0.18 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 122.616 1.198 . . . . 1.0 109.691 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.8 t -165.96 -26.22 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 112.23 -2.259 . . . . 1.0 112.658 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.488 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.4 m-30 -38.56 -59.03 0.96 Allowed 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 123.612 0.765 . . . . 1.0 112.244 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.6 p -45.53 -43.24 11.71 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 125.117 1.511 . . . . 1.0 111.769 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.05 -46.53 64.8 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.811 -1.086 . . . . 1.0 109.768 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.2 t -57.04 -36.14 70.13 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.103 -1.073 . . . . 1.0 108.103 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -65.69 -53.75 36.82 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 105.1 -2.185 . . . . 1.0 105.1 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.82 -31.6 7.36 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 114.236 -1.347 . . . . 1.0 109.755 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.84 -54.35 5.43 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.475 -0.784 . . . . 1.0 112.088 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 50.7 t -104.28 -54.79 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 CA-C-N 115.655 -0.702 . . . . 1.0 111.674 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.61 20.48 1.09 Allowed Glycine 0 N--CA 1.491 2.309 0 O-C-N 124.043 0.839 . . . . 1.0 112.793 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -133.16 126.26 31.27 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 124.102 0.53 . . . . 1.0 110.465 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.15 73.9 0.94 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 124.54 1.15 . . . . 1.0 108.201 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.411 HG23 ' SG ' ' A' ' 35' ' ' CYS . 9.4 t -137.38 -173.24 3.42 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.429 0.633 . . . . 1.0 110.884 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.87 -179.69 16.18 Favored Glycine 0 N--CA 1.493 2.46 0 CA-C-N 113.429 -1.714 . . . . 1.0 113.745 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -134.53 172.48 12.86 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 114.001 -1.1 . . . . 1.0 111.346 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 45.6 t -112.34 111.56 22.5 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 102.273 -3.232 . . . . 1.0 102.273 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.2 m -130.73 123.42 29.22 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 112.437 -2.165 . . . . 1.0 108.097 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 p30 47.8 42.0 15.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 126.679 2.487 . . . . 1.0 112.116 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.95 11.21 60.44 Favored Glycine 0 N--CA 1.476 1.309 0 CA-C-N 113.132 -1.849 . . . . 1.0 112.289 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.3 mtt85 -126.34 163.72 22.64 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.187 -1.042 . . . . 1.0 108.187 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.496 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 7.4 t -72.21 143.03 49.0 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.506 -1.278 . . . . 1.0 114.308 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 35.8 t70 -136.39 77.0 1.63 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 112.051 -2.34 . . . . 1.0 107.56 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.411 ' SG ' HG23 ' A' ' 25' ' ' THR . 21.8 t . . . . . 0 N--CA 1.498 1.951 0 CA-C-O 118.016 -0.992 . . . . 1.0 111.27 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.57 0.7 . . . . 1.0 110.672 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.5 p -71.03 119.19 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 113.966 -1.47 . . . . 1.0 110.689 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.559 HG12 ' HB3' ' A' ' 33' ' ' CYS . 23.6 pt -130.23 159.29 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 CA-C-O 122.125 0.964 . . . . 1.0 112.779 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.22 -39.64 72.08 Favored Glycine 0 N--CA 1.489 2.195 0 CA-C-N 112.133 -2.303 . . . . 1.0 112.971 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -13.64 87.61 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 115.672 1.73 . . . . 1.0 115.672 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -40.7 124.31 2.04 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.693 1.246 . . . . 1.0 109.634 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 5.6 t -95.43 157.88 15.7 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 116.182 1.919 . . . . 1.0 116.182 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.515 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 14.7 t80 -121.68 -61.96 1.46 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 104.285 -2.487 . . . . 1.0 104.285 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -121.1 168.07 11.95 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 112.982 -1.917 . . . . 1.0 110.137 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.435 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 59.9 m -32.29 -59.64 0.38 Allowed Pre-proline 0 N--CA 1.501 2.109 0 O-C-N 125.051 1.469 . . . . 1.0 114.605 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.435 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 84.1 Cg_endo -61.37 -89.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.753 1.635 . . . . 1.0 112.045 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 t70 35.92 36.41 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 CA-C-O 124.113 1.911 . . . . 1.0 108.508 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.403 ' N ' ' C ' ' A' ' 11' ' ' PRO . 15.1 t -170.36 -25.33 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 111.118 -2.765 . . . . 1.0 112.382 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -38.45 -59.51 0.9 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 123.984 0.803 . . . . 1.0 111.618 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.3 t -51.83 -44.43 63.56 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 124.939 1.399 . . . . 1.0 112.657 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.43 -46.81 78.46 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 124.025 0.828 . . . . 1.0 113.055 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.1 t -68.72 -31.02 69.8 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.012 -1.477 . . . . 1.0 107.012 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.419 ' HZ3' ' HB3' ' A' ' 18' ' ' LYS . 6.0 ttpm? -64.11 -50.29 68.87 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.24 -1.022 . . . . 1.0 108.24 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -70.15 -26.3 63.87 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.002 -1.479 . . . . 1.0 109.505 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 tt -65.15 -59.18 4.38 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.963 -0.695 . . . . 1.0 110.138 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.01 -42.73 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 114.171 1.175 . . . . 1.0 114.171 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.03 10.82 1.69 Allowed Glycine 0 N--CA 1.491 2.337 0 CA-C-O 119.569 -0.573 . . . . 1.0 112.759 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -129.68 128.9 43.49 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 123.722 0.307 . . . . 1.0 110.468 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.02 68.71 0.7 Allowed 'General case' 0 N--CA 1.503 2.202 0 O-C-N 124.87 1.356 . . . . 1.0 109.954 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.6 p -115.61 175.78 5.37 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.151 -1.386 . . . . 1.0 113.048 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.78 150.58 9.34 Favored Glycine 0 N--CA 1.49 2.263 0 CA-C-N 113.254 -1.794 . . . . 1.0 110.989 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -122.55 -178.48 3.92 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 113.521 -1.339 . . . . 1.0 111.01 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.5 t -111.27 109.42 19.43 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 111.903 -2.408 . . . . 1.0 108.209 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.3 m -138.71 131.56 29.4 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 112.837 -1.983 . . . . 1.0 111.001 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 51.06 40.1 24.81 Favored 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 112.811 -1.995 . . . . 1.0 108.33 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.0 19.16 50.0 Favored Glycine 0 N--CA 1.489 2.223 0 CA-C-N 113.259 -1.791 . . . . 1.0 113.356 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.0 mtp-105 -134.26 160.11 38.88 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.559 ' HB3' HG12 ' A' ' 3' ' ' ILE . 43.5 t -72.53 139.17 47.41 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 114.826 1.417 . . . . 1.0 114.826 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 11.2 p-10 -134.02 94.09 3.2 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.185 -2.154 . . . . 1.0 105.185 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.504 2.227 0 CA-C-N 115.252 -0.885 . . . . 1.0 109.741 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 121.602 0.715 . . . . 1.0 111.355 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.01 114.24 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-N 114.163 -1.38 . . . . 1.0 109.094 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.54 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 33.8 pt -134.93 164.04 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 N-CA-C 114.136 1.162 . . . . 1.0 114.136 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.62 -39.59 93.56 Favored Glycine 0 N--CA 1.479 1.534 0 CA-C-N 112.868 -1.969 . . . . 1.0 112.564 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -12.0 88.01 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 115.372 1.619 . . . . 1.0 115.372 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.0 mtt85 -39.8 122.91 1.49 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 124.817 1.323 . . . . 1.0 110.873 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 9.0 t -107.11 158.53 17.0 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 114.974 1.472 . . . . 1.0 114.974 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.52 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.9 t80 -123.48 -56.6 1.7 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 112.424 -2.171 . . . . 1.0 105.996 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.458 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -115.4 153.71 30.56 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 113.406 -1.724 . . . . 1.0 110.011 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.473 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.3 m -25.22 -57.94 0.16 Allowed Pre-proline 0 N--CA 1.508 2.437 0 O-C-N 125.092 1.495 . . . . 1.0 114.909 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.473 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 95.7 Cg_endo -62.82 -91.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.874 1.716 . . . . 1.0 112.058 173.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.8 t70 35.99 35.44 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 123.725 1.726 . . . . 1.0 108.889 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.4 ' N ' ' C ' ' A' ' 11' ' ' PRO . 49.3 t -170.73 -23.11 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 110.802 -2.908 . . . . 1.0 112.541 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -38.63 -59.94 0.87 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 123.415 0.447 . . . . 1.0 111.569 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.5 t -47.92 -40.4 21.86 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 124.933 1.396 . . . . 1.0 112.243 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.02 -54.48 13.0 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 123.715 0.635 . . . . 1.0 110.139 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.8 t -55.01 -32.65 61.97 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.553 -0.906 . . . . 1.0 108.553 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -67.14 -50.87 59.74 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 105.906 -1.887 . . . . 1.0 105.906 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -70.48 -9.03 55.5 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 113.756 -1.565 . . . . 1.0 111.554 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -90.68 -60.1 2.01 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.7 -0.852 . . . . 1.0 108.7 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 p -111.58 -39.24 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 124.129 0.893 . . . . 1.0 112.763 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.98 14.03 1.69 Allowed Glycine 0 N--CA 1.493 2.446 0 CA-C-O 119.635 -0.536 . . . . 1.0 113.285 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.426 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 3.2 mptp? -132.23 127.45 35.8 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 123.966 0.451 . . . . 1.0 110.257 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.09 68.41 0.7 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 125.065 1.478 . . . . 1.0 109.723 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.453 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 12.2 p -119.26 -179.12 3.75 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.252 -1.34 . . . . 1.0 114.299 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.41 153.91 9.25 Favored Glycine 0 N--CA 1.494 2.542 0 CA-C-N 113.419 -1.718 . . . . 1.0 111.704 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -119.45 167.21 12.17 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.33 -0.935 . . . . 1.0 108.672 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 13.5 t -101.42 90.64 4.15 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 102.917 -2.994 . . . . 1.0 102.917 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.7 m -110.78 115.57 29.78 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 109.497 -3.501 . . . . 1.0 111.43 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 52.8 39.03 28.08 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 112.425 -2.17 . . . . 1.0 108.465 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.61 25.59 68.99 Favored Glycine 0 N--CA 1.483 1.816 0 CA-C-N 113.065 -1.88 . . . . 1.0 111.858 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.2 mtt-85 -136.42 159.25 42.36 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.004 -1.48 . . . . 1.0 107.004 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.54 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 40.1 t -72.36 140.3 48.37 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 114.293 1.22 . . . . 1.0 114.293 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -135.18 84.49 2.1 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 124.978 1.424 . . . . 1.0 107.348 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.453 ' SG ' ' C ' ' A' ' 25' ' ' THR . 6.5 t . . . . . 0 N--CA 1.501 2.104 0 CA-C-O 116.787 -1.577 . . . . 1.0 111.239 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 122.023 0.916 . . . . 1.0 111.508 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.8 p -70.55 121.44 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-N 113.493 -1.685 . . . . 1.0 109.727 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.58 HG12 ' HB3' ' A' ' 33' ' ' CYS . 23.1 pt -128.83 160.25 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 121.916 0.865 . . . . 1.0 112.882 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.96 43.81 3.24 Favored Glycine 0 C--O 1.211 -1.338 0 CA-C-N 112.589 -2.096 . . . . 1.0 112.671 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -105.36 102.53 12.01 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 101.555 -3.498 . . . . 1.0 101.555 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -39.03 137.53 0.67 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 113.425 -1.716 . . . . 1.0 113.19 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.6 p -121.84 159.37 26.92 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.582 -1.19 . . . . 1.0 110.148 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -118.51 -59.82 1.84 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 106.175 -1.787 . . . . 1.0 106.175 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.37 163.81 12.54 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 113.188 -1.824 . . . . 1.0 106.591 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.472 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 75.5 m -35.93 -55.26 1.3 Allowed Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 125.156 1.535 . . . . 1.0 112.125 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.5 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 81.2 Cg_endo -67.07 -93.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 120.858 1.038 . . . . 1.0 113.009 171.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 t70 36.97 34.46 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 CA-C-O 123.351 1.548 . . . . 1.0 109.678 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.5 t -166.35 -27.53 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 110.766 -2.924 . . . . 1.0 111.307 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.5 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.0 m-85 -38.38 -55.34 1.38 Allowed 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 124.456 1.103 . . . . 1.0 112.45 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.5 p -47.1 -48.72 22.79 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 124.322 1.014 . . . . 1.0 109.887 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.02 -45.15 90.19 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.708 -1.133 . . . . 1.0 110.379 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 25' ' ' THR . 10.5 m -57.59 -35.56 70.57 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.998 -1.001 . . . . 1.0 109.372 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -70.8 -46.41 62.89 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.381 -1.711 . . . . 1.0 106.381 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.28 -15.19 62.86 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 114.157 -1.383 . . . . 1.0 113.623 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.0 mt -110.46 -43.62 3.85 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 113.86 1.059 . . . . 1.0 113.86 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.0 t -98.89 -36.22 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 114.555 -1.202 . . . . 1.0 110.033 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.57 -28.79 4.16 Favored Glycine 0 N--CA 1.489 2.207 0 O-C-N 123.866 0.729 . . . . 1.0 113.07 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.428 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 8.6 mptt -129.23 152.04 49.23 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 112.405 0.52 . . . . 1.0 112.405 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.52 78.51 0.79 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 114.274 -1.33 . . . . 1.0 109.218 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.418 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 7.6 t -128.38 -178.22 4.48 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.551 0.691 . . . . 1.0 111.627 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.53 -169.0 13.84 Favored Glycine 0 N--CA 1.495 2.6 0 CA-C-N 113.216 -1.811 . . . . 1.0 112.567 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -155.13 173.06 17.14 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.024 -1.088 . . . . 1.0 108.388 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 47.4 t -102.13 118.1 36.19 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.178 -1.786 . . . . 1.0 106.178 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.1 m -129.75 125.81 36.72 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 112.867 -1.97 . . . . 1.0 110.834 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 50.55 40.87 24.55 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 125.198 1.561 . . . . 1.0 109.15 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.86 18.92 55.06 Favored Glycine 0 N--CA 1.488 2.142 0 CA-C-N 113.148 -1.842 . . . . 1.0 113.51 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -128.62 163.32 25.31 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.778 -1.564 . . . . 1.0 106.778 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.58 ' HB3' HG12 ' A' ' 3' ' ' ILE . 11.2 t -73.49 143.75 46.47 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.177 -1.409 . . . . 1.0 113.263 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -131.24 85.04 2.23 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 104.53 -2.396 . . . . 1.0 104.53 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.5 2.071 0 C-N-CA 119.76 -0.776 . . . . 1.0 109.957 -179.514 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.887 0.851 . . . . 1.0 111.617 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 41.1 t -70.78 117.84 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-N 113.61 -1.632 . . . . 1.0 108.53 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.566 HG12 ' HB3' ' A' ' 33' ' ' CYS . 23.6 pt -128.96 154.64 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 114.549 1.314 . . . . 1.0 114.549 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -48.87 -43.24 30.39 Favored Glycine 0 N--CA 1.477 1.433 0 CA-C-N 110.824 -2.898 . . . . 1.0 111.758 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -26.15 91.98 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 126.106 1.709 . . . . 1.0 112.333 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -39.85 149.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.938 -1.483 . . . . 1.0 113.63 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.451 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 5.0 t -107.63 157.28 18.2 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.714 -1.13 . . . . 1.0 112.124 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.467 ' CD2' ' HG2' ' A' ' 9' ' ' ARG . 15.9 t80 -119.72 -64.88 1.22 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 103.023 -2.954 . . . . 1.0 103.023 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.467 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 9.0 mmt85 -123.85 168.83 12.23 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 112.277 -2.238 . . . . 1.0 106.533 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.457 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 67.9 m -29.02 -58.36 0.25 Allowed Pre-proline 0 N--CA 1.504 2.261 0 N-CA-C 114.677 1.362 . . . . 1.0 114.677 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.457 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 71.1 Cg_endo -66.96 -93.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.426 1.418 . . . . 1.0 113.262 175.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.401 ' H ' ' HG2' ' A' ' 11' ' ' PRO . 15.6 t70 37.89 33.73 0.05 Allowed 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 123.399 1.571 . . . . 1.0 109.906 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.5 t -164.51 -26.85 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 110.851 -2.886 . . . . 1.0 111.432 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.407 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.2 m-85 -38.74 -58.27 1.09 Allowed 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 123.68 0.792 . . . . 1.0 111.777 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.0 m -48.15 -45.7 33.61 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 124.625 1.203 . . . . 1.0 110.749 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.444 ' HA ' ' HG2' ' A' ' 19' ' ' LYS . . . -66.03 -41.56 90.77 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.608 -1.178 . . . . 1.0 112.309 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 25' ' ' THR . 24.2 m -66.81 -32.02 73.03 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.907 -1.042 . . . . 1.0 109.01 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.405 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 6.6 ttpm? -70.77 -52.57 19.87 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.753 -1.203 . . . . 1.0 107.753 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HG2' ' HA ' ' A' ' 16' ' ' ALA . 58.6 pttt -70.92 -17.16 62.7 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 118.903 -1.119 . . . . 1.0 113.448 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.1 mt -101.88 -41.99 6.3 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 113.25 0.833 . . . . 1.0 113.25 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.1 t -101.49 -34.7 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 124.293 0.996 . . . . 1.0 110.321 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.17 -29.64 3.85 Favored Glycine 0 N--CA 1.493 2.464 0 O-C-N 123.731 0.645 . . . . 1.0 113.065 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.612 ' H ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -128.5 156.58 43.03 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 112.97 0.73 . . . . 1.0 112.97 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.88 73.64 0.59 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 113.975 -1.466 . . . . 1.0 112.95 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.449 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 0.8 OUTLIER -114.32 -171.29 1.89 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.964 -1.016 . . . . 1.0 110.102 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.86 156.02 12.32 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.853 -0.899 . . . . 1.0 110.853 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 54.5 mtmt -132.53 169.88 15.96 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.331 -0.988 . . . . 1.0 108.331 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.6 t -105.11 100.61 10.2 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 104.8 -2.296 . . . . 1.0 104.8 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.7 m -121.66 118.71 29.84 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 110.736 -2.938 . . . . 1.0 112.069 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.7 m120 47.7 42.31 15.2 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 112.562 -2.108 . . . . 1.0 110.013 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.89 23.08 69.06 Favored Glycine 0 N--CA 1.482 1.763 0 CA-C-N 113.229 -1.805 . . . . 1.0 113.09 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.2 mtp85 -136.48 160.47 38.66 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.74 -1.208 . . . . 1.0 107.74 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.566 ' HB3' HG12 ' A' ' 3' ' ' ILE . 19.5 t -72.57 142.12 48.42 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.437 -1.305 . . . . 1.0 114.118 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 35.0 t0 -131.38 88.98 2.65 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 105.326 -2.102 . . . . 1.0 105.326 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.501 2.106 0 CA-C-O 118.394 -0.812 . . . . 1.0 109.372 -179.773 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 2' ' ' VAL . 18.6 t . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 108.438 -0.949 . . . . 1.0 108.438 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 5.3 p -71.39 118.61 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-N 114.901 -1.045 . . . . 1.0 109.272 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.571 HG12 ' HB3' ' A' ' 33' ' ' CYS . 35.1 pt -133.2 152.55 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 114.603 1.335 . . . . 1.0 114.603 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.67 -38.3 63.48 Favored Glycine 0 N--CA 1.482 1.741 0 CA-C-N 111.717 -2.492 . . . . 1.0 110.747 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -32.33 103.11 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 125.918 1.599 . . . . 1.0 110.217 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -39.46 151.96 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.815 1.783 . . . . 1.0 115.815 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 1.4 t -112.87 154.62 26.04 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.222 -1.354 . . . . 1.0 111.47 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.419 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 1.2 t80 -121.31 -62.86 1.38 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 103.684 -2.71 . . . . 1.0 103.684 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -119.89 166.61 13.07 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 111.895 -2.411 . . . . 1.0 106.173 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.467 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.7 m -35.55 -55.47 1.15 Allowed Pre-proline 0 N--CA 1.506 2.364 0 N-CA-C 113.355 0.872 . . . . 1.0 113.355 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.467 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 83.6 Cg_endo -63.64 -94.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.632 1.555 . . . . 1.0 112.011 173.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.0 t70 36.09 34.76 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.373 0 CA-C-O 123.358 1.552 . . . . 1.0 109.316 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.415 ' N ' ' C ' ' A' ' 11' ' ' PRO . 42.7 t -171.14 -19.99 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 110.738 -2.937 . . . . 1.0 112.562 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -38.51 -59.2 0.94 Allowed 'General case' 0 N--CA 1.503 2.215 0 CA-C-N 118.632 0.651 . . . . 1.0 110.93 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 76.1 p -47.58 -39.95 17.98 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.99 1.431 . . . . 1.0 112.153 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.09 -49.35 51.81 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.697 -0.683 . . . . 1.0 109.573 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.6 t -55.09 -40.88 70.9 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.239 -1.393 . . . . 1.0 107.239 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -59.24 -53.53 57.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 106.566 -1.642 . . . . 1.0 106.566 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -48.43 -34.59 11.25 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 113.567 -1.651 . . . . 1.0 109.846 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.4 mt -80.97 -51.58 8.37 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.391 0.886 . . . . 1.0 113.391 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -113.49 -44.72 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-N 117.867 0.303 . . . . 1.0 111.489 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.67 12.86 2.37 Favored Glycine 0 N--CA 1.492 2.387 0 CA-C-O 119.362 -0.688 . . . . 1.0 114.056 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.79 129.99 50.55 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 123.784 0.343 . . . . 1.0 110.515 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.35 68.17 0.75 Allowed 'General case' 0 N--CA 1.506 2.358 0 O-C-N 124.624 1.203 . . . . 1.0 109.417 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.481 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 12.5 p -118.47 -179.94 3.94 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.628 -1.169 . . . . 1.0 113.418 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.8 158.95 12.24 Favored Glycine 0 N--CA 1.493 2.464 0 CA-C-N 113.852 -1.522 . . . . 1.0 113.04 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -127.03 177.23 6.77 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 122.076 0.941 . . . . 1.0 108.524 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.7 t -101.71 111.84 24.22 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 112.492 -2.14 . . . . 1.0 107.829 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 49.9 m -126.23 120.69 30.66 Favored 'General case' 0 N--CA 1.503 2.175 0 CA-C-N 112.1 -2.318 . . . . 1.0 111.559 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 48.76 42.84 20.47 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 113.452 -1.704 . . . . 1.0 109.684 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.15 21.38 61.63 Favored Glycine 0 N--CA 1.486 2.005 0 CA-C-N 113.733 -1.576 . . . . 1.0 113.241 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.8 mtt-85 -133.15 161.45 34.4 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 106.916 -1.513 . . . . 1.0 106.916 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.571 ' HB3' HG12 ' A' ' 3' ' ' ILE . 35.0 t -72.57 141.73 48.42 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.607 1.336 . . . . 1.0 114.607 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.5 t70 -135.24 83.31 2.01 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 125.631 1.832 . . . . 1.0 109.112 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.481 ' SG ' ' C ' ' A' ' 25' ' ' THR . 9.6 t . . . . . 0 N--CA 1.502 2.13 0 C-N-CA 119.25 -0.98 . . . . 1.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.711 0.767 . . . . 1.0 112.407 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 58.0 t -71.04 115.28 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 113.839 -1.528 . . . . 1.0 109.052 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.521 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 29.2 pt -133.97 163.63 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 115.273 1.583 . . . . 1.0 115.273 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.75 -43.08 96.66 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-N 111.398 -2.637 . . . . 1.0 111.572 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.42 ' HB3' HG13 ' A' ' 3' ' ' ILE . 53.1 tp60 -15.23 88.34 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 O-C-N 126.173 1.749 . . . . 1.0 113.774 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -39.89 134.17 1.49 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 124.88 1.362 . . . . 1.0 110.75 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 9.7 t -116.69 159.19 22.61 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.663 -1.153 . . . . 1.0 113.09 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.44 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 19.1 t80 -119.46 -61.89 1.57 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 104.254 -2.499 . . . . 1.0 104.254 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.432 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -118.15 161.28 20.12 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 112.891 -1.959 . . . . 1.0 110.318 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.425 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 75.8 m -18.42 -60.09 0.05 OUTLIER Pre-proline 0 N--CA 1.506 2.338 0 N-CA-C 117.948 2.573 . . . . 1.0 117.948 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 44.7 Cg_endo -72.44 -96.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.6 1.533 . . . . 1.0 113.185 176.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.404 ' H ' ' HG2' ' A' ' 11' ' ' PRO . 5.5 t0 44.52 28.59 0.33 Allowed 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 122.253 1.025 . . . . 1.0 109.542 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 t -167.07 -22.99 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 113.367 -1.742 . . . . 1.0 114.177 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.453 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 6.6 m-30 -39.12 -62.99 0.58 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 112.228 0.455 . . . . 1.0 112.228 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.1 t -43.36 -46.68 6.61 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 125.358 1.661 . . . . 1.0 111.13 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.434 ' HA ' ' HG2' ' A' ' 19' ' ' LYS . . . -63.61 -45.17 91.53 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 114.035 -1.439 . . . . 1.0 111.224 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.1 t -62.73 -38.97 92.6 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.935 -1.135 . . . . 1.0 107.935 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -60.95 -51.38 69.5 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.434 ' HG2' ' HA ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -70.92 -18.03 62.67 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 118.091 -1.444 . . . . 1.0 112.262 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 mp -87.33 -50.14 6.78 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 112.94 0.719 . . . . 1.0 112.94 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.2 m -112.16 -30.79 2.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 118.832 -0.604 . . . . 1.0 112.172 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.89 -26.62 2.99 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 116.491 1.356 . . . . 1.0 116.491 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -122.65 135.16 54.52 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 114.542 1.312 . . . . 1.0 114.542 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.78 67.72 0.6 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 113.609 -1.632 . . . . 1.0 111.862 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.9 t -131.79 -163.32 1.32 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.543 -0.753 . . . . 1.0 110.364 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.51 -176.06 17.45 Favored Glycine 0 N--CA 1.498 2.81 0 CA-C-N 113.769 -1.56 . . . . 1.0 111.222 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -136.0 171.64 14.18 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.523 0.678 . . . . 1.0 110.021 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.0 t -105.31 114.44 28.63 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 106.406 -1.702 . . . . 1.0 106.406 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.5 m -123.36 118.35 27.31 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 112.6 -2.091 . . . . 1.0 114.304 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 45.16 39.26 3.87 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 114.073 -1.421 . . . . 1.0 112.014 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.6 18.29 79.81 Favored Glycine 0 N--CA 1.476 1.335 0 CA-C-N 112.886 -1.961 . . . . 1.0 115.221 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.7 mtp-105 -135.32 156.41 49.0 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.2 -1.037 . . . . 1.0 108.2 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.521 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 20.1 t -72.9 138.49 46.25 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 116.556 2.058 . . . . 1.0 116.556 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 0.8 OUTLIER -133.36 82.34 1.98 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 125.283 1.615 . . . . 1.0 108.757 178.421 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.499 1.996 0 CA-C-O 116.52 -1.705 . . . . 1.0 110.736 -179.758 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 2' ' ' VAL . 22.6 t . . . . . 0 N--CA 1.497 1.924 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.3 p -70.89 119.98 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 114.998 -1.001 . . . . 1.0 108.609 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.519 HG12 ' HB3' ' A' ' 33' ' ' CYS . 22.8 pt -129.21 159.72 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 114.929 1.455 . . . . 1.0 114.929 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.32 -45.16 44.87 Favored Glycine 0 N--CA 1.478 1.44 0 CA-C-N 110.755 -2.929 . . . . 1.0 111.63 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.452 ' HB3' HG13 ' A' ' 3' ' ' ILE . 3.7 tp-100 -21.26 90.73 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 O-C-N 125.794 1.526 . . . . 1.0 113.137 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.3 ptt-85 -46.2 142.51 2.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 124.63 1.206 . . . . 1.0 108.689 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 28.0 p -113.32 158.88 20.01 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 118.839 -1.144 . . . . 1.0 112.273 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -116.73 -59.79 1.92 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 105.741 -1.948 . . . . 1.0 105.741 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.3 mtt85 -114.84 169.5 9.03 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 112.058 -2.337 . . . . 1.0 106.879 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.475 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 73.5 m -37.58 -56.26 1.79 Allowed Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 124.776 1.298 . . . . 1.0 111.726 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.475 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 97.9 Cg_endo -64.97 -95.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.248 1.299 . . . . 1.0 112.945 175.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.1 t70 37.19 30.58 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 O-C-N 125.401 1.688 . . . . 1.0 109.578 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.431 ' N ' ' C ' ' A' ' 11' ' ' PRO . 42.7 t -164.81 -22.92 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 111.244 -2.707 . . . . 1.0 112.832 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.426 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.1 m-85 -38.6 -58.61 1.02 Allowed 'General case' 0 N--CA 1.503 2.206 0 CA-C-N 118.306 0.503 . . . . 1.0 110.434 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.4 p -53.54 -44.75 69.47 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 124.635 1.21 . . . . 1.0 111.086 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.23 -57.94 10.65 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 120.35 -0.54 . . . . 1.0 110.933 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.8 t -52.51 -45.24 66.15 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.412 -1.329 . . . . 1.0 107.412 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -50.98 -47.72 61.37 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -62.85 -36.31 82.84 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 114.565 -1.198 . . . . 1.0 110.126 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.46 -54.64 11.48 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 113.64 0.978 . . . . 1.0 113.64 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 m -105.42 -43.58 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 114.103 1.149 . . . . 1.0 114.103 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.28 17.23 2.01 Favored Glycine 0 N--CA 1.494 2.557 0 O-C-N 123.536 0.522 . . . . 1.0 112.199 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -134.14 130.53 37.46 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 123.877 0.398 . . . . 1.0 110.198 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.56 71.68 0.7 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 124.533 1.146 . . . . 1.0 108.555 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.3 p -119.57 177.16 5.04 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.485 -1.234 . . . . 1.0 113.281 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.93 153.35 17.56 Favored Glycine 0 N--CA 1.49 2.261 0 CA-C-N 113.64 -1.618 . . . . 1.0 111.191 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.8 -176.67 3.84 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 124.829 0.958 . . . . 1.0 108.552 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.2 t -108.42 109.34 20.61 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 112.063 -2.335 . . . . 1.0 108.661 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.9 m -136.26 129.34 31.37 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-N 112.683 -2.053 . . . . 1.0 110.066 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 51.15 40.73 26.55 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 112.817 -1.992 . . . . 1.0 107.729 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.35 13.56 44.21 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-N 113.358 -1.746 . . . . 1.0 114.283 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.4 mmt-85 -129.93 159.88 35.3 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.371 -0.974 . . . . 1.0 108.371 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.519 ' HB3' HG12 ' A' ' 3' ' ' ILE . 15.6 t -72.68 140.53 47.95 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.85 1.426 . . . . 1.0 114.85 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 7.7 p-10 -130.7 94.98 3.74 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 105.587 -2.005 . . . . 1.0 105.587 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.502 2.161 0 CA-C-O 118.013 -0.994 . . . . 1.0 110.174 -179.887 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.635 0.731 . . . . 1.0 111.098 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.5 p -70.49 115.03 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-N 113.949 -1.478 . . . . 1.0 109.243 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.514 HG12 ' HB3' ' A' ' 33' ' ' CYS . 36.6 pt -137.8 165.49 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 115.659 1.725 . . . . 1.0 115.659 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.97 -42.92 95.11 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-N 111.89 -2.414 . . . . 1.0 111.271 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -21.31 98.8 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 O-C-N 125.66 1.447 . . . . 1.0 112.929 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.1 ptt-85 -39.67 141.35 0.41 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 125.146 1.529 . . . . 1.0 112.848 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.419 ' SG ' ' O ' ' A' ' 9' ' ' ARG . 11.9 t -112.69 155.31 24.71 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.644 -1.162 . . . . 1.0 110.712 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -120.41 -61.13 1.61 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 104.986 -2.227 . . . . 1.0 104.986 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.419 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 42.6 mtt85 -117.69 165.29 13.78 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 112.69 -2.05 . . . . 1.0 108.342 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.419 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.0 m -32.02 -53.52 0.53 Allowed Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 125.189 1.556 . . . . 1.0 113.613 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.462 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 49.7 Cg_endo -70.56 -94.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.585 1.523 . . . . 1.0 114.698 169.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 t70 41.17 30.45 0.11 Allowed 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 123.156 1.455 . . . . 1.0 110.062 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.4 t -165.34 -27.91 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 112.14 -2.3 . . . . 1.0 112.524 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.462 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 5.7 m-30 -38.98 -61.48 0.74 Allowed 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 112.834 0.679 . . . . 1.0 112.834 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.9 t -42.49 -43.89 3.86 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 125.39 1.681 . . . . 1.0 110.947 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.43 -43.93 68.92 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.386 -1.279 . . . . 1.0 110.183 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.1 t -60.94 -31.34 70.89 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.117 -1.068 . . . . 1.0 108.117 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -70.48 -53.82 14.77 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.138 -1.801 . . . . 1.0 106.138 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -59.43 -19.19 45.51 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 112.397 -2.183 . . . . 1.0 112.292 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.4 tp -102.92 -54.49 2.62 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 113.357 0.873 . . . . 1.0 113.357 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.5 t -92.88 -41.31 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-N 113.121 -1.854 . . . . 1.0 112.087 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.09 -23.05 3.94 Favored Glycine 0 N--CA 1.488 2.141 0 CA-C-O 119.348 -0.695 . . . . 1.0 113.03 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -126.1 134.98 51.2 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 113.815 1.043 . . . . 1.0 113.815 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.62 70.32 0.67 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 114.331 -1.304 . . . . 1.0 112.355 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.405 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 12.4 t -130.19 -166.74 1.72 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.025 -0.732 . . . . 1.0 109.025 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.4 -176.86 16.53 Favored Glycine 0 N--CA 1.492 2.39 0 CA-C-N 113.495 -1.684 . . . . 1.0 114.879 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HG2' ' N ' ' A' ' 28' ' ' CYS . 24.5 ttmm -133.38 165.54 24.62 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.822 -1.689 . . . . 1.0 109.263 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.409 ' N ' ' HG2' ' A' ' 27' ' ' LYS . 49.6 t -110.03 112.21 24.07 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 103.159 -2.904 . . . . 1.0 103.159 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 89.8 m -125.12 123.52 39.87 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 112.576 -2.102 . . . . 1.0 112.208 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.5 m120 44.53 41.17 4.5 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 112.878 -1.965 . . . . 1.0 111.552 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.26 27.06 71.97 Favored Glycine 0 N--CA 1.484 1.861 0 CA-C-N 113.254 -1.794 . . . . 1.0 112.72 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.6 mtt-85 -136.32 159.8 40.66 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.703 -1.591 . . . . 1.0 106.703 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.514 ' HB3' HG12 ' A' ' 3' ' ' ILE . 13.0 t -72.87 142.3 47.94 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 113.945 1.091 . . . . 1.0 113.945 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.6 t70 -137.59 73.79 1.46 Allowed 'General case' 0 C--N 1.298 -1.634 0 O-C-N 125.561 1.788 . . . . 1.0 108.358 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 25' ' ' THR . 13.2 t . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 116.712 -1.613 . . . . 1.0 111.194 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.704 0.764 . . . . 1.0 111.693 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 50.3 t -70.59 116.07 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-N 113.949 -1.478 . . . . 1.0 109.503 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.658 HG12 ' HB3' ' A' ' 33' ' ' CYS . 33.1 pt -130.43 152.7 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-O 122.58 1.181 . . . . 1.0 113.585 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.73 -35.51 86.51 Favored Glycine 0 N--CA 1.483 1.783 0 CA-C-N 111.385 -2.643 . . . . 1.0 111.895 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.426 ' HB2' HD12 ' A' ' 3' ' ' ILE . 3.4 tm0? -22.56 94.12 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 126.229 1.782 . . . . 1.0 112.318 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -39.53 131.75 1.66 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 124.549 1.156 . . . . 1.0 112.417 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.508 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 4.5 t -111.69 159.6 18.06 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 124.615 1.197 . . . . 1.0 114.001 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.508 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 0.9 OUTLIER -121.38 -57.42 1.84 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 113.365 -1.743 . . . . 1.0 107.644 179.816 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.471 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 35.5 mmt-85 -115.73 166.56 11.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.35 1.031 . . . . 1.0 110.485 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.431 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.6 m -32.85 -56.92 0.52 Allowed Pre-proline 0 N--CA 1.502 2.158 0 N-CA-C 114.84 1.422 . . . . 1.0 114.84 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.465 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 97.3 Cg_endo -65.96 -92.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.3 1.333 . . . . 1.0 112.723 176.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.405 ' H ' ' HG2' ' A' ' 11' ' ' PRO . 6.0 t0 40.15 32.34 0.12 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 122.993 1.378 . . . . 1.0 108.774 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.3 t -166.94 -26.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 112.47 -2.15 . . . . 1.0 112.223 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.465 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.7 m-85 -38.73 -58.09 1.11 Allowed 'General case' 0 N--CA 1.505 2.32 0 C-N-CA 123.431 0.693 . . . . 1.0 111.6 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.3 t -49.14 -46.67 45.46 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 124.306 1.004 . . . . 1.0 110.641 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.35 -35.26 79.02 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.96 -1.018 . . . . 1.0 112.117 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 25' ' ' THR . 45.5 m -69.77 -35.38 74.87 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.685 -0.857 . . . . 1.0 108.685 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -70.63 -42.84 70.34 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.707 -1.22 . . . . 1.0 107.707 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -69.99 -29.07 66.07 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 112.622 -2.081 . . . . 1.0 113.648 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.63 -34.68 8.09 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.334 1.235 . . . . 1.0 114.334 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.3 t -104.42 -35.7 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 123.943 0.777 . . . . 1.0 109.953 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.23 -30.76 3.8 Favored Glycine 0 N--CA 1.489 2.177 0 C-N-CA 120.803 -0.713 . . . . 1.0 113.879 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.644 ' H ' ' HZ2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -123.84 151.19 43.69 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 120.67 -0.412 . . . . 1.0 111.189 -179.369 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.4 75.27 0.76 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 125.016 1.447 . . . . 1.0 108.643 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.473 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 14.9 t -122.33 -162.8 1.03 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.046 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.459 ' HA3' ' SG ' ' A' ' 35' ' ' CYS . . . 82.6 167.0 39.79 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.488 -1.445 . . . . 1.0 109.488 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -139.36 -172.01 3.26 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 118.676 -1.21 . . . . 1.0 111.508 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.4 t -107.06 117.82 35.06 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 111.41 -2.632 . . . . 1.0 109.191 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.1 m -139.94 134.15 31.15 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 113.474 -1.693 . . . . 1.0 109.885 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 47.61 41.21 13.08 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 113.723 -1.58 . . . . 1.0 109.878 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.65 18.98 53.8 Favored Glycine 0 N--CA 1.491 2.362 0 CA-C-N 113.512 -1.676 . . . . 1.0 114.828 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.8 mtp85 -136.53 157.5 46.63 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.022 -1.473 . . . . 1.0 107.022 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.658 ' HB3' HG12 ' A' ' 3' ' ' ILE . 42.6 t -73.12 139.0 46.13 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.236 1.199 . . . . 1.0 114.236 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -135.79 95.55 3.26 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 102.743 -3.058 . . . . 1.0 102.743 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.459 ' SG ' ' HA3' ' A' ' 26' ' ' GLY . 6.5 t . . . . . 0 N--CA 1.495 1.792 0 CA-C-N 113.546 -1.661 . . . . 1.0 110.746 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 122.105 0.955 . . . . 1.0 112.408 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 64.8 t -70.71 114.75 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-N 113.232 -1.803 . . . . 1.0 108.446 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.502 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 33.5 pt -136.29 166.62 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 115.954 1.835 . . . . 1.0 115.954 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 5' ' ' GLN . . . -61.02 -43.15 99.8 Favored Glycine 0 N--CA 1.473 1.119 0 CA-C-N 111.736 -2.483 . . . . 1.0 111.469 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.408 ' HB3' HG13 ' A' ' 3' ' ' ILE . 4.0 tp-100 -14.84 90.75 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.429 0 O-C-N 125.843 1.554 . . . . 1.0 113.135 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -39.81 133.82 1.51 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 125.224 1.578 . . . . 1.0 110.767 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.484 ' SG ' ' O ' ' A' ' 9' ' ' ARG . 35.2 t -117.6 156.61 27.84 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 124.342 1.026 . . . . 1.0 113.53 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.432 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.3 t80 -120.99 -61.07 1.59 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 105.637 -1.986 . . . . 1.0 105.637 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.484 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 20.4 mtt-85 -114.19 159.98 19.51 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 113.136 -1.847 . . . . 1.0 109.264 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.449 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.3 m -24.5 -56.14 0.15 Allowed Pre-proline 0 N--CA 1.506 2.352 0 O-C-N 125.201 1.563 . . . . 1.0 114.949 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.449 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 67.2 Cg_endo -67.1 -96.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.755 1.637 . . . . 1.0 114.07 170.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.7 t70 38.38 32.28 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 123.539 1.638 . . . . 1.0 109.819 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.6 t -171.46 -18.08 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 111.324 -2.671 . . . . 1.0 113.83 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -38.66 -59.99 0.87 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 112.723 0.638 . . . . 1.0 112.723 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.6 p -46.48 -44.73 17.82 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 124.921 1.388 . . . . 1.0 111.86 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.78 -43.78 87.77 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 114.816 -1.084 . . . . 1.0 109.316 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.6 t -57.81 -50.56 72.86 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.739 -1.578 . . . . 1.0 106.739 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -50.67 -53.93 27.14 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.361 -0.977 . . . . 1.0 108.361 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -51.77 -32.88 32.75 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 112.724 -2.035 . . . . 1.0 110.982 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.0 mt -90.01 -57.82 2.72 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 115.771 1.767 . . . . 1.0 115.771 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 m -99.14 -35.82 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 113.155 0.798 . . . . 1.0 113.155 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.16 -22.32 3.59 Favored Glycine 0 N--CA 1.492 2.393 0 CA-C-O 118.512 -1.16 . . . . 1.0 115.915 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.574 ' H ' ' HD3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -124.56 144.68 50.01 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 118.299 1.05 . . . . 1.0 113.022 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.77 68.85 0.64 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 113.6 -1.636 . . . . 1.0 113.4 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.432 HG23 ' SG ' ' A' ' 35' ' ' CYS . 8.9 t -133.06 -163.24 1.32 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.494 ' CA ' ' SG ' ' A' ' 35' ' ' CYS . . . 122.65 174.98 14.54 Favored Glycine 0 N--CA 1.495 2.579 0 CA-C-N 114.018 -1.446 . . . . 1.0 113.534 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -121.35 161.32 22.28 Favored 'General case' 0 C--O 1.206 -1.22 0 CA-C-N 113.457 -1.372 . . . . 1.0 109.342 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.1 t -111.67 101.7 10.06 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 103.55 -2.759 . . . . 1.0 103.55 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.2 m -118.19 121.32 40.2 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 110.944 -2.844 . . . . 1.0 112.997 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 45.29 39.82 4.65 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 113.204 -1.816 . . . . 1.0 111.082 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.37 29.43 75.05 Favored Glycine 0 N--CA 1.486 2.029 0 CA-C-N 112.917 -1.947 . . . . 1.0 112.792 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -139.45 153.04 47.48 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.289 -1.745 . . . . 1.0 106.289 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.502 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 6.1 t -73.8 139.01 44.87 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 117.155 2.28 . . . . 1.0 117.155 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -134.4 80.51 1.86 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 125.54 1.775 . . . . 1.0 107.167 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.494 ' SG ' ' CA ' ' A' ' 26' ' ' GLY . 5.8 t . . . . . 0 N--CA 1.501 2.077 0 CA-C-O 116.239 -1.839 . . . . 1.0 111.455 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.438 HG23 ' H1 ' ' A' ' 1' ' ' VAL . 15.6 t . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 108.373 -0.973 . . . . 1.0 108.373 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 48.9 t -71.68 111.65 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 106.073 -1.825 . . . . 1.0 106.073 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.55 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 37.3 pt -133.7 160.07 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 114.931 1.456 . . . . 1.0 114.931 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.95 42.76 3.18 Favored Glycine 0 C--O 1.21 -1.349 0 CA-C-N 112.153 -2.294 . . . . 1.0 111.873 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -105.15 107.31 18.22 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 101.891 -3.374 . . . . 1.0 101.891 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -39.09 138.91 0.53 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 125.425 1.703 . . . . 1.0 114.083 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.1 t -112.86 153.12 28.39 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.908 -1.496 . . . . 1.0 110.185 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -120.01 -56.87 1.99 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 104.927 -2.249 . . . . 1.0 104.927 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.439 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -117.89 155.08 30.79 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 113.393 -1.731 . . . . 1.0 106.57 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.46 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 71.9 m -24.01 -56.44 0.14 Allowed Pre-proline 0 N--CA 1.506 2.337 0 N-CA-C 115.137 1.532 . . . . 1.0 115.137 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.46 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 70.1 Cg_endo -67.25 -94.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.79 1.66 . . . . 1.0 113.222 170.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t70 40.93 29.53 0.08 Allowed 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.629 1.204 . . . . 1.0 109.9 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 t -166.33 -24.11 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 111.966 -2.379 . . . . 1.0 112.759 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 6.0 m-30 -38.72 -60.94 0.77 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 112.439 0.533 . . . . 1.0 112.439 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.4 t -44.74 -42.23 7.51 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 125.253 1.596 . . . . 1.0 111.375 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.28 -47.55 60.74 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 115.091 -0.958 . . . . 1.0 109.076 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.1 t -53.99 -40.72 67.17 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.324 -1.362 . . . . 1.0 107.324 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.4 ' HA ' ' N ' ' A' ' 23' ' ' LYS . 32.4 ttmt -60.84 -54.24 47.56 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 105.967 -1.864 . . . . 1.0 105.967 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -48.01 -31.71 5.7 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 113.473 -1.694 . . . . 1.0 110.03 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.7 mt -84.33 -50.84 7.46 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.569 0.952 . . . . 1.0 113.569 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 p -112.63 -45.66 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 CA-C-N 117.806 0.276 . . . . 1.0 111.159 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.18 18.8 1.46 Allowed Glycine 0 N--CA 1.491 2.324 0 CA-C-O 119.067 -0.852 . . . . 1.0 114.774 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.4 ' N ' ' HA ' ' A' ' 18' ' ' LYS . 14.2 mmmm -133.58 126.09 30.22 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 117.291 0.545 . . . . 1.0 112.207 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.43 68.78 0.8 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 124.88 1.362 . . . . 1.0 109.793 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.45 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 9.7 t -135.94 -171.53 2.89 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.679 -0.691 . . . . 1.0 110.088 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.75 -179.31 16.19 Favored Glycine 0 N--CA 1.493 2.467 0 CA-C-N 113.546 -1.661 . . . . 1.0 113.371 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -131.68 171.87 12.95 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 113.982 -1.109 . . . . 1.0 110.845 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.2 t -115.27 112.12 21.95 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 100.375 -3.935 . . . . 1.0 100.375 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.2 m -132.12 127.8 36.78 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 112.227 -2.261 . . . . 1.0 107.929 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.4 p30 46.41 43.89 12.33 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 125.929 2.018 . . . . 1.0 111.903 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.42 13.87 46.14 Favored Glycine 0 N--CA 1.479 1.547 0 CA-C-N 112.876 -1.965 . . . . 1.0 112.463 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.6 mtt-85 -128.21 163.66 24.22 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.863 -1.162 . . . . 1.0 107.863 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.55 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 9.4 t -72.93 142.17 47.84 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 114.702 1.371 . . . . 1.0 114.702 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.487 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 35.6 t70 -135.29 76.69 1.63 Allowed 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 112.454 -2.157 . . . . 1.0 107.324 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 25' ' ' THR . 23.6 t . . . . . 0 N--CA 1.502 2.125 0 CA-C-O 118.261 -0.876 . . . . 1.0 111.306 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.74 0.781 . . . . 1.0 111.575 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.3 p -70.85 123.61 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-N 113.473 -1.694 . . . . 1.0 108.31 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.505 HG12 ' HB3' ' A' ' 33' ' ' CYS . 16.5 pt -133.7 163.08 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 115.214 1.561 . . . . 1.0 115.214 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.42 -46.86 36.34 Favored Glycine 0 N--CA 1.478 1.472 0 CA-C-N 111.036 -2.802 . . . . 1.0 112.528 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.402 ' HB3' HG13 ' A' ' 3' ' ' ILE . 3.8 tp-100 -19.83 92.71 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 O-C-N 125.926 1.604 . . . . 1.0 114.085 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -48.17 141.81 5.92 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 124.603 1.19 . . . . 1.0 109.662 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.7 p -123.36 160.55 26.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 124.154 0.909 . . . . 1.0 113.234 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -118.1 -58.57 1.99 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 104.454 -2.424 . . . . 1.0 104.454 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -112.73 166.45 11.35 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 126.166 2.166 . . . . 1.0 106.638 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.456 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 75.4 m -33.66 -61.24 0.4 Allowed Pre-proline 0 N--CA 1.502 2.139 0 N-CA-C 114.614 1.339 . . . . 1.0 114.614 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.456 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 73.2 Cg_endo -61.33 -92.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 121.255 1.304 . . . . 1.0 110.315 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t0 34.77 36.96 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 123.812 1.767 . . . . 1.0 108.765 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.417 ' N ' ' C ' ' A' ' 11' ' ' PRO . 48.5 t -168.72 -26.23 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 110.444 -3.071 . . . . 1.0 111.465 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -37.93 -56.66 1.1 Allowed 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 123.439 0.695 . . . . 1.0 111.489 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 55.0 m -54.63 -40.42 68.93 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 124.391 1.057 . . . . 1.0 111.892 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.96 -52.38 24.84 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 123.591 0.557 . . . . 1.0 110.71 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 t -60.28 -27.73 67.52 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.129 -1.063 . . . . 1.0 108.129 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -70.38 -50.33 39.82 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.769 -1.567 . . . . 1.0 106.769 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -59.81 -29.13 68.02 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 112.77 -2.014 . . . . 1.0 113.085 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -102.02 -35.46 8.95 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.54 1.682 . . . . 1.0 115.54 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.7 t -104.97 -40.49 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 123.61 0.568 . . . . 1.0 110.049 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.12 -29.18 3.09 Favored Glycine 0 N--CA 1.486 1.986 0 CA-C-O 118.894 -0.948 . . . . 1.0 114.166 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -124.77 159.25 31.39 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.095 1.517 . . . . 1.0 115.095 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.03 71.96 0.57 Allowed 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 113.554 -1.657 . . . . 1.0 113.46 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.427 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 2.3 p -119.73 172.13 7.9 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.633 -1.167 . . . . 1.0 112.169 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.95 147.26 9.24 Favored Glycine 0 N--CA 1.491 2.34 0 CA-C-N 113.748 -1.569 . . . . 1.0 111.332 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -121.92 173.68 7.36 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 113.326 -1.437 . . . . 1.0 109.646 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.2 t -103.73 112.1 24.89 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 104.268 -2.493 . . . . 1.0 104.268 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.3 m -130.34 130.34 44.31 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 111.857 -2.429 . . . . 1.0 106.45 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 44.06 44.76 6.4 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 125.123 1.514 . . . . 1.0 111.825 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.46 11.76 22.83 Favored Glycine 0 N--CA 1.487 2.068 0 CA-C-N 112.982 -1.917 . . . . 1.0 114.096 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.2 mtp85 -128.06 163.95 23.48 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.505 ' HB3' HG12 ' A' ' 3' ' ' ILE . 49.5 t -72.41 143.69 48.44 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.212 -1.395 . . . . 1.0 113.819 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 65.2 t0 -133.17 84.08 2.11 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 126.108 2.13 . . . . 1.0 107.077 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' A' ' 25' ' ' THR . 8.8 t . . . . . 0 N--CA 1.503 2.18 0 CA-C-O 118.626 -0.702 . . . . 1.0 110.105 -179.793 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.498 0.666 . . . . 1.0 111.634 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.8 p -70.71 122.78 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 114.447 -1.251 . . . . 1.0 108.129 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.529 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 32.7 pt -136.0 160.24 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 N-CA-C 115.794 1.775 . . . . 1.0 115.794 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.21 -44.41 57.51 Favored Glycine 0 N--CA 1.478 1.469 0 CA-C-N 111.093 -2.776 . . . . 1.0 111.183 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.427 ' HB3' HG13 ' A' ' 3' ' ' ILE . 46.5 tp60 -24.42 91.86 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 125.873 1.572 . . . . 1.0 112.856 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -40.0 149.11 0.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 125.263 1.602 . . . . 1.0 112.966 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.412 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 2.1 t -110.1 153.48 24.61 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 124.648 1.218 . . . . 1.0 112.523 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.412 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 1.1 t80 -122.01 -62.35 1.4 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 102.801 -3.037 . . . . 1.0 102.801 179.35 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -119.62 166.11 13.59 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 112.093 -2.321 . . . . 1.0 105.838 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.471 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 75.3 m -33.37 -56.39 0.62 Allowed Pre-proline 0 N--CA 1.505 2.318 0 N-CA-C 114.229 1.196 . . . . 1.0 114.229 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.471 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 88.3 Cg_endo -64.15 -94.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 121.891 1.727 . . . . 1.0 111.826 174.542 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.0 t70 35.07 36.66 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 CA-C-O 123.844 1.783 . . . . 1.0 109.389 -179.282 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 50.4 t -168.61 -25.25 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 109.8 -3.364 . . . . 1.0 111.567 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -37.86 -57.21 1.04 Allowed 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 122.913 0.485 . . . . 1.0 111.587 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.8 t -49.68 -51.72 36.24 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 125.046 1.466 . . . . 1.0 109.116 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.17 -55.53 32.0 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 120.343 -0.543 . . . . 1.0 112.448 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.7 t -59.2 -27.99 66.23 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 115.397 -0.82 . . . . 1.0 109.499 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -70.12 -46.29 65.08 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 179.268 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -70.3 -22.6 62.82 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 114.242 -1.344 . . . . 1.0 113.034 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.2 mp -100.03 -33.48 10.47 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 113.911 1.078 . . . . 1.0 113.911 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.0 t -113.06 -43.97 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 124.05 0.844 . . . . 1.0 110.696 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.66 -25.45 3.41 Favored Glycine 0 N--CA 1.49 2.254 0 CA-C-O 119.075 -0.847 . . . . 1.0 114.429 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -120.99 155.87 33.37 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 113.476 0.917 . . . . 1.0 113.476 -179.426 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.86 69.88 0.71 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 125.084 1.49 . . . . 1.0 109.392 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.8 p -115.32 173.72 6.37 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.496 -1.229 . . . . 1.0 113.273 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.4 152.68 8.81 Favored Glycine 0 N--CA 1.49 2.295 0 CA-C-N 113.844 -1.525 . . . . 1.0 111.199 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -125.1 170.7 10.93 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.342 -1.355 . . . . 1.0 107.342 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.8 t -103.35 109.9 21.69 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.158 -1.793 . . . . 1.0 106.158 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.9 m -133.31 130.73 39.29 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 112.593 -2.094 . . . . 1.0 107.661 -179.379 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.417 ' ND2' ' HD2' ' A' ' 32' ' ' ARG . 6.1 p-10 44.64 44.17 7.17 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 125.107 1.504 . . . . 1.0 112.103 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.67 14.84 30.91 Favored Glycine 0 N--CA 1.487 2.063 0 CA-C-N 113.125 -1.852 . . . . 1.0 113.125 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.417 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 44.9 mtt-85 -130.65 165.52 22.66 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.552 -0.907 . . . . 1.0 108.552 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.529 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 13.3 t -72.45 144.91 47.93 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.517 -1.273 . . . . 1.0 114.318 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 36.9 t70 -134.98 82.95 1.99 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 126.385 2.303 . . . . 1.0 107.798 179.003 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.503 2.186 0 CA-C-O 116.237 -1.839 . . . . 1.0 110.405 -179.733 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 122.113 0.959 . . . . 1.0 111.995 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.3 p -70.22 122.4 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-N 112.998 -1.91 . . . . 1.0 108.965 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.472 HG12 ' HB3' ' A' ' 33' ' ' CYS . 1.2 pt -131.55 159.12 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 122.278 1.037 . . . . 1.0 113.526 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -39.95 -54.07 3.07 Favored Glycine 0 N--CA 1.483 1.81 0 CA-C-N 111.471 -2.604 . . . . 1.0 112.08 179.528 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -14.0 85.42 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 O-C-N 126.619 2.011 . . . . 1.0 112.923 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -40.15 145.28 0.16 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 113.666 -1.606 . . . . 1.0 112.368 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.5 t -114.91 148.05 39.16 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 124.42 1.075 . . . . 1.0 111.987 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.492 ' HB3' ' HD3' ' A' ' 9' ' ' ARG . 3.7 t80 -123.15 -54.99 1.79 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 103.391 -2.818 . . . . 1.0 103.391 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.492 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -117.13 153.82 32.12 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 113.366 -1.743 . . . . 1.0 107.696 179.665 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.482 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.7 m -28.49 -56.23 0.25 Allowed Pre-proline 0 N--CA 1.504 2.273 0 N-CA-C 114.101 1.149 . . . . 1.0 114.101 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.482 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 86.8 Cg_endo -64.99 -90.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.931 1.754 . . . . 1.0 112.365 170.68 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.408 ' H ' ' HG2' ' A' ' 11' ' ' PRO . 8.4 t70 36.51 34.93 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 123.572 1.653 . . . . 1.0 109.796 -179.448 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.7 t -168.45 -26.09 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 110.427 -3.079 . . . . 1.0 111.117 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -38.6 -58.26 1.07 Allowed 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 122.985 0.514 . . . . 1.0 111.812 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 64.8 p -45.48 -45.15 12.97 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 124.672 1.232 . . . . 1.0 110.957 179.396 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.462 ' HA ' ' HG3' ' A' ' 19' ' ' LYS . . . -66.89 -44.64 80.32 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.433 -1.258 . . . . 1.0 111.109 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 25' ' ' THR . 20.2 m -62.8 -32.38 73.54 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.444 -1.253 . . . . 1.0 108.191 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -70.18 -52.59 22.19 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.265 -1.383 . . . . 1.0 107.265 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HG3' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -71.08 -11.82 61.17 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 117.638 -1.625 . . . . 1.0 111.653 179.986 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 40.9 mt -93.67 -54.97 3.43 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 112.21 0.448 . . . . 1.0 112.21 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.0 m -109.36 -20.32 6.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 118.637 -0.697 . . . . 1.0 112.465 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.46 -33.89 2.59 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 117.83 1.892 . . . . 1.0 117.83 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.571 ' H ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -128.52 162.85 26.26 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 115.458 1.651 . . . . 1.0 115.458 -179.35 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.56 70.63 0.66 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 113.351 -1.749 . . . . 1.0 110.856 179.669 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.422 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 8.2 t -121.58 -177.91 3.67 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.709 0.766 . . . . 1.0 110.687 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.51 174.65 15.24 Favored Glycine 0 N--CA 1.491 2.322 0 CA-C-N 112.941 -1.936 . . . . 1.0 112.096 179.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.459 ' HG2' ' N ' ' A' ' 28' ' ' CYS . 39.0 ttmt -134.19 167.46 20.64 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.78 -1.21 . . . . 1.0 108.51 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.459 ' N ' ' HG2' ' A' ' 27' ' ' LYS . 50.5 t -108.46 110.01 21.43 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 104.88 -2.267 . . . . 1.0 104.88 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.8 m -128.92 124.71 35.86 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 112.609 -2.087 . . . . 1.0 111.962 -179.557 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.4 m120 44.32 42.16 5.03 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 112.864 -1.971 . . . . 1.0 111.424 -179.365 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.74 24.81 70.05 Favored Glycine 0 N--CA 1.484 1.854 0 CA-C-N 113.567 -1.651 . . . . 1.0 113.525 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.0 mtp85 -136.53 160.28 39.27 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 107.028 -1.471 . . . . 1.0 107.028 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.472 ' HB3' HG12 ' A' ' 3' ' ' ILE . 21.2 t -72.88 145.3 46.98 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.178 -1.409 . . . . 1.0 112.197 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 34.3 t70 -129.75 82.58 2.08 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 103.814 -2.662 . . . . 1.0 103.814 178.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.501 2.079 0 CA-C-O 118.366 -0.826 . . . . 1.0 110.604 -179.406 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.174 0.512 . . . . 1.0 111.141 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.3 p -70.88 122.38 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-N 114.654 -1.157 . . . . 1.0 109.884 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.538 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 28.2 pt -133.82 162.43 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 N-CA-C 114.195 1.184 . . . . 1.0 114.195 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.66 44.49 3.26 Favored Glycine 0 C--O 1.211 -1.318 0 CA-C-N 112.201 -2.272 . . . . 1.0 111.955 -179.877 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -103.88 92.26 4.33 Favored 'General case' 0 N--CA 1.486 1.342 1 N-CA-C 99.934 -4.099 . . . . 1.0 99.934 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -38.98 142.31 0.23 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 125.694 1.871 . . . . 1.0 112.576 -179.584 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 0.5 OUTLIER -112.77 160.46 17.95 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 116.093 1.886 . . . . 1.0 116.093 -179.605 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.525 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 20.3 t80 -121.24 -58.95 1.76 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 102.794 -3.039 . . . . 1.0 102.794 179.652 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.473 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 11.0 mmm180 -118.14 166.33 12.7 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 113.023 -1.898 . . . . 1.0 109.526 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.473 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.7 m -33.06 -58.7 0.46 Allowed Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 124.997 1.435 . . . . 1.0 114.305 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.473 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 91.1 Cg_endo -62.75 -92.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.951 1.767 . . . . 1.0 111.592 177.14 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 t70 38.24 31.52 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 123.368 1.556 . . . . 1.0 109.144 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.412 ' N ' ' C ' ' A' ' 11' ' ' PRO . 49.1 t -171.55 -17.1 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 111.678 -2.51 . . . . 1.0 113.687 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -38.81 -62.01 0.67 Allowed 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 118.936 0.789 . . . . 1.0 110.451 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.3 m -48.7 -47.48 41.03 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.619 1.2 . . . . 1.0 112.077 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.47 -45.07 92.69 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 114.759 -1.109 . . . . 1.0 111.567 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.1 t -62.87 -48.93 76.9 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 105.802 -1.925 . . . . 1.0 105.802 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.43 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 5.3 ttpm? -47.82 -50.34 26.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 123.373 0.42 . . . . 1.0 110.76 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -70.28 -27.63 64.56 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 117.427 -1.709 . . . . 1.0 111.207 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.0 mt -76.44 -50.97 12.75 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.027 1.121 . . . . 1.0 114.027 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 m -109.37 -36.11 2.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 123.66 0.784 . . . . 1.0 111.955 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.421 ' C ' ' HD3' ' A' ' 23' ' ' LYS . . . 134.51 -20.41 3.92 Favored Glycine 0 N--CA 1.49 2.265 0 CA-C-O 119.083 -0.843 . . . . 1.0 114.726 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.421 ' HD3' ' C ' ' A' ' 22' ' ' GLY . 1.7 mppt? -116.98 136.82 52.65 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 112.709 0.633 . . . . 1.0 112.709 -179.467 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.12 68.37 0.71 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 125.125 1.516 . . . . 1.0 110.749 179.591 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.452 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 11.2 p -121.87 -175.64 3.15 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.294 -1.321 . . . . 1.0 113.032 -179.491 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.36 154.27 10.96 Favored Glycine 0 N--CA 1.492 2.383 0 CA-C-N 114.075 -1.421 . . . . 1.0 112.356 179.625 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.38 175.91 6.46 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.086 0.946 . . . . 1.0 109.947 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.9 t -97.37 112.03 24.03 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 112.676 -2.056 . . . . 1.0 106.488 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.417 ' HB ' ' HB2' ' A' ' 34' ' ' ASP . 37.2 m -128.18 119.64 25.67 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 111.971 -2.377 . . . . 1.0 111.933 -179.572 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 50.24 43.57 26.3 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 113.519 -1.673 . . . . 1.0 108.659 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.95 16.39 57.15 Favored Glycine 0 N--CA 1.486 2.022 0 CA-C-N 113.719 -1.582 . . . . 1.0 114.131 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.8 mtp-105 -131.22 161.32 32.49 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.202 -1.036 . . . . 1.0 108.202 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.538 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 47.3 t -72.56 140.65 48.22 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.724 -1.19 . . . . 1.0 114.143 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.417 ' HB2' ' HB ' ' A' ' 29' ' ' THR . 9.4 t70 -135.69 90.63 2.62 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 125.107 1.504 . . . . 1.0 107.13 178.526 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.452 ' SG ' ' C ' ' A' ' 25' ' ' THR . 10.8 t . . . . . 0 N--CA 1.501 2.104 0 CA-C-O 118.588 -0.72 . . . . 1.0 110.313 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 2' ' ' VAL . 19.2 t . . . . . 0 N--CA 1.499 2.005 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 5.8 p -71.03 116.87 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.567 -0.901 . . . . 1.0 108.567 179.481 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.61 HG12 ' HB3' ' A' ' 33' ' ' CYS . 35.3 pt -132.02 158.0 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 N-CA-C 114.304 1.224 . . . . 1.0 114.304 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.28 -39.86 73.52 Favored Glycine 0 N--CA 1.488 2.115 0 CA-C-N 111.859 -2.428 . . . . 1.0 111.522 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -28.18 96.59 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 O-C-N 125.867 1.569 . . . . 1.0 111.309 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -39.62 144.1 0.19 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 124.934 1.396 . . . . 1.0 114.447 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.7 p -128.06 157.68 40.03 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.074 -0.966 . . . . 1.0 110.694 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -120.26 -56.69 1.98 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 105.474 -2.047 . . . . 1.0 105.474 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.48 159.9 16.32 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 125.7 1.875 . . . . 1.0 107.158 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.455 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.4 m -35.1 -57.08 0.86 Allowed Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 125.313 1.633 . . . . 1.0 112.894 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.455 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 72.5 Cg_endo -60.54 -91.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.275 1.317 . . . . 1.0 111.056 175.293 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t0 33.47 39.54 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 123.981 1.848 . . . . 1.0 108.794 -179.335 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.9 t -172.75 -26.39 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 109.972 -3.285 . . . . 1.0 110.603 -179.628 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -38.27 -55.41 1.33 Allowed 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 123.588 0.755 . . . . 1.0 112.084 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.7 p -49.45 -48.98 47.18 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 124.214 0.946 . . . . 1.0 110.68 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.67 -55.26 36.57 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 124.03 0.831 . . . . 1.0 109.58 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 25' ' ' THR . 98.6 m -48.86 -41.56 33.6 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.194 -1.366 . . . . 1.0 111.064 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.451 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 6.6 ttpm? -66.65 -47.01 73.87 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.559 -1.645 . . . . 1.0 106.559 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -70.27 -11.51 60.95 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 113.384 -1.735 . . . . 1.0 112.348 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.3 mt -101.52 -53.28 3.02 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 112.684 0.624 . . . . 1.0 112.684 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.7 m -109.13 -26.35 3.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 119.19 -0.433 . . . . 1.0 111.633 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 126.68 -20.17 6.12 Favored Glycine 0 N--CA 1.493 2.434 0 CA-C-O 119.026 -0.874 . . . . 1.0 114.969 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.509 ' HB2' ' HZ3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -122.66 141.84 51.32 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 113.22 0.822 . . . . 1.0 113.22 -179.497 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.99 71.71 0.82 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 125.214 1.571 . . . . 1.0 110.108 179.365 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.515 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 6.0 t -122.64 179.1 4.73 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.748 0.785 . . . . 1.0 112.036 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.08 167.67 18.88 Favored Glycine 0 N--CA 1.498 2.774 0 CA-C-N 113.271 -1.786 . . . . 1.0 111.813 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.402 ' HB3' ' NZ ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -132.68 175.89 8.93 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.721 0.772 . . . . 1.0 109.955 179.95 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.4 t -103.07 116.13 31.93 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 113.31 -1.768 . . . . 1.0 106.44 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 78.4 m -127.93 127.29 43.07 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 112.525 -2.125 . . . . 1.0 109.747 -179.571 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.3 m120 47.47 40.59 11.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 125.096 1.498 . . . . 1.0 111.062 -179.488 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.07 19.88 64.19 Favored Glycine 0 N--CA 1.483 1.832 0 CA-C-N 113.281 -1.781 . . . . 1.0 113.916 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.0 mtt-85 -132.7 162.51 31.22 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.479 -1.304 . . . . 1.0 107.479 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.61 ' HB3' HG12 ' A' ' 3' ' ' ILE . 41.8 t -72.79 143.64 47.83 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.889 -1.124 . . . . 1.0 113.243 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 36.8 t70 -134.75 78.1 1.72 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 104.128 -2.545 . . . . 1.0 104.128 178.745 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.1 t . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 117.863 -1.065 . . . . 1.0 111.078 -179.408 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 2' ' ' VAL . 10.6 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 108.381 -0.97 . . . . 1.0 108.381 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 5.7 p -71.51 119.02 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.426 -0.953 . . . . 1.0 108.426 179.384 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.53 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 27.4 pt -136.7 164.23 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 N-CA-C 114.809 1.411 . . . . 1.0 114.809 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.35 -43.51 76.06 Favored Glycine 0 N--CA 1.479 1.532 0 CA-C-N 112.051 -2.34 . . . . 1.0 112.08 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.401 ' HB3' HG13 ' A' ' 3' ' ' ILE . 52.4 tp60 -17.14 90.91 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 O-C-N 125.723 1.484 . . . . 1.0 114.12 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -39.96 136.5 1.11 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 125.065 1.478 . . . . 1.0 111.338 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 10.1 t -119.52 159.33 24.53 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 114.276 1.213 . . . . 1.0 114.276 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.503 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 15.4 t80 -120.53 -62.89 1.41 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 105.519 -2.03 . . . . 1.0 105.519 179.728 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.489 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 1.6 mmp_? -113.8 161.67 17.27 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.598 -1.637 . . . . 1.0 108.753 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.43 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 62.1 m -23.84 -59.21 0.12 Allowed Pre-proline 0 N--CA 1.504 2.27 0 N-CA-C 115.695 1.739 . . . . 1.0 115.695 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.43 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 77.5 Cg_endo -66.92 -93.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.157 0 C-N-CA 121.265 1.31 . . . . 1.0 113.86 176.339 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t0 40.23 33.52 0.17 Allowed 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 123.253 1.501 . . . . 1.0 108.942 -179.486 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.1 t -168.74 -24.21 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 111.859 -2.428 . . . . 1.0 112.827 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.414 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.2 m-85 -38.6 -59.72 0.89 Allowed 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 123.159 0.584 . . . . 1.0 111.967 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 77.8 p -48.05 -41.91 27.15 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 124.923 1.39 . . . . 1.0 111.893 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.98 -49.06 55.39 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.637 -0.711 . . . . 1.0 110.735 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 t -60.32 -29.87 69.14 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -70.81 -50.19 38.22 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.302 -1.37 . . . . 1.0 107.302 179.287 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -70.65 -13.4 62.07 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 113.225 -1.807 . . . . 1.0 113.719 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.8 mt -109.93 -43.37 4.01 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.363 0.875 . . . . 1.0 113.363 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.4 t -102.54 -34.71 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 114.859 -1.064 . . . . 1.0 110.323 -179.638 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.24 -31.65 3.11 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-O 119.105 -0.83 . . . . 1.0 114.175 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -123.6 150.82 43.66 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 113.725 1.009 . . . . 1.0 113.725 -179.348 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.42 72.99 0.71 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 113.827 -1.533 . . . . 1.0 109.815 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.429 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 17.9 p -117.11 -179.0 3.57 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.705 -1.134 . . . . 1.0 112.252 -179.786 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.03 166.5 13.24 Favored Glycine 0 N--CA 1.494 2.504 0 CA-C-N 114.515 -1.22 . . . . 1.0 115.34 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.561 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -134.05 168.58 18.55 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 112.847 -1.677 . . . . 1.0 107.282 179.696 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.439 ' N ' ' HG3' ' A' ' 27' ' ' LYS . 30.7 t -107.98 104.86 14.4 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 104.471 -2.418 . . . . 1.0 104.471 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.7 m -122.31 124.36 43.56 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 111.575 -2.557 . . . . 1.0 111.208 -179.371 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.2 m120 46.62 39.86 7.59 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 112.89 -1.959 . . . . 1.0 110.921 -179.321 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.96 27.21 70.96 Favored Glycine 0 N--CA 1.485 1.914 0 CA-C-N 113.106 -1.861 . . . . 1.0 112.513 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.0 mtt-85 -137.36 161.27 36.74 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.334 -1.358 . . . . 1.0 107.334 179.688 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.53 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 46.8 t -72.38 143.39 48.6 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.854 1.057 . . . . 1.0 113.854 179.692 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 34.2 t70 -136.39 81.99 1.91 Allowed 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.502 -1.681 . . . . 1.0 108.641 178.869 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.429 ' SG ' ' C ' ' A' ' 25' ' ' THR . 12.3 t . . . . . 0 N--CA 1.499 1.994 0 CA-C-O 116.148 -1.882 . . . . 1.0 110.828 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.497 ' H2 ' ' HB3' ' A' ' 35' ' ' CYS . 11.5 t . . . . . 0 N--CA 1.495 1.825 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.408 ' N ' HG12 ' A' ' 1' ' ' VAL . 7.1 p -71.23 121.66 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-N 114.683 -1.144 . . . . 1.0 109.682 179.763 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.588 HG12 ' HB3' ' A' ' 33' ' ' CYS . 19.6 pt -125.7 150.61 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-O 122.697 1.237 . . . . 1.0 113.594 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.79 -39.29 46.93 Favored Glycine 0 N--CA 1.479 1.505 0 CA-C-N 110.914 -2.857 . . . . 1.0 112.478 179.826 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -30.9 93.37 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 125.665 1.45 . . . . 1.0 112.89 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -40.44 144.38 0.24 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 124.879 1.362 . . . . 1.0 111.997 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.0 p -121.42 160.69 23.59 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 124.039 0.837 . . . . 1.0 110.985 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.475 ' HB3' ' HD3' ' A' ' 9' ' ' ARG . 3.4 t80 -119.96 -57.68 1.93 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.578 -1.267 . . . . 1.0 107.578 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.475 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -108.18 164.87 11.92 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 113.269 -1.787 . . . . 1.0 107.152 -179.975 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.485 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.1 m -39.25 -56.5 2.64 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 124.782 1.301 . . . . 1.0 112.095 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.485 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 84.0 Cg_endo -64.83 -93.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 121.252 1.301 . . . . 1.0 111.238 173.048 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.8 t70 35.51 35.12 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 125.411 1.695 . . . . 1.0 109.635 -179.614 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.404 ' N ' ' C ' ' A' ' 11' ' ' PRO . 36.7 t -167.74 -28.79 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 110.399 -3.092 . . . . 1.0 110.37 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -37.62 -52.24 1.21 Allowed 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 123.822 0.849 . . . . 1.0 112.438 179.697 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.8 m -56.51 -61.1 2.65 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.994 -0.743 . . . . 1.0 108.994 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.93 -54.69 5.14 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 124.314 1.008 . . . . 1.0 111.052 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 25' ' ' THR . 17.4 m -49.48 -54.42 17.88 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 113.366 -1.743 . . . . 1.0 107.601 179.473 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.428 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 5.7 ttpm? -50.01 -47.78 52.88 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 179.576 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -19.74 63.1 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 114.972 -1.013 . . . . 1.0 112.489 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.8 mt -92.41 -50.27 5.72 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 114.478 1.288 . . . . 1.0 114.478 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.5 m -105.51 -30.56 2.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 C-N-CA 123.477 0.711 . . . . 1.0 111.293 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.72 -28.12 3.43 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 116.165 1.226 . . . . 1.0 116.165 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -124.5 156.03 37.96 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 114.161 1.171 . . . . 1.0 114.161 -179.341 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.45 72.85 0.72 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 113.803 -1.544 . . . . 1.0 110.218 179.781 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.504 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 7.5 t -128.41 -176.26 3.76 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.745 0.783 . . . . 1.0 110.431 -179.839 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.5 160.33 30.04 Favored Glycine 0 N--CA 1.494 2.515 0 CA-C-N 113.411 -1.722 . . . . 1.0 109.605 179.713 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.85 -172.39 2.86 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.333 1.063 . . . . 1.0 111.127 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.1 t -110.92 114.81 28.41 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 111.482 -2.599 . . . . 1.0 107.398 179.571 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.2 m -139.64 133.25 30.39 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 113.161 -1.836 . . . . 1.0 109.286 -179.781 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 49.22 42.19 21.21 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 113.958 -1.474 . . . . 1.0 108.208 -179.545 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 58.41 14.57 20.67 Favored Glycine 0 N--CA 1.49 2.287 0 CA-C-N 113.745 -1.57 . . . . 1.0 114.871 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.6 mtp-105 -130.45 160.01 35.35 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.112 -1.44 . . . . 1.0 107.112 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.588 ' HB3' HG12 ' A' ' 3' ' ' ILE . 14.6 t -73.38 143.17 46.93 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.136 -1.426 . . . . 1.0 113.381 -179.937 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -129.05 88.18 2.67 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 101.23 -3.619 . . . . 1.0 101.23 178.43 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.497 ' HB3' ' H2 ' ' A' ' 1' ' ' VAL . 4.5 t . . . . . 0 N--CA 1.502 2.134 0 CA-C-O 117.001 -1.476 . . . . 1.0 111.535 -179.482 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 121.757 0.789 . . . . 1.0 111.608 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.0 p -70.66 123.63 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-N 113.721 -1.581 . . . . 1.0 108.518 179.664 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.509 HG12 ' HB3' ' A' ' 33' ' ' CYS . 19.1 pt -134.39 165.26 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 N-CA-C 115.148 1.536 . . . . 1.0 115.148 -179.871 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -53.14 -48.0 59.76 Favored Glycine 0 N--CA 1.478 1.465 0 CA-C-N 111.096 -2.775 . . . . 1.0 111.575 179.847 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -20.51 86.49 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.474 0 O-C-N 125.882 1.578 . . . . 1.0 113.034 -179.917 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -40.0 146.58 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.097 -1.411 . . . . 1.0 112.37 -179.961 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.404 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 5.6 t -110.09 152.36 26.08 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 124.582 1.176 . . . . 1.0 113.465 -179.918 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.404 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 1.8 t80 -125.39 -58.73 1.42 Allowed 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 102.465 -3.161 . . . . 1.0 102.465 179.498 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.04 161.0 20.99 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.376 -1.712 . . . . 1.0 106.376 179.306 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.496 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 73.2 m -30.96 -57.39 0.36 Allowed Pre-proline 0 N--CA 1.506 2.369 0 N-CA-C 114.429 1.27 . . . . 1.0 114.429 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.496 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 83.9 Cg_endo -63.93 -93.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.919 1.746 . . . . 1.0 111.17 173.763 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 t70 36.55 34.12 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 CA-C-O 123.294 1.521 . . . . 1.0 109.375 -179.483 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.422 ' N ' ' C ' ' A' ' 11' ' ' PRO . 54.0 t -169.26 -21.59 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 110.579 -3.009 . . . . 1.0 112.453 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -38.65 -58.51 1.04 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 118.469 0.577 . . . . 1.0 111.64 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.2 t -50.32 -39.64 46.53 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.963 1.414 . . . . 1.0 111.828 179.574 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.16 -48.71 56.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 123.516 0.51 . . . . 1.0 111.137 179.878 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.0 t -61.94 -32.91 73.37 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.425 -1.324 . . . . 1.0 107.425 179.705 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.416 ' O ' ' N ' ' A' ' 22' ' ' GLY . 24.7 ttmm -65.04 -53.72 41.41 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 105.62 -1.992 . . . . 1.0 105.62 179.594 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -50.26 -35.56 27.54 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 114.181 -1.372 . . . . 1.0 109.189 179.692 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.0 tp -67.66 -60.06 2.84 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 114.824 -1.08 . . . . 1.0 111.669 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.09 -48.48 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 124.253 0.97 . . . . 1.0 113.046 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 133.45 23.98 0.71 Allowed Glycine 0 N--CA 1.492 2.376 0 O-C-N 123.417 0.448 . . . . 1.0 113.484 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -133.46 131.37 39.82 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.481 -0.563 . . . . 1.0 109.481 179.881 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.18 68.06 0.7 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 124.722 1.264 . . . . 1.0 109.63 179.364 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.6 p -115.37 174.92 5.75 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.482 -1.235 . . . . 1.0 112.895 -179.647 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.51 152.89 8.57 Favored Glycine 0 N--CA 1.489 2.213 0 CA-C-N 113.74 -1.573 . . . . 1.0 111.605 179.72 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 36.8 mtmm -122.71 174.78 6.89 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 113.637 -1.282 . . . . 1.0 108.245 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.2 t -110.17 109.06 19.43 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 105.36 -2.089 . . . . 1.0 105.36 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.2 m -133.07 126.08 31.03 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 112.264 -2.244 . . . . 1.0 108.382 -179.61 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.3 p30 47.52 41.3 12.86 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 125.907 2.004 . . . . 1.0 112.345 -179.459 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.63 13.77 59.3 Favored Glycine 0 N--CA 1.478 1.435 0 CA-C-N 113.15 -1.841 . . . . 1.0 112.145 -179.83 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.7 mmt-85 -128.6 161.94 28.45 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.668 -0.864 . . . . 1.0 108.668 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.509 ' HB3' HG12 ' A' ' 3' ' ' ILE . 12.5 t -72.6 143.56 48.18 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.461 -1.296 . . . . 1.0 113.392 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 9.9 t70 -134.16 84.31 2.11 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 125.971 2.045 . . . . 1.0 106.555 179.117 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.503 2.203 0 CA-C-O 118.415 -0.802 . . . . 1.0 110.472 -179.784 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.6 m . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 122.028 0.918 . . . . 1.0 111.644 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.7 p -70.39 121.44 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-N 113.502 -1.681 . . . . 1.0 109.45 179.653 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.592 HG12 ' HB3' ' A' ' 33' ' ' CYS . 15.6 pt -128.19 152.89 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 122.265 1.031 . . . . 1.0 113.719 -179.883 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -46.91 -41.35 13.66 Favored Glycine 0 N--CA 1.489 2.191 0 CA-C-N 111.15 -2.75 . . . . 1.0 112.717 179.864 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -28.46 99.79 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 125.501 1.353 . . . . 1.0 112.215 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -39.96 147.36 0.09 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 124.824 1.327 . . . . 1.0 113.711 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.462 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 5.2 t -113.77 157.74 21.87 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.998 -1.001 . . . . 1.0 110.985 -179.95 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.462 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.1 t80 -119.65 -62.79 1.45 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 103.189 -2.893 . . . . 1.0 103.189 179.731 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -124.97 171.45 10.2 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.141 -1.39 . . . . 1.0 107.946 179.65 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.443 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 61.1 m -31.69 -56.34 0.44 Allowed Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 125.07 1.482 . . . . 1.0 114.045 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.443 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 63.1 Cg_endo -68.94 -94.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.674 1.583 . . . . 1.0 113.748 173.058 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.2 t70 38.17 32.54 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 CA-C-O 123.158 1.456 . . . . 1.0 109.806 -179.461 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.3 t -165.44 -25.74 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 111.341 -2.663 . . . . 1.0 111.618 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -38.79 -59.83 0.91 Allowed 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 123.131 0.572 . . . . 1.0 112.466 179.717 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.6 m -45.13 -43.85 10.14 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 124.805 1.316 . . . . 1.0 110.987 179.609 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.02 -50.85 60.77 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.954 -1.021 . . . . 1.0 109.817 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.1 m -54.0 -34.58 60.24 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.755 -1.111 . . . . 1.0 110.276 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -70.65 -51.19 29.52 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.012 -1.848 . . . . 1.0 106.012 179.425 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -70.73 -8.95 55.98 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 113.653 -1.612 . . . . 1.0 113.049 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.72 -51.56 3.16 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 123.4 0.437 . . . . 1.0 110.096 -179.78 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.8 t -104.91 -35.73 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 114.727 -1.124 . . . . 1.0 112.437 -179.319 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 139.42 -30.56 2.41 Favored Glycine 0 N--CA 1.485 1.931 0 CA-C-O 118.676 -1.069 . . . . 1.0 114.667 179.779 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.51 ' HD3' ' N ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -123.01 150.65 42.75 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 114.424 1.268 . . . . 1.0 114.424 -179.529 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.5 70.49 0.64 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 113.504 -1.68 . . . . 1.0 112.022 179.76 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.9 t -124.12 -174.79 3.08 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.931 0.872 . . . . 1.0 110.791 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.38 -178.75 16.32 Favored Glycine 0 N--CA 1.492 2.425 0 CA-C-N 113.007 -1.906 . . . . 1.0 112.125 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.497 ' NZ ' ' H ' ' A' ' 28' ' ' CYS . 0.2 OUTLIER -143.46 170.65 15.4 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.78 -1.21 . . . . 1.0 108.245 179.94 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.497 ' H ' ' NZ ' ' A' ' 27' ' ' LYS . 49.4 t -108.87 115.27 29.76 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.203 -1.777 . . . . 1.0 106.203 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.415 ' CB ' ' HB2' ' A' ' 34' ' ' ASP . 95.3 m -132.33 128.48 37.78 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 113.142 -1.845 . . . . 1.0 112.28 -179.632 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 46.67 40.52 8.71 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 113.571 -1.649 . . . . 1.0 110.312 -179.707 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.55 28.22 64.78 Favored Glycine 0 N--CA 1.487 2.07 0 CA-C-N 113.544 -1.662 . . . . 1.0 112.705 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.6 mtt-85 -136.83 163.74 29.94 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.3 -1.741 . . . . 1.0 106.3 179.682 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.592 ' HB3' HG12 ' A' ' 3' ' ' ILE . 30.5 t -72.76 144.84 47.46 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 118.612 -1.235 . . . . 1.0 112.777 179.682 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 11.3 t70 -129.95 81.64 2.02 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 105.595 -2.002 . . . . 1.0 105.595 178.722 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.502 2.145 0 C-N-CA 119.259 -0.976 . . . . 1.0 110.305 -179.496 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 121.214 0.531 . . . . 1.0 111.728 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.7 p -70.79 123.48 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-N 114.777 -1.101 . . . . 1.0 108.651 179.603 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.497 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 24.1 pt -137.17 165.3 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 N-CA-C 116.575 2.065 . . . . 1.0 116.575 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.77 -48.41 36.87 Favored Glycine 0 N--CA 1.477 1.422 0 CA-C-N 109.94 -3.3 . . . . 1.0 111.347 179.643 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.424 ' HB3' HG13 ' A' ' 3' ' ' ILE . 3.6 tp-100 -23.44 89.77 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 O-C-N 125.787 1.522 . . . . 1.0 113.083 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 -47.69 148.66 1.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.409 -1.269 . . . . 1.0 110.838 179.85 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 8.7 t -117.11 156.36 27.74 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.982 1.104 . . . . 1.0 113.982 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.45 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.9 t80 -123.36 -56.76 1.7 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 105.104 -2.184 . . . . 1.0 105.104 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.468 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -116.32 152.13 34.5 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 112.879 -1.964 . . . . 1.0 108.102 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.463 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.4 m -22.67 -59.07 0.1 OUTLIER Pre-proline 0 N--CA 1.506 2.369 0 N-CA-C 115.581 1.697 . . . . 1.0 115.581 -179.857 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.47 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 98.6 Cg_endo -65.67 -91.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.45 1.433 . . . . 1.0 113.223 174.161 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.407 ' H ' ' HG2' ' A' ' 11' ' ' PRO . 6.4 t70 41.0 30.74 0.11 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 123.023 1.392 . . . . 1.0 109.166 -179.56 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.3 t -167.3 -24.88 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 112.294 -2.23 . . . . 1.0 112.737 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.47 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.2 m-85 -38.93 -59.59 0.95 Allowed 'General case' 0 N--CA 1.505 2.315 0 C-N-CA 122.947 0.499 . . . . 1.0 111.81 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 p -48.75 -39.88 26.62 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 125.01 1.444 . . . . 1.0 111.776 179.63 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.404 ' HA ' ' HZ3' ' A' ' 19' ' ' LYS . . . -70.19 -50.38 40.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 123.999 0.812 . . . . 1.0 110.662 179.855 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.7 t -60.09 -30.01 68.96 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.537 -0.912 . . . . 1.0 108.537 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -70.44 -49.87 44.26 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.884 -1.154 . . . . 1.0 107.884 179.211 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HZ3' ' HA ' ' A' ' 16' ' ' ALA . 7.1 ttpm? -70.4 -15.11 62.8 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.102 -1.863 . . . . 1.0 113.06 -179.918 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.8 mt -108.41 -43.36 4.35 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 113.852 1.056 . . . . 1.0 113.852 -179.745 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.4 t -101.46 -35.29 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-N 114.802 -1.09 . . . . 1.0 110.081 -179.724 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.23 -32.14 2.9 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 120.69 -0.767 . . . . 1.0 114.106 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -125.72 153.41 43.97 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 113.722 1.008 . . . . 1.0 113.722 -179.465 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.79 74.59 0.6 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 113.818 -1.537 . . . . 1.0 113.556 -179.735 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.432 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 0.9 OUTLIER -120.7 -178.27 3.68 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.705 -1.134 . . . . 1.0 111.333 179.906 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.71 163.1 11.83 Favored Glycine 0 N--CA 1.492 2.432 0 CA-C-N 114.351 -1.295 . . . . 1.0 113.35 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -131.53 166.13 22.05 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 113.636 -1.282 . . . . 1.0 108.167 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.6 t -103.32 94.64 5.61 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 103.138 -2.912 . . . . 1.0 103.138 179.992 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 83.1 m -112.97 115.1 27.86 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 109.984 -3.28 . . . . 1.0 112.482 -179.328 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 48.75 41.11 17.48 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 111.453 -2.612 . . . . 1.0 108.739 -179.78 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.0 28.31 72.61 Favored Glycine 0 N--CA 1.482 1.74 0 CA-C-N 113.364 -1.743 . . . . 1.0 112.434 -179.767 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -137.6 157.25 46.91 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 106.173 -1.788 . . . . 1.0 106.173 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.497 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 34.5 t -72.78 140.74 47.92 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.451 -1.3 . . . . 1.0 113.913 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 25.6 t70 -135.55 86.56 2.25 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 125.382 1.676 . . . . 1.0 108.54 178.729 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.432 ' SG ' ' C ' ' A' ' 25' ' ' THR . 8.1 t . . . . . 0 N--CA 1.5 2.058 0 CA-C-O 116.292 -1.813 . . . . 1.0 110.58 -179.861 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 2' ' ' VAL . 19.5 t . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 108.497 -0.927 . . . . 1.0 108.497 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.445 ' N ' HG12 ' A' ' 1' ' ' VAL . 6.2 p -71.26 117.57 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.299 -1.0 . . . . 1.0 108.299 179.377 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.573 HG12 ' HB3' ' A' ' 33' ' ' CYS . 27.8 pt -131.47 164.53 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 113.7 1.0 . . . . 1.0 113.7 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.99 44.88 3.43 Favored Glycine 0 C--O 1.21 -1.393 0 CA-C-N 112.595 -2.093 . . . . 1.0 112.124 -179.861 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -100.27 104.94 16.45 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 102.699 -3.074 . . . . 1.0 102.699 179.59 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -39.01 129.39 1.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 113.229 -1.805 . . . . 1.0 112.7 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 24.0 t -120.93 163.09 18.77 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.481 -1.691 . . . . 1.0 112.372 179.794 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.519 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 13.2 t80 -119.8 -64.8 1.22 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 104.855 -2.276 . . . . 1.0 104.855 179.676 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.448 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -119.62 163.69 16.99 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 112.468 -2.151 . . . . 1.0 111.897 179.736 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.3 m -16.49 -62.79 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.231 0 N-CA-C 117.566 2.432 . . . . 1.0 117.566 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.426 ' HG2' ' H ' ' A' ' 12' ' ' ASP . 71.3 Cg_endo -68.48 -92.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 121.343 1.362 . . . . 1.0 112.213 178.837 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.441 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 4.1 t0 36.63 35.18 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 123.502 1.62 . . . . 1.0 109.961 -179.671 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.0 t -168.3 -23.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 110.761 -2.927 . . . . 1.0 111.764 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -38.35 -56.53 1.23 Allowed 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 123.955 0.902 . . . . 1.0 113.225 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.0 t -46.08 -53.26 10.56 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 124.685 1.24 . . . . 1.0 109.326 179.496 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.07 -39.62 90.58 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 113.73 -1.577 . . . . 1.0 112.292 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 25' ' ' THR . 60.0 m -69.14 -28.68 66.66 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.842 -1.072 . . . . 1.0 108.576 179.936 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -71.05 -52.78 17.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.061 -1.459 . . . . 1.0 107.061 179.319 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -71.04 -19.86 62.45 Favored 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 118.091 -1.444 . . . . 1.0 114.767 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -105.92 -33.79 7.83 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 113.313 0.857 . . . . 1.0 113.313 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 t -106.89 -30.97 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 123.722 0.638 . . . . 1.0 110.07 -179.563 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.67 -34.91 2.77 Favored Glycine 0 N--CA 1.49 2.249 0 O-C-N 123.855 0.722 . . . . 1.0 114.584 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -135.81 169.29 17.8 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 113.245 0.831 . . . . 1.0 113.245 -179.363 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.86 69.33 0.69 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 113.683 -1.598 . . . . 1.0 110.797 179.521 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.5 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 4.5 t -121.67 179.01 4.61 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.61 -179.818 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.97 175.06 18.9 Favored Glycine 0 N--CA 1.493 2.459 0 CA-C-N 113.292 -1.776 . . . . 1.0 111.965 179.847 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.94 175.65 9.04 Favored 'General case' 0 C--O 1.205 -1.277 0 CA-C-O 122.074 0.94 . . . . 1.0 112.73 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.7 t -114.63 109.44 18.23 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 112.396 -2.183 . . . . 1.0 105.429 -179.926 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.9 m -126.47 126.44 43.76 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 112.103 -2.317 . . . . 1.0 110.952 -179.501 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 m120 45.18 40.86 5.3 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 113.464 -1.698 . . . . 1.0 111.52 -179.52 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.1 27.42 68.89 Favored Glycine 0 N--CA 1.485 1.942 0 CA-C-N 113.415 -1.72 . . . . 1.0 112.412 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.6 mtt-85 -136.63 160.54 38.5 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.385 -1.709 . . . . 1.0 106.385 179.796 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.573 ' HB3' HG12 ' A' ' 3' ' ' ILE . 38.9 t -73.06 144.52 47.04 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.609 -1.237 . . . . 1.0 113.076 179.869 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 32.6 t70 -133.89 76.45 1.66 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.048 -2.204 . . . . 1.0 105.048 178.742 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.1 t . . . . . 0 N--CA 1.501 2.1 0 CA-C-O 117.761 -1.114 . . . . 1.0 111.34 -179.341 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.569 HG12 ' HB3' ' A' ' 33' ' ' CYS . 14.6 pt -125.59 159.66 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 122.818 1.294 . . . . 1.0 113.348 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.74 43.71 3.27 Favored Glycine 0 C--O 1.204 -1.731 0 CA-C-N 112.029 -2.35 . . . . 1.0 113.389 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -105.83 88.23 2.77 Favored 'General case' 0 C--N 1.308 -1.208 1 N-CA-C 98.638 -4.578 . . . . 1.0 98.638 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -38.94 147.19 0.06 Allowed 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 113.275 -1.784 . . . . 1.0 113.401 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 0.5 OUTLIER -112.49 160.64 17.58 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 116.919 2.192 . . . . 1.0 116.919 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.533 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.7 t80 -123.11 -58.68 1.63 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 103.301 -2.851 . . . . 1.0 103.301 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.413 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 42.6 mtt85 -116.36 165.2 13.48 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 112.689 -2.05 . . . . 1.0 110.018 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.458 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 67.3 m -34.73 -59.2 0.62 Allowed Pre-proline 0 N--CA 1.503 2.216 0 O-C-N 124.731 1.269 . . . . 1.0 113.54 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.458 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 88.2 Cg_endo -62.18 -86.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.056 0 C-N-CA 121.976 1.784 . . . . 1.0 112.253 176.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.41 ' H ' ' HG2' ' A' ' 11' ' ' PRO . 6.1 t70 34.16 36.89 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 CA-C-O 124.305 2.002 . . . . 1.0 109.129 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.402 ' N ' ' C ' ' A' ' 11' ' ' PRO . 15.9 t -170.05 -27.18 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 110.21 -3.177 . . . . 1.0 111.502 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -38.2 -55.45 1.3 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 123.712 0.632 . . . . 1.0 112.18 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 61.8 m -50.49 -51.78 44.3 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 124.386 1.054 . . . . 1.0 110.074 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.438 ' HA ' ' HG3' ' A' ' 19' ' ' LYS . . . -58.18 -47.54 83.09 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 122.825 1.297 . . . . 1.0 111.515 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 25' ' ' THR . 35.5 m -58.68 -39.55 81.02 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 113.735 -1.575 . . . . 1.0 108.688 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -64.7 -52.16 58.65 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.282 -1.377 . . . . 1.0 107.282 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HG3' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -71.58 -10.72 60.21 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 117.677 -1.609 . . . . 1.0 113.129 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.7 mt -92.61 -50.35 5.64 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 119.409 -0.329 . . . . 1.0 111.549 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.7 p -114.07 -32.38 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 123.481 0.488 . . . . 1.0 110.69 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.99 -19.75 3.67 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 116.031 1.172 . . . . 1.0 116.031 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -128.42 151.28 49.56 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 114.54 1.311 . . . . 1.0 114.54 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.2 70.76 0.84 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 113.784 -1.553 . . . . 1.0 110.403 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.512 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 5.1 t -122.9 176.39 6.03 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.9 0.857 . . . . 1.0 112.298 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.69 160.37 27.81 Favored Glycine 0 N--CA 1.493 2.467 0 CA-C-N 112.671 -2.058 . . . . 1.0 110.197 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.415 ' HD3' ' H ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -130.4 -178.33 4.72 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.359 1.076 . . . . 1.0 112.824 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 38.7 t -90.12 109.39 20.45 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 111.895 -2.411 . . . . 1.0 107.809 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.434 ' CB ' ' HB2' ' A' ' 34' ' ' ASP . 44.0 m -126.34 119.53 27.58 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 111.679 -2.509 . . . . 1.0 110.992 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 50.33 43.43 26.63 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.453 -1.703 . . . . 1.0 109.013 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.94 20.55 53.65 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-N 113.623 -1.626 . . . . 1.0 113.026 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.0 mtt85 -132.86 160.87 35.7 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.095 -1.446 . . . . 1.0 107.095 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.569 ' HB3' HG12 ' A' ' 3' ' ' ILE . 42.9 t -73.22 142.07 47.31 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 118.381 -1.328 . . . . 1.0 114.005 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.434 ' HB2' ' CB ' ' A' ' 29' ' ' THR . 18.9 t70 -128.01 85.94 2.41 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 102.822 -3.029 . . . . 1.0 102.822 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.501 2.106 0 CA-C-O 116.75 -1.595 . . . . 1.0 111.47 -179.487 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 48.9 t . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 107.115 -1.439 . . . . 1.0 107.115 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.548 HG12 ' HB3' ' A' ' 33' ' ' CYS . 30.1 pt -129.58 163.37 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 114.301 1.223 . . . . 1.0 114.301 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.97 43.76 3.29 Favored Glycine 0 C--O 1.213 -1.196 0 CA-C-N 112.188 -2.278 . . . . 1.0 112.436 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -106.3 100.3 9.84 Favored 'General case' 0 N--CA 1.486 1.348 1 N-CA-C 99.919 -4.104 . . . . 1.0 99.919 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.525 ' HE ' HH22 ' A' ' 32' ' ' ARG . 64.6 mtt85 -38.94 144.5 0.12 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 125.253 1.596 . . . . 1.0 114.58 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.7 t -110.7 156.06 21.56 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.255 -1.793 . . . . 1.0 111.505 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -120.81 -61.9 1.51 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 103.88 -2.637 . . . . 1.0 103.88 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -118.71 167.58 11.53 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 112.861 -1.972 . . . . 1.0 107.558 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.409 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 50.7 m -26.57 -49.64 0.18 Allowed Pre-proline 0 N--CA 1.507 2.376 0 N-CA-C 115.015 1.487 . . . . 1.0 115.015 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.464 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . 0.9 OUTLIER -88.86 -83.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.319 -0.977 0 C-N-CA 121.864 1.709 . . . . 1.0 108.639 -176.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.9 t70 37.1 32.43 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 123.149 1.452 . . . . 1.0 110.104 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.551 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 41.8 t -164.6 -26.17 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 111.3 -2.682 . . . . 1.0 112.95 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.464 ' CD1' ' HB3' ' A' ' 11' ' ' PRO . 3.3 m-85 -38.19 -55.18 1.33 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 123.988 0.915 . . . . 1.0 113.072 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 55.5 m -47.7 -53.63 14.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 124.861 1.35 . . . . 1.0 108.648 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.09 -51.05 70.83 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.04 -0.982 . . . . 1.0 111.035 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.551 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 94.6 m -54.57 -33.48 60.33 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.247 -1.342 . . . . 1.0 109.695 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -70.67 -48.92 52.33 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.057 -1.831 . . . . 1.0 106.057 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -70.45 -14.13 62.41 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-N 114.551 -1.204 . . . . 1.0 113.538 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.7 mt -107.14 -44.08 4.46 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 113.578 0.955 . . . . 1.0 113.578 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 37.1 t -99.67 -36.56 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-N 114.647 -1.16 . . . . 1.0 109.782 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.76 -30.23 3.43 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 120.615 -0.802 . . . . 1.0 113.974 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -128.01 151.06 49.61 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 114.077 1.14 . . . . 1.0 114.077 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.39 77.06 0.76 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 114.118 -1.401 . . . . 1.0 109.327 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.1 t -128.71 -172.87 2.82 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.766 -0.652 . . . . 1.0 109.324 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.677 ' HA3' ' SG ' ' A' ' 35' ' ' CYS . . . 118.89 -179.37 16.8 Favored Glycine 0 N--CA 1.493 2.458 0 CA-C-N 113.217 -1.81 . . . . 1.0 115.902 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -142.74 168.38 19.86 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 112.296 -1.952 . . . . 1.0 107.012 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.3 t -105.63 115.03 29.55 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 105.031 -2.211 . . . . 1.0 105.031 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.2 m -128.23 123.76 34.99 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 112.923 -1.944 . . . . 1.0 112.48 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 45.98 42.14 8.99 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 112.92 -1.945 . . . . 1.0 110.076 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.18 27.46 67.47 Favored Glycine 0 N--CA 1.489 2.171 0 CA-C-N 113.769 -1.56 . . . . 1.0 112.752 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.525 HH22 ' HE ' ' A' ' 6' ' ' ARG . 36.0 mmt180 -135.78 161.87 34.37 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 106.308 -1.738 . . . . 1.0 106.308 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.548 ' HB3' HG12 ' A' ' 3' ' ' ILE . 13.8 t -73.4 142.43 46.97 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 114.807 1.41 . . . . 1.0 114.807 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 11.3 t70 -130.45 79.78 1.92 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 125.791 1.932 . . . . 1.0 108.227 178.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.677 ' SG ' ' HA3' ' A' ' 26' ' ' GLY . 1.3 m . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 118.136 -0.935 . . . . 1.0 111.067 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 52.7 t . . . . . 0 N--CA 1.496 1.86 0 N-CA-C 107.413 -1.329 . . . . 1.0 107.413 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.557 HG12 ' HB3' ' A' ' 33' ' ' CYS . 33.5 pt -134.03 163.63 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 115.563 1.69 . . . . 1.0 115.563 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.12 -44.63 88.55 Favored Glycine 0 N--CA 1.478 1.46 0 CA-C-N 111.499 -2.591 . . . . 1.0 110.791 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -28.37 90.5 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.455 0 O-C-N 126.096 1.704 . . . . 1.0 110.755 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -39.94 146.88 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.832 1.419 . . . . 1.0 114.832 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.8 p -125.67 159.25 32.72 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.376 -1.284 . . . . 1.0 110.057 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.401 ' H ' ' CB ' ' A' ' 12' ' ' ASP . 12.8 t80 -119.41 -55.21 2.14 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 106.177 -1.786 . . . . 1.0 106.177 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.464 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -111.14 162.08 15.29 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 113.048 -1.887 . . . . 1.0 106.719 179.785 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.447 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 58.4 m -30.85 -55.8 0.38 Allowed Pre-proline 0 N--CA 1.503 2.199 0 O-C-N 125.091 1.494 . . . . 1.0 113.533 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.495 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 53.9 Cg_endo -70.19 -95.05 0.01 OUTLIER 'Trans proline' 0 C--O 1.205 -1.141 0 C-N-CA 121.248 1.299 . . . . 1.0 113.946 170.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.401 ' CB ' ' H ' ' A' ' 8' ' ' TYR . 4.9 t70 39.99 32.82 0.12 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 124.862 1.351 . . . . 1.0 109.593 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.2 t -167.59 -25.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 111.809 -2.45 . . . . 1.0 112.392 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.495 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.5 m-30 -38.5 -59.15 0.94 Allowed 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 123.698 0.799 . . . . 1.0 112.173 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.9 p -45.92 -46.22 15.92 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 125.162 1.539 . . . . 1.0 111.37 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.8 -41.76 87.05 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.428 -1.26 . . . . 1.0 111.231 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.8 t -69.34 -27.46 65.38 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.267 -0.879 . . . . 1.0 109.025 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -70.17 -53.63 16.35 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.955 -1.498 . . . . 1.0 106.955 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -71.14 -21.22 62.21 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 114.161 1.171 . . . . 1.0 114.161 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.8 mp -98.26 -33.57 11.04 Favored 'General case' 0 N--CA 1.509 2.511 0 N-CA-C 112.847 0.684 . . . . 1.0 112.847 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.82 -37.78 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 123.677 0.611 . . . . 1.0 109.856 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.19 -31.75 2.65 Favored Glycine 0 N--CA 1.489 2.196 0 CA-C-O 118.785 -1.008 . . . . 1.0 114.917 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -128.13 145.67 50.94 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 115.22 1.563 . . . . 1.0 115.22 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.82 72.58 0.81 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 113.491 -1.686 . . . . 1.0 110.409 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.426 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 7.8 t -133.04 -173.43 3.19 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.278 0.561 . . . . 1.0 109.769 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.28 -170.82 13.61 Favored Glycine 0 N--CA 1.495 2.569 0 CA-C-N 113.579 -1.646 . . . . 1.0 114.219 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -147.38 167.8 23.44 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 113.683 -1.259 . . . . 1.0 108.817 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.2 t -104.82 117.59 34.43 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.322 -1.733 . . . . 1.0 106.322 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.7 m -125.66 122.91 37.74 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 113.319 -1.764 . . . . 1.0 111.203 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 45.74 41.54 7.57 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 112.798 -2.001 . . . . 1.0 111.279 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.67 21.95 71.36 Favored Glycine 0 N--CA 1.482 1.719 0 CA-C-N 113.385 -1.734 . . . . 1.0 113.592 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.1 mmt-85 -131.7 158.87 39.99 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.667 -1.605 . . . . 1.0 106.667 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.557 ' HB3' HG12 ' A' ' 3' ' ' ILE . 9.1 t -72.62 142.18 48.35 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.58 -1.248 . . . . 1.0 113.708 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.4 t70 -135.07 78.37 1.73 Allowed 'General case' 0 C--N 1.295 -1.764 0 O-C-N 125.969 2.043 . . . . 1.0 106.862 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.426 ' SG ' ' O ' ' A' ' 25' ' ' THR . 37.1 t . . . . . 0 N--CA 1.498 1.947 0 C-N-CA 119.717 -0.793 . . . . 1.0 111.281 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.4 p . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.481 HG12 ' HB3' ' A' ' 33' ' ' CYS . 22.9 pt -135.02 169.31 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 115.1 1.518 . . . . 1.0 115.1 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.01 -47.26 81.38 Favored Glycine 0 N--CA 1.478 1.489 0 CA-C-N 111.577 -2.556 . . . . 1.0 111.869 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -20.96 90.61 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.516 0 O-C-N 125.85 1.559 . . . . 1.0 112.884 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -39.79 142.3 0.34 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 124.851 1.344 . . . . 1.0 112.361 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.1 p -124.64 162.45 24.1 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 124.58 1.175 . . . . 1.0 111.042 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -118.24 -61.87 1.62 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 102.782 -3.044 . . . . 1.0 102.782 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -117.79 168.25 10.64 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.407 -2.072 . . . . 1.0 105.407 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.426 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.7 m -29.85 -54.59 0.33 Allowed Pre-proline 0 N--CA 1.503 2.198 0 O-C-N 124.692 1.245 . . . . 1.0 113.823 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.426 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 54.3 Cg_endo -67.78 -104.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 121.568 1.512 . . . . 1.0 113.841 172.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.8 t70 39.34 30.54 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 123.2 1.476 . . . . 1.0 110.031 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.7 t -168.15 -15.29 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 111.255 -2.702 . . . . 1.0 113.598 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.4 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 6.0 m-30 -38.74 -58.8 1.02 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 113.675 0.991 . . . . 1.0 113.675 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.0 t -45.27 -48.18 12.92 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 124.849 1.343 . . . . 1.0 110.734 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.74 -53.4 54.89 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.623 -1.172 . . . . 1.0 108.734 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.2 t -49.55 -39.66 35.55 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.811 -1.086 . . . . 1.0 110.12 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -65.95 -47.79 73.5 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.503 -1.295 . . . . 1.0 107.503 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -70.09 -11.82 61.16 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 112.862 -1.972 . . . . 1.0 111.885 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.6 mt -104.47 -52.72 2.84 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.105 1.15 . . . . 1.0 114.105 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.3 m -108.61 -16.68 8.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 118.687 -0.673 . . . . 1.0 112.525 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.99 -38.23 1.97 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 118.354 2.101 . . . . 1.0 118.354 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -126.57 153.75 44.83 Favored 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 115.243 1.572 . . . . 1.0 115.243 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.54 68.88 0.59 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 113.316 -1.766 . . . . 1.0 112.204 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.8 t -130.25 -168.65 2.0 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.549 ' CA ' ' SG ' ' A' ' 35' ' ' CYS . . . 124.78 174.42 14.0 Favored Glycine 0 N--CA 1.497 2.707 0 CA-C-N 113.517 -1.674 . . . . 1.0 115.136 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -131.4 164.46 25.64 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 112.13 -2.035 . . . . 1.0 108.483 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.5 t -107.46 112.07 24.68 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 104.654 -2.35 . . . . 1.0 104.654 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 84.8 m -128.18 123.69 34.93 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 112.371 -2.195 . . . . 1.0 112.131 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 51.49 39.78 25.38 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 113.2 -1.818 . . . . 1.0 108.905 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.49 21.05 62.02 Favored Glycine 0 N--CA 1.486 2.017 0 CA-C-N 113.286 -1.779 . . . . 1.0 112.386 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.6 mtp85 -129.87 164.03 25.03 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.677 -1.231 . . . . 1.0 107.677 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.481 ' HB3' HG12 ' A' ' 3' ' ' ILE . 4.3 t -72.56 145.28 47.51 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.926 -1.109 . . . . 1.0 112.975 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.7 t70 -133.57 83.57 2.06 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 112.693 -2.049 . . . . 1.0 107.992 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.549 ' SG ' ' CA ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.017 0 CA-C-O 118.439 -0.791 . . . . 1.0 111.106 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 55.6 t . . . . . 0 N--CA 1.497 1.879 0 N-CA-C 105.659 -1.978 . . . . 1.0 105.659 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.498 HG12 ' HB3' ' A' ' 33' ' ' CYS . 36.1 pt -135.04 168.49 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 115.875 1.806 . . . . 1.0 115.875 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.54 -45.67 83.66 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 111.814 -2.448 . . . . 1.0 111.041 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.5 tp60 -22.64 90.08 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.45 0 O-C-N 125.943 1.614 . . . . 1.0 113.112 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -39.82 143.16 0.27 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 113.916 -1.493 . . . . 1.0 113.15 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.4 p -124.36 163.93 20.7 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.916 -1.038 . . . . 1.0 109.826 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.439 ' H ' ' HB3' ' A' ' 12' ' ' ASP . 17.0 t80 -117.15 -61.08 1.76 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 104.298 -2.482 . . . . 1.0 104.298 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -116.82 169.41 9.4 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 112.418 -2.174 . . . . 1.0 106.97 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.462 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 73.1 m -28.55 -54.98 0.26 Allowed Pre-proline 0 N--CA 1.503 2.179 0 O-C-N 124.942 1.401 . . . . 1.0 113.944 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.462 ' HD3' ' HB2' ' A' ' 10' ' ' SER . 28.8 Cg_endo -73.74 -100.6 0.01 OUTLIER 'Trans proline' 0 C--O 1.208 -0.984 0 C-N-CA 121.776 1.651 . . . . 1.0 114.917 170.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.439 ' HB3' ' H ' ' A' ' 8' ' ' TYR . 12.5 t70 41.86 28.63 0.09 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 124.79 1.306 . . . . 1.0 110.163 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.0 t -164.58 -21.91 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 112.109 -2.314 . . . . 1.0 113.138 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.459 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 6.3 m-30 -38.78 -61.37 0.73 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 112.913 0.708 . . . . 1.0 112.913 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.3 p -43.84 -42.72 5.83 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 125.174 1.546 . . . . 1.0 112.165 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.99 -49.84 47.54 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 114.188 -1.369 . . . . 1.0 108.771 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.7 t -55.45 -34.97 64.97 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.292 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -66.49 -51.09 60.42 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 106.464 -1.68 . . . . 1.0 106.464 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.41 ' NZ ' ' HB2' ' A' ' 19' ' ' LYS . 4.4 ttmp? -59.77 -24.74 64.33 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.039 -1.891 . . . . 1.0 112.197 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.0 mp -101.27 -33.74 9.93 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 116.101 1.889 . . . . 1.0 116.101 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.13 -37.79 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 123.453 0.471 . . . . 1.0 110.771 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.41 -30.77 2.58 Favored Glycine 0 N--CA 1.488 2.145 0 CA-C-O 118.435 -1.203 . . . . 1.0 115.041 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.48 141.46 51.98 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 115.146 1.535 . . . . 1.0 115.146 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.74 71.79 0.76 Allowed 'General case' 0 N--CA 1.503 2.209 0 CA-C-N 113.609 -1.632 . . . . 1.0 112.697 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.414 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 14.7 t -133.08 -168.16 2.04 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.431 0.634 . . . . 1.0 109.453 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.09 -174.69 16.2 Favored Glycine 0 N--CA 1.493 2.458 0 CA-C-N 113.577 -1.647 . . . . 1.0 115.359 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.48 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -138.1 162.63 33.69 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 112.833 -1.683 . . . . 1.0 108.518 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.417 ' H ' ' HE2' ' A' ' 27' ' ' LYS . 42.0 t -106.08 114.81 29.17 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 103.757 -2.683 . . . . 1.0 103.757 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 78.1 m -128.61 124.44 35.85 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 112.923 -1.944 . . . . 1.0 112.354 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 50.8 39.91 23.34 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 113.152 -1.84 . . . . 1.0 109.041 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.16 22.02 62.42 Favored Glycine 0 N--CA 1.484 1.854 0 CA-C-N 113.283 -1.78 . . . . 1.0 112.816 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.1 mtp-105 -130.89 163.29 27.77 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.14 -1.43 . . . . 1.0 107.14 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.498 ' HB3' HG12 ' A' ' 3' ' ' ILE . 2.5 t -72.69 142.61 48.23 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.213 1.19 . . . . 1.0 114.213 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.515 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.5 t70 -135.54 74.91 1.53 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 112.262 -2.245 . . . . 1.0 106.338 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 25' ' ' THR . 41.9 t . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 118.278 -0.868 . . . . 1.0 111.83 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.3 p . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 108.774 -0.824 . . . . 1.0 108.774 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.507 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 33.0 pt -135.37 165.42 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 115.531 1.678 . . . . 1.0 115.531 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.84 44.2 3.33 Favored Glycine 0 C--O 1.21 -1.361 0 CA-C-N 111.314 -2.675 . . . . 1.0 111.826 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -109.8 96.6 6.36 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 100.64 -3.837 . . . . 1.0 100.64 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -39.11 147.74 0.06 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 125.381 1.676 . . . . 1.0 113.732 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.1 t -116.56 154.16 30.93 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 113.523 -1.672 . . . . 1.0 111.602 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -120.23 -55.95 2.02 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 104.323 -2.473 . . . . 1.0 104.323 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.434 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -119.2 154.02 34.01 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 113.498 -1.683 . . . . 1.0 106.792 179.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.438 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.9 m -22.0 -56.01 0.09 OUTLIER Pre-proline 0 N--CA 1.506 2.364 0 N-CA-C 115.773 1.768 . . . . 1.0 115.773 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.473 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 63.6 Cg_endo -69.19 -94.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.733 1.622 . . . . 1.0 113.531 169.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.7 t70 42.52 28.19 0.11 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 124.537 1.148 . . . . 1.0 110.246 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.6 t -164.47 -26.99 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 112.49 -2.141 . . . . 1.0 112.572 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.473 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 5.9 m-30 -38.73 -61.51 0.71 Allowed 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 112.582 0.586 . . . . 1.0 112.582 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.8 m -42.04 -43.77 3.32 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 125.509 1.755 . . . . 1.0 111.062 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.51 -49.0 58.69 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 114.389 -1.278 . . . . 1.0 109.113 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.5 t -56.8 -30.04 63.3 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 124.053 0.846 . . . . 1.0 108.954 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -70.72 -51.52 26.9 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 105.912 -1.884 . . . . 1.0 105.912 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -70.65 -10.78 60.16 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 113.755 -1.566 . . . . 1.0 113.878 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.4 mt -108.69 -43.5 4.25 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 112.903 0.705 . . . . 1.0 112.903 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.4 t -105.23 -38.24 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-N 114.748 -1.114 . . . . 1.0 110.464 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.0 -30.19 2.86 Favored Glycine 0 N--CA 1.488 2.161 0 CA-C-O 118.854 -0.97 . . . . 1.0 114.378 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -122.62 139.27 54.12 Favored 'General case' 0 N--CA 1.506 2.375 0 N-CA-C 114.407 1.262 . . . . 1.0 114.407 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.16 68.93 0.74 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 125.146 1.529 . . . . 1.0 111.086 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.433 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 9.2 t -132.64 -169.14 2.18 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.303 -0.862 . . . . 1.0 109.041 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.31 -173.11 16.27 Favored Glycine 0 N--CA 1.493 2.443 0 CA-C-N 113.751 -1.568 . . . . 1.0 113.711 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -136.96 167.64 21.12 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.654 -1.273 . . . . 1.0 109.568 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.5 t -109.87 112.33 24.3 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 103.485 -2.783 . . . . 1.0 103.485 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.8 m -127.37 123.28 35.84 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 112.829 -1.987 . . . . 1.0 112.604 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 49.91 40.63 21.31 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 113.134 -1.848 . . . . 1.0 108.599 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.52 22.94 62.09 Favored Glycine 0 N--CA 1.484 1.85 0 CA-C-N 113.231 -1.804 . . . . 1.0 113.211 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -131.07 162.34 30.05 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 106.048 -1.834 . . . . 1.0 106.048 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.507 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 9.1 t -73.33 141.56 47.1 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.043 1.498 . . . . 1.0 115.043 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.2 t70 -136.64 77.39 1.65 Allowed 'General case' 0 C--N 1.298 -1.673 0 O-C-N 125.825 1.953 . . . . 1.0 107.699 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.433 ' SG ' ' O ' ' A' ' 25' ' ' THR . 29.9 t . . . . . 0 N--CA 1.5 2.041 0 C-N-CA 119.609 -0.836 . . . . 1.0 111.372 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.2 p . . . . . 0 N--CA 1.495 1.811 0 N-CA-C 109.009 -0.738 . . . . 1.0 109.009 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.495 HG12 ' HB3' ' A' ' 33' ' ' CYS . 1.5 pt -132.18 159.75 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 114.1 1.148 . . . . 1.0 114.1 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -40.47 -53.34 3.54 Favored Glycine 0 N--CA 1.486 1.99 0 CA-C-N 111.22 -2.718 . . . . 1.0 112.206 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -16.13 85.62 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 O-C-N 126.195 1.761 . . . . 1.0 113.217 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -51.05 144.8 8.37 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.772 -1.104 . . . . 1.0 109.607 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.0 p -123.01 164.16 19.09 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 114.249 1.203 . . . . 1.0 114.249 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -118.07 -57.77 2.06 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 104.686 -2.338 . . . . 1.0 104.686 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -114.39 168.43 9.85 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 112.949 -1.932 . . . . 1.0 107.247 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.452 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.3 m -35.29 -58.8 0.74 Allowed Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 124.961 1.413 . . . . 1.0 113.412 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.452 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 84.7 Cg_endo -62.15 -95.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.391 1.394 . . . . 1.0 112.423 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 t0 37.91 32.34 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 123.147 1.451 . . . . 1.0 108.809 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.422 ' N ' ' C ' ' A' ' 11' ' ' PRO . 23.9 t -165.41 -24.94 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 111.945 -2.389 . . . . 1.0 112.298 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -38.21 -55.71 1.28 Allowed 'General case' 0 N--CA 1.508 2.466 0 C-N-CA 123.1 0.56 . . . . 1.0 110.778 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.6 p -53.31 -49.18 67.57 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 124.579 1.175 . . . . 1.0 110.119 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.5 -55.62 29.67 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.681 0.753 . . . . 1.0 110.765 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 25' ' ' THR . 56.5 m -48.58 -49.33 37.1 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.165 -1.38 . . . . 1.0 108.317 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -55.61 -49.59 72.4 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.167 0.984 . . . . 1.0 108.443 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -59.8 -26.73 65.99 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-N 113.852 -1.522 . . . . 1.0 111.46 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.1 mp -85.6 -55.79 3.82 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 120.082 -0.647 . . . . 1.0 112.31 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.2 m -107.3 -46.21 7.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 C-N-CA 122.922 0.489 . . . . 1.0 112.25 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.8 28.34 1.29 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 111.215 -0.754 . . . . 1.0 111.215 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -135.41 126.84 28.58 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 124.268 0.628 . . . . 1.0 110.293 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.35 69.04 0.8 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 124.909 1.381 . . . . 1.0 108.923 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.463 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 12.4 t -127.66 -173.46 2.92 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.898 0.856 . . . . 1.0 111.576 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.85 158.62 27.55 Favored Glycine 0 N--CA 1.495 2.572 0 CA-C-N 112.612 -2.086 . . . . 1.0 109.598 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -132.99 179.29 6.27 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.605 0.716 . . . . 1.0 110.312 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.2 t -100.04 118.07 35.64 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 113.512 -1.676 . . . . 1.0 106.704 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.5 m -132.24 130.39 40.88 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 112.633 -2.076 . . . . 1.0 106.552 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.6 p30 45.5 41.44 6.77 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 125.286 1.616 . . . . 1.0 112.76 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.05 12.4 49.13 Favored Glycine 0 N--CA 1.479 1.561 0 CA-C-N 113.412 -1.722 . . . . 1.0 113.435 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.8 mmt-85 -127.71 162.55 26.3 Favored 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.495 ' HB3' HG12 ' A' ' 3' ' ' ILE . 42.9 t -72.59 146.47 46.66 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 117.7 -1.6 . . . . 1.0 112.08 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 34.0 t70 -129.69 85.69 2.33 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 104.878 -2.267 . . . . 1.0 104.878 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.504 2.246 0 CA-C-O 116.452 -1.737 . . . . 1.0 111.112 -179.44 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.6 p . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 107.204 -1.406 . . . . 1.0 107.204 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.496 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 35.9 pt -136.83 166.35 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 116.349 1.981 . . . . 1.0 116.349 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.03 -46.05 85.61 Favored Glycine 0 N--CA 1.478 1.448 0 CA-C-N 111.235 -2.711 . . . . 1.0 110.637 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.419 ' HB3' HG13 ' A' ' 3' ' ' ILE . 49.2 tp60 -22.76 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.323 0 O-C-N 125.9 1.588 . . . . 1.0 112.44 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -40.11 151.01 0.05 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 125.274 1.609 . . . . 1.0 114.041 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 t -117.21 149.6 40.14 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 113.538 -1.665 . . . . 1.0 110.318 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.484 ' HB3' ' HD3' ' A' ' 9' ' ' ARG . 3.0 t80 -122.08 -54.8 1.9 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 102.553 -3.129 . . . . 1.0 102.553 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.484 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -118.65 154.05 33.31 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 105.941 -1.874 . . . . 1.0 105.941 179.675 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.45 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 67.8 m -25.2 -55.78 0.17 Allowed Pre-proline 0 N--CA 1.505 2.324 0 N-CA-C 114.748 1.388 . . . . 1.0 114.748 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.488 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 64.4 Cg_endo -69.04 -93.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 121.149 1.233 . . . . 1.0 113.629 170.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.4 t70 42.31 30.01 0.18 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 122.616 1.198 . . . . 1.0 109.691 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.8 t -165.96 -26.22 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 112.23 -2.259 . . . . 1.0 112.658 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.488 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.4 m-30 -38.56 -59.03 0.96 Allowed 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 123.612 0.765 . . . . 1.0 112.244 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.6 p -45.53 -43.24 11.71 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 125.117 1.511 . . . . 1.0 111.769 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.05 -46.53 64.8 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.811 -1.086 . . . . 1.0 109.768 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.2 t -57.04 -36.14 70.13 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.103 -1.073 . . . . 1.0 108.103 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -65.69 -53.75 36.82 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 105.1 -2.185 . . . . 1.0 105.1 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.82 -31.6 7.36 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 114.236 -1.347 . . . . 1.0 109.755 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.84 -54.35 5.43 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.475 -0.784 . . . . 1.0 112.088 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 50.7 t -104.28 -54.79 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 CA-C-N 115.655 -0.702 . . . . 1.0 111.674 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.61 20.48 1.09 Allowed Glycine 0 N--CA 1.491 2.309 0 O-C-N 124.043 0.839 . . . . 1.0 112.793 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -133.16 126.26 31.27 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 124.102 0.53 . . . . 1.0 110.465 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.15 73.9 0.94 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 124.54 1.15 . . . . 1.0 108.201 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.411 HG23 ' SG ' ' A' ' 35' ' ' CYS . 9.4 t -137.38 -173.24 3.42 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.429 0.633 . . . . 1.0 110.884 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.87 -179.69 16.18 Favored Glycine 0 N--CA 1.493 2.46 0 CA-C-N 113.429 -1.714 . . . . 1.0 113.745 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -134.53 172.48 12.86 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 114.001 -1.1 . . . . 1.0 111.346 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 45.6 t -112.34 111.56 22.5 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 102.273 -3.232 . . . . 1.0 102.273 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.2 m -130.73 123.42 29.22 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 112.437 -2.165 . . . . 1.0 108.097 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 p30 47.8 42.0 15.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 126.679 2.487 . . . . 1.0 112.116 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.95 11.21 60.44 Favored Glycine 0 N--CA 1.476 1.309 0 CA-C-N 113.132 -1.849 . . . . 1.0 112.289 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.3 mtt85 -126.34 163.72 22.64 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.187 -1.042 . . . . 1.0 108.187 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.496 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 7.4 t -72.21 143.03 49.0 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.506 -1.278 . . . . 1.0 114.308 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 35.8 t70 -136.39 77.0 1.63 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 112.051 -2.34 . . . . 1.0 107.56 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.411 ' SG ' HG23 ' A' ' 25' ' ' THR . 21.8 t . . . . . 0 N--CA 1.498 1.951 0 CA-C-O 118.016 -0.992 . . . . 1.0 111.27 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.5 p . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 110.689 -0.115 . . . . 1.0 110.689 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.559 HG12 ' HB3' ' A' ' 33' ' ' CYS . 23.6 pt -130.23 159.29 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 CA-C-O 122.125 0.964 . . . . 1.0 112.779 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.22 -39.64 72.08 Favored Glycine 0 N--CA 1.489 2.195 0 CA-C-N 112.133 -2.303 . . . . 1.0 112.971 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -13.64 87.61 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 115.672 1.73 . . . . 1.0 115.672 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -40.7 124.31 2.04 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.693 1.246 . . . . 1.0 109.634 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 5.6 t -95.43 157.88 15.7 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 116.182 1.919 . . . . 1.0 116.182 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.515 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 14.7 t80 -121.68 -61.96 1.46 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 104.285 -2.487 . . . . 1.0 104.285 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -121.1 168.07 11.95 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 112.982 -1.917 . . . . 1.0 110.137 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.435 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 59.9 m -32.29 -59.64 0.38 Allowed Pre-proline 0 N--CA 1.501 2.109 0 O-C-N 125.051 1.469 . . . . 1.0 114.605 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.435 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 84.1 Cg_endo -61.37 -89.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.753 1.635 . . . . 1.0 112.045 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 t70 35.92 36.41 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 CA-C-O 124.113 1.911 . . . . 1.0 108.508 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.403 ' N ' ' C ' ' A' ' 11' ' ' PRO . 15.1 t -170.36 -25.33 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 111.118 -2.765 . . . . 1.0 112.382 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -38.45 -59.51 0.9 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 123.984 0.803 . . . . 1.0 111.618 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.3 t -51.83 -44.43 63.56 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 124.939 1.399 . . . . 1.0 112.657 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.43 -46.81 78.46 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 124.025 0.828 . . . . 1.0 113.055 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.1 t -68.72 -31.02 69.8 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.012 -1.477 . . . . 1.0 107.012 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.419 ' HZ3' ' HB3' ' A' ' 18' ' ' LYS . 6.0 ttpm? -64.11 -50.29 68.87 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.24 -1.022 . . . . 1.0 108.24 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -70.15 -26.3 63.87 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.002 -1.479 . . . . 1.0 109.505 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 tt -65.15 -59.18 4.38 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.963 -0.695 . . . . 1.0 110.138 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.01 -42.73 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 114.171 1.175 . . . . 1.0 114.171 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.03 10.82 1.69 Allowed Glycine 0 N--CA 1.491 2.337 0 CA-C-O 119.569 -0.573 . . . . 1.0 112.759 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -129.68 128.9 43.49 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 123.722 0.307 . . . . 1.0 110.468 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.02 68.71 0.7 Allowed 'General case' 0 N--CA 1.503 2.202 0 O-C-N 124.87 1.356 . . . . 1.0 109.954 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.6 p -115.61 175.78 5.37 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.151 -1.386 . . . . 1.0 113.048 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.78 150.58 9.34 Favored Glycine 0 N--CA 1.49 2.263 0 CA-C-N 113.254 -1.794 . . . . 1.0 110.989 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -122.55 -178.48 3.92 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 113.521 -1.339 . . . . 1.0 111.01 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.5 t -111.27 109.42 19.43 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 111.903 -2.408 . . . . 1.0 108.209 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.3 m -138.71 131.56 29.4 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 112.837 -1.983 . . . . 1.0 111.001 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 51.06 40.1 24.81 Favored 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 112.811 -1.995 . . . . 1.0 108.33 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.0 19.16 50.0 Favored Glycine 0 N--CA 1.489 2.223 0 CA-C-N 113.259 -1.791 . . . . 1.0 113.356 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.0 mtp-105 -134.26 160.11 38.88 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.559 ' HB3' HG12 ' A' ' 3' ' ' ILE . 43.5 t -72.53 139.17 47.41 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 114.826 1.417 . . . . 1.0 114.826 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 11.2 p-10 -134.02 94.09 3.2 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.185 -2.154 . . . . 1.0 105.185 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.504 2.227 0 CA-C-N 115.252 -0.885 . . . . 1.0 109.741 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.8 t . . . . . 0 N--CA 1.499 2.023 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.54 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 33.8 pt -134.93 164.04 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 N-CA-C 114.136 1.162 . . . . 1.0 114.136 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.62 -39.59 93.56 Favored Glycine 0 N--CA 1.479 1.534 0 CA-C-N 112.868 -1.969 . . . . 1.0 112.564 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -12.0 88.01 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 115.372 1.619 . . . . 1.0 115.372 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.0 mtt85 -39.8 122.91 1.49 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 124.817 1.323 . . . . 1.0 110.873 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 9.0 t -107.11 158.53 17.0 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 114.974 1.472 . . . . 1.0 114.974 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.52 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.9 t80 -123.48 -56.6 1.7 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 112.424 -2.171 . . . . 1.0 105.996 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.458 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -115.4 153.71 30.56 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 113.406 -1.724 . . . . 1.0 110.011 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.473 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.3 m -25.22 -57.94 0.16 Allowed Pre-proline 0 N--CA 1.508 2.437 0 O-C-N 125.092 1.495 . . . . 1.0 114.909 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.473 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 95.7 Cg_endo -62.82 -91.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.874 1.716 . . . . 1.0 112.058 173.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.8 t70 35.99 35.44 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 123.725 1.726 . . . . 1.0 108.889 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.4 ' N ' ' C ' ' A' ' 11' ' ' PRO . 49.3 t -170.73 -23.11 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 110.802 -2.908 . . . . 1.0 112.541 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -38.63 -59.94 0.87 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 123.415 0.447 . . . . 1.0 111.569 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.5 t -47.92 -40.4 21.86 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 124.933 1.396 . . . . 1.0 112.243 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.02 -54.48 13.0 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 123.715 0.635 . . . . 1.0 110.139 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.8 t -55.01 -32.65 61.97 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.553 -0.906 . . . . 1.0 108.553 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -67.14 -50.87 59.74 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 105.906 -1.887 . . . . 1.0 105.906 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -70.48 -9.03 55.5 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 113.756 -1.565 . . . . 1.0 111.554 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -90.68 -60.1 2.01 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.7 -0.852 . . . . 1.0 108.7 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 p -111.58 -39.24 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 124.129 0.893 . . . . 1.0 112.763 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.98 14.03 1.69 Allowed Glycine 0 N--CA 1.493 2.446 0 CA-C-O 119.635 -0.536 . . . . 1.0 113.285 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.426 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 3.2 mptp? -132.23 127.45 35.8 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 123.966 0.451 . . . . 1.0 110.257 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.09 68.41 0.7 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 125.065 1.478 . . . . 1.0 109.723 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.453 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 12.2 p -119.26 -179.12 3.75 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.252 -1.34 . . . . 1.0 114.299 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.41 153.91 9.25 Favored Glycine 0 N--CA 1.494 2.542 0 CA-C-N 113.419 -1.718 . . . . 1.0 111.704 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -119.45 167.21 12.17 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.33 -0.935 . . . . 1.0 108.672 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 13.5 t -101.42 90.64 4.15 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 102.917 -2.994 . . . . 1.0 102.917 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.7 m -110.78 115.57 29.78 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 109.497 -3.501 . . . . 1.0 111.43 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 52.8 39.03 28.08 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 112.425 -2.17 . . . . 1.0 108.465 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.61 25.59 68.99 Favored Glycine 0 N--CA 1.483 1.816 0 CA-C-N 113.065 -1.88 . . . . 1.0 111.858 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.2 mtt-85 -136.42 159.25 42.36 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.004 -1.48 . . . . 1.0 107.004 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.54 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 40.1 t -72.36 140.3 48.37 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 114.293 1.22 . . . . 1.0 114.293 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -135.18 84.49 2.1 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 124.978 1.424 . . . . 1.0 107.348 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.453 ' SG ' ' C ' ' A' ' 25' ' ' THR . 6.5 t . . . . . 0 N--CA 1.501 2.104 0 CA-C-O 116.787 -1.577 . . . . 1.0 111.239 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.727 -0.472 . . . . 1.0 109.727 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.58 HG12 ' HB3' ' A' ' 33' ' ' CYS . 23.1 pt -128.83 160.25 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 121.916 0.865 . . . . 1.0 112.882 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.96 43.81 3.24 Favored Glycine 0 C--O 1.211 -1.338 0 CA-C-N 112.589 -2.096 . . . . 1.0 112.671 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -105.36 102.53 12.01 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 101.555 -3.498 . . . . 1.0 101.555 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -39.03 137.53 0.67 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 113.425 -1.716 . . . . 1.0 113.19 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.6 p -121.84 159.37 26.92 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.582 -1.19 . . . . 1.0 110.148 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -118.51 -59.82 1.84 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 106.175 -1.787 . . . . 1.0 106.175 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.37 163.81 12.54 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 113.188 -1.824 . . . . 1.0 106.591 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.472 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 75.5 m -35.93 -55.26 1.3 Allowed Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 125.156 1.535 . . . . 1.0 112.125 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.5 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 81.2 Cg_endo -67.07 -93.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 120.858 1.038 . . . . 1.0 113.009 171.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 t70 36.97 34.46 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 CA-C-O 123.351 1.548 . . . . 1.0 109.678 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.5 t -166.35 -27.53 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 110.766 -2.924 . . . . 1.0 111.307 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.5 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.0 m-85 -38.38 -55.34 1.38 Allowed 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 124.456 1.103 . . . . 1.0 112.45 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.5 p -47.1 -48.72 22.79 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 124.322 1.014 . . . . 1.0 109.887 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.02 -45.15 90.19 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.708 -1.133 . . . . 1.0 110.379 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 25' ' ' THR . 10.5 m -57.59 -35.56 70.57 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.998 -1.001 . . . . 1.0 109.372 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -70.8 -46.41 62.89 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.381 -1.711 . . . . 1.0 106.381 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.28 -15.19 62.86 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 114.157 -1.383 . . . . 1.0 113.623 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.0 mt -110.46 -43.62 3.85 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 113.86 1.059 . . . . 1.0 113.86 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.0 t -98.89 -36.22 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 114.555 -1.202 . . . . 1.0 110.033 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.57 -28.79 4.16 Favored Glycine 0 N--CA 1.489 2.207 0 O-C-N 123.866 0.729 . . . . 1.0 113.07 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.428 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 8.6 mptt -129.23 152.04 49.23 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 112.405 0.52 . . . . 1.0 112.405 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.52 78.51 0.79 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 114.274 -1.33 . . . . 1.0 109.218 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.418 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 7.6 t -128.38 -178.22 4.48 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.551 0.691 . . . . 1.0 111.627 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.53 -169.0 13.84 Favored Glycine 0 N--CA 1.495 2.6 0 CA-C-N 113.216 -1.811 . . . . 1.0 112.567 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -155.13 173.06 17.14 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.024 -1.088 . . . . 1.0 108.388 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 47.4 t -102.13 118.1 36.19 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.178 -1.786 . . . . 1.0 106.178 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.1 m -129.75 125.81 36.72 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 112.867 -1.97 . . . . 1.0 110.834 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 50.55 40.87 24.55 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 125.198 1.561 . . . . 1.0 109.15 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.86 18.92 55.06 Favored Glycine 0 N--CA 1.488 2.142 0 CA-C-N 113.148 -1.842 . . . . 1.0 113.51 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -128.62 163.32 25.31 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.778 -1.564 . . . . 1.0 106.778 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.58 ' HB3' HG12 ' A' ' 3' ' ' ILE . 11.2 t -73.49 143.75 46.47 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.177 -1.409 . . . . 1.0 113.263 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -131.24 85.04 2.23 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 104.53 -2.396 . . . . 1.0 104.53 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.5 2.071 0 C-N-CA 119.76 -0.776 . . . . 1.0 109.957 -179.514 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 41.1 t . . . . . 0 N--CA 1.494 1.731 0 N-CA-C 108.53 -0.915 . . . . 1.0 108.53 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.566 HG12 ' HB3' ' A' ' 33' ' ' CYS . 23.6 pt -128.96 154.64 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 114.549 1.314 . . . . 1.0 114.549 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -48.87 -43.24 30.39 Favored Glycine 0 N--CA 1.477 1.433 0 CA-C-N 110.824 -2.898 . . . . 1.0 111.758 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -26.15 91.98 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 126.106 1.709 . . . . 1.0 112.333 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -39.85 149.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.938 -1.483 . . . . 1.0 113.63 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.451 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 5.0 t -107.63 157.28 18.2 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.714 -1.13 . . . . 1.0 112.124 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.467 ' CD2' ' HG2' ' A' ' 9' ' ' ARG . 15.9 t80 -119.72 -64.88 1.22 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 103.023 -2.954 . . . . 1.0 103.023 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.467 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 9.0 mmt85 -123.85 168.83 12.23 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 112.277 -2.238 . . . . 1.0 106.533 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.457 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 67.9 m -29.02 -58.36 0.25 Allowed Pre-proline 0 N--CA 1.504 2.261 0 N-CA-C 114.677 1.362 . . . . 1.0 114.677 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.457 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 71.1 Cg_endo -66.96 -93.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.426 1.418 . . . . 1.0 113.262 175.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.401 ' H ' ' HG2' ' A' ' 11' ' ' PRO . 15.6 t70 37.89 33.73 0.05 Allowed 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 123.399 1.571 . . . . 1.0 109.906 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.5 t -164.51 -26.85 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 110.851 -2.886 . . . . 1.0 111.432 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.407 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.2 m-85 -38.74 -58.27 1.09 Allowed 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 123.68 0.792 . . . . 1.0 111.777 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.0 m -48.15 -45.7 33.61 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 124.625 1.203 . . . . 1.0 110.749 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.444 ' HA ' ' HG2' ' A' ' 19' ' ' LYS . . . -66.03 -41.56 90.77 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.608 -1.178 . . . . 1.0 112.309 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 25' ' ' THR . 24.2 m -66.81 -32.02 73.03 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.907 -1.042 . . . . 1.0 109.01 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.405 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 6.6 ttpm? -70.77 -52.57 19.87 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.753 -1.203 . . . . 1.0 107.753 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HG2' ' HA ' ' A' ' 16' ' ' ALA . 58.6 pttt -70.92 -17.16 62.7 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 118.903 -1.119 . . . . 1.0 113.448 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.1 mt -101.88 -41.99 6.3 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 113.25 0.833 . . . . 1.0 113.25 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.1 t -101.49 -34.7 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 124.293 0.996 . . . . 1.0 110.321 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.17 -29.64 3.85 Favored Glycine 0 N--CA 1.493 2.464 0 O-C-N 123.731 0.645 . . . . 1.0 113.065 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.612 ' H ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -128.5 156.58 43.03 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 112.97 0.73 . . . . 1.0 112.97 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.88 73.64 0.59 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 113.975 -1.466 . . . . 1.0 112.95 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.449 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 0.8 OUTLIER -114.32 -171.29 1.89 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.964 -1.016 . . . . 1.0 110.102 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.86 156.02 12.32 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.853 -0.899 . . . . 1.0 110.853 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 54.5 mtmt -132.53 169.88 15.96 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.331 -0.988 . . . . 1.0 108.331 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.6 t -105.11 100.61 10.2 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 104.8 -2.296 . . . . 1.0 104.8 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.7 m -121.66 118.71 29.84 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 110.736 -2.938 . . . . 1.0 112.069 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 47.7 42.31 15.2 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 112.562 -2.108 . . . . 1.0 110.013 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.89 23.08 69.06 Favored Glycine 0 N--CA 1.482 1.763 0 CA-C-N 113.229 -1.805 . . . . 1.0 113.09 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.2 mtp85 -136.48 160.47 38.66 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.74 -1.208 . . . . 1.0 107.74 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.566 ' HB3' HG12 ' A' ' 3' ' ' ILE . 19.5 t -72.57 142.12 48.42 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.437 -1.305 . . . . 1.0 114.118 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 35.0 t0 -131.38 88.98 2.65 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 105.326 -2.102 . . . . 1.0 105.326 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.501 2.106 0 CA-C-O 118.394 -0.812 . . . . 1.0 109.372 -179.773 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 5.3 p . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.571 HG12 ' HB3' ' A' ' 33' ' ' CYS . 35.1 pt -133.2 152.55 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 114.603 1.335 . . . . 1.0 114.603 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.67 -38.3 63.48 Favored Glycine 0 N--CA 1.482 1.741 0 CA-C-N 111.717 -2.492 . . . . 1.0 110.747 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -32.33 103.11 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 125.918 1.599 . . . . 1.0 110.217 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -39.46 151.96 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.815 1.783 . . . . 1.0 115.815 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 1.4 t -112.87 154.62 26.04 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.222 -1.354 . . . . 1.0 111.47 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.419 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 1.2 t80 -121.31 -62.86 1.38 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 103.684 -2.71 . . . . 1.0 103.684 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -119.89 166.61 13.07 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 111.895 -2.411 . . . . 1.0 106.173 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.467 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.7 m -35.55 -55.47 1.15 Allowed Pre-proline 0 N--CA 1.506 2.364 0 N-CA-C 113.355 0.872 . . . . 1.0 113.355 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.467 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 83.6 Cg_endo -63.64 -94.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.632 1.555 . . . . 1.0 112.011 173.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.0 t70 36.09 34.76 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.373 0 CA-C-O 123.358 1.552 . . . . 1.0 109.316 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.415 ' N ' ' C ' ' A' ' 11' ' ' PRO . 42.7 t -171.14 -19.99 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 110.738 -2.937 . . . . 1.0 112.562 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -38.51 -59.2 0.94 Allowed 'General case' 0 N--CA 1.503 2.215 0 CA-C-N 118.632 0.651 . . . . 1.0 110.93 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 76.1 p -47.58 -39.95 17.98 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.99 1.431 . . . . 1.0 112.153 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.09 -49.35 51.81 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.697 -0.683 . . . . 1.0 109.573 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.6 t -55.09 -40.88 70.9 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.239 -1.393 . . . . 1.0 107.239 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -59.24 -53.53 57.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 106.566 -1.642 . . . . 1.0 106.566 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -48.43 -34.59 11.25 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 113.567 -1.651 . . . . 1.0 109.846 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.4 mt -80.97 -51.58 8.37 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.391 0.886 . . . . 1.0 113.391 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -113.49 -44.72 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-N 117.867 0.303 . . . . 1.0 111.489 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.67 12.86 2.37 Favored Glycine 0 N--CA 1.492 2.387 0 CA-C-O 119.362 -0.688 . . . . 1.0 114.056 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.79 129.99 50.55 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 123.784 0.343 . . . . 1.0 110.515 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.35 68.17 0.75 Allowed 'General case' 0 N--CA 1.506 2.358 0 O-C-N 124.624 1.203 . . . . 1.0 109.417 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.481 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 12.5 p -118.47 -179.94 3.94 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.628 -1.169 . . . . 1.0 113.418 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.8 158.95 12.24 Favored Glycine 0 N--CA 1.493 2.464 0 CA-C-N 113.852 -1.522 . . . . 1.0 113.04 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -127.03 177.23 6.77 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 122.076 0.941 . . . . 1.0 108.524 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.7 t -101.71 111.84 24.22 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 112.492 -2.14 . . . . 1.0 107.829 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 49.9 m -126.23 120.69 30.66 Favored 'General case' 0 N--CA 1.503 2.175 0 CA-C-N 112.1 -2.318 . . . . 1.0 111.559 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 48.76 42.84 20.47 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 113.452 -1.704 . . . . 1.0 109.684 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.15 21.38 61.63 Favored Glycine 0 N--CA 1.486 2.005 0 CA-C-N 113.733 -1.576 . . . . 1.0 113.241 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.8 mtt-85 -133.15 161.45 34.4 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 106.916 -1.513 . . . . 1.0 106.916 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.571 ' HB3' HG12 ' A' ' 3' ' ' ILE . 35.0 t -72.57 141.73 48.42 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.607 1.336 . . . . 1.0 114.607 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.5 t70 -135.24 83.31 2.01 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 125.631 1.832 . . . . 1.0 109.112 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.481 ' SG ' ' C ' ' A' ' 25' ' ' THR . 9.6 t . . . . . 0 N--CA 1.502 2.13 0 C-N-CA 119.25 -0.98 . . . . 1.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 58.0 t . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 109.052 -0.721 . . . . 1.0 109.052 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.521 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 29.2 pt -133.97 163.63 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 115.273 1.583 . . . . 1.0 115.273 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.75 -43.08 96.66 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-N 111.398 -2.637 . . . . 1.0 111.572 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.42 ' HB3' HG13 ' A' ' 3' ' ' ILE . 53.1 tp60 -15.23 88.34 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 O-C-N 126.173 1.749 . . . . 1.0 113.774 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -39.89 134.17 1.49 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 124.88 1.362 . . . . 1.0 110.75 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 9.7 t -116.69 159.19 22.61 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.663 -1.153 . . . . 1.0 113.09 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.44 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 19.1 t80 -119.46 -61.89 1.57 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 104.254 -2.499 . . . . 1.0 104.254 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.432 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -118.15 161.28 20.12 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 112.891 -1.959 . . . . 1.0 110.318 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.425 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 75.8 m -18.42 -60.09 0.05 OUTLIER Pre-proline 0 N--CA 1.506 2.338 0 N-CA-C 117.948 2.573 . . . . 1.0 117.948 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 44.7 Cg_endo -72.44 -96.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.6 1.533 . . . . 1.0 113.185 176.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.404 ' H ' ' HG2' ' A' ' 11' ' ' PRO . 5.5 t0 44.52 28.59 0.33 Allowed 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 122.253 1.025 . . . . 1.0 109.542 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 t -167.07 -22.99 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 113.367 -1.742 . . . . 1.0 114.177 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.453 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 6.6 m-30 -39.12 -62.99 0.58 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 112.228 0.455 . . . . 1.0 112.228 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.1 t -43.36 -46.68 6.61 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 125.358 1.661 . . . . 1.0 111.13 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.434 ' HA ' ' HG2' ' A' ' 19' ' ' LYS . . . -63.61 -45.17 91.53 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 114.035 -1.439 . . . . 1.0 111.224 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.1 t -62.73 -38.97 92.6 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.935 -1.135 . . . . 1.0 107.935 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -60.95 -51.38 69.5 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.434 ' HG2' ' HA ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -70.92 -18.03 62.67 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 118.091 -1.444 . . . . 1.0 112.262 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 mp -87.33 -50.14 6.78 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 112.94 0.719 . . . . 1.0 112.94 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.2 m -112.16 -30.79 2.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 118.832 -0.604 . . . . 1.0 112.172 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.89 -26.62 2.99 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 116.491 1.356 . . . . 1.0 116.491 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -122.65 135.16 54.52 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 114.542 1.312 . . . . 1.0 114.542 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.78 67.72 0.6 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 113.609 -1.632 . . . . 1.0 111.862 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.9 t -131.79 -163.32 1.32 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.543 -0.753 . . . . 1.0 110.364 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.51 -176.06 17.45 Favored Glycine 0 N--CA 1.498 2.81 0 CA-C-N 113.769 -1.56 . . . . 1.0 111.222 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -136.0 171.64 14.18 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.523 0.678 . . . . 1.0 110.021 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.0 t -105.31 114.44 28.63 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 106.406 -1.702 . . . . 1.0 106.406 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.5 m -123.36 118.35 27.31 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 112.6 -2.091 . . . . 1.0 114.304 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 45.16 39.26 3.87 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 114.073 -1.421 . . . . 1.0 112.014 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.6 18.29 79.81 Favored Glycine 0 N--CA 1.476 1.335 0 CA-C-N 112.886 -1.961 . . . . 1.0 115.221 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.7 mtp-105 -135.32 156.41 49.0 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.2 -1.037 . . . . 1.0 108.2 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.521 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 20.1 t -72.9 138.49 46.25 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 116.556 2.058 . . . . 1.0 116.556 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 0.8 OUTLIER -133.36 82.34 1.98 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 125.283 1.615 . . . . 1.0 108.757 178.421 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.499 1.996 0 CA-C-O 116.52 -1.705 . . . . 1.0 110.736 -179.758 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.3 p . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 108.609 -0.885 . . . . 1.0 108.609 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.519 HG12 ' HB3' ' A' ' 33' ' ' CYS . 22.8 pt -129.21 159.72 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 114.929 1.455 . . . . 1.0 114.929 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.32 -45.16 44.87 Favored Glycine 0 N--CA 1.478 1.44 0 CA-C-N 110.755 -2.929 . . . . 1.0 111.63 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.452 ' HB3' HG13 ' A' ' 3' ' ' ILE . 3.7 tp-100 -21.26 90.73 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 O-C-N 125.794 1.526 . . . . 1.0 113.137 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.3 ptt-85 -46.2 142.51 2.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 124.63 1.206 . . . . 1.0 108.689 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 28.0 p -113.32 158.88 20.01 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 118.839 -1.144 . . . . 1.0 112.273 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -116.73 -59.79 1.92 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 105.741 -1.948 . . . . 1.0 105.741 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.3 mtt85 -114.84 169.5 9.03 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 112.058 -2.337 . . . . 1.0 106.879 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.475 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 73.5 m -37.58 -56.26 1.79 Allowed Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 124.776 1.298 . . . . 1.0 111.726 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.475 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 97.9 Cg_endo -64.97 -95.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.248 1.299 . . . . 1.0 112.945 175.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.1 t70 37.19 30.58 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 O-C-N 125.401 1.688 . . . . 1.0 109.578 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.431 ' N ' ' C ' ' A' ' 11' ' ' PRO . 42.7 t -164.81 -22.92 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 111.244 -2.707 . . . . 1.0 112.832 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.426 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.1 m-85 -38.6 -58.61 1.02 Allowed 'General case' 0 N--CA 1.503 2.206 0 CA-C-N 118.306 0.503 . . . . 1.0 110.434 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.4 p -53.54 -44.75 69.47 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 124.635 1.21 . . . . 1.0 111.086 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.23 -57.94 10.65 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 120.35 -0.54 . . . . 1.0 110.933 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.8 t -52.51 -45.24 66.15 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.412 -1.329 . . . . 1.0 107.412 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -50.98 -47.72 61.37 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -62.85 -36.31 82.84 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 114.565 -1.198 . . . . 1.0 110.126 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.46 -54.64 11.48 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 113.64 0.978 . . . . 1.0 113.64 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 m -105.42 -43.58 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 114.103 1.149 . . . . 1.0 114.103 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.28 17.23 2.01 Favored Glycine 0 N--CA 1.494 2.557 0 O-C-N 123.536 0.522 . . . . 1.0 112.199 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -134.14 130.53 37.46 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 123.877 0.398 . . . . 1.0 110.198 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.56 71.68 0.7 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 124.533 1.146 . . . . 1.0 108.555 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.3 p -119.57 177.16 5.04 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.485 -1.234 . . . . 1.0 113.281 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.93 153.35 17.56 Favored Glycine 0 N--CA 1.49 2.261 0 CA-C-N 113.64 -1.618 . . . . 1.0 111.191 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.8 -176.67 3.84 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 124.829 0.958 . . . . 1.0 108.552 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.2 t -108.42 109.34 20.61 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 112.063 -2.335 . . . . 1.0 108.661 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.9 m -136.26 129.34 31.37 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-N 112.683 -2.053 . . . . 1.0 110.066 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 51.15 40.73 26.55 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 112.817 -1.992 . . . . 1.0 107.729 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.35 13.56 44.21 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-N 113.358 -1.746 . . . . 1.0 114.283 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.4 mmt-85 -129.93 159.88 35.3 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.371 -0.974 . . . . 1.0 108.371 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.519 ' HB3' HG12 ' A' ' 3' ' ' ILE . 15.6 t -72.68 140.53 47.95 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.85 1.426 . . . . 1.0 114.85 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 7.7 p-10 -130.7 94.98 3.74 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 105.587 -2.005 . . . . 1.0 105.587 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.502 2.161 0 CA-C-O 118.013 -0.994 . . . . 1.0 110.174 -179.887 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.5 p . . . . . 0 N--CA 1.495 1.785 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.514 HG12 ' HB3' ' A' ' 33' ' ' CYS . 36.6 pt -137.8 165.49 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 115.659 1.725 . . . . 1.0 115.659 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.97 -42.92 95.11 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-N 111.89 -2.414 . . . . 1.0 111.271 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -21.31 98.8 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 O-C-N 125.66 1.447 . . . . 1.0 112.929 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.1 ptt-85 -39.67 141.35 0.41 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 125.146 1.529 . . . . 1.0 112.848 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.419 ' SG ' ' O ' ' A' ' 9' ' ' ARG . 11.9 t -112.69 155.31 24.71 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.644 -1.162 . . . . 1.0 110.712 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -120.41 -61.13 1.61 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 104.986 -2.227 . . . . 1.0 104.986 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.419 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 42.6 mtt85 -117.69 165.29 13.78 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 112.69 -2.05 . . . . 1.0 108.342 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.419 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.0 m -32.02 -53.52 0.53 Allowed Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 125.189 1.556 . . . . 1.0 113.613 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.462 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 49.7 Cg_endo -70.56 -94.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.585 1.523 . . . . 1.0 114.698 169.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 t70 41.17 30.45 0.11 Allowed 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 123.156 1.455 . . . . 1.0 110.062 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.4 t -165.34 -27.91 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 112.14 -2.3 . . . . 1.0 112.524 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.462 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 5.7 m-30 -38.98 -61.48 0.74 Allowed 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 112.834 0.679 . . . . 1.0 112.834 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.9 t -42.49 -43.89 3.86 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 125.39 1.681 . . . . 1.0 110.947 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.43 -43.93 68.92 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.386 -1.279 . . . . 1.0 110.183 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.1 t -60.94 -31.34 70.89 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.117 -1.068 . . . . 1.0 108.117 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -70.48 -53.82 14.77 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.138 -1.801 . . . . 1.0 106.138 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -59.43 -19.19 45.51 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 112.397 -2.183 . . . . 1.0 112.292 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.4 tp -102.92 -54.49 2.62 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 113.357 0.873 . . . . 1.0 113.357 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.5 t -92.88 -41.31 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-N 113.121 -1.854 . . . . 1.0 112.087 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.09 -23.05 3.94 Favored Glycine 0 N--CA 1.488 2.141 0 CA-C-O 119.348 -0.695 . . . . 1.0 113.03 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -126.1 134.98 51.2 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 113.815 1.043 . . . . 1.0 113.815 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.62 70.32 0.67 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 114.331 -1.304 . . . . 1.0 112.355 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.405 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 12.4 t -130.19 -166.74 1.72 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.025 -0.732 . . . . 1.0 109.025 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.4 -176.86 16.53 Favored Glycine 0 N--CA 1.492 2.39 0 CA-C-N 113.495 -1.684 . . . . 1.0 114.879 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HG2' ' N ' ' A' ' 28' ' ' CYS . 24.5 ttmm -133.38 165.54 24.62 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.822 -1.689 . . . . 1.0 109.263 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.409 ' N ' ' HG2' ' A' ' 27' ' ' LYS . 49.6 t -110.03 112.21 24.07 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 103.159 -2.904 . . . . 1.0 103.159 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 89.8 m -125.12 123.52 39.87 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 112.576 -2.102 . . . . 1.0 112.208 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 44.53 41.17 4.5 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 112.878 -1.965 . . . . 1.0 111.552 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.26 27.06 71.97 Favored Glycine 0 N--CA 1.484 1.861 0 CA-C-N 113.254 -1.794 . . . . 1.0 112.72 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.6 mtt-85 -136.32 159.8 40.66 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.703 -1.591 . . . . 1.0 106.703 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.514 ' HB3' HG12 ' A' ' 3' ' ' ILE . 13.0 t -72.87 142.3 47.94 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 113.945 1.091 . . . . 1.0 113.945 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.6 t70 -137.59 73.79 1.46 Allowed 'General case' 0 C--N 1.298 -1.634 0 O-C-N 125.561 1.788 . . . . 1.0 108.358 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 25' ' ' THR . 13.2 t . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 116.712 -1.613 . . . . 1.0 111.194 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 50.3 t . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 109.503 -0.555 . . . . 1.0 109.503 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.658 HG12 ' HB3' ' A' ' 33' ' ' CYS . 33.1 pt -130.43 152.7 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-O 122.58 1.181 . . . . 1.0 113.585 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.73 -35.51 86.51 Favored Glycine 0 N--CA 1.483 1.783 0 CA-C-N 111.385 -2.643 . . . . 1.0 111.895 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.426 ' HB2' HD12 ' A' ' 3' ' ' ILE . 3.4 tm0? -22.56 94.12 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 126.229 1.782 . . . . 1.0 112.318 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -39.53 131.75 1.66 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 124.549 1.156 . . . . 1.0 112.417 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.508 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 4.5 t -111.69 159.6 18.06 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 124.615 1.197 . . . . 1.0 114.001 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.508 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 0.9 OUTLIER -121.38 -57.42 1.84 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 113.365 -1.743 . . . . 1.0 107.644 179.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.471 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 35.5 mmt-85 -115.73 166.56 11.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.35 1.031 . . . . 1.0 110.485 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.431 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.6 m -32.85 -56.92 0.52 Allowed Pre-proline 0 N--CA 1.502 2.158 0 N-CA-C 114.84 1.422 . . . . 1.0 114.84 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.465 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 97.3 Cg_endo -65.96 -92.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.3 1.333 . . . . 1.0 112.723 176.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.405 ' H ' ' HG2' ' A' ' 11' ' ' PRO . 6.0 t0 40.15 32.34 0.12 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 122.993 1.378 . . . . 1.0 108.774 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.3 t -166.94 -26.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 112.47 -2.15 . . . . 1.0 112.223 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.465 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.7 m-85 -38.73 -58.09 1.11 Allowed 'General case' 0 N--CA 1.505 2.32 0 C-N-CA 123.431 0.693 . . . . 1.0 111.6 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.3 t -49.14 -46.67 45.46 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 124.306 1.004 . . . . 1.0 110.641 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.35 -35.26 79.02 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.96 -1.018 . . . . 1.0 112.117 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 25' ' ' THR . 45.5 m -69.77 -35.38 74.87 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.685 -0.857 . . . . 1.0 108.685 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -70.63 -42.84 70.34 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.707 -1.22 . . . . 1.0 107.707 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -69.99 -29.07 66.07 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 112.622 -2.081 . . . . 1.0 113.648 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.63 -34.68 8.09 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.334 1.235 . . . . 1.0 114.334 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.3 t -104.42 -35.7 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 123.943 0.777 . . . . 1.0 109.953 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.23 -30.76 3.8 Favored Glycine 0 N--CA 1.489 2.177 0 C-N-CA 120.803 -0.713 . . . . 1.0 113.879 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.644 ' H ' ' HZ2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -123.84 151.19 43.69 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 120.67 -0.412 . . . . 1.0 111.189 -179.369 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.4 75.27 0.76 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 125.016 1.447 . . . . 1.0 108.643 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.473 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 14.9 t -122.33 -162.8 1.03 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.046 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.459 ' HA3' ' SG ' ' A' ' 35' ' ' CYS . . . 82.6 167.0 39.79 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.488 -1.445 . . . . 1.0 109.488 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -139.36 -172.01 3.26 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 118.676 -1.21 . . . . 1.0 111.508 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.4 t -107.06 117.82 35.06 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 111.41 -2.632 . . . . 1.0 109.191 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.1 m -139.94 134.15 31.15 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 113.474 -1.693 . . . . 1.0 109.885 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 47.61 41.21 13.08 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 113.723 -1.58 . . . . 1.0 109.878 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.65 18.98 53.8 Favored Glycine 0 N--CA 1.491 2.362 0 CA-C-N 113.512 -1.676 . . . . 1.0 114.828 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.8 mtp85 -136.53 157.5 46.63 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.022 -1.473 . . . . 1.0 107.022 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.658 ' HB3' HG12 ' A' ' 3' ' ' ILE . 42.6 t -73.12 139.0 46.13 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.236 1.199 . . . . 1.0 114.236 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -135.79 95.55 3.26 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 102.743 -3.058 . . . . 1.0 102.743 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.459 ' SG ' ' HA3' ' A' ' 26' ' ' GLY . 6.5 t . . . . . 0 N--CA 1.495 1.792 0 CA-C-N 113.546 -1.661 . . . . 1.0 110.746 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 64.8 t . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 108.446 -0.946 . . . . 1.0 108.446 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.502 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 33.5 pt -136.29 166.62 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 115.954 1.835 . . . . 1.0 115.954 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 5' ' ' GLN . . . -61.02 -43.15 99.8 Favored Glycine 0 N--CA 1.473 1.119 0 CA-C-N 111.736 -2.483 . . . . 1.0 111.469 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.408 ' HB3' HG13 ' A' ' 3' ' ' ILE . 4.0 tp-100 -14.84 90.75 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.429 0 O-C-N 125.843 1.554 . . . . 1.0 113.135 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -39.81 133.82 1.51 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 125.224 1.578 . . . . 1.0 110.767 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.484 ' SG ' ' O ' ' A' ' 9' ' ' ARG . 35.2 t -117.6 156.61 27.84 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 124.342 1.026 . . . . 1.0 113.53 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.432 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.3 t80 -120.99 -61.07 1.59 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 105.637 -1.986 . . . . 1.0 105.637 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.484 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 20.4 mtt-85 -114.19 159.98 19.51 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 113.136 -1.847 . . . . 1.0 109.264 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.449 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.3 m -24.5 -56.14 0.15 Allowed Pre-proline 0 N--CA 1.506 2.352 0 O-C-N 125.201 1.563 . . . . 1.0 114.949 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.449 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 67.2 Cg_endo -67.1 -96.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.755 1.637 . . . . 1.0 114.07 170.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.7 t70 38.38 32.28 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 123.539 1.638 . . . . 1.0 109.819 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.6 t -171.46 -18.08 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 111.324 -2.671 . . . . 1.0 113.83 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -38.66 -59.99 0.87 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 112.723 0.638 . . . . 1.0 112.723 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.6 p -46.48 -44.73 17.82 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 124.921 1.388 . . . . 1.0 111.86 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.78 -43.78 87.77 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 114.816 -1.084 . . . . 1.0 109.316 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.6 t -57.81 -50.56 72.86 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.739 -1.578 . . . . 1.0 106.739 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -50.67 -53.93 27.14 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.361 -0.977 . . . . 1.0 108.361 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -51.77 -32.88 32.75 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 112.724 -2.035 . . . . 1.0 110.982 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.0 mt -90.01 -57.82 2.72 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 115.771 1.767 . . . . 1.0 115.771 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 m -99.14 -35.82 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 113.155 0.798 . . . . 1.0 113.155 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.16 -22.32 3.59 Favored Glycine 0 N--CA 1.492 2.393 0 CA-C-O 118.512 -1.16 . . . . 1.0 115.915 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.574 ' H ' ' HD3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -124.56 144.68 50.01 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 118.299 1.05 . . . . 1.0 113.022 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.77 68.85 0.64 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 113.6 -1.636 . . . . 1.0 113.4 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.432 HG23 ' SG ' ' A' ' 35' ' ' CYS . 8.9 t -133.06 -163.24 1.32 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.494 ' CA ' ' SG ' ' A' ' 35' ' ' CYS . . . 122.65 174.98 14.54 Favored Glycine 0 N--CA 1.495 2.579 0 CA-C-N 114.018 -1.446 . . . . 1.0 113.534 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -121.35 161.32 22.28 Favored 'General case' 0 C--O 1.206 -1.22 0 CA-C-N 113.457 -1.372 . . . . 1.0 109.342 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.1 t -111.67 101.7 10.06 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 103.55 -2.759 . . . . 1.0 103.55 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.2 m -118.19 121.32 40.2 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 110.944 -2.844 . . . . 1.0 112.997 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.7 t30 45.29 39.82 4.65 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 113.204 -1.816 . . . . 1.0 111.082 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.37 29.43 75.05 Favored Glycine 0 N--CA 1.486 2.029 0 CA-C-N 112.917 -1.947 . . . . 1.0 112.792 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -139.45 153.04 47.48 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.289 -1.745 . . . . 1.0 106.289 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.502 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 6.1 t -73.8 139.01 44.87 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 117.155 2.28 . . . . 1.0 117.155 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -134.4 80.51 1.86 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 125.54 1.775 . . . . 1.0 107.167 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.494 ' SG ' ' CA ' ' A' ' 26' ' ' GLY . 5.8 t . . . . . 0 N--CA 1.501 2.077 0 CA-C-O 116.239 -1.839 . . . . 1.0 111.455 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 48.9 t . . . . . 0 N--CA 1.496 1.846 0 N-CA-C 106.073 -1.825 . . . . 1.0 106.073 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.55 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 37.3 pt -133.7 160.07 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 114.931 1.456 . . . . 1.0 114.931 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.95 42.76 3.18 Favored Glycine 0 C--O 1.21 -1.349 0 CA-C-N 112.153 -2.294 . . . . 1.0 111.873 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -105.15 107.31 18.22 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 101.891 -3.374 . . . . 1.0 101.891 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -39.09 138.91 0.53 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 125.425 1.703 . . . . 1.0 114.083 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.1 t -112.86 153.12 28.39 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.908 -1.496 . . . . 1.0 110.185 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -120.01 -56.87 1.99 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 104.927 -2.249 . . . . 1.0 104.927 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.439 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -117.89 155.08 30.79 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 113.393 -1.731 . . . . 1.0 106.57 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.46 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 71.9 m -24.01 -56.44 0.14 Allowed Pre-proline 0 N--CA 1.506 2.337 0 N-CA-C 115.137 1.532 . . . . 1.0 115.137 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.46 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 70.1 Cg_endo -67.25 -94.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.79 1.66 . . . . 1.0 113.222 170.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t70 40.93 29.53 0.08 Allowed 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.629 1.204 . . . . 1.0 109.9 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 t -166.33 -24.11 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 111.966 -2.379 . . . . 1.0 112.759 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 6.0 m-30 -38.72 -60.94 0.77 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 112.439 0.533 . . . . 1.0 112.439 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.4 t -44.74 -42.23 7.51 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 125.253 1.596 . . . . 1.0 111.375 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.28 -47.55 60.74 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 115.091 -0.958 . . . . 1.0 109.076 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.1 t -53.99 -40.72 67.17 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.324 -1.362 . . . . 1.0 107.324 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.4 ' HA ' ' N ' ' A' ' 23' ' ' LYS . 32.4 ttmt -60.84 -54.24 47.56 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 105.967 -1.864 . . . . 1.0 105.967 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -48.01 -31.71 5.7 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 113.473 -1.694 . . . . 1.0 110.03 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.7 mt -84.33 -50.84 7.46 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.569 0.952 . . . . 1.0 113.569 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 p -112.63 -45.66 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 CA-C-N 117.806 0.276 . . . . 1.0 111.159 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.18 18.8 1.46 Allowed Glycine 0 N--CA 1.491 2.324 0 CA-C-O 119.067 -0.852 . . . . 1.0 114.774 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.4 ' N ' ' HA ' ' A' ' 18' ' ' LYS . 14.2 mmmm -133.58 126.09 30.22 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 117.291 0.545 . . . . 1.0 112.207 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.43 68.78 0.8 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 124.88 1.362 . . . . 1.0 109.793 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.45 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 9.7 t -135.94 -171.53 2.89 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.679 -0.691 . . . . 1.0 110.088 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.75 -179.31 16.19 Favored Glycine 0 N--CA 1.493 2.467 0 CA-C-N 113.546 -1.661 . . . . 1.0 113.371 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -131.68 171.87 12.95 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 113.982 -1.109 . . . . 1.0 110.845 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.2 t -115.27 112.12 21.95 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 100.375 -3.935 . . . . 1.0 100.375 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.2 m -132.12 127.8 36.78 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 112.227 -2.261 . . . . 1.0 107.929 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.4 p30 46.41 43.89 12.33 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 125.929 2.018 . . . . 1.0 111.903 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.42 13.87 46.14 Favored Glycine 0 N--CA 1.479 1.547 0 CA-C-N 112.876 -1.965 . . . . 1.0 112.463 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.6 mtt-85 -128.21 163.66 24.22 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.863 -1.162 . . . . 1.0 107.863 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.55 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 9.4 t -72.93 142.17 47.84 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 114.702 1.371 . . . . 1.0 114.702 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.487 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 35.6 t70 -135.29 76.69 1.63 Allowed 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 112.454 -2.157 . . . . 1.0 107.324 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 25' ' ' THR . 23.6 t . . . . . 0 N--CA 1.502 2.125 0 CA-C-O 118.261 -0.876 . . . . 1.0 111.306 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.3 p . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 108.31 -0.996 . . . . 1.0 108.31 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.505 HG12 ' HB3' ' A' ' 33' ' ' CYS . 16.5 pt -133.7 163.08 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 115.214 1.561 . . . . 1.0 115.214 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.42 -46.86 36.34 Favored Glycine 0 N--CA 1.478 1.472 0 CA-C-N 111.036 -2.802 . . . . 1.0 112.528 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.402 ' HB3' HG13 ' A' ' 3' ' ' ILE . 3.8 tp-100 -19.83 92.71 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 O-C-N 125.926 1.604 . . . . 1.0 114.085 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -48.17 141.81 5.92 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 124.603 1.19 . . . . 1.0 109.662 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.7 p -123.36 160.55 26.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 124.154 0.909 . . . . 1.0 113.234 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -118.1 -58.57 1.99 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 104.454 -2.424 . . . . 1.0 104.454 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -112.73 166.45 11.35 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 126.166 2.166 . . . . 1.0 106.638 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.456 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 75.4 m -33.66 -61.24 0.4 Allowed Pre-proline 0 N--CA 1.502 2.139 0 N-CA-C 114.614 1.339 . . . . 1.0 114.614 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.456 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 73.2 Cg_endo -61.33 -92.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 121.255 1.304 . . . . 1.0 110.315 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t0 34.77 36.96 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 123.812 1.767 . . . . 1.0 108.765 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.417 ' N ' ' C ' ' A' ' 11' ' ' PRO . 48.5 t -168.72 -26.23 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 110.444 -3.071 . . . . 1.0 111.465 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -37.93 -56.66 1.1 Allowed 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 123.439 0.695 . . . . 1.0 111.489 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 55.0 m -54.63 -40.42 68.93 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 124.391 1.057 . . . . 1.0 111.892 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.96 -52.38 24.84 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 123.591 0.557 . . . . 1.0 110.71 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 t -60.28 -27.73 67.52 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.129 -1.063 . . . . 1.0 108.129 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -70.38 -50.33 39.82 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.769 -1.567 . . . . 1.0 106.769 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -59.81 -29.13 68.02 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 112.77 -2.014 . . . . 1.0 113.085 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -102.02 -35.46 8.95 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.54 1.682 . . . . 1.0 115.54 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.7 t -104.97 -40.49 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 123.61 0.568 . . . . 1.0 110.049 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.12 -29.18 3.09 Favored Glycine 0 N--CA 1.486 1.986 0 CA-C-O 118.894 -0.948 . . . . 1.0 114.166 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -124.77 159.25 31.39 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.095 1.517 . . . . 1.0 115.095 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.03 71.96 0.57 Allowed 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 113.554 -1.657 . . . . 1.0 113.46 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.427 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 2.3 p -119.73 172.13 7.9 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.633 -1.167 . . . . 1.0 112.169 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.95 147.26 9.24 Favored Glycine 0 N--CA 1.491 2.34 0 CA-C-N 113.748 -1.569 . . . . 1.0 111.332 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -121.92 173.68 7.36 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 113.326 -1.437 . . . . 1.0 109.646 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.2 t -103.73 112.1 24.89 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 104.268 -2.493 . . . . 1.0 104.268 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.3 m -130.34 130.34 44.31 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 111.857 -2.429 . . . . 1.0 106.45 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 44.06 44.76 6.4 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 125.123 1.514 . . . . 1.0 111.825 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.46 11.76 22.83 Favored Glycine 0 N--CA 1.487 2.068 0 CA-C-N 112.982 -1.917 . . . . 1.0 114.096 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.2 mtp85 -128.06 163.95 23.48 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.505 ' HB3' HG12 ' A' ' 3' ' ' ILE . 49.5 t -72.41 143.69 48.44 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.212 -1.395 . . . . 1.0 113.819 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 65.2 t0 -133.17 84.08 2.11 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 126.108 2.13 . . . . 1.0 107.077 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' A' ' 25' ' ' THR . 8.8 t . . . . . 0 N--CA 1.503 2.18 0 CA-C-O 118.626 -0.702 . . . . 1.0 110.105 -179.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.8 p . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 108.129 -1.063 . . . . 1.0 108.129 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.529 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 32.7 pt -136.0 160.24 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 N-CA-C 115.794 1.775 . . . . 1.0 115.794 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.21 -44.41 57.51 Favored Glycine 0 N--CA 1.478 1.469 0 CA-C-N 111.093 -2.776 . . . . 1.0 111.183 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.427 ' HB3' HG13 ' A' ' 3' ' ' ILE . 46.5 tp60 -24.42 91.86 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 125.873 1.572 . . . . 1.0 112.856 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -40.0 149.11 0.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 125.263 1.602 . . . . 1.0 112.966 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.412 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 2.1 t -110.1 153.48 24.61 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 124.648 1.218 . . . . 1.0 112.523 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.412 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 1.1 t80 -122.01 -62.35 1.4 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 102.801 -3.037 . . . . 1.0 102.801 179.35 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -119.62 166.11 13.59 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 112.093 -2.321 . . . . 1.0 105.838 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.471 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 75.3 m -33.37 -56.39 0.62 Allowed Pre-proline 0 N--CA 1.505 2.318 0 N-CA-C 114.229 1.196 . . . . 1.0 114.229 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.471 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 88.3 Cg_endo -64.15 -94.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 121.891 1.727 . . . . 1.0 111.826 174.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.0 t70 35.07 36.66 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 CA-C-O 123.844 1.783 . . . . 1.0 109.389 -179.282 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 50.4 t -168.61 -25.25 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 109.8 -3.364 . . . . 1.0 111.567 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -37.86 -57.21 1.04 Allowed 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 122.913 0.485 . . . . 1.0 111.587 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.8 t -49.68 -51.72 36.24 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 125.046 1.466 . . . . 1.0 109.116 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.17 -55.53 32.0 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 120.343 -0.543 . . . . 1.0 112.448 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.7 t -59.2 -27.99 66.23 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 115.397 -0.82 . . . . 1.0 109.499 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -70.12 -46.29 65.08 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 179.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -70.3 -22.6 62.82 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 114.242 -1.344 . . . . 1.0 113.034 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.2 mp -100.03 -33.48 10.47 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 113.911 1.078 . . . . 1.0 113.911 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.0 t -113.06 -43.97 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 124.05 0.844 . . . . 1.0 110.696 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.66 -25.45 3.41 Favored Glycine 0 N--CA 1.49 2.254 0 CA-C-O 119.075 -0.847 . . . . 1.0 114.429 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -120.99 155.87 33.37 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 113.476 0.917 . . . . 1.0 113.476 -179.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.86 69.88 0.71 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 125.084 1.49 . . . . 1.0 109.392 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.8 p -115.32 173.72 6.37 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.496 -1.229 . . . . 1.0 113.273 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.4 152.68 8.81 Favored Glycine 0 N--CA 1.49 2.295 0 CA-C-N 113.844 -1.525 . . . . 1.0 111.199 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -125.1 170.7 10.93 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.342 -1.355 . . . . 1.0 107.342 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.8 t -103.35 109.9 21.69 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.158 -1.793 . . . . 1.0 106.158 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.9 m -133.31 130.73 39.29 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 112.593 -2.094 . . . . 1.0 107.661 -179.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.417 ' ND2' ' HD2' ' A' ' 32' ' ' ARG . 6.1 p-10 44.64 44.17 7.17 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 125.107 1.504 . . . . 1.0 112.103 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.67 14.84 30.91 Favored Glycine 0 N--CA 1.487 2.063 0 CA-C-N 113.125 -1.852 . . . . 1.0 113.125 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.417 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 44.9 mtt-85 -130.65 165.52 22.66 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.552 -0.907 . . . . 1.0 108.552 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.529 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 13.3 t -72.45 144.91 47.93 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.517 -1.273 . . . . 1.0 114.318 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 36.9 t70 -134.98 82.95 1.99 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 126.385 2.303 . . . . 1.0 107.798 179.003 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.503 2.186 0 CA-C-O 116.237 -1.839 . . . . 1.0 110.405 -179.733 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.3 p . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 108.965 -0.754 . . . . 1.0 108.965 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.472 HG12 ' HB3' ' A' ' 33' ' ' CYS . 1.2 pt -131.55 159.12 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 122.278 1.037 . . . . 1.0 113.526 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -39.95 -54.07 3.07 Favored Glycine 0 N--CA 1.483 1.81 0 CA-C-N 111.471 -2.604 . . . . 1.0 112.08 179.528 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -14.0 85.42 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 O-C-N 126.619 2.011 . . . . 1.0 112.923 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -40.15 145.28 0.16 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 113.666 -1.606 . . . . 1.0 112.368 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.5 t -114.91 148.05 39.16 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 124.42 1.075 . . . . 1.0 111.987 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.492 ' HB3' ' HD3' ' A' ' 9' ' ' ARG . 3.7 t80 -123.15 -54.99 1.79 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 103.391 -2.818 . . . . 1.0 103.391 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.492 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -117.13 153.82 32.12 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 113.366 -1.743 . . . . 1.0 107.696 179.665 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.482 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.7 m -28.49 -56.23 0.25 Allowed Pre-proline 0 N--CA 1.504 2.273 0 N-CA-C 114.101 1.149 . . . . 1.0 114.101 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.482 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 86.8 Cg_endo -64.99 -90.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.931 1.754 . . . . 1.0 112.365 170.68 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.408 ' H ' ' HG2' ' A' ' 11' ' ' PRO . 8.4 t70 36.51 34.93 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 123.572 1.653 . . . . 1.0 109.796 -179.448 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.7 t -168.45 -26.09 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 110.427 -3.079 . . . . 1.0 111.117 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -38.6 -58.26 1.07 Allowed 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 122.985 0.514 . . . . 1.0 111.812 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 64.8 p -45.48 -45.15 12.97 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 124.672 1.232 . . . . 1.0 110.957 179.396 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.462 ' HA ' ' HG3' ' A' ' 19' ' ' LYS . . . -66.89 -44.64 80.32 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.433 -1.258 . . . . 1.0 111.109 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 25' ' ' THR . 20.2 m -62.8 -32.38 73.54 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.444 -1.253 . . . . 1.0 108.191 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -70.18 -52.59 22.19 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.265 -1.383 . . . . 1.0 107.265 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HG3' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -71.08 -11.82 61.17 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 117.638 -1.625 . . . . 1.0 111.653 179.986 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 40.9 mt -93.67 -54.97 3.43 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 112.21 0.448 . . . . 1.0 112.21 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.0 m -109.36 -20.32 6.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 118.637 -0.697 . . . . 1.0 112.465 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.46 -33.89 2.59 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 117.83 1.892 . . . . 1.0 117.83 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.571 ' H ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -128.52 162.85 26.26 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 115.458 1.651 . . . . 1.0 115.458 -179.35 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.56 70.63 0.66 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 113.351 -1.749 . . . . 1.0 110.856 179.669 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.422 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 8.2 t -121.58 -177.91 3.67 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.709 0.766 . . . . 1.0 110.687 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.51 174.65 15.24 Favored Glycine 0 N--CA 1.491 2.322 0 CA-C-N 112.941 -1.936 . . . . 1.0 112.096 179.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.459 ' HG2' ' N ' ' A' ' 28' ' ' CYS . 39.0 ttmt -134.19 167.46 20.64 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.78 -1.21 . . . . 1.0 108.51 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.459 ' N ' ' HG2' ' A' ' 27' ' ' LYS . 50.5 t -108.46 110.01 21.43 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 104.88 -2.267 . . . . 1.0 104.88 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.8 m -128.92 124.71 35.86 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 112.609 -2.087 . . . . 1.0 111.962 -179.557 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 44.32 42.16 5.03 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 112.864 -1.971 . . . . 1.0 111.424 -179.365 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.74 24.81 70.05 Favored Glycine 0 N--CA 1.484 1.854 0 CA-C-N 113.567 -1.651 . . . . 1.0 113.525 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.0 mtp85 -136.53 160.28 39.27 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 107.028 -1.471 . . . . 1.0 107.028 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.472 ' HB3' HG12 ' A' ' 3' ' ' ILE . 21.2 t -72.88 145.3 46.98 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.178 -1.409 . . . . 1.0 112.197 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 34.3 t70 -129.75 82.58 2.08 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 103.814 -2.662 . . . . 1.0 103.814 178.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.501 2.079 0 CA-C-O 118.366 -0.826 . . . . 1.0 110.604 -179.406 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.3 p . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 109.884 -0.413 . . . . 1.0 109.884 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.538 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 28.2 pt -133.82 162.43 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 N-CA-C 114.195 1.184 . . . . 1.0 114.195 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.66 44.49 3.26 Favored Glycine 0 C--O 1.211 -1.318 0 CA-C-N 112.201 -2.272 . . . . 1.0 111.955 -179.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -103.88 92.26 4.33 Favored 'General case' 0 N--CA 1.486 1.342 1 N-CA-C 99.934 -4.099 . . . . 1.0 99.934 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -38.98 142.31 0.23 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 125.694 1.871 . . . . 1.0 112.576 -179.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 0.5 OUTLIER -112.77 160.46 17.95 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 116.093 1.886 . . . . 1.0 116.093 -179.605 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.525 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 20.3 t80 -121.24 -58.95 1.76 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 102.794 -3.039 . . . . 1.0 102.794 179.652 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.473 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 11.0 mmm180 -118.14 166.33 12.7 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 113.023 -1.898 . . . . 1.0 109.526 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.473 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.7 m -33.06 -58.7 0.46 Allowed Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 124.997 1.435 . . . . 1.0 114.305 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.473 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 91.1 Cg_endo -62.75 -92.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.951 1.767 . . . . 1.0 111.592 177.14 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 t70 38.24 31.52 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 123.368 1.556 . . . . 1.0 109.144 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.412 ' N ' ' C ' ' A' ' 11' ' ' PRO . 49.1 t -171.55 -17.1 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 111.678 -2.51 . . . . 1.0 113.687 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -38.81 -62.01 0.67 Allowed 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 118.936 0.789 . . . . 1.0 110.451 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.3 m -48.7 -47.48 41.03 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.619 1.2 . . . . 1.0 112.077 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.47 -45.07 92.69 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 114.759 -1.109 . . . . 1.0 111.567 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.1 t -62.87 -48.93 76.9 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 105.802 -1.925 . . . . 1.0 105.802 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.43 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 5.3 ttpm? -47.82 -50.34 26.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 123.373 0.42 . . . . 1.0 110.76 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -70.28 -27.63 64.56 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 117.427 -1.709 . . . . 1.0 111.207 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.0 mt -76.44 -50.97 12.75 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.027 1.121 . . . . 1.0 114.027 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 m -109.37 -36.11 2.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 123.66 0.784 . . . . 1.0 111.955 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.421 ' C ' ' HD3' ' A' ' 23' ' ' LYS . . . 134.51 -20.41 3.92 Favored Glycine 0 N--CA 1.49 2.265 0 CA-C-O 119.083 -0.843 . . . . 1.0 114.726 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.421 ' HD3' ' C ' ' A' ' 22' ' ' GLY . 1.7 mppt? -116.98 136.82 52.65 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 112.709 0.633 . . . . 1.0 112.709 -179.467 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.12 68.37 0.71 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 125.125 1.516 . . . . 1.0 110.749 179.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.452 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 11.2 p -121.87 -175.64 3.15 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.294 -1.321 . . . . 1.0 113.032 -179.491 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.36 154.27 10.96 Favored Glycine 0 N--CA 1.492 2.383 0 CA-C-N 114.075 -1.421 . . . . 1.0 112.356 179.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.38 175.91 6.46 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.086 0.946 . . . . 1.0 109.947 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.9 t -97.37 112.03 24.03 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 112.676 -2.056 . . . . 1.0 106.488 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.417 ' HB ' ' HB2' ' A' ' 34' ' ' ASP . 37.2 m -128.18 119.64 25.67 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 111.971 -2.377 . . . . 1.0 111.933 -179.572 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 50.24 43.57 26.3 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 113.519 -1.673 . . . . 1.0 108.659 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.95 16.39 57.15 Favored Glycine 0 N--CA 1.486 2.022 0 CA-C-N 113.719 -1.582 . . . . 1.0 114.131 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.8 mtp-105 -131.22 161.32 32.49 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.202 -1.036 . . . . 1.0 108.202 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.538 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 47.3 t -72.56 140.65 48.22 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.724 -1.19 . . . . 1.0 114.143 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.417 ' HB2' ' HB ' ' A' ' 29' ' ' THR . 9.4 t70 -135.69 90.63 2.62 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 125.107 1.504 . . . . 1.0 107.13 178.526 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.452 ' SG ' ' C ' ' A' ' 25' ' ' THR . 10.8 t . . . . . 0 N--CA 1.501 2.104 0 CA-C-O 118.588 -0.72 . . . . 1.0 110.313 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 5.8 p . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 108.567 -0.901 . . . . 1.0 108.567 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.61 HG12 ' HB3' ' A' ' 33' ' ' CYS . 35.3 pt -132.02 158.0 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 N-CA-C 114.304 1.224 . . . . 1.0 114.304 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.28 -39.86 73.52 Favored Glycine 0 N--CA 1.488 2.115 0 CA-C-N 111.859 -2.428 . . . . 1.0 111.522 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -28.18 96.59 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 O-C-N 125.867 1.569 . . . . 1.0 111.309 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -39.62 144.1 0.19 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 124.934 1.396 . . . . 1.0 114.447 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.7 p -128.06 157.68 40.03 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.074 -0.966 . . . . 1.0 110.694 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -120.26 -56.69 1.98 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 105.474 -2.047 . . . . 1.0 105.474 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.48 159.9 16.32 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 125.7 1.875 . . . . 1.0 107.158 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.455 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.4 m -35.1 -57.08 0.86 Allowed Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 125.313 1.633 . . . . 1.0 112.894 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.455 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 72.5 Cg_endo -60.54 -91.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.275 1.317 . . . . 1.0 111.056 175.293 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t0 33.47 39.54 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 123.981 1.848 . . . . 1.0 108.794 -179.335 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.9 t -172.75 -26.39 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 109.972 -3.285 . . . . 1.0 110.603 -179.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -38.27 -55.41 1.33 Allowed 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 123.588 0.755 . . . . 1.0 112.084 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.7 p -49.45 -48.98 47.18 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 124.214 0.946 . . . . 1.0 110.68 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.67 -55.26 36.57 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 124.03 0.831 . . . . 1.0 109.58 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 25' ' ' THR . 98.6 m -48.86 -41.56 33.6 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.194 -1.366 . . . . 1.0 111.064 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.451 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 6.6 ttpm? -66.65 -47.01 73.87 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.559 -1.645 . . . . 1.0 106.559 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -70.27 -11.51 60.95 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 113.384 -1.735 . . . . 1.0 112.348 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.3 mt -101.52 -53.28 3.02 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 112.684 0.624 . . . . 1.0 112.684 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.7 m -109.13 -26.35 3.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 119.19 -0.433 . . . . 1.0 111.633 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 126.68 -20.17 6.12 Favored Glycine 0 N--CA 1.493 2.434 0 CA-C-O 119.026 -0.874 . . . . 1.0 114.969 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.509 ' HB2' ' HZ3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -122.66 141.84 51.32 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 113.22 0.822 . . . . 1.0 113.22 -179.497 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.99 71.71 0.82 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 125.214 1.571 . . . . 1.0 110.108 179.365 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.515 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 6.0 t -122.64 179.1 4.73 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.748 0.785 . . . . 1.0 112.036 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.08 167.67 18.88 Favored Glycine 0 N--CA 1.498 2.774 0 CA-C-N 113.271 -1.786 . . . . 1.0 111.813 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.402 ' HB3' ' NZ ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -132.68 175.89 8.93 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.721 0.772 . . . . 1.0 109.955 179.95 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.4 t -103.07 116.13 31.93 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 113.31 -1.768 . . . . 1.0 106.44 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 78.4 m -127.93 127.29 43.07 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 112.525 -2.125 . . . . 1.0 109.747 -179.571 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 47.47 40.59 11.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 125.096 1.498 . . . . 1.0 111.062 -179.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.07 19.88 64.19 Favored Glycine 0 N--CA 1.483 1.832 0 CA-C-N 113.281 -1.781 . . . . 1.0 113.916 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.0 mtt-85 -132.7 162.51 31.22 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.479 -1.304 . . . . 1.0 107.479 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.61 ' HB3' HG12 ' A' ' 3' ' ' ILE . 41.8 t -72.79 143.64 47.83 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.889 -1.124 . . . . 1.0 113.243 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 36.8 t70 -134.75 78.1 1.72 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 104.128 -2.545 . . . . 1.0 104.128 178.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.1 t . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 117.863 -1.065 . . . . 1.0 111.078 -179.408 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 5.7 p . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 108.426 -0.953 . . . . 1.0 108.426 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.53 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 27.4 pt -136.7 164.23 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 N-CA-C 114.809 1.411 . . . . 1.0 114.809 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.35 -43.51 76.06 Favored Glycine 0 N--CA 1.479 1.532 0 CA-C-N 112.051 -2.34 . . . . 1.0 112.08 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.401 ' HB3' HG13 ' A' ' 3' ' ' ILE . 52.4 tp60 -17.14 90.91 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 O-C-N 125.723 1.484 . . . . 1.0 114.12 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -39.96 136.5 1.11 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 125.065 1.478 . . . . 1.0 111.338 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 10.1 t -119.52 159.33 24.53 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 114.276 1.213 . . . . 1.0 114.276 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.503 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 15.4 t80 -120.53 -62.89 1.41 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 105.519 -2.03 . . . . 1.0 105.519 179.728 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.489 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 1.6 mmp_? -113.8 161.67 17.27 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.598 -1.637 . . . . 1.0 108.753 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.43 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 62.1 m -23.84 -59.21 0.12 Allowed Pre-proline 0 N--CA 1.504 2.27 0 N-CA-C 115.695 1.739 . . . . 1.0 115.695 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.43 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 77.5 Cg_endo -66.92 -93.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.157 0 C-N-CA 121.265 1.31 . . . . 1.0 113.86 176.339 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t0 40.23 33.52 0.17 Allowed 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 123.253 1.501 . . . . 1.0 108.942 -179.486 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.1 t -168.74 -24.21 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 111.859 -2.428 . . . . 1.0 112.827 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.414 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.2 m-85 -38.6 -59.72 0.89 Allowed 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 123.159 0.584 . . . . 1.0 111.967 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 77.8 p -48.05 -41.91 27.15 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 124.923 1.39 . . . . 1.0 111.893 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.98 -49.06 55.39 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.637 -0.711 . . . . 1.0 110.735 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 t -60.32 -29.87 69.14 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -70.81 -50.19 38.22 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.302 -1.37 . . . . 1.0 107.302 179.287 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -70.65 -13.4 62.07 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 113.225 -1.807 . . . . 1.0 113.719 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.8 mt -109.93 -43.37 4.01 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.363 0.875 . . . . 1.0 113.363 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.4 t -102.54 -34.71 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 114.859 -1.064 . . . . 1.0 110.323 -179.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.24 -31.65 3.11 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-O 119.105 -0.83 . . . . 1.0 114.175 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -123.6 150.82 43.66 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 113.725 1.009 . . . . 1.0 113.725 -179.348 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.42 72.99 0.71 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 113.827 -1.533 . . . . 1.0 109.815 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.429 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 17.9 p -117.11 -179.0 3.57 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.705 -1.134 . . . . 1.0 112.252 -179.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.03 166.5 13.24 Favored Glycine 0 N--CA 1.494 2.504 0 CA-C-N 114.515 -1.22 . . . . 1.0 115.34 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.561 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -134.05 168.58 18.55 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 112.847 -1.677 . . . . 1.0 107.282 179.696 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.439 ' N ' ' HG3' ' A' ' 27' ' ' LYS . 30.7 t -107.98 104.86 14.4 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 104.471 -2.418 . . . . 1.0 104.471 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.7 m -122.31 124.36 43.56 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 111.575 -2.557 . . . . 1.0 111.208 -179.371 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 46.62 39.86 7.59 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 112.89 -1.959 . . . . 1.0 110.921 -179.321 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.96 27.21 70.96 Favored Glycine 0 N--CA 1.485 1.914 0 CA-C-N 113.106 -1.861 . . . . 1.0 112.513 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.0 mtt-85 -137.36 161.27 36.74 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.334 -1.358 . . . . 1.0 107.334 179.688 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.53 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 46.8 t -72.38 143.39 48.6 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.854 1.057 . . . . 1.0 113.854 179.692 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 34.2 t70 -136.39 81.99 1.91 Allowed 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.502 -1.681 . . . . 1.0 108.641 178.869 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.429 ' SG ' ' C ' ' A' ' 25' ' ' THR . 12.3 t . . . . . 0 N--CA 1.499 1.994 0 CA-C-O 116.148 -1.882 . . . . 1.0 110.828 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.588 HG12 ' HB3' ' A' ' 33' ' ' CYS . 19.6 pt -125.7 150.61 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-O 122.697 1.237 . . . . 1.0 113.594 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.79 -39.29 46.93 Favored Glycine 0 N--CA 1.479 1.505 0 CA-C-N 110.914 -2.857 . . . . 1.0 112.478 179.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -30.9 93.37 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 125.665 1.45 . . . . 1.0 112.89 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -40.44 144.38 0.24 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 124.879 1.362 . . . . 1.0 111.997 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.0 p -121.42 160.69 23.59 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 124.039 0.837 . . . . 1.0 110.985 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.475 ' HB3' ' HD3' ' A' ' 9' ' ' ARG . 3.4 t80 -119.96 -57.68 1.93 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.578 -1.267 . . . . 1.0 107.578 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.475 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -108.18 164.87 11.92 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 113.269 -1.787 . . . . 1.0 107.152 -179.975 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.485 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.1 m -39.25 -56.5 2.64 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 124.782 1.301 . . . . 1.0 112.095 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.485 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 84.0 Cg_endo -64.83 -93.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 121.252 1.301 . . . . 1.0 111.238 173.048 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.8 t70 35.51 35.12 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 125.411 1.695 . . . . 1.0 109.635 -179.614 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.404 ' N ' ' C ' ' A' ' 11' ' ' PRO . 36.7 t -167.74 -28.79 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 110.399 -3.092 . . . . 1.0 110.37 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -37.62 -52.24 1.21 Allowed 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 123.822 0.849 . . . . 1.0 112.438 179.697 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.8 m -56.51 -61.1 2.65 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.994 -0.743 . . . . 1.0 108.994 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.93 -54.69 5.14 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 124.314 1.008 . . . . 1.0 111.052 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 25' ' ' THR . 17.4 m -49.48 -54.42 17.88 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 113.366 -1.743 . . . . 1.0 107.601 179.473 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.428 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 5.7 ttpm? -50.01 -47.78 52.88 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 179.576 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -19.74 63.1 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 114.972 -1.013 . . . . 1.0 112.489 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.8 mt -92.41 -50.27 5.72 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 114.478 1.288 . . . . 1.0 114.478 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.5 m -105.51 -30.56 2.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 C-N-CA 123.477 0.711 . . . . 1.0 111.293 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.72 -28.12 3.43 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 116.165 1.226 . . . . 1.0 116.165 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -124.5 156.03 37.96 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 114.161 1.171 . . . . 1.0 114.161 -179.341 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.45 72.85 0.72 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 113.803 -1.544 . . . . 1.0 110.218 179.781 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.504 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 7.5 t -128.41 -176.26 3.76 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.745 0.783 . . . . 1.0 110.431 -179.839 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.5 160.33 30.04 Favored Glycine 0 N--CA 1.494 2.515 0 CA-C-N 113.411 -1.722 . . . . 1.0 109.605 179.713 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.85 -172.39 2.86 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.333 1.063 . . . . 1.0 111.127 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.1 t -110.92 114.81 28.41 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 111.482 -2.599 . . . . 1.0 107.398 179.571 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.2 m -139.64 133.25 30.39 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 113.161 -1.836 . . . . 1.0 109.286 -179.781 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 49.22 42.19 21.21 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 113.958 -1.474 . . . . 1.0 108.208 -179.545 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 58.41 14.57 20.67 Favored Glycine 0 N--CA 1.49 2.287 0 CA-C-N 113.745 -1.57 . . . . 1.0 114.871 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.6 mtp-105 -130.45 160.01 35.35 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.112 -1.44 . . . . 1.0 107.112 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.588 ' HB3' HG12 ' A' ' 3' ' ' ILE . 14.6 t -73.38 143.17 46.93 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.136 -1.426 . . . . 1.0 113.381 -179.937 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -129.05 88.18 2.67 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 101.23 -3.619 . . . . 1.0 101.23 178.43 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.502 2.134 0 CA-C-O 117.001 -1.476 . . . . 1.0 111.535 -179.482 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.0 p . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 108.518 -0.919 . . . . 1.0 108.518 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.509 HG12 ' HB3' ' A' ' 33' ' ' CYS . 19.1 pt -134.39 165.26 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 N-CA-C 115.148 1.536 . . . . 1.0 115.148 -179.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -53.14 -48.0 59.76 Favored Glycine 0 N--CA 1.478 1.465 0 CA-C-N 111.096 -2.775 . . . . 1.0 111.575 179.847 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -20.51 86.49 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.474 0 O-C-N 125.882 1.578 . . . . 1.0 113.034 -179.917 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -40.0 146.58 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.097 -1.411 . . . . 1.0 112.37 -179.961 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.404 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 5.6 t -110.09 152.36 26.08 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 124.582 1.176 . . . . 1.0 113.465 -179.918 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.404 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 1.8 t80 -125.39 -58.73 1.42 Allowed 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 102.465 -3.161 . . . . 1.0 102.465 179.498 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.04 161.0 20.99 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.376 -1.712 . . . . 1.0 106.376 179.306 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.496 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 73.2 m -30.96 -57.39 0.36 Allowed Pre-proline 0 N--CA 1.506 2.369 0 N-CA-C 114.429 1.27 . . . . 1.0 114.429 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.496 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 83.9 Cg_endo -63.93 -93.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.919 1.746 . . . . 1.0 111.17 173.763 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 t70 36.55 34.12 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 CA-C-O 123.294 1.521 . . . . 1.0 109.375 -179.483 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.422 ' N ' ' C ' ' A' ' 11' ' ' PRO . 54.0 t -169.26 -21.59 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 110.579 -3.009 . . . . 1.0 112.453 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -38.65 -58.51 1.04 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 118.469 0.577 . . . . 1.0 111.64 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.2 t -50.32 -39.64 46.53 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.963 1.414 . . . . 1.0 111.828 179.574 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.16 -48.71 56.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 123.516 0.51 . . . . 1.0 111.137 179.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.0 t -61.94 -32.91 73.37 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.425 -1.324 . . . . 1.0 107.425 179.705 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.416 ' O ' ' N ' ' A' ' 22' ' ' GLY . 24.7 ttmm -65.04 -53.72 41.41 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 105.62 -1.992 . . . . 1.0 105.62 179.594 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -50.26 -35.56 27.54 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 114.181 -1.372 . . . . 1.0 109.189 179.692 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.0 tp -67.66 -60.06 2.84 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 114.824 -1.08 . . . . 1.0 111.669 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.09 -48.48 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 124.253 0.97 . . . . 1.0 113.046 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 133.45 23.98 0.71 Allowed Glycine 0 N--CA 1.492 2.376 0 O-C-N 123.417 0.448 . . . . 1.0 113.484 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -133.46 131.37 39.82 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.481 -0.563 . . . . 1.0 109.481 179.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.18 68.06 0.7 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 124.722 1.264 . . . . 1.0 109.63 179.364 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.6 p -115.37 174.92 5.75 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.482 -1.235 . . . . 1.0 112.895 -179.647 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.51 152.89 8.57 Favored Glycine 0 N--CA 1.489 2.213 0 CA-C-N 113.74 -1.573 . . . . 1.0 111.605 179.72 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 36.8 mtmm -122.71 174.78 6.89 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 113.637 -1.282 . . . . 1.0 108.245 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.2 t -110.17 109.06 19.43 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 105.36 -2.089 . . . . 1.0 105.36 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.2 m -133.07 126.08 31.03 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 112.264 -2.244 . . . . 1.0 108.382 -179.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.3 p30 47.52 41.3 12.86 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 125.907 2.004 . . . . 1.0 112.345 -179.459 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.63 13.77 59.3 Favored Glycine 0 N--CA 1.478 1.435 0 CA-C-N 113.15 -1.841 . . . . 1.0 112.145 -179.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.7 mmt-85 -128.6 161.94 28.45 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.668 -0.864 . . . . 1.0 108.668 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.509 ' HB3' HG12 ' A' ' 3' ' ' ILE . 12.5 t -72.6 143.56 48.18 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.461 -1.296 . . . . 1.0 113.392 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 9.9 t70 -134.16 84.31 2.11 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 125.971 2.045 . . . . 1.0 106.555 179.117 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.503 2.203 0 CA-C-O 118.415 -0.802 . . . . 1.0 110.472 -179.784 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.7 p . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.45 -0.574 . . . . 1.0 109.45 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.592 HG12 ' HB3' ' A' ' 33' ' ' CYS . 15.6 pt -128.19 152.89 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 122.265 1.031 . . . . 1.0 113.719 -179.883 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -46.91 -41.35 13.66 Favored Glycine 0 N--CA 1.489 2.191 0 CA-C-N 111.15 -2.75 . . . . 1.0 112.717 179.864 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.452 HE22 ' HA ' ' A' ' 13' ' ' CYS . 1.2 tm0? -28.46 99.79 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 125.501 1.353 . . . . 1.0 112.215 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -39.96 147.36 0.09 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 124.824 1.327 . . . . 1.0 113.711 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.462 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 5.2 t -113.77 157.74 21.87 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.998 -1.001 . . . . 1.0 110.985 -179.95 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.462 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.1 t80 -119.65 -62.79 1.45 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 103.189 -2.893 . . . . 1.0 103.189 179.731 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -124.97 171.45 10.2 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.141 -1.39 . . . . 1.0 107.946 179.65 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.443 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 61.1 m -31.69 -56.34 0.44 Allowed Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 125.07 1.482 . . . . 1.0 114.045 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.443 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 63.1 Cg_endo -68.94 -94.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.674 1.583 . . . . 1.0 113.748 173.058 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.2 t70 38.17 32.54 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 CA-C-O 123.158 1.456 . . . . 1.0 109.806 -179.461 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.452 ' HA ' HE22 ' A' ' 5' ' ' GLN . 22.3 t -165.44 -25.74 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 111.341 -2.663 . . . . 1.0 111.618 -179.912 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -38.79 -59.83 0.91 Allowed 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 123.131 0.572 . . . . 1.0 112.466 179.717 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.6 m -45.13 -43.85 10.14 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 124.805 1.316 . . . . 1.0 110.987 179.609 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.02 -50.85 60.77 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.954 -1.021 . . . . 1.0 109.817 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.1 m -54.0 -34.58 60.24 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.755 -1.111 . . . . 1.0 110.276 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -70.65 -51.19 29.52 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.012 -1.848 . . . . 1.0 106.012 179.425 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -70.73 -8.95 55.98 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 113.653 -1.612 . . . . 1.0 113.049 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.72 -51.56 3.16 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 123.4 0.437 . . . . 1.0 110.096 -179.78 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.8 t -104.91 -35.73 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 114.727 -1.124 . . . . 1.0 112.437 -179.319 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 139.42 -30.56 2.41 Favored Glycine 0 N--CA 1.485 1.931 0 CA-C-O 118.676 -1.069 . . . . 1.0 114.667 179.779 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.51 ' HD3' ' N ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -123.01 150.65 42.75 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 114.424 1.268 . . . . 1.0 114.424 -179.529 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.5 70.49 0.64 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 113.504 -1.68 . . . . 1.0 112.022 179.76 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.9 t -124.12 -174.79 3.08 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.931 0.872 . . . . 1.0 110.791 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.38 -178.75 16.32 Favored Glycine 0 N--CA 1.492 2.425 0 CA-C-N 113.007 -1.906 . . . . 1.0 112.125 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.497 ' NZ ' ' H ' ' A' ' 28' ' ' CYS . 0.2 OUTLIER -143.46 170.65 15.4 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.78 -1.21 . . . . 1.0 108.245 179.94 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.497 ' H ' ' NZ ' ' A' ' 27' ' ' LYS . 49.4 t -108.87 115.27 29.76 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.203 -1.777 . . . . 1.0 106.203 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.415 ' CB ' ' HB2' ' A' ' 34' ' ' ASP . 95.3 m -132.33 128.48 37.78 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 113.142 -1.845 . . . . 1.0 112.28 -179.632 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 46.67 40.52 8.71 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 113.571 -1.649 . . . . 1.0 110.312 -179.707 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.55 28.22 64.78 Favored Glycine 0 N--CA 1.487 2.07 0 CA-C-N 113.544 -1.662 . . . . 1.0 112.705 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.6 mtt-85 -136.83 163.74 29.94 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.3 -1.741 . . . . 1.0 106.3 179.682 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.592 ' HB3' HG12 ' A' ' 3' ' ' ILE . 30.5 t -72.76 144.84 47.46 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 118.612 -1.235 . . . . 1.0 112.777 179.682 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 11.3 t70 -129.95 81.64 2.02 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 105.595 -2.002 . . . . 1.0 105.595 178.722 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.502 2.145 0 C-N-CA 119.259 -0.976 . . . . 1.0 110.305 -179.496 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.7 p . . . . . 0 N--CA 1.497 1.913 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.497 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 24.1 pt -137.17 165.3 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 N-CA-C 116.575 2.065 . . . . 1.0 116.575 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.77 -48.41 36.87 Favored Glycine 0 N--CA 1.477 1.422 0 CA-C-N 109.94 -3.3 . . . . 1.0 111.347 179.643 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.424 ' HB3' HG13 ' A' ' 3' ' ' ILE . 3.6 tp-100 -23.44 89.77 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 O-C-N 125.787 1.522 . . . . 1.0 113.083 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 -47.69 148.66 1.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.409 -1.269 . . . . 1.0 110.838 179.85 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 8.7 t -117.11 156.36 27.74 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.982 1.104 . . . . 1.0 113.982 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.45 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.9 t80 -123.36 -56.76 1.7 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 105.104 -2.184 . . . . 1.0 105.104 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.468 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -116.32 152.13 34.5 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 112.879 -1.964 . . . . 1.0 108.102 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.463 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.4 m -22.67 -59.07 0.1 OUTLIER Pre-proline 0 N--CA 1.506 2.369 0 N-CA-C 115.581 1.697 . . . . 1.0 115.581 -179.857 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.47 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 98.6 Cg_endo -65.67 -91.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.45 1.433 . . . . 1.0 113.223 174.161 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.407 ' H ' ' HG2' ' A' ' 11' ' ' PRO . 6.4 t70 41.0 30.74 0.11 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 123.023 1.392 . . . . 1.0 109.166 -179.56 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.3 t -167.3 -24.88 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 112.294 -2.23 . . . . 1.0 112.737 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.47 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.2 m-85 -38.93 -59.59 0.95 Allowed 'General case' 0 N--CA 1.505 2.315 0 C-N-CA 122.947 0.499 . . . . 1.0 111.81 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 p -48.75 -39.88 26.62 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 125.01 1.444 . . . . 1.0 111.776 179.63 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.404 ' HA ' ' HZ3' ' A' ' 19' ' ' LYS . . . -70.19 -50.38 40.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 123.999 0.812 . . . . 1.0 110.662 179.855 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.7 t -60.09 -30.01 68.96 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.537 -0.912 . . . . 1.0 108.537 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -70.44 -49.87 44.26 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.884 -1.154 . . . . 1.0 107.884 179.211 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HZ3' ' HA ' ' A' ' 16' ' ' ALA . 7.1 ttpm? -70.4 -15.11 62.8 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.102 -1.863 . . . . 1.0 113.06 -179.918 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.8 mt -108.41 -43.36 4.35 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 113.852 1.056 . . . . 1.0 113.852 -179.745 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.4 t -101.46 -35.29 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-N 114.802 -1.09 . . . . 1.0 110.081 -179.724 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.23 -32.14 2.9 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 120.69 -0.767 . . . . 1.0 114.106 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -125.72 153.41 43.97 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 113.722 1.008 . . . . 1.0 113.722 -179.465 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.79 74.59 0.6 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 113.818 -1.537 . . . . 1.0 113.556 -179.735 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.432 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 0.9 OUTLIER -120.7 -178.27 3.68 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.705 -1.134 . . . . 1.0 111.333 179.906 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.71 163.1 11.83 Favored Glycine 0 N--CA 1.492 2.432 0 CA-C-N 114.351 -1.295 . . . . 1.0 113.35 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -131.53 166.13 22.05 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 113.636 -1.282 . . . . 1.0 108.167 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.6 t -103.32 94.64 5.61 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 103.138 -2.912 . . . . 1.0 103.138 179.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 83.1 m -112.97 115.1 27.86 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 109.984 -3.28 . . . . 1.0 112.482 -179.328 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 48.75 41.11 17.48 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 111.453 -2.612 . . . . 1.0 108.739 -179.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.0 28.31 72.61 Favored Glycine 0 N--CA 1.482 1.74 0 CA-C-N 113.364 -1.743 . . . . 1.0 112.434 -179.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -137.6 157.25 46.91 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 106.173 -1.788 . . . . 1.0 106.173 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.497 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 34.5 t -72.78 140.74 47.92 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.451 -1.3 . . . . 1.0 113.913 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 25.6 t70 -135.55 86.56 2.25 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 125.382 1.676 . . . . 1.0 108.54 178.729 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.432 ' SG ' ' C ' ' A' ' 25' ' ' THR . 8.1 t . . . . . 0 N--CA 1.5 2.058 0 CA-C-O 116.292 -1.813 . . . . 1.0 110.58 -179.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.2 p . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 108.299 -1.0 . . . . 1.0 108.299 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.573 HG12 ' HB3' ' A' ' 33' ' ' CYS . 27.8 pt -131.47 164.53 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 113.7 1.0 . . . . 1.0 113.7 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.99 44.88 3.43 Favored Glycine 0 C--O 1.21 -1.393 0 CA-C-N 112.595 -2.093 . . . . 1.0 112.124 -179.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -100.27 104.94 16.45 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 102.699 -3.074 . . . . 1.0 102.699 179.59 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -39.01 129.39 1.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 113.229 -1.805 . . . . 1.0 112.7 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 24.0 t -120.93 163.09 18.77 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.481 -1.691 . . . . 1.0 112.372 179.794 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.519 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 13.2 t80 -119.8 -64.8 1.22 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 104.855 -2.276 . . . . 1.0 104.855 179.676 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.448 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -119.62 163.69 16.99 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 112.468 -2.151 . . . . 1.0 111.897 179.736 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.3 m -16.49 -62.79 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.231 0 N-CA-C 117.566 2.432 . . . . 1.0 117.566 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.426 ' HG2' ' H ' ' A' ' 12' ' ' ASP . 71.3 Cg_endo -68.48 -92.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 121.343 1.362 . . . . 1.0 112.213 178.837 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.441 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 4.1 t0 36.63 35.18 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 123.502 1.62 . . . . 1.0 109.961 -179.671 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.0 t -168.3 -23.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 110.761 -2.927 . . . . 1.0 111.764 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -38.35 -56.53 1.23 Allowed 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 123.955 0.902 . . . . 1.0 113.225 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.0 t -46.08 -53.26 10.56 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 124.685 1.24 . . . . 1.0 109.326 179.496 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.07 -39.62 90.58 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 113.73 -1.577 . . . . 1.0 112.292 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 25' ' ' THR . 60.0 m -69.14 -28.68 66.66 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.842 -1.072 . . . . 1.0 108.576 179.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -71.05 -52.78 17.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.061 -1.459 . . . . 1.0 107.061 179.319 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -71.04 -19.86 62.45 Favored 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 118.091 -1.444 . . . . 1.0 114.767 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -105.92 -33.79 7.83 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 113.313 0.857 . . . . 1.0 113.313 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 t -106.89 -30.97 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 123.722 0.638 . . . . 1.0 110.07 -179.563 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.67 -34.91 2.77 Favored Glycine 0 N--CA 1.49 2.249 0 O-C-N 123.855 0.722 . . . . 1.0 114.584 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -135.81 169.29 17.8 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 113.245 0.831 . . . . 1.0 113.245 -179.363 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.86 69.33 0.69 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 113.683 -1.598 . . . . 1.0 110.797 179.521 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.5 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 4.5 t -121.67 179.01 4.61 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.61 -179.818 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.97 175.06 18.9 Favored Glycine 0 N--CA 1.493 2.459 0 CA-C-N 113.292 -1.776 . . . . 1.0 111.965 179.847 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.94 175.65 9.04 Favored 'General case' 0 C--O 1.205 -1.277 0 CA-C-O 122.074 0.94 . . . . 1.0 112.73 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.7 t -114.63 109.44 18.23 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 112.396 -2.183 . . . . 1.0 105.429 -179.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.9 m -126.47 126.44 43.76 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 112.103 -2.317 . . . . 1.0 110.952 -179.501 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 m120 45.18 40.86 5.3 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 113.464 -1.698 . . . . 1.0 111.52 -179.52 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.1 27.42 68.89 Favored Glycine 0 N--CA 1.485 1.942 0 CA-C-N 113.415 -1.72 . . . . 1.0 112.412 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.6 mtt-85 -136.63 160.54 38.5 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.385 -1.709 . . . . 1.0 106.385 179.796 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.573 ' HB3' HG12 ' A' ' 3' ' ' ILE . 38.9 t -73.06 144.52 47.04 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.609 -1.237 . . . . 1.0 113.076 179.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 32.6 t70 -133.89 76.45 1.66 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.048 -2.204 . . . . 1.0 105.048 178.742 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.1 t . . . . . 0 N--CA 1.501 2.1 0 CA-C-O 117.761 -1.114 . . . . 1.0 111.34 -179.341 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.444 ' H2 ' ' HB3' ' A' ' 35' ' ' CYS . 14.1 t . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 108.555 -0.906 . . . . 1.0 108.555 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.431 ' N ' HG12 ' A' ' 1' ' ' VAL . 7.7 p -71.05 123.17 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 114.477 -1.238 . . . . 1.0 109.688 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.569 HG12 ' HB3' ' A' ' 33' ' ' CYS . 14.6 pt -125.59 159.66 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 122.818 1.294 . . . . 1.0 113.348 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.74 43.71 3.27 Favored Glycine 0 C--O 1.204 -1.731 0 CA-C-N 112.029 -2.35 . . . . 1.0 113.389 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -105.83 88.23 2.77 Favored 'General case' 0 C--N 1.308 -1.208 1 N-CA-C 98.638 -4.578 . . . . 1.0 98.638 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -38.94 147.19 0.06 Allowed 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 113.275 -1.784 . . . . 1.0 113.401 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 0.5 OUTLIER -112.49 160.64 17.58 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 116.919 2.192 . . . . 1.0 116.919 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.533 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.7 t80 -123.11 -58.68 1.63 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 103.301 -2.851 . . . . 1.0 103.301 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.413 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 42.6 mtt85 -116.36 165.2 13.48 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 112.689 -2.05 . . . . 1.0 110.018 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.458 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 67.3 m -34.73 -59.2 0.62 Allowed Pre-proline 0 N--CA 1.503 2.216 0 O-C-N 124.731 1.269 . . . . 1.0 113.54 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.458 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 88.2 Cg_endo -62.18 -86.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.056 0 C-N-CA 121.976 1.784 . . . . 1.0 112.253 176.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.41 ' H ' ' HG2' ' A' ' 11' ' ' PRO . 6.1 t70 34.16 36.89 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 CA-C-O 124.305 2.002 . . . . 1.0 109.129 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.402 ' N ' ' C ' ' A' ' 11' ' ' PRO . 15.9 t -170.05 -27.18 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 110.21 -3.177 . . . . 1.0 111.502 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -38.2 -55.45 1.3 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 123.712 0.632 . . . . 1.0 112.18 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 61.8 m -50.49 -51.78 44.3 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 124.386 1.054 . . . . 1.0 110.074 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.438 ' HA ' ' HG3' ' A' ' 19' ' ' LYS . . . -58.18 -47.54 83.09 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 122.825 1.297 . . . . 1.0 111.515 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 25' ' ' THR . 35.5 m -58.68 -39.55 81.02 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 113.735 -1.575 . . . . 1.0 108.688 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -64.7 -52.16 58.65 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.282 -1.377 . . . . 1.0 107.282 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HG3' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -71.58 -10.72 60.21 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 117.677 -1.609 . . . . 1.0 113.129 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.7 mt -92.61 -50.35 5.64 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 119.409 -0.329 . . . . 1.0 111.549 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.7 p -114.07 -32.38 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 123.481 0.488 . . . . 1.0 110.69 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.99 -19.75 3.67 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 116.031 1.172 . . . . 1.0 116.031 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -128.42 151.28 49.56 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 114.54 1.311 . . . . 1.0 114.54 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.2 70.76 0.84 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 113.784 -1.553 . . . . 1.0 110.403 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.512 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 5.1 t -122.9 176.39 6.03 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.9 0.857 . . . . 1.0 112.298 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.69 160.37 27.81 Favored Glycine 0 N--CA 1.493 2.467 0 CA-C-N 112.671 -2.058 . . . . 1.0 110.197 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.415 ' HD3' ' H ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -130.4 -178.33 4.72 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.359 1.076 . . . . 1.0 112.824 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 38.7 t -90.12 109.39 20.45 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 111.895 -2.411 . . . . 1.0 107.809 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.434 ' CB ' ' HB2' ' A' ' 34' ' ' ASP . 44.0 m -126.34 119.53 27.58 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 111.679 -2.509 . . . . 1.0 110.992 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 50.33 43.43 26.63 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.453 -1.703 . . . . 1.0 109.013 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.94 20.55 53.65 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-N 113.623 -1.626 . . . . 1.0 113.026 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.0 mtt85 -132.86 160.87 35.7 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.095 -1.446 . . . . 1.0 107.095 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.569 ' HB3' HG12 ' A' ' 3' ' ' ILE . 42.9 t -73.22 142.07 47.31 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 118.381 -1.328 . . . . 1.0 114.005 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.434 ' HB2' ' CB ' ' A' ' 29' ' ' THR . 18.9 t70 -128.01 85.94 2.41 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 102.822 -3.029 . . . . 1.0 102.822 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.444 ' HB3' ' H2 ' ' A' ' 1' ' ' VAL . 5.8 t . . . . . 0 N--CA 1.501 2.106 0 CA-C-O 116.75 -1.595 . . . . 1.0 111.47 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.478 0.656 . . . . 1.0 111.857 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 48.9 t -70.7 119.88 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 107.115 -1.439 . . . . 1.0 107.115 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.548 HG12 ' HB3' ' A' ' 33' ' ' CYS . 30.1 pt -129.58 163.37 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 114.301 1.223 . . . . 1.0 114.301 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.97 43.76 3.29 Favored Glycine 0 C--O 1.213 -1.196 0 CA-C-N 112.188 -2.278 . . . . 1.0 112.436 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -106.3 100.3 9.84 Favored 'General case' 0 N--CA 1.486 1.348 1 N-CA-C 99.919 -4.104 . . . . 1.0 99.919 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.525 ' HE ' HH22 ' A' ' 32' ' ' ARG . 64.6 mtt85 -38.94 144.5 0.12 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 125.253 1.596 . . . . 1.0 114.58 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.7 t -110.7 156.06 21.56 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.255 -1.793 . . . . 1.0 111.505 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -120.81 -61.9 1.51 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 103.88 -2.637 . . . . 1.0 103.88 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -118.71 167.58 11.53 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 112.861 -1.972 . . . . 1.0 107.558 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.409 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 50.7 m -26.57 -49.64 0.18 Allowed Pre-proline 0 N--CA 1.507 2.376 0 N-CA-C 115.015 1.487 . . . . 1.0 115.015 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.464 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . 0.9 OUTLIER -88.86 -83.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.319 -0.977 0 C-N-CA 121.864 1.709 . . . . 1.0 108.639 -176.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.9 t70 37.1 32.43 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 123.149 1.452 . . . . 1.0 110.104 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.551 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 41.8 t -164.6 -26.17 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 111.3 -2.682 . . . . 1.0 112.95 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.464 ' CD1' ' HB3' ' A' ' 11' ' ' PRO . 3.3 m-85 -38.19 -55.18 1.33 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 123.988 0.915 . . . . 1.0 113.072 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 55.5 m -47.7 -53.63 14.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 124.861 1.35 . . . . 1.0 108.648 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.09 -51.05 70.83 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.04 -0.982 . . . . 1.0 111.035 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.551 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 94.6 m -54.57 -33.48 60.33 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.247 -1.342 . . . . 1.0 109.695 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -70.67 -48.92 52.33 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.057 -1.831 . . . . 1.0 106.057 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -70.45 -14.13 62.41 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-N 114.551 -1.204 . . . . 1.0 113.538 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.7 mt -107.14 -44.08 4.46 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 113.578 0.955 . . . . 1.0 113.578 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 37.1 t -99.67 -36.56 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-N 114.647 -1.16 . . . . 1.0 109.782 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.76 -30.23 3.43 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 120.615 -0.802 . . . . 1.0 113.974 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -128.01 151.06 49.61 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 114.077 1.14 . . . . 1.0 114.077 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.39 77.06 0.76 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 114.118 -1.401 . . . . 1.0 109.327 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.1 t -128.71 -172.87 2.82 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.766 -0.652 . . . . 1.0 109.324 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.677 ' HA3' ' SG ' ' A' ' 35' ' ' CYS . . . 118.89 -179.37 16.8 Favored Glycine 0 N--CA 1.493 2.458 0 CA-C-N 113.217 -1.81 . . . . 1.0 115.902 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -142.74 168.38 19.86 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 112.296 -1.952 . . . . 1.0 107.012 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.3 t -105.63 115.03 29.55 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 105.031 -2.211 . . . . 1.0 105.031 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.2 m -128.23 123.76 34.99 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 112.923 -1.944 . . . . 1.0 112.48 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 45.98 42.14 8.99 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 112.92 -1.945 . . . . 1.0 110.076 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.18 27.46 67.47 Favored Glycine 0 N--CA 1.489 2.171 0 CA-C-N 113.769 -1.56 . . . . 1.0 112.752 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.525 HH22 ' HE ' ' A' ' 6' ' ' ARG . 36.0 mmt180 -135.78 161.87 34.37 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 106.308 -1.738 . . . . 1.0 106.308 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.548 ' HB3' HG12 ' A' ' 3' ' ' ILE . 13.8 t -73.4 142.43 46.97 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 114.807 1.41 . . . . 1.0 114.807 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 11.3 t70 -130.45 79.78 1.92 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 125.791 1.932 . . . . 1.0 108.227 178.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.677 ' SG ' ' HA3' ' A' ' 26' ' ' GLY . 1.3 m . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 118.136 -0.935 . . . . 1.0 111.067 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.582 0.706 . . . . 1.0 111.559 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 52.7 t -71.14 117.06 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 113.838 -1.528 . . . . 1.0 107.413 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.557 HG12 ' HB3' ' A' ' 33' ' ' CYS . 33.5 pt -134.03 163.63 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 115.563 1.69 . . . . 1.0 115.563 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.12 -44.63 88.55 Favored Glycine 0 N--CA 1.478 1.46 0 CA-C-N 111.499 -2.591 . . . . 1.0 110.791 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -28.37 90.5 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.455 0 O-C-N 126.096 1.704 . . . . 1.0 110.755 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -39.94 146.88 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.832 1.419 . . . . 1.0 114.832 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.8 p -125.67 159.25 32.72 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.376 -1.284 . . . . 1.0 110.057 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.401 ' H ' ' CB ' ' A' ' 12' ' ' ASP . 12.8 t80 -119.41 -55.21 2.14 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 106.177 -1.786 . . . . 1.0 106.177 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.464 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -111.14 162.08 15.29 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 113.048 -1.887 . . . . 1.0 106.719 179.785 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.447 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 58.4 m -30.85 -55.8 0.38 Allowed Pre-proline 0 N--CA 1.503 2.199 0 O-C-N 125.091 1.494 . . . . 1.0 113.533 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.495 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 53.9 Cg_endo -70.19 -95.05 0.01 OUTLIER 'Trans proline' 0 C--O 1.205 -1.141 0 C-N-CA 121.248 1.299 . . . . 1.0 113.946 170.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.401 ' CB ' ' H ' ' A' ' 8' ' ' TYR . 4.9 t70 39.99 32.82 0.12 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 124.862 1.351 . . . . 1.0 109.593 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.2 t -167.59 -25.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 111.809 -2.45 . . . . 1.0 112.392 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.495 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.5 m-30 -38.5 -59.15 0.94 Allowed 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 123.698 0.799 . . . . 1.0 112.173 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.9 p -45.92 -46.22 15.92 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 125.162 1.539 . . . . 1.0 111.37 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.8 -41.76 87.05 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.428 -1.26 . . . . 1.0 111.231 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.8 t -69.34 -27.46 65.38 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.267 -0.879 . . . . 1.0 109.025 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -70.17 -53.63 16.35 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.955 -1.498 . . . . 1.0 106.955 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -71.14 -21.22 62.21 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 114.161 1.171 . . . . 1.0 114.161 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.8 mp -98.26 -33.57 11.04 Favored 'General case' 0 N--CA 1.509 2.511 0 N-CA-C 112.847 0.684 . . . . 1.0 112.847 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.82 -37.78 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 123.677 0.611 . . . . 1.0 109.856 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.19 -31.75 2.65 Favored Glycine 0 N--CA 1.489 2.196 0 CA-C-O 118.785 -1.008 . . . . 1.0 114.917 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -128.13 145.67 50.94 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 115.22 1.563 . . . . 1.0 115.22 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.82 72.58 0.81 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 113.491 -1.686 . . . . 1.0 110.409 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.426 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 7.8 t -133.04 -173.43 3.19 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.278 0.561 . . . . 1.0 109.769 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.28 -170.82 13.61 Favored Glycine 0 N--CA 1.495 2.569 0 CA-C-N 113.579 -1.646 . . . . 1.0 114.219 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -147.38 167.8 23.44 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 113.683 -1.259 . . . . 1.0 108.817 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.2 t -104.82 117.59 34.43 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.322 -1.733 . . . . 1.0 106.322 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.7 m -125.66 122.91 37.74 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 113.319 -1.764 . . . . 1.0 111.203 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 45.74 41.54 7.57 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 112.798 -2.001 . . . . 1.0 111.279 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.67 21.95 71.36 Favored Glycine 0 N--CA 1.482 1.719 0 CA-C-N 113.385 -1.734 . . . . 1.0 113.592 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.1 mmt-85 -131.7 158.87 39.99 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.667 -1.605 . . . . 1.0 106.667 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.557 ' HB3' HG12 ' A' ' 3' ' ' ILE . 9.1 t -72.62 142.18 48.35 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.58 -1.248 . . . . 1.0 113.708 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.4 t70 -135.07 78.37 1.73 Allowed 'General case' 0 C--N 1.295 -1.764 0 O-C-N 125.969 2.043 . . . . 1.0 106.862 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.426 ' SG ' ' O ' ' A' ' 25' ' ' THR . 37.1 t . . . . . 0 N--CA 1.498 1.947 0 C-N-CA 119.717 -0.793 . . . . 1.0 111.281 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.289 0.566 . . . . 1.0 111.071 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.4 p -70.95 120.89 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 114.426 -1.261 . . . . 1.0 108.911 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.481 HG12 ' HB3' ' A' ' 33' ' ' CYS . 22.9 pt -135.02 169.31 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 115.1 1.518 . . . . 1.0 115.1 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.01 -47.26 81.38 Favored Glycine 0 N--CA 1.478 1.489 0 CA-C-N 111.577 -2.556 . . . . 1.0 111.869 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -20.96 90.61 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.516 0 O-C-N 125.85 1.559 . . . . 1.0 112.884 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -39.79 142.3 0.34 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 124.851 1.344 . . . . 1.0 112.361 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.1 p -124.64 162.45 24.1 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 124.58 1.175 . . . . 1.0 111.042 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -118.24 -61.87 1.62 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 102.782 -3.044 . . . . 1.0 102.782 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -117.79 168.25 10.64 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 105.407 -2.072 . . . . 1.0 105.407 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.426 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.7 m -29.85 -54.59 0.33 Allowed Pre-proline 0 N--CA 1.503 2.198 0 O-C-N 124.692 1.245 . . . . 1.0 113.823 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.426 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 54.3 Cg_endo -67.78 -104.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 121.568 1.512 . . . . 1.0 113.841 172.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.8 t70 39.34 30.54 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 123.2 1.476 . . . . 1.0 110.031 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.7 t -168.15 -15.29 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 111.255 -2.702 . . . . 1.0 113.598 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.4 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 6.0 m-30 -38.74 -58.8 1.02 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 113.675 0.991 . . . . 1.0 113.675 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.0 t -45.27 -48.18 12.92 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 124.849 1.343 . . . . 1.0 110.734 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.74 -53.4 54.89 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.623 -1.172 . . . . 1.0 108.734 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.2 t -49.55 -39.66 35.55 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.811 -1.086 . . . . 1.0 110.12 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -65.95 -47.79 73.5 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.503 -1.295 . . . . 1.0 107.503 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -70.09 -11.82 61.16 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 112.862 -1.972 . . . . 1.0 111.885 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.6 mt -104.47 -52.72 2.84 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.105 1.15 . . . . 1.0 114.105 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.3 m -108.61 -16.68 8.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 118.687 -0.673 . . . . 1.0 112.525 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.99 -38.23 1.97 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 118.354 2.101 . . . . 1.0 118.354 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -126.57 153.75 44.83 Favored 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 115.243 1.572 . . . . 1.0 115.243 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.54 68.88 0.59 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 113.316 -1.766 . . . . 1.0 112.204 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.8 t -130.25 -168.65 2.0 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.549 ' CA ' ' SG ' ' A' ' 35' ' ' CYS . . . 124.78 174.42 14.0 Favored Glycine 0 N--CA 1.497 2.707 0 CA-C-N 113.517 -1.674 . . . . 1.0 115.136 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -131.4 164.46 25.64 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 112.13 -2.035 . . . . 1.0 108.483 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.5 t -107.46 112.07 24.68 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 104.654 -2.35 . . . . 1.0 104.654 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 84.8 m -128.18 123.69 34.93 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 112.371 -2.195 . . . . 1.0 112.131 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 51.49 39.78 25.38 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 113.2 -1.818 . . . . 1.0 108.905 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.49 21.05 62.02 Favored Glycine 0 N--CA 1.486 2.017 0 CA-C-N 113.286 -1.779 . . . . 1.0 112.386 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.6 mtp85 -129.87 164.03 25.03 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.677 -1.231 . . . . 1.0 107.677 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.481 ' HB3' HG12 ' A' ' 3' ' ' ILE . 4.3 t -72.56 145.28 47.51 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.926 -1.109 . . . . 1.0 112.975 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.7 t70 -133.57 83.57 2.06 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 112.693 -2.049 . . . . 1.0 107.992 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.549 ' SG ' ' CA ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.017 0 CA-C-O 118.439 -0.791 . . . . 1.0 111.106 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 2' ' ' VAL . 17.2 t . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 108.243 -1.021 . . . . 1.0 108.243 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 55.6 t -71.66 109.13 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 105.659 -1.978 . . . . 1.0 105.659 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.498 HG12 ' HB3' ' A' ' 33' ' ' CYS . 36.1 pt -135.04 168.49 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 115.875 1.806 . . . . 1.0 115.875 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.54 -45.67 83.66 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 111.814 -2.448 . . . . 1.0 111.041 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.5 tp60 -22.64 90.08 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.45 0 O-C-N 125.943 1.614 . . . . 1.0 113.112 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -39.82 143.16 0.27 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 113.916 -1.493 . . . . 1.0 113.15 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.4 p -124.36 163.93 20.7 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.916 -1.038 . . . . 1.0 109.826 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.439 ' H ' ' HB3' ' A' ' 12' ' ' ASP . 17.0 t80 -117.15 -61.08 1.76 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 104.298 -2.482 . . . . 1.0 104.298 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -116.82 169.41 9.4 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 112.418 -2.174 . . . . 1.0 106.97 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.462 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 73.1 m -28.55 -54.98 0.26 Allowed Pre-proline 0 N--CA 1.503 2.179 0 O-C-N 124.942 1.401 . . . . 1.0 113.944 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.462 ' HD3' ' HB2' ' A' ' 10' ' ' SER . 28.8 Cg_endo -73.74 -100.6 0.01 OUTLIER 'Trans proline' 0 C--O 1.208 -0.984 0 C-N-CA 121.776 1.651 . . . . 1.0 114.917 170.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.439 ' HB3' ' H ' ' A' ' 8' ' ' TYR . 12.5 t70 41.86 28.63 0.09 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 124.79 1.306 . . . . 1.0 110.163 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.0 t -164.58 -21.91 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 112.109 -2.314 . . . . 1.0 113.138 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.459 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 6.3 m-30 -38.78 -61.37 0.73 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 112.913 0.708 . . . . 1.0 112.913 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.3 p -43.84 -42.72 5.83 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 125.174 1.546 . . . . 1.0 112.165 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.99 -49.84 47.54 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 114.188 -1.369 . . . . 1.0 108.771 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.7 t -55.45 -34.97 64.97 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.292 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -66.49 -51.09 60.42 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 106.464 -1.68 . . . . 1.0 106.464 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.41 ' NZ ' ' HB2' ' A' ' 19' ' ' LYS . 4.4 ttmp? -59.77 -24.74 64.33 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.039 -1.891 . . . . 1.0 112.197 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.0 mp -101.27 -33.74 9.93 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 116.101 1.889 . . . . 1.0 116.101 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.13 -37.79 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 123.453 0.471 . . . . 1.0 110.771 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.41 -30.77 2.58 Favored Glycine 0 N--CA 1.488 2.145 0 CA-C-O 118.435 -1.203 . . . . 1.0 115.041 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.48 141.46 51.98 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 115.146 1.535 . . . . 1.0 115.146 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.74 71.79 0.76 Allowed 'General case' 0 N--CA 1.503 2.209 0 CA-C-N 113.609 -1.632 . . . . 1.0 112.697 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.414 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 14.7 t -133.08 -168.16 2.04 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.431 0.634 . . . . 1.0 109.453 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.09 -174.69 16.2 Favored Glycine 0 N--CA 1.493 2.458 0 CA-C-N 113.577 -1.647 . . . . 1.0 115.359 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.48 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -138.1 162.63 33.69 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 112.833 -1.683 . . . . 1.0 108.518 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.417 ' H ' ' HE2' ' A' ' 27' ' ' LYS . 42.0 t -106.08 114.81 29.17 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 103.757 -2.683 . . . . 1.0 103.757 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 78.1 m -128.61 124.44 35.85 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 112.923 -1.944 . . . . 1.0 112.354 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 50.8 39.91 23.34 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 113.152 -1.84 . . . . 1.0 109.041 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.16 22.02 62.42 Favored Glycine 0 N--CA 1.484 1.854 0 CA-C-N 113.283 -1.78 . . . . 1.0 112.816 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.1 mtp-105 -130.89 163.29 27.77 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.14 -1.43 . . . . 1.0 107.14 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.498 ' HB3' HG12 ' A' ' 3' ' ' ILE . 2.5 t -72.69 142.61 48.23 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.213 1.19 . . . . 1.0 114.213 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.515 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.5 t70 -135.54 74.91 1.53 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 112.262 -2.245 . . . . 1.0 106.338 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 25' ' ' THR . 41.9 t . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 118.278 -0.868 . . . . 1.0 111.83 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.24 0.543 . . . . 1.0 111.227 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.3 p -70.82 119.78 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-N 114.371 -1.286 . . . . 1.0 108.774 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.507 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 33.0 pt -135.37 165.42 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 115.531 1.678 . . . . 1.0 115.531 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.84 44.2 3.33 Favored Glycine 0 C--O 1.21 -1.361 0 CA-C-N 111.314 -2.675 . . . . 1.0 111.826 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -109.8 96.6 6.36 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 100.64 -3.837 . . . . 1.0 100.64 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -39.11 147.74 0.06 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 125.381 1.676 . . . . 1.0 113.732 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.1 t -116.56 154.16 30.93 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 113.523 -1.672 . . . . 1.0 111.602 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -120.23 -55.95 2.02 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 104.323 -2.473 . . . . 1.0 104.323 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.434 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -119.2 154.02 34.01 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 113.498 -1.683 . . . . 1.0 106.792 179.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.438 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.9 m -22.0 -56.01 0.09 OUTLIER Pre-proline 0 N--CA 1.506 2.364 0 N-CA-C 115.773 1.768 . . . . 1.0 115.773 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.473 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 63.6 Cg_endo -69.19 -94.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.733 1.622 . . . . 1.0 113.531 169.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.7 t70 42.52 28.19 0.11 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 124.537 1.148 . . . . 1.0 110.246 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.6 t -164.47 -26.99 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 112.49 -2.141 . . . . 1.0 112.572 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.473 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 5.9 m-30 -38.73 -61.51 0.71 Allowed 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 112.582 0.586 . . . . 1.0 112.582 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.8 m -42.04 -43.77 3.32 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 125.509 1.755 . . . . 1.0 111.062 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.51 -49.0 58.69 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 114.389 -1.278 . . . . 1.0 109.113 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.5 t -56.8 -30.04 63.3 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 124.053 0.846 . . . . 1.0 108.954 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -70.72 -51.52 26.9 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 105.912 -1.884 . . . . 1.0 105.912 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -70.65 -10.78 60.16 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 113.755 -1.566 . . . . 1.0 113.878 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.4 mt -108.69 -43.5 4.25 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 112.903 0.705 . . . . 1.0 112.903 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.4 t -105.23 -38.24 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-N 114.748 -1.114 . . . . 1.0 110.464 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.0 -30.19 2.86 Favored Glycine 0 N--CA 1.488 2.161 0 CA-C-O 118.854 -0.97 . . . . 1.0 114.378 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -122.62 139.27 54.12 Favored 'General case' 0 N--CA 1.506 2.375 0 N-CA-C 114.407 1.262 . . . . 1.0 114.407 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.16 68.93 0.74 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 125.146 1.529 . . . . 1.0 111.086 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.433 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 9.2 t -132.64 -169.14 2.18 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.303 -0.862 . . . . 1.0 109.041 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.31 -173.11 16.27 Favored Glycine 0 N--CA 1.493 2.443 0 CA-C-N 113.751 -1.568 . . . . 1.0 113.711 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -136.96 167.64 21.12 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.654 -1.273 . . . . 1.0 109.568 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.5 t -109.87 112.33 24.3 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 103.485 -2.783 . . . . 1.0 103.485 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.8 m -127.37 123.28 35.84 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 112.829 -1.987 . . . . 1.0 112.604 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 49.91 40.63 21.31 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 113.134 -1.848 . . . . 1.0 108.599 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.52 22.94 62.09 Favored Glycine 0 N--CA 1.484 1.85 0 CA-C-N 113.231 -1.804 . . . . 1.0 113.211 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -131.07 162.34 30.05 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 106.048 -1.834 . . . . 1.0 106.048 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.507 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 9.1 t -73.33 141.56 47.1 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.043 1.498 . . . . 1.0 115.043 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.2 t70 -136.64 77.39 1.65 Allowed 'General case' 0 C--N 1.298 -1.673 0 O-C-N 125.825 1.953 . . . . 1.0 107.699 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.433 ' SG ' ' O ' ' A' ' 25' ' ' THR . 29.9 t . . . . . 0 N--CA 1.5 2.041 0 C-N-CA 119.609 -0.836 . . . . 1.0 111.372 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.0 m . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.497 0.665 . . . . 1.0 112.089 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.2 p -70.6 124.68 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-N 114.198 -1.365 . . . . 1.0 109.009 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.495 HG12 ' HB3' ' A' ' 33' ' ' CYS . 1.5 pt -132.18 159.75 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 114.1 1.148 . . . . 1.0 114.1 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -40.47 -53.34 3.54 Favored Glycine 0 N--CA 1.486 1.99 0 CA-C-N 111.22 -2.718 . . . . 1.0 112.206 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -16.13 85.62 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 O-C-N 126.195 1.761 . . . . 1.0 113.217 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -51.05 144.8 8.37 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.772 -1.104 . . . . 1.0 109.607 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.0 p -123.01 164.16 19.09 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 114.249 1.203 . . . . 1.0 114.249 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -118.07 -57.77 2.06 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 104.686 -2.338 . . . . 1.0 104.686 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -114.39 168.43 9.85 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 112.949 -1.932 . . . . 1.0 107.247 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.452 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.3 m -35.29 -58.8 0.74 Allowed Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 124.961 1.413 . . . . 1.0 113.412 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.452 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 84.7 Cg_endo -62.15 -95.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.391 1.394 . . . . 1.0 112.423 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 t0 37.91 32.34 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 123.147 1.451 . . . . 1.0 108.809 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.422 ' N ' ' C ' ' A' ' 11' ' ' PRO . 23.9 t -165.41 -24.94 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 111.945 -2.389 . . . . 1.0 112.298 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -38.21 -55.71 1.28 Allowed 'General case' 0 N--CA 1.508 2.466 0 C-N-CA 123.1 0.56 . . . . 1.0 110.778 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.6 p -53.31 -49.18 67.57 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 124.579 1.175 . . . . 1.0 110.119 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.5 -55.62 29.67 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.681 0.753 . . . . 1.0 110.765 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 25' ' ' THR . 56.5 m -48.58 -49.33 37.1 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.165 -1.38 . . . . 1.0 108.317 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -55.61 -49.59 72.4 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.167 0.984 . . . . 1.0 108.443 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -59.8 -26.73 65.99 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-N 113.852 -1.522 . . . . 1.0 111.46 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.1 mp -85.6 -55.79 3.82 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 120.082 -0.647 . . . . 1.0 112.31 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.2 m -107.3 -46.21 7.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 C-N-CA 122.922 0.489 . . . . 1.0 112.25 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.8 28.34 1.29 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 111.215 -0.754 . . . . 1.0 111.215 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -135.41 126.84 28.58 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 124.268 0.628 . . . . 1.0 110.293 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.35 69.04 0.8 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 124.909 1.381 . . . . 1.0 108.923 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.463 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 12.4 t -127.66 -173.46 2.92 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.898 0.856 . . . . 1.0 111.576 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.85 158.62 27.55 Favored Glycine 0 N--CA 1.495 2.572 0 CA-C-N 112.612 -2.086 . . . . 1.0 109.598 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -132.99 179.29 6.27 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.605 0.716 . . . . 1.0 110.312 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.2 t -100.04 118.07 35.64 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 113.512 -1.676 . . . . 1.0 106.704 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.5 m -132.24 130.39 40.88 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 112.633 -2.076 . . . . 1.0 106.552 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.6 p30 45.5 41.44 6.77 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 125.286 1.616 . . . . 1.0 112.76 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.05 12.4 49.13 Favored Glycine 0 N--CA 1.479 1.561 0 CA-C-N 113.412 -1.722 . . . . 1.0 113.435 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.8 mmt-85 -127.71 162.55 26.3 Favored 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 108.292 -1.003 . . . . 1.0 108.292 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.495 ' HB3' HG12 ' A' ' 3' ' ' ILE . 42.9 t -72.59 146.47 46.66 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 117.7 -1.6 . . . . 1.0 112.08 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 34.0 t70 -129.69 85.69 2.33 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 104.878 -2.267 . . . . 1.0 104.878 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.504 2.246 0 CA-C-O 116.452 -1.737 . . . . 1.0 111.112 -179.44 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 2' ' ' VAL . 14.4 t . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 108.245 -1.02 . . . . 1.0 108.245 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.6 p -71.39 115.41 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.204 -1.406 . . . . 1.0 107.204 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.496 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 35.9 pt -136.83 166.35 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 116.349 1.981 . . . . 1.0 116.349 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.03 -46.05 85.61 Favored Glycine 0 N--CA 1.478 1.448 0 CA-C-N 111.235 -2.711 . . . . 1.0 110.637 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.419 ' HB3' HG13 ' A' ' 3' ' ' ILE . 49.2 tp60 -22.76 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.323 0 O-C-N 125.9 1.588 . . . . 1.0 112.44 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -40.11 151.01 0.05 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 125.274 1.609 . . . . 1.0 114.041 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 t -117.21 149.6 40.14 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 113.538 -1.665 . . . . 1.0 110.318 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.484 ' HB3' ' HD3' ' A' ' 9' ' ' ARG . 3.0 t80 -122.08 -54.8 1.9 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 102.553 -3.129 . . . . 1.0 102.553 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.484 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -118.65 154.05 33.31 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 105.941 -1.874 . . . . 1.0 105.941 179.675 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.45 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 67.8 m -25.2 -55.78 0.17 Allowed Pre-proline 0 N--CA 1.505 2.324 0 N-CA-C 114.748 1.388 . . . . 1.0 114.748 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.488 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 64.4 Cg_endo -69.04 -93.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 121.149 1.233 . . . . 1.0 113.629 170.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.4 t70 42.31 30.01 0.18 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 122.616 1.198 . . . . 1.0 109.691 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.8 t -165.96 -26.22 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 112.23 -2.259 . . . . 1.0 112.658 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.488 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.4 m-30 -38.56 -59.03 0.96 Allowed 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 123.612 0.765 . . . . 1.0 112.244 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.6 p -45.53 -43.24 11.71 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 125.117 1.511 . . . . 1.0 111.769 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.05 -46.53 64.8 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.811 -1.086 . . . . 1.0 109.768 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.2 t -57.04 -36.14 70.13 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.103 -1.073 . . . . 1.0 108.103 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -65.69 -53.75 36.82 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 105.1 -2.185 . . . . 1.0 105.1 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.82 -31.6 7.36 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 114.236 -1.347 . . . . 1.0 109.755 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.84 -54.35 5.43 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.475 -0.784 . . . . 1.0 112.088 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 50.7 t -104.28 -54.79 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 CA-C-N 115.655 -0.702 . . . . 1.0 111.674 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.61 20.48 1.09 Allowed Glycine 0 N--CA 1.491 2.309 0 O-C-N 124.043 0.839 . . . . 1.0 112.793 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -133.16 126.26 31.27 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 124.102 0.53 . . . . 1.0 110.465 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.15 73.9 0.94 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 124.54 1.15 . . . . 1.0 108.201 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.411 HG23 ' SG ' ' A' ' 35' ' ' CYS . 9.4 t -137.38 -173.24 3.42 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.429 0.633 . . . . 1.0 110.884 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.87 -179.69 16.18 Favored Glycine 0 N--CA 1.493 2.46 0 CA-C-N 113.429 -1.714 . . . . 1.0 113.745 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -134.53 172.48 12.86 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 114.001 -1.1 . . . . 1.0 111.346 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 45.6 t -112.34 111.56 22.5 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 102.273 -3.232 . . . . 1.0 102.273 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.2 m -130.73 123.42 29.22 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 112.437 -2.165 . . . . 1.0 108.097 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 p30 47.8 42.0 15.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 126.679 2.487 . . . . 1.0 112.116 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.95 11.21 60.44 Favored Glycine 0 N--CA 1.476 1.309 0 CA-C-N 113.132 -1.849 . . . . 1.0 112.289 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.3 mtt85 -126.34 163.72 22.64 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.187 -1.042 . . . . 1.0 108.187 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.496 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 7.4 t -72.21 143.03 49.0 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.506 -1.278 . . . . 1.0 114.308 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 35.8 t70 -136.39 77.0 1.63 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 112.051 -2.34 . . . . 1.0 107.56 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.411 ' SG ' HG23 ' A' ' 25' ' ' THR . 21.8 t . . . . . 0 N--CA 1.498 1.951 0 CA-C-O 118.016 -0.992 . . . . 1.0 111.27 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.57 0.7 . . . . 1.0 110.672 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.5 p -71.03 119.19 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 113.966 -1.47 . . . . 1.0 110.689 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.559 HG12 ' HB3' ' A' ' 33' ' ' CYS . 23.6 pt -130.23 159.29 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 CA-C-O 122.125 0.964 . . . . 1.0 112.779 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.22 -39.64 72.08 Favored Glycine 0 N--CA 1.489 2.195 0 CA-C-N 112.133 -2.303 . . . . 1.0 112.971 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -13.64 87.61 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 115.672 1.73 . . . . 1.0 115.672 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -40.7 124.31 2.04 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.693 1.246 . . . . 1.0 109.634 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 5.6 t -95.43 157.88 15.7 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 116.182 1.919 . . . . 1.0 116.182 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.515 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 14.7 t80 -121.68 -61.96 1.46 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 104.285 -2.487 . . . . 1.0 104.285 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -121.1 168.07 11.95 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 112.982 -1.917 . . . . 1.0 110.137 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.435 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 59.9 m -32.29 -59.64 0.38 Allowed Pre-proline 0 N--CA 1.501 2.109 0 O-C-N 125.051 1.469 . . . . 1.0 114.605 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.435 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 84.1 Cg_endo -61.37 -89.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.753 1.635 . . . . 1.0 112.045 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 t70 35.92 36.41 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 CA-C-O 124.113 1.911 . . . . 1.0 108.508 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.403 ' N ' ' C ' ' A' ' 11' ' ' PRO . 15.1 t -170.36 -25.33 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 111.118 -2.765 . . . . 1.0 112.382 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -38.45 -59.51 0.9 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 123.984 0.803 . . . . 1.0 111.618 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.3 t -51.83 -44.43 63.56 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 124.939 1.399 . . . . 1.0 112.657 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.43 -46.81 78.46 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 124.025 0.828 . . . . 1.0 113.055 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.1 t -68.72 -31.02 69.8 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.012 -1.477 . . . . 1.0 107.012 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.419 ' HZ3' ' HB3' ' A' ' 18' ' ' LYS . 6.0 ttpm? -64.11 -50.29 68.87 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.24 -1.022 . . . . 1.0 108.24 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -70.15 -26.3 63.87 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.002 -1.479 . . . . 1.0 109.505 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 tt -65.15 -59.18 4.38 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.963 -0.695 . . . . 1.0 110.138 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.01 -42.73 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 114.171 1.175 . . . . 1.0 114.171 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.03 10.82 1.69 Allowed Glycine 0 N--CA 1.491 2.337 0 CA-C-O 119.569 -0.573 . . . . 1.0 112.759 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -129.68 128.9 43.49 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 123.722 0.307 . . . . 1.0 110.468 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.02 68.71 0.7 Allowed 'General case' 0 N--CA 1.503 2.202 0 O-C-N 124.87 1.356 . . . . 1.0 109.954 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.6 p -115.61 175.78 5.37 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.151 -1.386 . . . . 1.0 113.048 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.78 150.58 9.34 Favored Glycine 0 N--CA 1.49 2.263 0 CA-C-N 113.254 -1.794 . . . . 1.0 110.989 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -122.55 -178.48 3.92 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 113.521 -1.339 . . . . 1.0 111.01 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.5 t -111.27 109.42 19.43 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 111.903 -2.408 . . . . 1.0 108.209 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.3 m -138.71 131.56 29.4 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 112.837 -1.983 . . . . 1.0 111.001 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 51.06 40.1 24.81 Favored 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 112.811 -1.995 . . . . 1.0 108.33 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.0 19.16 50.0 Favored Glycine 0 N--CA 1.489 2.223 0 CA-C-N 113.259 -1.791 . . . . 1.0 113.356 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.0 mtp-105 -134.26 160.11 38.88 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.559 ' HB3' HG12 ' A' ' 3' ' ' ILE . 43.5 t -72.53 139.17 47.41 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 114.826 1.417 . . . . 1.0 114.826 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 11.2 p-10 -134.02 94.09 3.2 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.185 -2.154 . . . . 1.0 105.185 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.504 2.227 0 CA-C-N 115.252 -0.885 . . . . 1.0 109.741 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 121.602 0.715 . . . . 1.0 111.355 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.01 114.24 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-N 114.163 -1.38 . . . . 1.0 109.094 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.54 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 33.8 pt -134.93 164.04 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 N-CA-C 114.136 1.162 . . . . 1.0 114.136 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.62 -39.59 93.56 Favored Glycine 0 N--CA 1.479 1.534 0 CA-C-N 112.868 -1.969 . . . . 1.0 112.564 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -12.0 88.01 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 115.372 1.619 . . . . 1.0 115.372 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.0 mtt85 -39.8 122.91 1.49 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 124.817 1.323 . . . . 1.0 110.873 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 9.0 t -107.11 158.53 17.0 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 114.974 1.472 . . . . 1.0 114.974 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.52 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.9 t80 -123.48 -56.6 1.7 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 112.424 -2.171 . . . . 1.0 105.996 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.458 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -115.4 153.71 30.56 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 113.406 -1.724 . . . . 1.0 110.011 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.473 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.3 m -25.22 -57.94 0.16 Allowed Pre-proline 0 N--CA 1.508 2.437 0 O-C-N 125.092 1.495 . . . . 1.0 114.909 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.473 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 95.7 Cg_endo -62.82 -91.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.874 1.716 . . . . 1.0 112.058 173.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.8 t70 35.99 35.44 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 123.725 1.726 . . . . 1.0 108.889 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.4 ' N ' ' C ' ' A' ' 11' ' ' PRO . 49.3 t -170.73 -23.11 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 110.802 -2.908 . . . . 1.0 112.541 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -38.63 -59.94 0.87 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 123.415 0.447 . . . . 1.0 111.569 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.5 t -47.92 -40.4 21.86 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 124.933 1.396 . . . . 1.0 112.243 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.02 -54.48 13.0 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 123.715 0.635 . . . . 1.0 110.139 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.8 t -55.01 -32.65 61.97 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.553 -0.906 . . . . 1.0 108.553 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -67.14 -50.87 59.74 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 105.906 -1.887 . . . . 1.0 105.906 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -70.48 -9.03 55.5 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 113.756 -1.565 . . . . 1.0 111.554 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -90.68 -60.1 2.01 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.7 -0.852 . . . . 1.0 108.7 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 p -111.58 -39.24 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 124.129 0.893 . . . . 1.0 112.763 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.98 14.03 1.69 Allowed Glycine 0 N--CA 1.493 2.446 0 CA-C-O 119.635 -0.536 . . . . 1.0 113.285 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.426 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 3.2 mptp? -132.23 127.45 35.8 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 123.966 0.451 . . . . 1.0 110.257 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.09 68.41 0.7 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 125.065 1.478 . . . . 1.0 109.723 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.453 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 12.2 p -119.26 -179.12 3.75 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.252 -1.34 . . . . 1.0 114.299 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.41 153.91 9.25 Favored Glycine 0 N--CA 1.494 2.542 0 CA-C-N 113.419 -1.718 . . . . 1.0 111.704 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -119.45 167.21 12.17 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.33 -0.935 . . . . 1.0 108.672 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 13.5 t -101.42 90.64 4.15 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 102.917 -2.994 . . . . 1.0 102.917 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.7 m -110.78 115.57 29.78 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 109.497 -3.501 . . . . 1.0 111.43 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 52.8 39.03 28.08 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 112.425 -2.17 . . . . 1.0 108.465 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.61 25.59 68.99 Favored Glycine 0 N--CA 1.483 1.816 0 CA-C-N 113.065 -1.88 . . . . 1.0 111.858 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.2 mtt-85 -136.42 159.25 42.36 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.004 -1.48 . . . . 1.0 107.004 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.54 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 40.1 t -72.36 140.3 48.37 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 114.293 1.22 . . . . 1.0 114.293 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -135.18 84.49 2.1 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 124.978 1.424 . . . . 1.0 107.348 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.453 ' SG ' ' C ' ' A' ' 25' ' ' THR . 6.5 t . . . . . 0 N--CA 1.501 2.104 0 CA-C-O 116.787 -1.577 . . . . 1.0 111.239 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 122.023 0.916 . . . . 1.0 111.508 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.8 p -70.55 121.44 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-N 113.493 -1.685 . . . . 1.0 109.727 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.58 HG12 ' HB3' ' A' ' 33' ' ' CYS . 23.1 pt -128.83 160.25 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 121.916 0.865 . . . . 1.0 112.882 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.96 43.81 3.24 Favored Glycine 0 C--O 1.211 -1.338 0 CA-C-N 112.589 -2.096 . . . . 1.0 112.671 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -105.36 102.53 12.01 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 101.555 -3.498 . . . . 1.0 101.555 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -39.03 137.53 0.67 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 113.425 -1.716 . . . . 1.0 113.19 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.6 p -121.84 159.37 26.92 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.582 -1.19 . . . . 1.0 110.148 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -118.51 -59.82 1.84 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 106.175 -1.787 . . . . 1.0 106.175 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.37 163.81 12.54 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 113.188 -1.824 . . . . 1.0 106.591 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.472 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 75.5 m -35.93 -55.26 1.3 Allowed Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 125.156 1.535 . . . . 1.0 112.125 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.5 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 81.2 Cg_endo -67.07 -93.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 120.858 1.038 . . . . 1.0 113.009 171.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 t70 36.97 34.46 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 CA-C-O 123.351 1.548 . . . . 1.0 109.678 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.5 t -166.35 -27.53 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 110.766 -2.924 . . . . 1.0 111.307 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.5 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.0 m-85 -38.38 -55.34 1.38 Allowed 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 124.456 1.103 . . . . 1.0 112.45 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.5 p -47.1 -48.72 22.79 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 124.322 1.014 . . . . 1.0 109.887 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.02 -45.15 90.19 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.708 -1.133 . . . . 1.0 110.379 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 25' ' ' THR . 10.5 m -57.59 -35.56 70.57 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.998 -1.001 . . . . 1.0 109.372 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -70.8 -46.41 62.89 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.381 -1.711 . . . . 1.0 106.381 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.28 -15.19 62.86 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 114.157 -1.383 . . . . 1.0 113.623 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.0 mt -110.46 -43.62 3.85 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 113.86 1.059 . . . . 1.0 113.86 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.0 t -98.89 -36.22 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 114.555 -1.202 . . . . 1.0 110.033 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.57 -28.79 4.16 Favored Glycine 0 N--CA 1.489 2.207 0 O-C-N 123.866 0.729 . . . . 1.0 113.07 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.428 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 8.6 mptt -129.23 152.04 49.23 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 112.405 0.52 . . . . 1.0 112.405 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.52 78.51 0.79 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 114.274 -1.33 . . . . 1.0 109.218 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.418 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 7.6 t -128.38 -178.22 4.48 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.551 0.691 . . . . 1.0 111.627 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.53 -169.0 13.84 Favored Glycine 0 N--CA 1.495 2.6 0 CA-C-N 113.216 -1.811 . . . . 1.0 112.567 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -155.13 173.06 17.14 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.024 -1.088 . . . . 1.0 108.388 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 47.4 t -102.13 118.1 36.19 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.178 -1.786 . . . . 1.0 106.178 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.1 m -129.75 125.81 36.72 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 112.867 -1.97 . . . . 1.0 110.834 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 50.55 40.87 24.55 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 125.198 1.561 . . . . 1.0 109.15 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.86 18.92 55.06 Favored Glycine 0 N--CA 1.488 2.142 0 CA-C-N 113.148 -1.842 . . . . 1.0 113.51 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -128.62 163.32 25.31 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.778 -1.564 . . . . 1.0 106.778 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.58 ' HB3' HG12 ' A' ' 3' ' ' ILE . 11.2 t -73.49 143.75 46.47 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.177 -1.409 . . . . 1.0 113.263 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -131.24 85.04 2.23 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 104.53 -2.396 . . . . 1.0 104.53 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.5 2.071 0 C-N-CA 119.76 -0.776 . . . . 1.0 109.957 -179.514 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.887 0.851 . . . . 1.0 111.617 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 41.1 t -70.78 117.84 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-N 113.61 -1.632 . . . . 1.0 108.53 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.566 HG12 ' HB3' ' A' ' 33' ' ' CYS . 23.6 pt -128.96 154.64 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 114.549 1.314 . . . . 1.0 114.549 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -48.87 -43.24 30.39 Favored Glycine 0 N--CA 1.477 1.433 0 CA-C-N 110.824 -2.898 . . . . 1.0 111.758 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -26.15 91.98 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 126.106 1.709 . . . . 1.0 112.333 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -39.85 149.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.938 -1.483 . . . . 1.0 113.63 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.451 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 5.0 t -107.63 157.28 18.2 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.714 -1.13 . . . . 1.0 112.124 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.467 ' CD2' ' HG2' ' A' ' 9' ' ' ARG . 15.9 t80 -119.72 -64.88 1.22 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 103.023 -2.954 . . . . 1.0 103.023 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.467 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 9.0 mmt85 -123.85 168.83 12.23 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 112.277 -2.238 . . . . 1.0 106.533 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.457 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 67.9 m -29.02 -58.36 0.25 Allowed Pre-proline 0 N--CA 1.504 2.261 0 N-CA-C 114.677 1.362 . . . . 1.0 114.677 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.457 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 71.1 Cg_endo -66.96 -93.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.426 1.418 . . . . 1.0 113.262 175.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.401 ' H ' ' HG2' ' A' ' 11' ' ' PRO . 15.6 t70 37.89 33.73 0.05 Allowed 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 123.399 1.571 . . . . 1.0 109.906 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.5 t -164.51 -26.85 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 110.851 -2.886 . . . . 1.0 111.432 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.407 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.2 m-85 -38.74 -58.27 1.09 Allowed 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 123.68 0.792 . . . . 1.0 111.777 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.0 m -48.15 -45.7 33.61 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 124.625 1.203 . . . . 1.0 110.749 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.444 ' HA ' ' HG2' ' A' ' 19' ' ' LYS . . . -66.03 -41.56 90.77 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.608 -1.178 . . . . 1.0 112.309 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 25' ' ' THR . 24.2 m -66.81 -32.02 73.03 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.907 -1.042 . . . . 1.0 109.01 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.405 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 6.6 ttpm? -70.77 -52.57 19.87 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.753 -1.203 . . . . 1.0 107.753 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HG2' ' HA ' ' A' ' 16' ' ' ALA . 58.6 pttt -70.92 -17.16 62.7 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 118.903 -1.119 . . . . 1.0 113.448 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.1 mt -101.88 -41.99 6.3 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 113.25 0.833 . . . . 1.0 113.25 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.1 t -101.49 -34.7 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 124.293 0.996 . . . . 1.0 110.321 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.17 -29.64 3.85 Favored Glycine 0 N--CA 1.493 2.464 0 O-C-N 123.731 0.645 . . . . 1.0 113.065 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.612 ' H ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -128.5 156.58 43.03 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 112.97 0.73 . . . . 1.0 112.97 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.88 73.64 0.59 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 113.975 -1.466 . . . . 1.0 112.95 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.449 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 0.8 OUTLIER -114.32 -171.29 1.89 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.964 -1.016 . . . . 1.0 110.102 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.86 156.02 12.32 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.853 -0.899 . . . . 1.0 110.853 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 54.5 mtmt -132.53 169.88 15.96 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.331 -0.988 . . . . 1.0 108.331 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.6 t -105.11 100.61 10.2 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 104.8 -2.296 . . . . 1.0 104.8 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.7 m -121.66 118.71 29.84 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 110.736 -2.938 . . . . 1.0 112.069 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 47.7 42.31 15.2 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 112.562 -2.108 . . . . 1.0 110.013 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.89 23.08 69.06 Favored Glycine 0 N--CA 1.482 1.763 0 CA-C-N 113.229 -1.805 . . . . 1.0 113.09 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.2 mtp85 -136.48 160.47 38.66 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.74 -1.208 . . . . 1.0 107.74 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.566 ' HB3' HG12 ' A' ' 3' ' ' ILE . 19.5 t -72.57 142.12 48.42 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.437 -1.305 . . . . 1.0 114.118 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 35.0 t0 -131.38 88.98 2.65 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 105.326 -2.102 . . . . 1.0 105.326 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.501 2.106 0 CA-C-O 118.394 -0.812 . . . . 1.0 109.372 -179.773 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 2' ' ' VAL . 18.6 t . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 108.438 -0.949 . . . . 1.0 108.438 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 5.3 p -71.39 118.61 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-N 114.901 -1.045 . . . . 1.0 109.272 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.571 HG12 ' HB3' ' A' ' 33' ' ' CYS . 35.1 pt -133.2 152.55 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 114.603 1.335 . . . . 1.0 114.603 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.67 -38.3 63.48 Favored Glycine 0 N--CA 1.482 1.741 0 CA-C-N 111.717 -2.492 . . . . 1.0 110.747 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -32.33 103.11 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 125.918 1.599 . . . . 1.0 110.217 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -39.46 151.96 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.815 1.783 . . . . 1.0 115.815 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 1.4 t -112.87 154.62 26.04 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.222 -1.354 . . . . 1.0 111.47 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.419 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 1.2 t80 -121.31 -62.86 1.38 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 103.684 -2.71 . . . . 1.0 103.684 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -119.89 166.61 13.07 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 111.895 -2.411 . . . . 1.0 106.173 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.467 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.7 m -35.55 -55.47 1.15 Allowed Pre-proline 0 N--CA 1.506 2.364 0 N-CA-C 113.355 0.872 . . . . 1.0 113.355 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.467 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 83.6 Cg_endo -63.64 -94.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.632 1.555 . . . . 1.0 112.011 173.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.0 t70 36.09 34.76 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.373 0 CA-C-O 123.358 1.552 . . . . 1.0 109.316 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.415 ' N ' ' C ' ' A' ' 11' ' ' PRO . 42.7 t -171.14 -19.99 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 110.738 -2.937 . . . . 1.0 112.562 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -38.51 -59.2 0.94 Allowed 'General case' 0 N--CA 1.503 2.215 0 CA-C-N 118.632 0.651 . . . . 1.0 110.93 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 76.1 p -47.58 -39.95 17.98 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.99 1.431 . . . . 1.0 112.153 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.09 -49.35 51.81 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.697 -0.683 . . . . 1.0 109.573 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.6 t -55.09 -40.88 70.9 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.239 -1.393 . . . . 1.0 107.239 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -59.24 -53.53 57.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 106.566 -1.642 . . . . 1.0 106.566 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -48.43 -34.59 11.25 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 113.567 -1.651 . . . . 1.0 109.846 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.4 mt -80.97 -51.58 8.37 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.391 0.886 . . . . 1.0 113.391 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -113.49 -44.72 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-N 117.867 0.303 . . . . 1.0 111.489 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.67 12.86 2.37 Favored Glycine 0 N--CA 1.492 2.387 0 CA-C-O 119.362 -0.688 . . . . 1.0 114.056 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.79 129.99 50.55 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 123.784 0.343 . . . . 1.0 110.515 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.35 68.17 0.75 Allowed 'General case' 0 N--CA 1.506 2.358 0 O-C-N 124.624 1.203 . . . . 1.0 109.417 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.481 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 12.5 p -118.47 -179.94 3.94 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.628 -1.169 . . . . 1.0 113.418 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.8 158.95 12.24 Favored Glycine 0 N--CA 1.493 2.464 0 CA-C-N 113.852 -1.522 . . . . 1.0 113.04 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -127.03 177.23 6.77 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 122.076 0.941 . . . . 1.0 108.524 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.7 t -101.71 111.84 24.22 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 112.492 -2.14 . . . . 1.0 107.829 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 49.9 m -126.23 120.69 30.66 Favored 'General case' 0 N--CA 1.503 2.175 0 CA-C-N 112.1 -2.318 . . . . 1.0 111.559 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 48.76 42.84 20.47 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 113.452 -1.704 . . . . 1.0 109.684 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.15 21.38 61.63 Favored Glycine 0 N--CA 1.486 2.005 0 CA-C-N 113.733 -1.576 . . . . 1.0 113.241 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.8 mtt-85 -133.15 161.45 34.4 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 106.916 -1.513 . . . . 1.0 106.916 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.571 ' HB3' HG12 ' A' ' 3' ' ' ILE . 35.0 t -72.57 141.73 48.42 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.607 1.336 . . . . 1.0 114.607 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.5 t70 -135.24 83.31 2.01 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 125.631 1.832 . . . . 1.0 109.112 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.481 ' SG ' ' C ' ' A' ' 25' ' ' THR . 9.6 t . . . . . 0 N--CA 1.502 2.13 0 C-N-CA 119.25 -0.98 . . . . 1.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.711 0.767 . . . . 1.0 112.407 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 58.0 t -71.04 115.28 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 113.839 -1.528 . . . . 1.0 109.052 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.521 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 29.2 pt -133.97 163.63 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 115.273 1.583 . . . . 1.0 115.273 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.75 -43.08 96.66 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-N 111.398 -2.637 . . . . 1.0 111.572 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.42 ' HB3' HG13 ' A' ' 3' ' ' ILE . 53.1 tp60 -15.23 88.34 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 O-C-N 126.173 1.749 . . . . 1.0 113.774 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -39.89 134.17 1.49 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 124.88 1.362 . . . . 1.0 110.75 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 9.7 t -116.69 159.19 22.61 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.663 -1.153 . . . . 1.0 113.09 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.44 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 19.1 t80 -119.46 -61.89 1.57 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 104.254 -2.499 . . . . 1.0 104.254 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.432 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -118.15 161.28 20.12 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 112.891 -1.959 . . . . 1.0 110.318 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.425 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 75.8 m -18.42 -60.09 0.05 OUTLIER Pre-proline 0 N--CA 1.506 2.338 0 N-CA-C 117.948 2.573 . . . . 1.0 117.948 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 44.7 Cg_endo -72.44 -96.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.6 1.533 . . . . 1.0 113.185 176.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.404 ' H ' ' HG2' ' A' ' 11' ' ' PRO . 5.5 t0 44.52 28.59 0.33 Allowed 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 122.253 1.025 . . . . 1.0 109.542 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 t -167.07 -22.99 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 113.367 -1.742 . . . . 1.0 114.177 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.453 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 6.6 m-30 -39.12 -62.99 0.58 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 112.228 0.455 . . . . 1.0 112.228 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.1 t -43.36 -46.68 6.61 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 125.358 1.661 . . . . 1.0 111.13 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.434 ' HA ' ' HG2' ' A' ' 19' ' ' LYS . . . -63.61 -45.17 91.53 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 114.035 -1.439 . . . . 1.0 111.224 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.1 t -62.73 -38.97 92.6 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.935 -1.135 . . . . 1.0 107.935 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -60.95 -51.38 69.5 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.434 ' HG2' ' HA ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -70.92 -18.03 62.67 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 118.091 -1.444 . . . . 1.0 112.262 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 mp -87.33 -50.14 6.78 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 112.94 0.719 . . . . 1.0 112.94 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.2 m -112.16 -30.79 2.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 118.832 -0.604 . . . . 1.0 112.172 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.89 -26.62 2.99 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 116.491 1.356 . . . . 1.0 116.491 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -122.65 135.16 54.52 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 114.542 1.312 . . . . 1.0 114.542 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.78 67.72 0.6 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 113.609 -1.632 . . . . 1.0 111.862 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.9 t -131.79 -163.32 1.32 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.543 -0.753 . . . . 1.0 110.364 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.51 -176.06 17.45 Favored Glycine 0 N--CA 1.498 2.81 0 CA-C-N 113.769 -1.56 . . . . 1.0 111.222 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -136.0 171.64 14.18 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.523 0.678 . . . . 1.0 110.021 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.0 t -105.31 114.44 28.63 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 106.406 -1.702 . . . . 1.0 106.406 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.5 m -123.36 118.35 27.31 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 112.6 -2.091 . . . . 1.0 114.304 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 45.16 39.26 3.87 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 114.073 -1.421 . . . . 1.0 112.014 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.6 18.29 79.81 Favored Glycine 0 N--CA 1.476 1.335 0 CA-C-N 112.886 -1.961 . . . . 1.0 115.221 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.7 mtp-105 -135.32 156.41 49.0 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.2 -1.037 . . . . 1.0 108.2 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.521 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 20.1 t -72.9 138.49 46.25 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 116.556 2.058 . . . . 1.0 116.556 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 0.8 OUTLIER -133.36 82.34 1.98 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 125.283 1.615 . . . . 1.0 108.757 178.421 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.499 1.996 0 CA-C-O 116.52 -1.705 . . . . 1.0 110.736 -179.758 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 2' ' ' VAL . 22.6 t . . . . . 0 N--CA 1.497 1.924 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.3 p -70.89 119.98 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 114.998 -1.001 . . . . 1.0 108.609 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.519 HG12 ' HB3' ' A' ' 33' ' ' CYS . 22.8 pt -129.21 159.72 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 114.929 1.455 . . . . 1.0 114.929 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.32 -45.16 44.87 Favored Glycine 0 N--CA 1.478 1.44 0 CA-C-N 110.755 -2.929 . . . . 1.0 111.63 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.452 ' HB3' HG13 ' A' ' 3' ' ' ILE . 3.7 tp-100 -21.26 90.73 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 O-C-N 125.794 1.526 . . . . 1.0 113.137 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.3 ptt-85 -46.2 142.51 2.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 124.63 1.206 . . . . 1.0 108.689 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 28.0 p -113.32 158.88 20.01 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 118.839 -1.144 . . . . 1.0 112.273 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -116.73 -59.79 1.92 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 105.741 -1.948 . . . . 1.0 105.741 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.3 mtt85 -114.84 169.5 9.03 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 112.058 -2.337 . . . . 1.0 106.879 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.475 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 73.5 m -37.58 -56.26 1.79 Allowed Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 124.776 1.298 . . . . 1.0 111.726 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.475 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 97.9 Cg_endo -64.97 -95.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.248 1.299 . . . . 1.0 112.945 175.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.1 t70 37.19 30.58 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 O-C-N 125.401 1.688 . . . . 1.0 109.578 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.431 ' N ' ' C ' ' A' ' 11' ' ' PRO . 42.7 t -164.81 -22.92 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 111.244 -2.707 . . . . 1.0 112.832 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.426 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.1 m-85 -38.6 -58.61 1.02 Allowed 'General case' 0 N--CA 1.503 2.206 0 CA-C-N 118.306 0.503 . . . . 1.0 110.434 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.4 p -53.54 -44.75 69.47 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 124.635 1.21 . . . . 1.0 111.086 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.23 -57.94 10.65 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 120.35 -0.54 . . . . 1.0 110.933 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.8 t -52.51 -45.24 66.15 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.412 -1.329 . . . . 1.0 107.412 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -50.98 -47.72 61.37 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -62.85 -36.31 82.84 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 114.565 -1.198 . . . . 1.0 110.126 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.46 -54.64 11.48 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 113.64 0.978 . . . . 1.0 113.64 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 m -105.42 -43.58 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 114.103 1.149 . . . . 1.0 114.103 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.28 17.23 2.01 Favored Glycine 0 N--CA 1.494 2.557 0 O-C-N 123.536 0.522 . . . . 1.0 112.199 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -134.14 130.53 37.46 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 123.877 0.398 . . . . 1.0 110.198 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.56 71.68 0.7 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 124.533 1.146 . . . . 1.0 108.555 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.3 p -119.57 177.16 5.04 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.485 -1.234 . . . . 1.0 113.281 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.93 153.35 17.56 Favored Glycine 0 N--CA 1.49 2.261 0 CA-C-N 113.64 -1.618 . . . . 1.0 111.191 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.8 -176.67 3.84 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 124.829 0.958 . . . . 1.0 108.552 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.2 t -108.42 109.34 20.61 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 112.063 -2.335 . . . . 1.0 108.661 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.9 m -136.26 129.34 31.37 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-N 112.683 -2.053 . . . . 1.0 110.066 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 51.15 40.73 26.55 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 112.817 -1.992 . . . . 1.0 107.729 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.35 13.56 44.21 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-N 113.358 -1.746 . . . . 1.0 114.283 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.4 mmt-85 -129.93 159.88 35.3 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.371 -0.974 . . . . 1.0 108.371 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.519 ' HB3' HG12 ' A' ' 3' ' ' ILE . 15.6 t -72.68 140.53 47.95 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.85 1.426 . . . . 1.0 114.85 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 7.7 p-10 -130.7 94.98 3.74 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 105.587 -2.005 . . . . 1.0 105.587 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.502 2.161 0 CA-C-O 118.013 -0.994 . . . . 1.0 110.174 -179.887 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.635 0.731 . . . . 1.0 111.098 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.5 p -70.49 115.03 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-N 113.949 -1.478 . . . . 1.0 109.243 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.514 HG12 ' HB3' ' A' ' 33' ' ' CYS . 36.6 pt -137.8 165.49 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 115.659 1.725 . . . . 1.0 115.659 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.97 -42.92 95.11 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-N 111.89 -2.414 . . . . 1.0 111.271 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -21.31 98.8 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 O-C-N 125.66 1.447 . . . . 1.0 112.929 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.1 ptt-85 -39.67 141.35 0.41 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 125.146 1.529 . . . . 1.0 112.848 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.419 ' SG ' ' O ' ' A' ' 9' ' ' ARG . 11.9 t -112.69 155.31 24.71 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.644 -1.162 . . . . 1.0 110.712 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -120.41 -61.13 1.61 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 104.986 -2.227 . . . . 1.0 104.986 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.419 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 42.6 mtt85 -117.69 165.29 13.78 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 112.69 -2.05 . . . . 1.0 108.342 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.419 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.0 m -32.02 -53.52 0.53 Allowed Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 125.189 1.556 . . . . 1.0 113.613 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.462 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 49.7 Cg_endo -70.56 -94.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.585 1.523 . . . . 1.0 114.698 169.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 t70 41.17 30.45 0.11 Allowed 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 123.156 1.455 . . . . 1.0 110.062 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.4 t -165.34 -27.91 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 112.14 -2.3 . . . . 1.0 112.524 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.462 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 5.7 m-30 -38.98 -61.48 0.74 Allowed 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 112.834 0.679 . . . . 1.0 112.834 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.9 t -42.49 -43.89 3.86 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 125.39 1.681 . . . . 1.0 110.947 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.43 -43.93 68.92 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.386 -1.279 . . . . 1.0 110.183 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.1 t -60.94 -31.34 70.89 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.117 -1.068 . . . . 1.0 108.117 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -70.48 -53.82 14.77 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.138 -1.801 . . . . 1.0 106.138 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -59.43 -19.19 45.51 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 112.397 -2.183 . . . . 1.0 112.292 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.4 tp -102.92 -54.49 2.62 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 113.357 0.873 . . . . 1.0 113.357 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.5 t -92.88 -41.31 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-N 113.121 -1.854 . . . . 1.0 112.087 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.09 -23.05 3.94 Favored Glycine 0 N--CA 1.488 2.141 0 CA-C-O 119.348 -0.695 . . . . 1.0 113.03 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -126.1 134.98 51.2 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 113.815 1.043 . . . . 1.0 113.815 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.62 70.32 0.67 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 114.331 -1.304 . . . . 1.0 112.355 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.405 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 12.4 t -130.19 -166.74 1.72 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.025 -0.732 . . . . 1.0 109.025 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.4 -176.86 16.53 Favored Glycine 0 N--CA 1.492 2.39 0 CA-C-N 113.495 -1.684 . . . . 1.0 114.879 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HG2' ' N ' ' A' ' 28' ' ' CYS . 24.5 ttmm -133.38 165.54 24.62 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.822 -1.689 . . . . 1.0 109.263 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.409 ' N ' ' HG2' ' A' ' 27' ' ' LYS . 49.6 t -110.03 112.21 24.07 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 103.159 -2.904 . . . . 1.0 103.159 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 89.8 m -125.12 123.52 39.87 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 112.576 -2.102 . . . . 1.0 112.208 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 44.53 41.17 4.5 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 112.878 -1.965 . . . . 1.0 111.552 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.26 27.06 71.97 Favored Glycine 0 N--CA 1.484 1.861 0 CA-C-N 113.254 -1.794 . . . . 1.0 112.72 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.6 mtt-85 -136.32 159.8 40.66 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.703 -1.591 . . . . 1.0 106.703 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.514 ' HB3' HG12 ' A' ' 3' ' ' ILE . 13.0 t -72.87 142.3 47.94 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 113.945 1.091 . . . . 1.0 113.945 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 10.6 t70 -137.59 73.79 1.46 Allowed 'General case' 0 C--N 1.298 -1.634 0 O-C-N 125.561 1.788 . . . . 1.0 108.358 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 25' ' ' THR . 13.2 t . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 116.712 -1.613 . . . . 1.0 111.194 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.704 0.764 . . . . 1.0 111.693 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 50.3 t -70.59 116.07 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-N 113.949 -1.478 . . . . 1.0 109.503 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.658 HG12 ' HB3' ' A' ' 33' ' ' CYS . 33.1 pt -130.43 152.7 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-O 122.58 1.181 . . . . 1.0 113.585 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.73 -35.51 86.51 Favored Glycine 0 N--CA 1.483 1.783 0 CA-C-N 111.385 -2.643 . . . . 1.0 111.895 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.426 ' HB2' HD12 ' A' ' 3' ' ' ILE . 3.4 tm0? -22.56 94.12 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 126.229 1.782 . . . . 1.0 112.318 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -39.53 131.75 1.66 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 124.549 1.156 . . . . 1.0 112.417 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.508 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 4.5 t -111.69 159.6 18.06 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 124.615 1.197 . . . . 1.0 114.001 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.508 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 0.9 OUTLIER -121.38 -57.42 1.84 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 113.365 -1.743 . . . . 1.0 107.644 179.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.471 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 35.5 mmt-85 -115.73 166.56 11.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.35 1.031 . . . . 1.0 110.485 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.431 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.6 m -32.85 -56.92 0.52 Allowed Pre-proline 0 N--CA 1.502 2.158 0 N-CA-C 114.84 1.422 . . . . 1.0 114.84 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.465 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 97.3 Cg_endo -65.96 -92.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.3 1.333 . . . . 1.0 112.723 176.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.405 ' H ' ' HG2' ' A' ' 11' ' ' PRO . 6.0 t0 40.15 32.34 0.12 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 122.993 1.378 . . . . 1.0 108.774 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.3 t -166.94 -26.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 112.47 -2.15 . . . . 1.0 112.223 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.465 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.7 m-85 -38.73 -58.09 1.11 Allowed 'General case' 0 N--CA 1.505 2.32 0 C-N-CA 123.431 0.693 . . . . 1.0 111.6 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.3 t -49.14 -46.67 45.46 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 124.306 1.004 . . . . 1.0 110.641 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.35 -35.26 79.02 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.96 -1.018 . . . . 1.0 112.117 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 25' ' ' THR . 45.5 m -69.77 -35.38 74.87 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.685 -0.857 . . . . 1.0 108.685 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -70.63 -42.84 70.34 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.707 -1.22 . . . . 1.0 107.707 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -69.99 -29.07 66.07 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 112.622 -2.081 . . . . 1.0 113.648 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.63 -34.68 8.09 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.334 1.235 . . . . 1.0 114.334 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.3 t -104.42 -35.7 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 123.943 0.777 . . . . 1.0 109.953 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.23 -30.76 3.8 Favored Glycine 0 N--CA 1.489 2.177 0 C-N-CA 120.803 -0.713 . . . . 1.0 113.879 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.644 ' H ' ' HZ2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -123.84 151.19 43.69 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 120.67 -0.412 . . . . 1.0 111.189 -179.369 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.4 75.27 0.76 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 125.016 1.447 . . . . 1.0 108.643 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.473 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 14.9 t -122.33 -162.8 1.03 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.046 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.459 ' HA3' ' SG ' ' A' ' 35' ' ' CYS . . . 82.6 167.0 39.79 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.488 -1.445 . . . . 1.0 109.488 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -139.36 -172.01 3.26 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 118.676 -1.21 . . . . 1.0 111.508 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.4 t -107.06 117.82 35.06 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 111.41 -2.632 . . . . 1.0 109.191 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.1 m -139.94 134.15 31.15 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 113.474 -1.693 . . . . 1.0 109.885 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 47.61 41.21 13.08 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 113.723 -1.58 . . . . 1.0 109.878 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.65 18.98 53.8 Favored Glycine 0 N--CA 1.491 2.362 0 CA-C-N 113.512 -1.676 . . . . 1.0 114.828 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.8 mtp85 -136.53 157.5 46.63 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.022 -1.473 . . . . 1.0 107.022 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.658 ' HB3' HG12 ' A' ' 3' ' ' ILE . 42.6 t -73.12 139.0 46.13 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.236 1.199 . . . . 1.0 114.236 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -135.79 95.55 3.26 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 102.743 -3.058 . . . . 1.0 102.743 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.459 ' SG ' ' HA3' ' A' ' 26' ' ' GLY . 6.5 t . . . . . 0 N--CA 1.495 1.792 0 CA-C-N 113.546 -1.661 . . . . 1.0 110.746 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 122.105 0.955 . . . . 1.0 112.408 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 64.8 t -70.71 114.75 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-N 113.232 -1.803 . . . . 1.0 108.446 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.502 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 33.5 pt -136.29 166.62 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 115.954 1.835 . . . . 1.0 115.954 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 5' ' ' GLN . . . -61.02 -43.15 99.8 Favored Glycine 0 N--CA 1.473 1.119 0 CA-C-N 111.736 -2.483 . . . . 1.0 111.469 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.408 ' HB3' HG13 ' A' ' 3' ' ' ILE . 4.0 tp-100 -14.84 90.75 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.429 0 O-C-N 125.843 1.554 . . . . 1.0 113.135 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -39.81 133.82 1.51 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 125.224 1.578 . . . . 1.0 110.767 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.484 ' SG ' ' O ' ' A' ' 9' ' ' ARG . 35.2 t -117.6 156.61 27.84 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 124.342 1.026 . . . . 1.0 113.53 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.432 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.3 t80 -120.99 -61.07 1.59 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 105.637 -1.986 . . . . 1.0 105.637 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.484 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 20.4 mtt-85 -114.19 159.98 19.51 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 113.136 -1.847 . . . . 1.0 109.264 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.449 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.3 m -24.5 -56.14 0.15 Allowed Pre-proline 0 N--CA 1.506 2.352 0 O-C-N 125.201 1.563 . . . . 1.0 114.949 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.449 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 67.2 Cg_endo -67.1 -96.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.755 1.637 . . . . 1.0 114.07 170.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.7 t70 38.38 32.28 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 123.539 1.638 . . . . 1.0 109.819 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.6 t -171.46 -18.08 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 111.324 -2.671 . . . . 1.0 113.83 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -38.66 -59.99 0.87 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 112.723 0.638 . . . . 1.0 112.723 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.6 p -46.48 -44.73 17.82 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 124.921 1.388 . . . . 1.0 111.86 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.78 -43.78 87.77 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 114.816 -1.084 . . . . 1.0 109.316 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.6 t -57.81 -50.56 72.86 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.739 -1.578 . . . . 1.0 106.739 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -50.67 -53.93 27.14 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.361 -0.977 . . . . 1.0 108.361 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -51.77 -32.88 32.75 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 112.724 -2.035 . . . . 1.0 110.982 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.0 mt -90.01 -57.82 2.72 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 115.771 1.767 . . . . 1.0 115.771 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 m -99.14 -35.82 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 113.155 0.798 . . . . 1.0 113.155 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.16 -22.32 3.59 Favored Glycine 0 N--CA 1.492 2.393 0 CA-C-O 118.512 -1.16 . . . . 1.0 115.915 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.574 ' H ' ' HD3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -124.56 144.68 50.01 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 118.299 1.05 . . . . 1.0 113.022 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.77 68.85 0.64 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 113.6 -1.636 . . . . 1.0 113.4 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.432 HG23 ' SG ' ' A' ' 35' ' ' CYS . 8.9 t -133.06 -163.24 1.32 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.494 ' CA ' ' SG ' ' A' ' 35' ' ' CYS . . . 122.65 174.98 14.54 Favored Glycine 0 N--CA 1.495 2.579 0 CA-C-N 114.018 -1.446 . . . . 1.0 113.534 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -121.35 161.32 22.28 Favored 'General case' 0 C--O 1.206 -1.22 0 CA-C-N 113.457 -1.372 . . . . 1.0 109.342 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.1 t -111.67 101.7 10.06 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 103.55 -2.759 . . . . 1.0 103.55 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.2 m -118.19 121.32 40.2 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 110.944 -2.844 . . . . 1.0 112.997 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.7 t30 45.29 39.82 4.65 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 113.204 -1.816 . . . . 1.0 111.082 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.37 29.43 75.05 Favored Glycine 0 N--CA 1.486 2.029 0 CA-C-N 112.917 -1.947 . . . . 1.0 112.792 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -139.45 153.04 47.48 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.289 -1.745 . . . . 1.0 106.289 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.502 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 6.1 t -73.8 139.01 44.87 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 117.155 2.28 . . . . 1.0 117.155 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -134.4 80.51 1.86 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 125.54 1.775 . . . . 1.0 107.167 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.494 ' SG ' ' CA ' ' A' ' 26' ' ' GLY . 5.8 t . . . . . 0 N--CA 1.501 2.077 0 CA-C-O 116.239 -1.839 . . . . 1.0 111.455 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.438 HG23 ' H1 ' ' A' ' 1' ' ' VAL . 15.6 t . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 108.373 -0.973 . . . . 1.0 108.373 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 48.9 t -71.68 111.65 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 106.073 -1.825 . . . . 1.0 106.073 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.55 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 37.3 pt -133.7 160.07 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 N-CA-C 114.931 1.456 . . . . 1.0 114.931 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.95 42.76 3.18 Favored Glycine 0 C--O 1.21 -1.349 0 CA-C-N 112.153 -2.294 . . . . 1.0 111.873 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -105.15 107.31 18.22 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 101.891 -3.374 . . . . 1.0 101.891 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -39.09 138.91 0.53 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 125.425 1.703 . . . . 1.0 114.083 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.1 t -112.86 153.12 28.39 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.908 -1.496 . . . . 1.0 110.185 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -120.01 -56.87 1.99 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 104.927 -2.249 . . . . 1.0 104.927 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.439 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -117.89 155.08 30.79 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 113.393 -1.731 . . . . 1.0 106.57 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.46 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 71.9 m -24.01 -56.44 0.14 Allowed Pre-proline 0 N--CA 1.506 2.337 0 N-CA-C 115.137 1.532 . . . . 1.0 115.137 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.46 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 70.1 Cg_endo -67.25 -94.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.79 1.66 . . . . 1.0 113.222 170.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t70 40.93 29.53 0.08 Allowed 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.629 1.204 . . . . 1.0 109.9 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 t -166.33 -24.11 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 111.966 -2.379 . . . . 1.0 112.759 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 11' ' ' PRO . 6.0 m-30 -38.72 -60.94 0.77 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 112.439 0.533 . . . . 1.0 112.439 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.4 t -44.74 -42.23 7.51 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 125.253 1.596 . . . . 1.0 111.375 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.28 -47.55 60.74 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 115.091 -0.958 . . . . 1.0 109.076 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.1 t -53.99 -40.72 67.17 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.324 -1.362 . . . . 1.0 107.324 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.4 ' HA ' ' N ' ' A' ' 23' ' ' LYS . 32.4 ttmt -60.84 -54.24 47.56 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 105.967 -1.864 . . . . 1.0 105.967 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -48.01 -31.71 5.7 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 113.473 -1.694 . . . . 1.0 110.03 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.7 mt -84.33 -50.84 7.46 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.569 0.952 . . . . 1.0 113.569 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 p -112.63 -45.66 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 CA-C-N 117.806 0.276 . . . . 1.0 111.159 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.18 18.8 1.46 Allowed Glycine 0 N--CA 1.491 2.324 0 CA-C-O 119.067 -0.852 . . . . 1.0 114.774 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.4 ' N ' ' HA ' ' A' ' 18' ' ' LYS . 14.2 mmmm -133.58 126.09 30.22 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 117.291 0.545 . . . . 1.0 112.207 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.43 68.78 0.8 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 124.88 1.362 . . . . 1.0 109.793 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.45 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 9.7 t -135.94 -171.53 2.89 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.679 -0.691 . . . . 1.0 110.088 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.75 -179.31 16.19 Favored Glycine 0 N--CA 1.493 2.467 0 CA-C-N 113.546 -1.661 . . . . 1.0 113.371 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -131.68 171.87 12.95 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 113.982 -1.109 . . . . 1.0 110.845 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.2 t -115.27 112.12 21.95 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 100.375 -3.935 . . . . 1.0 100.375 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.2 m -132.12 127.8 36.78 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 112.227 -2.261 . . . . 1.0 107.929 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.4 p30 46.41 43.89 12.33 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 125.929 2.018 . . . . 1.0 111.903 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.42 13.87 46.14 Favored Glycine 0 N--CA 1.479 1.547 0 CA-C-N 112.876 -1.965 . . . . 1.0 112.463 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.6 mtt-85 -128.21 163.66 24.22 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.863 -1.162 . . . . 1.0 107.863 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.55 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 9.4 t -72.93 142.17 47.84 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 114.702 1.371 . . . . 1.0 114.702 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.487 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 35.6 t70 -135.29 76.69 1.63 Allowed 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 112.454 -2.157 . . . . 1.0 107.324 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 25' ' ' THR . 23.6 t . . . . . 0 N--CA 1.502 2.125 0 CA-C-O 118.261 -0.876 . . . . 1.0 111.306 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.74 0.781 . . . . 1.0 111.575 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.3 p -70.85 123.61 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-N 113.473 -1.694 . . . . 1.0 108.31 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.505 HG12 ' HB3' ' A' ' 33' ' ' CYS . 16.5 pt -133.7 163.08 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 115.214 1.561 . . . . 1.0 115.214 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.42 -46.86 36.34 Favored Glycine 0 N--CA 1.478 1.472 0 CA-C-N 111.036 -2.802 . . . . 1.0 112.528 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.402 ' HB3' HG13 ' A' ' 3' ' ' ILE . 3.8 tp-100 -19.83 92.71 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 O-C-N 125.926 1.604 . . . . 1.0 114.085 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -48.17 141.81 5.92 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 124.603 1.19 . . . . 1.0 109.662 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.7 p -123.36 160.55 26.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 124.154 0.909 . . . . 1.0 113.234 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -118.1 -58.57 1.99 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 104.454 -2.424 . . . . 1.0 104.454 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -112.73 166.45 11.35 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 126.166 2.166 . . . . 1.0 106.638 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.456 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 75.4 m -33.66 -61.24 0.4 Allowed Pre-proline 0 N--CA 1.502 2.139 0 N-CA-C 114.614 1.339 . . . . 1.0 114.614 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.456 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 73.2 Cg_endo -61.33 -92.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 121.255 1.304 . . . . 1.0 110.315 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t0 34.77 36.96 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 123.812 1.767 . . . . 1.0 108.765 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.417 ' N ' ' C ' ' A' ' 11' ' ' PRO . 48.5 t -168.72 -26.23 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 110.444 -3.071 . . . . 1.0 111.465 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -37.93 -56.66 1.1 Allowed 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 123.439 0.695 . . . . 1.0 111.489 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 55.0 m -54.63 -40.42 68.93 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 124.391 1.057 . . . . 1.0 111.892 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.96 -52.38 24.84 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 123.591 0.557 . . . . 1.0 110.71 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 t -60.28 -27.73 67.52 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.129 -1.063 . . . . 1.0 108.129 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -70.38 -50.33 39.82 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.769 -1.567 . . . . 1.0 106.769 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -59.81 -29.13 68.02 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 112.77 -2.014 . . . . 1.0 113.085 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -102.02 -35.46 8.95 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.54 1.682 . . . . 1.0 115.54 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.7 t -104.97 -40.49 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 123.61 0.568 . . . . 1.0 110.049 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.12 -29.18 3.09 Favored Glycine 0 N--CA 1.486 1.986 0 CA-C-O 118.894 -0.948 . . . . 1.0 114.166 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -124.77 159.25 31.39 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.095 1.517 . . . . 1.0 115.095 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.03 71.96 0.57 Allowed 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 113.554 -1.657 . . . . 1.0 113.46 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.427 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 2.3 p -119.73 172.13 7.9 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.633 -1.167 . . . . 1.0 112.169 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.95 147.26 9.24 Favored Glycine 0 N--CA 1.491 2.34 0 CA-C-N 113.748 -1.569 . . . . 1.0 111.332 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -121.92 173.68 7.36 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 113.326 -1.437 . . . . 1.0 109.646 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.2 t -103.73 112.1 24.89 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 104.268 -2.493 . . . . 1.0 104.268 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.3 m -130.34 130.34 44.31 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 111.857 -2.429 . . . . 1.0 106.45 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 44.06 44.76 6.4 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 125.123 1.514 . . . . 1.0 111.825 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.46 11.76 22.83 Favored Glycine 0 N--CA 1.487 2.068 0 CA-C-N 112.982 -1.917 . . . . 1.0 114.096 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.2 mtp85 -128.06 163.95 23.48 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.505 ' HB3' HG12 ' A' ' 3' ' ' ILE . 49.5 t -72.41 143.69 48.44 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.212 -1.395 . . . . 1.0 113.819 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 65.2 t0 -133.17 84.08 2.11 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 126.108 2.13 . . . . 1.0 107.077 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' A' ' 25' ' ' THR . 8.8 t . . . . . 0 N--CA 1.503 2.18 0 CA-C-O 118.626 -0.702 . . . . 1.0 110.105 -179.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.498 0.666 . . . . 1.0 111.634 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.8 p -70.71 122.78 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 114.447 -1.251 . . . . 1.0 108.129 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.529 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 32.7 pt -136.0 160.24 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 N-CA-C 115.794 1.775 . . . . 1.0 115.794 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.21 -44.41 57.51 Favored Glycine 0 N--CA 1.478 1.469 0 CA-C-N 111.093 -2.776 . . . . 1.0 111.183 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.427 ' HB3' HG13 ' A' ' 3' ' ' ILE . 46.5 tp60 -24.42 91.86 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 125.873 1.572 . . . . 1.0 112.856 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -40.0 149.11 0.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 125.263 1.602 . . . . 1.0 112.966 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.412 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 2.1 t -110.1 153.48 24.61 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 124.648 1.218 . . . . 1.0 112.523 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.412 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 1.1 t80 -122.01 -62.35 1.4 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 102.801 -3.037 . . . . 1.0 102.801 179.35 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -119.62 166.11 13.59 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 112.093 -2.321 . . . . 1.0 105.838 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.471 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 75.3 m -33.37 -56.39 0.62 Allowed Pre-proline 0 N--CA 1.505 2.318 0 N-CA-C 114.229 1.196 . . . . 1.0 114.229 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.471 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 88.3 Cg_endo -64.15 -94.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 121.891 1.727 . . . . 1.0 111.826 174.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.0 t70 35.07 36.66 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 CA-C-O 123.844 1.783 . . . . 1.0 109.389 -179.282 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 50.4 t -168.61 -25.25 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 109.8 -3.364 . . . . 1.0 111.567 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -37.86 -57.21 1.04 Allowed 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 122.913 0.485 . . . . 1.0 111.587 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.8 t -49.68 -51.72 36.24 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 125.046 1.466 . . . . 1.0 109.116 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.17 -55.53 32.0 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 120.343 -0.543 . . . . 1.0 112.448 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.7 t -59.2 -27.99 66.23 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 115.397 -0.82 . . . . 1.0 109.499 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -70.12 -46.29 65.08 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 179.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -70.3 -22.6 62.82 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 114.242 -1.344 . . . . 1.0 113.034 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.2 mp -100.03 -33.48 10.47 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 113.911 1.078 . . . . 1.0 113.911 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.0 t -113.06 -43.97 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 124.05 0.844 . . . . 1.0 110.696 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.66 -25.45 3.41 Favored Glycine 0 N--CA 1.49 2.254 0 CA-C-O 119.075 -0.847 . . . . 1.0 114.429 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -120.99 155.87 33.37 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 113.476 0.917 . . . . 1.0 113.476 -179.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.86 69.88 0.71 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 125.084 1.49 . . . . 1.0 109.392 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.8 p -115.32 173.72 6.37 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.496 -1.229 . . . . 1.0 113.273 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.4 152.68 8.81 Favored Glycine 0 N--CA 1.49 2.295 0 CA-C-N 113.844 -1.525 . . . . 1.0 111.199 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -125.1 170.7 10.93 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.342 -1.355 . . . . 1.0 107.342 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.8 t -103.35 109.9 21.69 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.158 -1.793 . . . . 1.0 106.158 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.9 m -133.31 130.73 39.29 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 112.593 -2.094 . . . . 1.0 107.661 -179.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.417 ' ND2' ' HD2' ' A' ' 32' ' ' ARG . 6.1 p-10 44.64 44.17 7.17 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 125.107 1.504 . . . . 1.0 112.103 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.67 14.84 30.91 Favored Glycine 0 N--CA 1.487 2.063 0 CA-C-N 113.125 -1.852 . . . . 1.0 113.125 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.417 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 44.9 mtt-85 -130.65 165.52 22.66 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.552 -0.907 . . . . 1.0 108.552 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.529 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 13.3 t -72.45 144.91 47.93 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.517 -1.273 . . . . 1.0 114.318 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 36.9 t70 -134.98 82.95 1.99 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 126.385 2.303 . . . . 1.0 107.798 179.003 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.503 2.186 0 CA-C-O 116.237 -1.839 . . . . 1.0 110.405 -179.733 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 122.113 0.959 . . . . 1.0 111.995 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.3 p -70.22 122.4 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-N 112.998 -1.91 . . . . 1.0 108.965 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.472 HG12 ' HB3' ' A' ' 33' ' ' CYS . 1.2 pt -131.55 159.12 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 122.278 1.037 . . . . 1.0 113.526 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -39.95 -54.07 3.07 Favored Glycine 0 N--CA 1.483 1.81 0 CA-C-N 111.471 -2.604 . . . . 1.0 112.08 179.528 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -14.0 85.42 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 O-C-N 126.619 2.011 . . . . 1.0 112.923 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -40.15 145.28 0.16 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 113.666 -1.606 . . . . 1.0 112.368 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.5 t -114.91 148.05 39.16 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 124.42 1.075 . . . . 1.0 111.987 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.492 ' HB3' ' HD3' ' A' ' 9' ' ' ARG . 3.7 t80 -123.15 -54.99 1.79 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 103.391 -2.818 . . . . 1.0 103.391 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.492 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -117.13 153.82 32.12 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 113.366 -1.743 . . . . 1.0 107.696 179.665 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.482 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.7 m -28.49 -56.23 0.25 Allowed Pre-proline 0 N--CA 1.504 2.273 0 N-CA-C 114.101 1.149 . . . . 1.0 114.101 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.482 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 86.8 Cg_endo -64.99 -90.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.931 1.754 . . . . 1.0 112.365 170.68 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.408 ' H ' ' HG2' ' A' ' 11' ' ' PRO . 8.4 t70 36.51 34.93 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 123.572 1.653 . . . . 1.0 109.796 -179.448 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.7 t -168.45 -26.09 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 110.427 -3.079 . . . . 1.0 111.117 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -38.6 -58.26 1.07 Allowed 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 122.985 0.514 . . . . 1.0 111.812 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 64.8 p -45.48 -45.15 12.97 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 124.672 1.232 . . . . 1.0 110.957 179.396 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.462 ' HA ' ' HG3' ' A' ' 19' ' ' LYS . . . -66.89 -44.64 80.32 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.433 -1.258 . . . . 1.0 111.109 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 25' ' ' THR . 20.2 m -62.8 -32.38 73.54 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.444 -1.253 . . . . 1.0 108.191 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -70.18 -52.59 22.19 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.265 -1.383 . . . . 1.0 107.265 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HG3' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -71.08 -11.82 61.17 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 117.638 -1.625 . . . . 1.0 111.653 179.986 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 40.9 mt -93.67 -54.97 3.43 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 112.21 0.448 . . . . 1.0 112.21 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.0 m -109.36 -20.32 6.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 118.637 -0.697 . . . . 1.0 112.465 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.46 -33.89 2.59 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 117.83 1.892 . . . . 1.0 117.83 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.571 ' H ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -128.52 162.85 26.26 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 115.458 1.651 . . . . 1.0 115.458 -179.35 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.56 70.63 0.66 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 113.351 -1.749 . . . . 1.0 110.856 179.669 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.422 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 8.2 t -121.58 -177.91 3.67 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.709 0.766 . . . . 1.0 110.687 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.51 174.65 15.24 Favored Glycine 0 N--CA 1.491 2.322 0 CA-C-N 112.941 -1.936 . . . . 1.0 112.096 179.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.459 ' HG2' ' N ' ' A' ' 28' ' ' CYS . 39.0 ttmt -134.19 167.46 20.64 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.78 -1.21 . . . . 1.0 108.51 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.459 ' N ' ' HG2' ' A' ' 27' ' ' LYS . 50.5 t -108.46 110.01 21.43 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 104.88 -2.267 . . . . 1.0 104.88 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.8 m -128.92 124.71 35.86 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 112.609 -2.087 . . . . 1.0 111.962 -179.557 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 44.32 42.16 5.03 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 112.864 -1.971 . . . . 1.0 111.424 -179.365 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.74 24.81 70.05 Favored Glycine 0 N--CA 1.484 1.854 0 CA-C-N 113.567 -1.651 . . . . 1.0 113.525 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.0 mtp85 -136.53 160.28 39.27 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 107.028 -1.471 . . . . 1.0 107.028 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.472 ' HB3' HG12 ' A' ' 3' ' ' ILE . 21.2 t -72.88 145.3 46.98 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.178 -1.409 . . . . 1.0 112.197 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 34.3 t70 -129.75 82.58 2.08 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 103.814 -2.662 . . . . 1.0 103.814 178.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.501 2.079 0 CA-C-O 118.366 -0.826 . . . . 1.0 110.604 -179.406 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.174 0.512 . . . . 1.0 111.141 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.3 p -70.88 122.38 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-N 114.654 -1.157 . . . . 1.0 109.884 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.538 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 28.2 pt -133.82 162.43 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 N-CA-C 114.195 1.184 . . . . 1.0 114.195 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.66 44.49 3.26 Favored Glycine 0 C--O 1.211 -1.318 0 CA-C-N 112.201 -2.272 . . . . 1.0 111.955 -179.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -103.88 92.26 4.33 Favored 'General case' 0 N--CA 1.486 1.342 1 N-CA-C 99.934 -4.099 . . . . 1.0 99.934 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -38.98 142.31 0.23 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 125.694 1.871 . . . . 1.0 112.576 -179.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 0.5 OUTLIER -112.77 160.46 17.95 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 116.093 1.886 . . . . 1.0 116.093 -179.605 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.525 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 20.3 t80 -121.24 -58.95 1.76 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 102.794 -3.039 . . . . 1.0 102.794 179.652 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.473 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 11.0 mmm180 -118.14 166.33 12.7 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 113.023 -1.898 . . . . 1.0 109.526 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.473 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.7 m -33.06 -58.7 0.46 Allowed Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 124.997 1.435 . . . . 1.0 114.305 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.473 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 91.1 Cg_endo -62.75 -92.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.951 1.767 . . . . 1.0 111.592 177.14 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 t70 38.24 31.52 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 123.368 1.556 . . . . 1.0 109.144 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.412 ' N ' ' C ' ' A' ' 11' ' ' PRO . 49.1 t -171.55 -17.1 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 111.678 -2.51 . . . . 1.0 113.687 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -38.81 -62.01 0.67 Allowed 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 118.936 0.789 . . . . 1.0 110.451 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.3 m -48.7 -47.48 41.03 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.619 1.2 . . . . 1.0 112.077 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.47 -45.07 92.69 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 114.759 -1.109 . . . . 1.0 111.567 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.1 t -62.87 -48.93 76.9 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 105.802 -1.925 . . . . 1.0 105.802 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.43 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 5.3 ttpm? -47.82 -50.34 26.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 123.373 0.42 . . . . 1.0 110.76 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -70.28 -27.63 64.56 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 117.427 -1.709 . . . . 1.0 111.207 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.0 mt -76.44 -50.97 12.75 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.027 1.121 . . . . 1.0 114.027 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 m -109.37 -36.11 2.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 123.66 0.784 . . . . 1.0 111.955 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.421 ' C ' ' HD3' ' A' ' 23' ' ' LYS . . . 134.51 -20.41 3.92 Favored Glycine 0 N--CA 1.49 2.265 0 CA-C-O 119.083 -0.843 . . . . 1.0 114.726 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.421 ' HD3' ' C ' ' A' ' 22' ' ' GLY . 1.7 mppt? -116.98 136.82 52.65 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 112.709 0.633 . . . . 1.0 112.709 -179.467 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.12 68.37 0.71 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 125.125 1.516 . . . . 1.0 110.749 179.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.452 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 11.2 p -121.87 -175.64 3.15 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.294 -1.321 . . . . 1.0 113.032 -179.491 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.36 154.27 10.96 Favored Glycine 0 N--CA 1.492 2.383 0 CA-C-N 114.075 -1.421 . . . . 1.0 112.356 179.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.38 175.91 6.46 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.086 0.946 . . . . 1.0 109.947 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.9 t -97.37 112.03 24.03 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 112.676 -2.056 . . . . 1.0 106.488 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.417 ' HB ' ' HB2' ' A' ' 34' ' ' ASP . 37.2 m -128.18 119.64 25.67 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 111.971 -2.377 . . . . 1.0 111.933 -179.572 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 50.24 43.57 26.3 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 113.519 -1.673 . . . . 1.0 108.659 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.95 16.39 57.15 Favored Glycine 0 N--CA 1.486 2.022 0 CA-C-N 113.719 -1.582 . . . . 1.0 114.131 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.8 mtp-105 -131.22 161.32 32.49 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.202 -1.036 . . . . 1.0 108.202 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.538 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 47.3 t -72.56 140.65 48.22 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.724 -1.19 . . . . 1.0 114.143 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.417 ' HB2' ' HB ' ' A' ' 29' ' ' THR . 9.4 t70 -135.69 90.63 2.62 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 125.107 1.504 . . . . 1.0 107.13 178.526 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.452 ' SG ' ' C ' ' A' ' 25' ' ' THR . 10.8 t . . . . . 0 N--CA 1.501 2.104 0 CA-C-O 118.588 -0.72 . . . . 1.0 110.313 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 2' ' ' VAL . 19.2 t . . . . . 0 N--CA 1.499 2.005 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 5.8 p -71.03 116.87 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.567 -0.901 . . . . 1.0 108.567 179.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.61 HG12 ' HB3' ' A' ' 33' ' ' CYS . 35.3 pt -132.02 158.0 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 N-CA-C 114.304 1.224 . . . . 1.0 114.304 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.28 -39.86 73.52 Favored Glycine 0 N--CA 1.488 2.115 0 CA-C-N 111.859 -2.428 . . . . 1.0 111.522 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -28.18 96.59 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 O-C-N 125.867 1.569 . . . . 1.0 111.309 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -39.62 144.1 0.19 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 124.934 1.396 . . . . 1.0 114.447 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.7 p -128.06 157.68 40.03 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.074 -0.966 . . . . 1.0 110.694 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -120.26 -56.69 1.98 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 105.474 -2.047 . . . . 1.0 105.474 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.48 159.9 16.32 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 125.7 1.875 . . . . 1.0 107.158 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.455 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 72.4 m -35.1 -57.08 0.86 Allowed Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 125.313 1.633 . . . . 1.0 112.894 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.455 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 72.5 Cg_endo -60.54 -91.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.275 1.317 . . . . 1.0 111.056 175.293 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t0 33.47 39.54 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 123.981 1.848 . . . . 1.0 108.794 -179.335 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.9 t -172.75 -26.39 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 109.972 -3.285 . . . . 1.0 110.603 -179.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -38.27 -55.41 1.33 Allowed 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 123.588 0.755 . . . . 1.0 112.084 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.7 p -49.45 -48.98 47.18 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 124.214 0.946 . . . . 1.0 110.68 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.67 -55.26 36.57 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 124.03 0.831 . . . . 1.0 109.58 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 25' ' ' THR . 98.6 m -48.86 -41.56 33.6 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.194 -1.366 . . . . 1.0 111.064 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.451 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 6.6 ttpm? -66.65 -47.01 73.87 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.559 -1.645 . . . . 1.0 106.559 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -70.27 -11.51 60.95 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 113.384 -1.735 . . . . 1.0 112.348 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.3 mt -101.52 -53.28 3.02 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 112.684 0.624 . . . . 1.0 112.684 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.7 m -109.13 -26.35 3.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 119.19 -0.433 . . . . 1.0 111.633 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 126.68 -20.17 6.12 Favored Glycine 0 N--CA 1.493 2.434 0 CA-C-O 119.026 -0.874 . . . . 1.0 114.969 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.509 ' HB2' ' HZ3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -122.66 141.84 51.32 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 113.22 0.822 . . . . 1.0 113.22 -179.497 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.99 71.71 0.82 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 125.214 1.571 . . . . 1.0 110.108 179.365 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.515 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 6.0 t -122.64 179.1 4.73 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.748 0.785 . . . . 1.0 112.036 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.08 167.67 18.88 Favored Glycine 0 N--CA 1.498 2.774 0 CA-C-N 113.271 -1.786 . . . . 1.0 111.813 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.402 ' HB3' ' NZ ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -132.68 175.89 8.93 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.721 0.772 . . . . 1.0 109.955 179.95 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.4 t -103.07 116.13 31.93 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 113.31 -1.768 . . . . 1.0 106.44 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 78.4 m -127.93 127.29 43.07 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 112.525 -2.125 . . . . 1.0 109.747 -179.571 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 47.47 40.59 11.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 125.096 1.498 . . . . 1.0 111.062 -179.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.07 19.88 64.19 Favored Glycine 0 N--CA 1.483 1.832 0 CA-C-N 113.281 -1.781 . . . . 1.0 113.916 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.0 mtt-85 -132.7 162.51 31.22 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.479 -1.304 . . . . 1.0 107.479 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.61 ' HB3' HG12 ' A' ' 3' ' ' ILE . 41.8 t -72.79 143.64 47.83 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.889 -1.124 . . . . 1.0 113.243 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 36.8 t70 -134.75 78.1 1.72 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 104.128 -2.545 . . . . 1.0 104.128 178.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.1 t . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 117.863 -1.065 . . . . 1.0 111.078 -179.408 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 2' ' ' VAL . 10.6 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 108.381 -0.97 . . . . 1.0 108.381 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 5.7 p -71.51 119.02 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.426 -0.953 . . . . 1.0 108.426 179.384 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.53 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 27.4 pt -136.7 164.23 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 N-CA-C 114.809 1.411 . . . . 1.0 114.809 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.35 -43.51 76.06 Favored Glycine 0 N--CA 1.479 1.532 0 CA-C-N 112.051 -2.34 . . . . 1.0 112.08 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.401 ' HB3' HG13 ' A' ' 3' ' ' ILE . 52.4 tp60 -17.14 90.91 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 O-C-N 125.723 1.484 . . . . 1.0 114.12 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -39.96 136.5 1.11 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 125.065 1.478 . . . . 1.0 111.338 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 10.1 t -119.52 159.33 24.53 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 114.276 1.213 . . . . 1.0 114.276 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.503 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 15.4 t80 -120.53 -62.89 1.41 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 105.519 -2.03 . . . . 1.0 105.519 179.728 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.489 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 1.6 mmp_? -113.8 161.67 17.27 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.598 -1.637 . . . . 1.0 108.753 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.43 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 62.1 m -23.84 -59.21 0.12 Allowed Pre-proline 0 N--CA 1.504 2.27 0 N-CA-C 115.695 1.739 . . . . 1.0 115.695 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.43 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 77.5 Cg_endo -66.92 -93.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.157 0 C-N-CA 121.265 1.31 . . . . 1.0 113.86 176.339 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t0 40.23 33.52 0.17 Allowed 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 123.253 1.501 . . . . 1.0 108.942 -179.486 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.1 t -168.74 -24.21 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 111.859 -2.428 . . . . 1.0 112.827 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.414 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.2 m-85 -38.6 -59.72 0.89 Allowed 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 123.159 0.584 . . . . 1.0 111.967 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 77.8 p -48.05 -41.91 27.15 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 124.923 1.39 . . . . 1.0 111.893 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.98 -49.06 55.39 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.637 -0.711 . . . . 1.0 110.735 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 t -60.32 -29.87 69.14 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -70.81 -50.19 38.22 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.302 -1.37 . . . . 1.0 107.302 179.287 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -70.65 -13.4 62.07 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 113.225 -1.807 . . . . 1.0 113.719 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.8 mt -109.93 -43.37 4.01 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.363 0.875 . . . . 1.0 113.363 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.4 t -102.54 -34.71 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 114.859 -1.064 . . . . 1.0 110.323 -179.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.24 -31.65 3.11 Favored Glycine 0 N--CA 1.49 2.279 0 CA-C-O 119.105 -0.83 . . . . 1.0 114.175 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -123.6 150.82 43.66 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 113.725 1.009 . . . . 1.0 113.725 -179.348 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.42 72.99 0.71 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 113.827 -1.533 . . . . 1.0 109.815 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.429 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 17.9 p -117.11 -179.0 3.57 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.705 -1.134 . . . . 1.0 112.252 -179.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.03 166.5 13.24 Favored Glycine 0 N--CA 1.494 2.504 0 CA-C-N 114.515 -1.22 . . . . 1.0 115.34 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.561 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -134.05 168.58 18.55 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 112.847 -1.677 . . . . 1.0 107.282 179.696 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.439 ' N ' ' HG3' ' A' ' 27' ' ' LYS . 30.7 t -107.98 104.86 14.4 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 104.471 -2.418 . . . . 1.0 104.471 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.7 m -122.31 124.36 43.56 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 111.575 -2.557 . . . . 1.0 111.208 -179.371 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 46.62 39.86 7.59 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 112.89 -1.959 . . . . 1.0 110.921 -179.321 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.96 27.21 70.96 Favored Glycine 0 N--CA 1.485 1.914 0 CA-C-N 113.106 -1.861 . . . . 1.0 112.513 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.0 mtt-85 -137.36 161.27 36.74 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.334 -1.358 . . . . 1.0 107.334 179.688 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.53 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 46.8 t -72.38 143.39 48.6 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.854 1.057 . . . . 1.0 113.854 179.692 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 34.2 t70 -136.39 81.99 1.91 Allowed 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.502 -1.681 . . . . 1.0 108.641 178.869 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.429 ' SG ' ' C ' ' A' ' 25' ' ' THR . 12.3 t . . . . . 0 N--CA 1.499 1.994 0 CA-C-O 116.148 -1.882 . . . . 1.0 110.828 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.497 ' H2 ' ' HB3' ' A' ' 35' ' ' CYS . 11.5 t . . . . . 0 N--CA 1.495 1.825 0 N-CA-C 108.6 -0.889 . . . . 1.0 108.6 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.408 ' N ' HG12 ' A' ' 1' ' ' VAL . 7.1 p -71.23 121.66 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-N 114.683 -1.144 . . . . 1.0 109.682 179.763 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.588 HG12 ' HB3' ' A' ' 33' ' ' CYS . 19.6 pt -125.7 150.61 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-O 122.697 1.237 . . . . 1.0 113.594 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.79 -39.29 46.93 Favored Glycine 0 N--CA 1.479 1.505 0 CA-C-N 110.914 -2.857 . . . . 1.0 112.478 179.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -30.9 93.37 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 125.665 1.45 . . . . 1.0 112.89 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -40.44 144.38 0.24 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 124.879 1.362 . . . . 1.0 111.997 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.0 p -121.42 160.69 23.59 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 124.039 0.837 . . . . 1.0 110.985 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.475 ' HB3' ' HD3' ' A' ' 9' ' ' ARG . 3.4 t80 -119.96 -57.68 1.93 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.578 -1.267 . . . . 1.0 107.578 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.475 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -108.18 164.87 11.92 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 113.269 -1.787 . . . . 1.0 107.152 -179.975 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.485 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.1 m -39.25 -56.5 2.64 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 124.782 1.301 . . . . 1.0 112.095 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.485 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 84.0 Cg_endo -64.83 -93.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 121.252 1.301 . . . . 1.0 111.238 173.048 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.8 t70 35.51 35.12 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 125.411 1.695 . . . . 1.0 109.635 -179.614 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.404 ' N ' ' C ' ' A' ' 11' ' ' PRO . 36.7 t -167.74 -28.79 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 110.399 -3.092 . . . . 1.0 110.37 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -37.62 -52.24 1.21 Allowed 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 123.822 0.849 . . . . 1.0 112.438 179.697 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.8 m -56.51 -61.1 2.65 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.994 -0.743 . . . . 1.0 108.994 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.93 -54.69 5.14 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 124.314 1.008 . . . . 1.0 111.052 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 25' ' ' THR . 17.4 m -49.48 -54.42 17.88 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 113.366 -1.743 . . . . 1.0 107.601 179.473 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.428 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 5.7 ttpm? -50.01 -47.78 52.88 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 179.576 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -19.74 63.1 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 114.972 -1.013 . . . . 1.0 112.489 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.8 mt -92.41 -50.27 5.72 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 114.478 1.288 . . . . 1.0 114.478 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.5 m -105.51 -30.56 2.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 C-N-CA 123.477 0.711 . . . . 1.0 111.293 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.72 -28.12 3.43 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 116.165 1.226 . . . . 1.0 116.165 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -124.5 156.03 37.96 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 114.161 1.171 . . . . 1.0 114.161 -179.341 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.45 72.85 0.72 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 113.803 -1.544 . . . . 1.0 110.218 179.781 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.504 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 7.5 t -128.41 -176.26 3.76 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.745 0.783 . . . . 1.0 110.431 -179.839 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.5 160.33 30.04 Favored Glycine 0 N--CA 1.494 2.515 0 CA-C-N 113.411 -1.722 . . . . 1.0 109.605 179.713 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.85 -172.39 2.86 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.333 1.063 . . . . 1.0 111.127 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.1 t -110.92 114.81 28.41 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 111.482 -2.599 . . . . 1.0 107.398 179.571 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.2 m -139.64 133.25 30.39 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 113.161 -1.836 . . . . 1.0 109.286 -179.781 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 49.22 42.19 21.21 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 113.958 -1.474 . . . . 1.0 108.208 -179.545 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 58.41 14.57 20.67 Favored Glycine 0 N--CA 1.49 2.287 0 CA-C-N 113.745 -1.57 . . . . 1.0 114.871 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.6 mtp-105 -130.45 160.01 35.35 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.112 -1.44 . . . . 1.0 107.112 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.588 ' HB3' HG12 ' A' ' 3' ' ' ILE . 14.6 t -73.38 143.17 46.93 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.136 -1.426 . . . . 1.0 113.381 -179.937 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -129.05 88.18 2.67 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 101.23 -3.619 . . . . 1.0 101.23 178.43 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.497 ' HB3' ' H2 ' ' A' ' 1' ' ' VAL . 4.5 t . . . . . 0 N--CA 1.502 2.134 0 CA-C-O 117.001 -1.476 . . . . 1.0 111.535 -179.482 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 121.757 0.789 . . . . 1.0 111.608 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 7.0 p -70.66 123.63 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-N 113.721 -1.581 . . . . 1.0 108.518 179.664 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.509 HG12 ' HB3' ' A' ' 33' ' ' CYS . 19.1 pt -134.39 165.26 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 N-CA-C 115.148 1.536 . . . . 1.0 115.148 -179.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -53.14 -48.0 59.76 Favored Glycine 0 N--CA 1.478 1.465 0 CA-C-N 111.096 -2.775 . . . . 1.0 111.575 179.847 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -20.51 86.49 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.474 0 O-C-N 125.882 1.578 . . . . 1.0 113.034 -179.917 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -40.0 146.58 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.097 -1.411 . . . . 1.0 112.37 -179.961 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.404 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 5.6 t -110.09 152.36 26.08 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 124.582 1.176 . . . . 1.0 113.465 -179.918 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.404 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 1.8 t80 -125.39 -58.73 1.42 Allowed 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 102.465 -3.161 . . . . 1.0 102.465 179.498 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.04 161.0 20.99 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.376 -1.712 . . . . 1.0 106.376 179.306 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.496 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 73.2 m -30.96 -57.39 0.36 Allowed Pre-proline 0 N--CA 1.506 2.369 0 N-CA-C 114.429 1.27 . . . . 1.0 114.429 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.496 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 83.9 Cg_endo -63.93 -93.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.919 1.746 . . . . 1.0 111.17 173.763 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 t70 36.55 34.12 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 CA-C-O 123.294 1.521 . . . . 1.0 109.375 -179.483 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.422 ' N ' ' C ' ' A' ' 11' ' ' PRO . 54.0 t -169.26 -21.59 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 110.579 -3.009 . . . . 1.0 112.453 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -38.65 -58.51 1.04 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 118.469 0.577 . . . . 1.0 111.64 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.2 t -50.32 -39.64 46.53 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.963 1.414 . . . . 1.0 111.828 179.574 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.16 -48.71 56.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 123.516 0.51 . . . . 1.0 111.137 179.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.0 t -61.94 -32.91 73.37 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.425 -1.324 . . . . 1.0 107.425 179.705 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.416 ' O ' ' N ' ' A' ' 22' ' ' GLY . 24.7 ttmm -65.04 -53.72 41.41 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 105.62 -1.992 . . . . 1.0 105.62 179.594 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -50.26 -35.56 27.54 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 114.181 -1.372 . . . . 1.0 109.189 179.692 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.0 tp -67.66 -60.06 2.84 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 114.824 -1.08 . . . . 1.0 111.669 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.09 -48.48 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 124.253 0.97 . . . . 1.0 113.046 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 133.45 23.98 0.71 Allowed Glycine 0 N--CA 1.492 2.376 0 O-C-N 123.417 0.448 . . . . 1.0 113.484 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -133.46 131.37 39.82 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.481 -0.563 . . . . 1.0 109.481 179.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.18 68.06 0.7 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 124.722 1.264 . . . . 1.0 109.63 179.364 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.6 p -115.37 174.92 5.75 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.482 -1.235 . . . . 1.0 112.895 -179.647 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.51 152.89 8.57 Favored Glycine 0 N--CA 1.489 2.213 0 CA-C-N 113.74 -1.573 . . . . 1.0 111.605 179.72 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 36.8 mtmm -122.71 174.78 6.89 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 113.637 -1.282 . . . . 1.0 108.245 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.2 t -110.17 109.06 19.43 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 105.36 -2.089 . . . . 1.0 105.36 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.2 m -133.07 126.08 31.03 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 112.264 -2.244 . . . . 1.0 108.382 -179.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.3 p30 47.52 41.3 12.86 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 125.907 2.004 . . . . 1.0 112.345 -179.459 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.63 13.77 59.3 Favored Glycine 0 N--CA 1.478 1.435 0 CA-C-N 113.15 -1.841 . . . . 1.0 112.145 -179.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.7 mmt-85 -128.6 161.94 28.45 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.668 -0.864 . . . . 1.0 108.668 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.509 ' HB3' HG12 ' A' ' 3' ' ' ILE . 12.5 t -72.6 143.56 48.18 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.461 -1.296 . . . . 1.0 113.392 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 9.9 t70 -134.16 84.31 2.11 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 125.971 2.045 . . . . 1.0 106.555 179.117 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.503 2.203 0 CA-C-O 118.415 -0.802 . . . . 1.0 110.472 -179.784 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.6 m . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 122.028 0.918 . . . . 1.0 111.644 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.7 p -70.39 121.44 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-N 113.502 -1.681 . . . . 1.0 109.45 179.653 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.592 HG12 ' HB3' ' A' ' 33' ' ' CYS . 15.6 pt -128.19 152.89 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 122.265 1.031 . . . . 1.0 113.719 -179.883 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -46.91 -41.35 13.66 Favored Glycine 0 N--CA 1.489 2.191 0 CA-C-N 111.15 -2.75 . . . . 1.0 112.717 179.864 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.452 HE22 ' HA ' ' A' ' 13' ' ' CYS . 1.2 tm0? -28.46 99.79 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 125.501 1.353 . . . . 1.0 112.215 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -39.96 147.36 0.09 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 124.824 1.327 . . . . 1.0 113.711 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.462 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 5.2 t -113.77 157.74 21.87 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.998 -1.001 . . . . 1.0 110.985 -179.95 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.462 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.1 t80 -119.65 -62.79 1.45 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 103.189 -2.893 . . . . 1.0 103.189 179.731 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -124.97 171.45 10.2 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.141 -1.39 . . . . 1.0 107.946 179.65 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.443 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 61.1 m -31.69 -56.34 0.44 Allowed Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 125.07 1.482 . . . . 1.0 114.045 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.443 ' CD ' ' HB2' ' A' ' 10' ' ' SER . 63.1 Cg_endo -68.94 -94.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.674 1.583 . . . . 1.0 113.748 173.058 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.2 t70 38.17 32.54 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 CA-C-O 123.158 1.456 . . . . 1.0 109.806 -179.461 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.452 ' HA ' HE22 ' A' ' 5' ' ' GLN . 22.3 t -165.44 -25.74 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 111.341 -2.663 . . . . 1.0 111.618 -179.912 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -38.79 -59.83 0.91 Allowed 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 123.131 0.572 . . . . 1.0 112.466 179.717 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.6 m -45.13 -43.85 10.14 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 124.805 1.316 . . . . 1.0 110.987 179.609 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.02 -50.85 60.77 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.954 -1.021 . . . . 1.0 109.817 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.1 m -54.0 -34.58 60.24 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.755 -1.111 . . . . 1.0 110.276 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -70.65 -51.19 29.52 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.012 -1.848 . . . . 1.0 106.012 179.425 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -70.73 -8.95 55.98 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 113.653 -1.612 . . . . 1.0 113.049 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.72 -51.56 3.16 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 123.4 0.437 . . . . 1.0 110.096 -179.78 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.8 t -104.91 -35.73 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 114.727 -1.124 . . . . 1.0 112.437 -179.319 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 139.42 -30.56 2.41 Favored Glycine 0 N--CA 1.485 1.931 0 CA-C-O 118.676 -1.069 . . . . 1.0 114.667 179.779 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.51 ' HD3' ' N ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -123.01 150.65 42.75 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 114.424 1.268 . . . . 1.0 114.424 -179.529 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.5 70.49 0.64 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 113.504 -1.68 . . . . 1.0 112.022 179.76 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.9 t -124.12 -174.79 3.08 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.931 0.872 . . . . 1.0 110.791 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.38 -178.75 16.32 Favored Glycine 0 N--CA 1.492 2.425 0 CA-C-N 113.007 -1.906 . . . . 1.0 112.125 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.497 ' NZ ' ' H ' ' A' ' 28' ' ' CYS . 0.2 OUTLIER -143.46 170.65 15.4 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.78 -1.21 . . . . 1.0 108.245 179.94 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.497 ' H ' ' NZ ' ' A' ' 27' ' ' LYS . 49.4 t -108.87 115.27 29.76 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.203 -1.777 . . . . 1.0 106.203 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.415 ' CB ' ' HB2' ' A' ' 34' ' ' ASP . 95.3 m -132.33 128.48 37.78 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 113.142 -1.845 . . . . 1.0 112.28 -179.632 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 46.67 40.52 8.71 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 113.571 -1.649 . . . . 1.0 110.312 -179.707 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.55 28.22 64.78 Favored Glycine 0 N--CA 1.487 2.07 0 CA-C-N 113.544 -1.662 . . . . 1.0 112.705 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.6 mtt-85 -136.83 163.74 29.94 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.3 -1.741 . . . . 1.0 106.3 179.682 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.592 ' HB3' HG12 ' A' ' 3' ' ' ILE . 30.5 t -72.76 144.84 47.46 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 118.612 -1.235 . . . . 1.0 112.777 179.682 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 11.3 t70 -129.95 81.64 2.02 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 105.595 -2.002 . . . . 1.0 105.595 178.722 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.502 2.145 0 C-N-CA 119.259 -0.976 . . . . 1.0 110.305 -179.496 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 121.214 0.531 . . . . 1.0 111.728 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 6.7 p -70.79 123.48 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-N 114.777 -1.101 . . . . 1.0 108.651 179.603 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.497 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 24.1 pt -137.17 165.3 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 N-CA-C 116.575 2.065 . . . . 1.0 116.575 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.77 -48.41 36.87 Favored Glycine 0 N--CA 1.477 1.422 0 CA-C-N 109.94 -3.3 . . . . 1.0 111.347 179.643 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.424 ' HB3' HG13 ' A' ' 3' ' ' ILE . 3.6 tp-100 -23.44 89.77 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 O-C-N 125.787 1.522 . . . . 1.0 113.083 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 -47.69 148.66 1.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.409 -1.269 . . . . 1.0 110.838 179.85 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 8.7 t -117.11 156.36 27.74 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.982 1.104 . . . . 1.0 113.982 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.45 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 2.9 t80 -123.36 -56.76 1.7 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 105.104 -2.184 . . . . 1.0 105.104 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.468 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -116.32 152.13 34.5 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 112.879 -1.964 . . . . 1.0 108.102 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.463 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 74.4 m -22.67 -59.07 0.1 OUTLIER Pre-proline 0 N--CA 1.506 2.369 0 N-CA-C 115.581 1.697 . . . . 1.0 115.581 -179.857 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.47 ' HA ' ' CD1' ' A' ' 14' ' ' TYR . 98.6 Cg_endo -65.67 -91.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.45 1.433 . . . . 1.0 113.223 174.161 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.407 ' H ' ' HG2' ' A' ' 11' ' ' PRO . 6.4 t70 41.0 30.74 0.11 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 123.023 1.392 . . . . 1.0 109.166 -179.56 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.3 t -167.3 -24.88 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 112.294 -2.23 . . . . 1.0 112.737 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.47 ' CD1' ' HA ' ' A' ' 11' ' ' PRO . 3.2 m-85 -38.93 -59.59 0.95 Allowed 'General case' 0 N--CA 1.505 2.315 0 C-N-CA 122.947 0.499 . . . . 1.0 111.81 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 p -48.75 -39.88 26.62 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 125.01 1.444 . . . . 1.0 111.776 179.63 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.404 ' HA ' ' HZ3' ' A' ' 19' ' ' LYS . . . -70.19 -50.38 40.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 123.999 0.812 . . . . 1.0 110.662 179.855 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.7 t -60.09 -30.01 68.96 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.537 -0.912 . . . . 1.0 108.537 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -70.44 -49.87 44.26 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.884 -1.154 . . . . 1.0 107.884 179.211 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HZ3' ' HA ' ' A' ' 16' ' ' ALA . 7.1 ttpm? -70.4 -15.11 62.8 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.102 -1.863 . . . . 1.0 113.06 -179.918 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.8 mt -108.41 -43.36 4.35 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 113.852 1.056 . . . . 1.0 113.852 -179.745 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.4 t -101.46 -35.29 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-N 114.802 -1.09 . . . . 1.0 110.081 -179.724 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.23 -32.14 2.9 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 120.69 -0.767 . . . . 1.0 114.106 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -125.72 153.41 43.97 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 113.722 1.008 . . . . 1.0 113.722 -179.465 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.79 74.59 0.6 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 113.818 -1.537 . . . . 1.0 113.556 -179.735 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.432 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 0.9 OUTLIER -120.7 -178.27 3.68 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.705 -1.134 . . . . 1.0 111.333 179.906 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.71 163.1 11.83 Favored Glycine 0 N--CA 1.492 2.432 0 CA-C-N 114.351 -1.295 . . . . 1.0 113.35 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -131.53 166.13 22.05 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 113.636 -1.282 . . . . 1.0 108.167 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.6 t -103.32 94.64 5.61 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 103.138 -2.912 . . . . 1.0 103.138 179.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 83.1 m -112.97 115.1 27.86 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 109.984 -3.28 . . . . 1.0 112.482 -179.328 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 48.75 41.11 17.48 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 111.453 -2.612 . . . . 1.0 108.739 -179.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.0 28.31 72.61 Favored Glycine 0 N--CA 1.482 1.74 0 CA-C-N 113.364 -1.743 . . . . 1.0 112.434 -179.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -137.6 157.25 46.91 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 106.173 -1.788 . . . . 1.0 106.173 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.497 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 34.5 t -72.78 140.74 47.92 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.451 -1.3 . . . . 1.0 113.913 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 25.6 t70 -135.55 86.56 2.25 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 125.382 1.676 . . . . 1.0 108.54 178.729 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.432 ' SG ' ' C ' ' A' ' 25' ' ' THR . 8.1 t . . . . . 0 N--CA 1.5 2.058 0 CA-C-O 116.292 -1.813 . . . . 1.0 110.58 -179.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 2' ' ' VAL . 19.5 t . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 108.497 -0.927 . . . . 1.0 108.497 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.445 ' N ' HG12 ' A' ' 1' ' ' VAL . 6.2 p -71.26 117.57 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.299 -1.0 . . . . 1.0 108.299 179.377 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.573 HG12 ' HB3' ' A' ' 33' ' ' CYS . 27.8 pt -131.47 164.53 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 113.7 1.0 . . . . 1.0 113.7 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.99 44.88 3.43 Favored Glycine 0 C--O 1.21 -1.393 0 CA-C-N 112.595 -2.093 . . . . 1.0 112.124 -179.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -100.27 104.94 16.45 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 102.699 -3.074 . . . . 1.0 102.699 179.59 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -39.01 129.39 1.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 113.229 -1.805 . . . . 1.0 112.7 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 8' ' ' TYR . 24.0 t -120.93 163.09 18.77 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.481 -1.691 . . . . 1.0 112.372 179.794 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.519 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 13.2 t80 -119.8 -64.8 1.22 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 104.855 -2.276 . . . . 1.0 104.855 179.676 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.448 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -119.62 163.69 16.99 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 112.468 -2.151 . . . . 1.0 111.897 179.736 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.3 m -16.49 -62.79 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.231 0 N-CA-C 117.566 2.432 . . . . 1.0 117.566 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.426 ' HG2' ' H ' ' A' ' 12' ' ' ASP . 71.3 Cg_endo -68.48 -92.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 121.343 1.362 . . . . 1.0 112.213 178.837 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.441 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 4.1 t0 36.63 35.18 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 123.502 1.62 . . . . 1.0 109.961 -179.671 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.0 t -168.3 -23.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 110.761 -2.927 . . . . 1.0 111.764 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -38.35 -56.53 1.23 Allowed 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 123.955 0.902 . . . . 1.0 113.225 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.0 t -46.08 -53.26 10.56 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 124.685 1.24 . . . . 1.0 109.326 179.496 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.07 -39.62 90.58 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 113.73 -1.577 . . . . 1.0 112.292 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 25' ' ' THR . 60.0 m -69.14 -28.68 66.66 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.842 -1.072 . . . . 1.0 108.576 179.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -71.05 -52.78 17.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.061 -1.459 . . . . 1.0 107.061 179.319 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -71.04 -19.86 62.45 Favored 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 118.091 -1.444 . . . . 1.0 114.767 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -105.92 -33.79 7.83 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 113.313 0.857 . . . . 1.0 113.313 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 t -106.89 -30.97 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 123.722 0.638 . . . . 1.0 110.07 -179.563 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.67 -34.91 2.77 Favored Glycine 0 N--CA 1.49 2.249 0 O-C-N 123.855 0.722 . . . . 1.0 114.584 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -135.81 169.29 17.8 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 113.245 0.831 . . . . 1.0 113.245 -179.363 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.86 69.33 0.69 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 113.683 -1.598 . . . . 1.0 110.797 179.521 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.5 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 4.5 t -121.67 179.01 4.61 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.61 -179.818 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.97 175.06 18.9 Favored Glycine 0 N--CA 1.493 2.459 0 CA-C-N 113.292 -1.776 . . . . 1.0 111.965 179.847 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.94 175.65 9.04 Favored 'General case' 0 C--O 1.205 -1.277 0 CA-C-O 122.074 0.94 . . . . 1.0 112.73 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 24.7 t -114.63 109.44 18.23 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 112.396 -2.183 . . . . 1.0 105.429 -179.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.9 m -126.47 126.44 43.76 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 112.103 -2.317 . . . . 1.0 110.952 -179.501 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 m120 45.18 40.86 5.3 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 113.464 -1.698 . . . . 1.0 111.52 -179.52 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.1 27.42 68.89 Favored Glycine 0 N--CA 1.485 1.942 0 CA-C-N 113.415 -1.72 . . . . 1.0 112.412 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.6 mtt-85 -136.63 160.54 38.5 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.385 -1.709 . . . . 1.0 106.385 179.796 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.573 ' HB3' HG12 ' A' ' 3' ' ' ILE . 38.9 t -73.06 144.52 47.04 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.609 -1.237 . . . . 1.0 113.076 179.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 2' ' ' VAL . 32.6 t70 -133.89 76.45 1.66 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.048 -2.204 . . . . 1.0 105.048 178.742 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.1 t . . . . . 0 N--CA 1.501 2.1 0 CA-C-O 117.761 -1.114 . . . . 1.0 111.34 -179.341 . . . . . . . . 0 0 . 1 stop_ save_